<SEC-DOCUMENT>0001078782-17-001585.txt : 20171114
<SEC-HEADER>0001078782-17-001585.hdr.sgml : 20171114
<ACCEPTANCE-DATETIME>20171114163445
ACCESSION NUMBER:		0001078782-17-001585
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		45
CONFORMED PERIOD OF REPORT:	20170930
FILED AS OF DATE:		20171114
DATE AS OF CHANGE:		20171114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SIGMA LABS, INC.
		CENTRAL INDEX KEY:			0000788611
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS MANUFACTURING INDUSTRIES [3990]
		IRS NUMBER:				820404220
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38015
		FILM NUMBER:		171202133

	BUSINESS ADDRESS:	
		STREET 1:		3900 PASEO DEL SOL
		CITY:			SANTE FE
		STATE:			NM
		ZIP:			87507
		BUSINESS PHONE:		(505) 438-2576

	MAIL ADDRESS:	
		STREET 1:		3900 PASEO DEL SOL
		CITY:			SANTE FE
		STATE:			NM
		ZIP:			87507

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FRAMEWAVES INC
		DATE OF NAME CHANGE:	20010130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MESSIDOR LTD
		DATE OF NAME CHANGE:	20010122
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>f10q093017_10q.htm
<DESCRIPTION>FORM 10-Q QUARTERLY REPORT
<TEXT>
<HTML>
<!-- Produced by Justeene Blankenship using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2017 [PPXAC8S3T1P2VKXCJE4E]. www.edgarsuite.com -->
<HEAD>
<TITLE>Form 10-Q Quarterly Report</TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:36pt;width:540pt><P align=center style='font:10pt Times New Roman;margin:0'><B>UNITED STATES </B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>Washington, D.C. 20549</P>
<P align=center style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>FORM 10-Q</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>(Mark One)</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'>[X]</KBD><KBD style=margin-left:36pt></KBD>QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>For the quarterly period ended September 30, 2017</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>OR</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'>[ &nbsp;&nbsp;]</KBD><KBD style=margin-left:36pt></KBD>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>Commission file number: 001-38015</P>
<P align=center style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR><TD valign=top style='width:540pt;border-bottom:1pt solid #000000'><P align=center style='font:14pt Times New Roman;margin:0'><B>Sigma Labs, Inc.</B></P>
</TD></TR>
<TR><TD valign=top style=width:540pt><P align=center style='font:10pt Times New Roman;margin:0'>(Exact name of registrant as specified in its charter)</P>
</TD></TR>
</TABLE>
<P align=center style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR><TD valign=top style='width:282.9pt;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>NEVADA</P>
</TD><TD valign=top style=width:11.8pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style='width:245.3pt;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>27-1865814</P>
</TD></TR>
<TR><TD valign=top style=width:282.9pt><P align=center style='font:10pt Times New Roman;margin:0'>(State or other jurisdiction of incorporation or</P>
<P align=center style='font:10pt Times New Roman;margin:0'>organization)</P>
</TD><TD valign=top style=width:11.8pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:245.3pt><P align=center style='font:10pt Times New Roman;margin:0'>(IRS Employer Identification No.)</P>
</TD></TR>
</TABLE>
<P align=center style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR><TD valign=top style=width:540pt><P align=center style='font:10pt Times New Roman;margin:0'>3900 Paseo del Sol</P>
</TD></TR>
<TR><TD valign=top style='width:540pt;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>Santa Fe, NM 87507</P>
</TD></TR>
<TR><TD valign=top style=width:540pt><P align=center style='font:10pt Times New Roman;margin:0'>(Address of principal executive offices)</P>
</TD></TR>
</TABLE>
<P align=center style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR><TD valign=top style='width:540pt;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>(505) 438-2576</P>
</TD></TR>
<TR><TD valign=top style=width:540pt><P align=center style='font:10pt Times New Roman;margin:0'>(Registrant&#8217;s telephone number)</P>
</TD></TR>
</TABLE>
<P align=center style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR><TD valign=top style=width:540pt><P align=center style='font:10pt Times New Roman;margin:0'>(Former Name or Former Address, if Changed Since Last Report</P>
</TD></TR>
</TABLE>
<P align=center style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</P>
<P align=right style='font:10pt Times New Roman;margin:0'>Yes [X] No [ &nbsp;&nbsp;]</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).</P>
<P align=right style='font:10pt Times New Roman;margin:0'>Yes [X] No [ &nbsp;&nbsp;]</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR><TD valign=top style=width:184.5pt><P style='font:10pt Times New Roman;margin:0'>Large accelerated filer</P>
</TD><TD valign=top style=width:86.25pt><P style='font:10pt Times New Roman;margin:0'>[ &nbsp;&nbsp;]</P>
</TD><TD valign=top style=width:137.25pt><P style='font:10pt Times New Roman;margin:0'>Accelerated Filer</P>
</TD><TD valign=top style=width:86.25pt><P style='font:10pt Times New Roman;margin:0'>[ &nbsp;&nbsp;]</P>
</TD></TR>
<TR><TD valign=top style=width:184.5pt><P style='font:10pt Times New Roman;margin:0'>Non-accelerated filer (do not check if a smaller reporting company)</P>
</TD><TD valign=top style=width:86.25pt><P style='font:10pt Times New Roman;margin:0'>[ &nbsp;&nbsp;]</P>
</TD><TD valign=top style=width:137.25pt><P style='font:10pt Times New Roman;margin:0'>Smaller reporting company</P>
</TD><TD valign=top style=width:86.25pt><P style='font:10pt Times New Roman;margin:0'>[X]</P>
</TD></TR>
<TR><TD valign=top style=width:184.5pt><P style='font:10pt Times New Roman;margin:0'>Emerging growth company</P>
</TD><TD valign=top style=width:86.25pt><P style='font:10pt Times New Roman;margin:0'>[ &nbsp;&nbsp;]</P>
</TD><TD valign=top style=width:137.25pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:86.25pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ &nbsp;&nbsp;]</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ &nbsp;&nbsp;] No [X]</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date: As of November 10, 2017, the issuer had 4,718,651 shares of common stock outstanding.</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P style='font:10pt Times New Roman;margin:0'><A name=eolPage2 />&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>SIGMA LABS, INC.</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B> </B>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>For the quarter ended September 30, 2017</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B> </B>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>FORM 10-Q</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B> </B>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>TABLE OF CONTENTS</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR><TD valign=top style=width:495pt><P style='font:10pt Times New Roman;margin:0'>PART I</P>
</TD><TD valign=bottom style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#FFFFFF style=width:495pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=bottom bgcolor=#FFFFFF style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:495pt><P style='font:10pt Times New Roman;margin:0'>ITEM 1. FINANCIAL STATEMENTS</P>
</TD><TD valign=bottom style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>3</P>
</TD></TR>
<TR><TD valign=top bgcolor=#FFFFFF style=width:495pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=bottom bgcolor=#FFFFFF style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:495pt><P style='font:10pt Times New Roman;margin:0'>ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</P>
</TD><TD valign=top style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>11</P>
</TD></TR>
<TR><TD valign=top bgcolor=#FFFFFF style=width:495pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=bottom bgcolor=#FFFFFF style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:495pt><P style='font:10pt Times New Roman;margin:0'>ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</P>
</TD><TD valign=bottom style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>18</P>
</TD></TR>
<TR><TD valign=top bgcolor=#FFFFFF style=width:495pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=bottom bgcolor=#FFFFFF style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:495pt><P style='font:10pt Times New Roman;margin:0'>ITEM 4. CONTROLS AND PROCEDURES</P>
</TD><TD valign=bottom style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>18</P>
</TD></TR>
<TR><TD valign=top bgcolor=#FFFFFF style=width:495pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=bottom bgcolor=#FFFFFF style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:495pt><P style='font:10pt Times New Roman;margin:0'>PART II</P>
</TD><TD valign=bottom style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#FFFFFF style=width:495pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=bottom bgcolor=#FFFFFF style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:495pt><P style='font:10pt Times New Roman;margin:0'>ITEM 1. LEGAL PROCEEDINGS</P>
</TD><TD valign=bottom style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>19</P>
</TD></TR>
<TR><TD valign=top bgcolor=#FFFFFF style=width:495pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=bottom bgcolor=#FFFFFF style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:495pt><P style='font:10pt Times New Roman;margin:0'>ITEM 1A. RISK FACTORS</P>
</TD><TD valign=bottom style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>19</P>
</TD></TR>
<TR><TD valign=top bgcolor=#FFFFFF style=width:495pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=bottom bgcolor=#FFFFFF style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:495pt><P style='font:10pt Times New Roman;margin:0'>ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.</P>
</TD><TD valign=bottom style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>19</P>
</TD></TR>
<TR><TD valign=top bgcolor=#FFFFFF style=width:495pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=bottom bgcolor=#FFFFFF style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:495pt><P style='font:10pt Times New Roman;margin:0'>ITEM 3. DEFAULTS UPON SENIOR SECURITIES</P>
</TD><TD valign=bottom style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>19</P>
</TD></TR>
<TR><TD valign=top bgcolor=#FFFFFF style=width:495pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=bottom bgcolor=#FFFFFF style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:495pt><P style='font:10pt Times New Roman;margin:0'>ITEM 4. MINE SAFETY DISCLOSURES</P>
</TD><TD valign=bottom style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>19</P>
</TD></TR>
<TR><TD valign=top bgcolor=#FFFFFF style=width:495pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=bottom bgcolor=#FFFFFF style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:495pt><P style='font:10pt Times New Roman;margin:0'>ITEM 5. OTHER INFORMATION</P>
</TD><TD valign=bottom style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>19</P>
</TD></TR>
<TR><TD valign=top bgcolor=#FFFFFF style=width:495pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=bottom bgcolor=#FFFFFF style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:495pt><P style='font:10pt Times New Roman;margin:0'>ITEM 6. EXHIBITS</P>
</TD><TD valign=bottom style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>19</P>
</TD></TR>
<TR><TD valign=top bgcolor=#FFFFFF style=width:495pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=bottom bgcolor=#FFFFFF style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:495pt><P style='font:10pt Times New Roman;margin:0'>SIGNATURES</P>
</TD><TD valign=bottom style=width:29.25pt><P align=right style='font:10pt Times New Roman;margin:0'>20</P>
</TD></TR>
</TABLE>
<P align=center style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'> <A name=eolPage3 />&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'> <A name=FIS_PART_I />&nbsp;</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>2</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'><A name=V438343_10Q_HTM_A_018 /><B>PART I</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B> </B><A name=FIS_FINANCIAL_STATEMENTS />&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><A name=V438343_10Q_HTM_A_019 /><B>ITEM 1. FINANCIAL STATEMENTS.</B></P>
<P style='font:10pt Times New Roman;margin:0'><A name=FIS_BALANCE_SHEET />&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:499.5pt><TR style=height:7.2pt><TD colspan=5 valign=bottom style=width:499.5pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'><B>Sigma Labs, Inc.</B></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=5 valign=bottom style=width:499.5pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'><B>Condensed Balance Sheets</B></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=5 valign=bottom style=width:499.5pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'><B>(Unaudited)</B></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:16pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:16pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:16pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.5pt;white-space:nowrap;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><B>September 30, </B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>2017</B></P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.7pt;white-space:nowrap;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><B>December 31, </B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>2016</B></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:16pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0'><B>ASSETS</B></P>
</TD><TD valign=bottom style=width:16pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0'><B>Current Assets:</B></P>
</TD><TD valign=bottom style=width:16pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Cash</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>2,691,487</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>398,391</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Accounts Receivable, net</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>105,725</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>288,236</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Notes Receivable, net</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>775,267</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Inventory</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>188,907</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>187,241</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Prepaid Assets</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>49,896</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>36,056</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:17.1pt'><B>Total Current Assets</B></P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.5pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,811,282</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.7pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>909,924</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0'><B>Other Assets:</B></P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Property and Equipment, net</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>446,449</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>564,933</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Intangible Assets, net</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>261,660</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>226,450</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Investment in Joint Venture</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>500</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>500</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Prepaid Stock Compensation</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.5pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>49,528</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.7pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>167,562</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:17.1pt'><B>Total Other Assets</B></P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>758,137</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.7pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>959,445</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.5pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.7pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0'><B>TOTAL ASSETS</B></P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:78.5pt;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>4,569,419</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:78.7pt;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>1,869,369</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0'><B>LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</B></P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0'><B>Current Liabilities:</B></P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Accounts Payable</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>114,747</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>112,175</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Notes Payable, net of original issue discount of $5,091 at </P>
<P style='font:10pt Times New Roman;margin:0;margin-left:17.1pt'>September 30, 2017 and net of original issue discount of $69,703 </P>
<P style='font:10pt Times New Roman;margin:0;margin-left:17.1pt'>and net of debt discount $358,280 at December 31, 2016</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>994,909</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>561,834</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Accrued Expenses</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>219,570</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>125,116</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:17.1pt'><B>Total Current Liabilities</B></P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.5pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>1,329,226</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.7pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>799,125</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0'><B>Long-Term Liabilities</B></P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Derivative Liability</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.5pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.7pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>93,206</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:17.1pt'><B>Total Long-Term Liability</B></P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.5pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.7pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>93,206</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0'><B>TOTAL LIABILITIES</B></P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>1,329,226</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>892,331</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0'><B>Stockholders&#8217; Equity</B></P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Preferred Stock, $0.001 par; 10,000,000 shares authorized;</P>
<P style='font:10pt Times New Roman;margin:0;margin-left:17.1pt'>None issued and outstanding</P>
</TD><TD valign=bottom style=width:16pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Common Stock, $0.001 par; 7,500,000 shares authorized;</P>
<P style='font:10pt Times New Roman;margin:0;margin-left:17.1pt'>4,577,651 and 3,133,789 issued and outstanding at</P>
<P style='font:10pt Times New Roman;margin:0;margin-left:17.1pt'>September 30, 2017 and December 31, 2016, respectively</P>
</TD><TD valign=bottom style=width:16pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>4,578</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>3,135</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Additional Paid-In Capital</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>16,046,185</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>10,734,857</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Accumulated Deficit</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>(12,810,570)</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>(9,760,954)</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:17.1pt'><B>Total Stockholders&#8217; Equity</B></P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,240,193</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:78.7pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>977,038</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:310.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:78.7pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:9pt><TD valign=bottom style=width:310.5pt><P style='font:10pt Times New Roman;margin:0'><B>TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY </B></P>
</TD><TD valign=bottom style=width:16pt><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:78.5pt;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>4,569,419</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:78.7pt;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>1,869,369</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>The accompanying notes are an integral part of these financial statements</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>3</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><TABLE align=center style=border-collapse:collapse;width:533.3pt><TR style=height:7.2pt><TD colspan=9 valign=bottom style=width:533.3pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'><B>Sigma Labs, Inc.</B></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=9 valign=bottom style=width:533.3pt><P align=center style='font:10pt Times New Roman;margin:0'><B>Condensed Statements of Operations</B></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=9 valign=bottom style=width:533.3pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'><B>(Unaudited)</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=3 valign=bottom style='width:123.6pt;white-space:nowrap;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><B>Three Months Ended</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>September 30</B></P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=3 valign=bottom style='width:133.45pt;white-space:nowrap;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><B>Nine Months Ended</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>September 30,</B></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:57pt;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><B>2017</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:50.8pt;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>2016</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:57.5pt;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><B>2017</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:60.15pt;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><B>2016</B></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0'><B>Revenues</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style=width:57pt><P align=right style='font:10pt Times New Roman;margin:0'>78,046</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style=width:50.8pt><P align=right style='font:10pt Times New Roman;margin:0'>189,952</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'>518,802</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style=width:60.15pt><P align=right style='font:10pt Times New Roman;margin:0'>642,230</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0'><B>COST OF REVENUE</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:57pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>81,214</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:50.8pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>69,259</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:57.5pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>267,160</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:60.15pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>207,744</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0'><B>GROSS PROFIT</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt><P align=right style='font:10pt Times New Roman;margin:0'>(3,168)</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt><P align=right style='font:10pt Times New Roman;margin:0'>120,693</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'>251,642</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt><P align=right style='font:10pt Times New Roman;margin:0'>434,486</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0'><B>EXPENSES:</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Other General and Administration</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt><P align=right style='font:10pt Times New Roman;margin:0'>576,855</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt><P align=right style='font:10pt Times New Roman;margin:0'>437,870</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'>1,814,843</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt><P align=right style='font:10pt Times New Roman;margin:0'>1,314,055</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Payroll Expense</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt><P align=right style='font:10pt Times New Roman;margin:0'>295,890</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt><P align=right style='font:10pt Times New Roman;margin:0'>259,010</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'>973,172</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt><P align=right style='font:10pt Times New Roman;margin:0'>727,494</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Stock-Based Compensation</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt><P align=right style='font:10pt Times New Roman;margin:0'>199,225</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt><P align=right style='font:10pt Times New Roman;margin:0'>105,641</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'>505,630</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt><P align=right style='font:10pt Times New Roman;margin:0'>236,554</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Research and Development</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt><P align=right style='font:10pt Times New Roman;margin:0'>57,947</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt><P align=right style='font:10pt Times New Roman;margin:0'>37,526</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'>225,562</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt><P align=right style='font:10pt Times New Roman;margin:0'>88,504</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0;margin-left:17.1pt'><B>Total Expenses</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:57pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>1,129,917</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:50.8pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>840,047</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:57.5pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,519,207</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:60.15pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>2,366,607</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0'><B>OTHER INCOME (EXPENSE)</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Interest Income</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt><P align=right style='font:10pt Times New Roman;margin:0'>13,675</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt><P align=right style='font:10pt Times New Roman;margin:0'>35</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'>26,616</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt><P align=right style='font:10pt Times New Roman;margin:0'>288</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Other Income- State Incentives</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt><P align=right style='font:10pt Times New Roman;margin:0'>2,500</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'>154,568</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Other Income-Decrease in fair value of derivative </P>
<P style='font:10pt Times New Roman;margin:0;margin-left:17.1pt'>liabilities</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'>93,206</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Other Expense &#8211;&nbsp;Debt discount amortization</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'> &nbsp;(56,441)</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0;margin-left:17.1pt'><B>Total Other Income</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:57pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>16,175</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:50.8pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>35</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:57.5pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>217,949</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:60.15pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>288</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'><B>LOSS BEFORE PROVISION FOR INCOME TAXES</B></P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>(1,116,910)</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>(719,320)</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>(3,049,616)</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>(1,931,833)</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'><B>Provision for income Taxes</B></P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:57pt;white-space:nowrap;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:50.8pt;white-space:nowrap;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:57.5pt;white-space:nowrap;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:60.15pt;white-space:nowrap;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'><B>Net Loss</B></P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:57pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>(1,116,910)</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:50.8pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>(719,320)</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:57.5pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>(3,049,616)</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:60.15pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>(1,931,833)</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'><B>Net Loss per Common Share</B> &#8211;&nbsp;<B>Basic and Diluted</B></P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:57pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>(0.24)</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:50.8pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>(0.23)</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:57.5pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>(0.70)</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:60.15pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>(0.62)</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'><B>Weighted Average Number of Shares</B></P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:50.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:57.5pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:60.15pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:244.65pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'><B>Outstanding</B> &#8211;&nbsp;<B>Basic and Diluted</B></P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:57pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>4,574,460</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:50.8pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,129,675</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:57.5pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>4,330,565</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:60.15pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,121,821</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>The accompanying notes are an integral part of these financial statements</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>4</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><TABLE align=center style=border-collapse:collapse;width:530.6pt><TR style=height:7.2pt><TD colspan=5 valign=bottom style=width:530.6pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'><B>Sigma Labs, Inc. </B></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=5 valign=bottom style=width:530.6pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'><B>Condensed Statements of Cash Flows</B></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=5 valign=bottom style=width:530.6pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'><B>(Unaudited)</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=3 valign=bottom style='width:141.3pt;white-space:nowrap;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><B>Nine Months ended</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>September 30,</B></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:59pt;white-space:nowrap;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><B>2017</B></P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:66.5pt;white-space:nowrap;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><B>2016</B></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0'><B>OPERATING ACTIVITIES</B></P>
</TD><TD valign=bottom style=width:15.8pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0'><B>Net Loss</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>(3,049,616)</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>(1,931,833)</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0'><B>Adjustments to reconcile Net Income (Loss) to Net Cash used in operating activities:</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0'><B>Noncash Expenses:</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Amortization &#8211;&nbsp;Patents</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>2,289</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>6,526</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Depreciation</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>134,865</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>131,879</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Stock Compensation</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>506,994</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>240,756</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Revaluation of derivative liability and debt discount related to notes payable</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>(93,206)</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:16.65pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Note Payable original issue discount</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>74,794</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Note Payable debt discount amortization</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>56,441</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0'><B>Change in assets and liabilities:</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Accounts Receivable</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>182,511</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>160,623</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Inventory</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>(1,666)</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>(64,530)</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Prepaid Assets</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>(13,840)</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>4,590</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Accounts Payable</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>2,572</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>104,824</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Notes Payable</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>301,839</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Accrued Expenses</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>94,454</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>24,799</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:17.1pt'><B>NET CASH USED IN OPERATING ACTIVITIES</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:59pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>(1,801,569)</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:66.5pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>(1,322,366)</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0'><B>INVESTING ACTIVITIES</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Purchase of Furniture and Equipment</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>(16,381)</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>(26,907)</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Purchase of Intangible Assets</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>(37,498)</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>(61,556)</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Notes Receivable</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>(775,267)</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Investment in Joint Venture</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>8,617</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Loss on Investment in Joint Venture</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:59pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:66.5pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>105</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:17.1pt'><B>NET CASH USED IN INVESTING ACTIVITIES</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>(829,146)</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>(79,741)</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'><B>FINANCING ACTIVITIES</B></P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Proceeds from issuance of common stock and warrants</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>5,225,650</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Amendment to Warrant Agreements</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:59pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>(301,839)</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:66.5pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0;margin-left:17.1pt'><B>NET CASH PROVIDED BY FINANCING ACTIVITIES</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:59pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>4,923,811</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:66.5pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0'><B>NET CASH DECREASE FOR PERIOD</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>2,293,096</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>(1,402,107)</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0'><B>CASH AT BEGINNING OF PERIOD</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:59pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>398,391</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:66.5pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>1,539,809</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:59pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:66.5pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0'><B>CASH AT END OF PERIOD</B></P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:59pt;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>2,691,487</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:66.5pt;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>137,702</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'><B>Supplemental Disclosure of Cash Flow Information:</B></P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>Cash paid during the period for:</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Interest</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:59pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>50,418</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:66.5pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Income Taxes</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:59pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:66.5pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'><B>Supplemental Schedule of Noncash Investing and Financing Activities:</B></P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:59pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:66.5pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Issuance of Common Stock for services</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:59pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>85,408</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:66.5pt;white-space:nowrap;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>152,265</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:373.5pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0;margin-left:8.1pt'>Writeoff of Debt Discount</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:59pt;white-space:nowrap;border-top:3px double #000000;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>(301,839)</P>
</TD><TD valign=bottom style=width:15.8pt;white-space:nowrap><P align=right style='font:10pt Times New Roman;margin:0'>$</P>
</TD><TD valign=bottom style='width:66.5pt;white-space:nowrap;border-top:3px double #000000;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>-</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>The accompanying notes are an integral part of these financial statements</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>5</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0;text-indent:-36pt;margin-left:36pt'><B>SIGMA LABS, INC.</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>September 30, 2017</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>NOTE 1 &#8211;&nbsp;Summary of Significant Accounting Policies</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>Nature of Business &#8211;&nbsp;</B>On September 13, 2010 Sigma Labs, Inc., formerly named Framewaves, Inc., a Nevada corporation, acquired 100% of the shares of B6 Sigma, Inc. by exchanging 6.67 shares of Framewaves, Inc. restricted common stock for each issued and outstanding share of B6 Sigma, Inc. The acquisition has been accounted for as a &#8220;reverse merger&#8221; and, accordingly, the operations of Framewaves, Inc. prior to the date of acquisition have been eliminated. Unless otherwise indicated or the context otherwise requires, the term &#8220;B6 Sigma&#8221; refers to B6 Sigma, Inc., a Delaware corporation, which, until the short-form merger referenced below, was our wholly-owned, operating company acquired in September 2010; the terms the &#8220;Company,&#8221; &#8220;Sigma,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to Sigma Labs, Inc., together with B6 Sigma, Inc. Prior to December 29, 2015, we conducted substantially all of our operations through B6 Sigma. On December 29, 2015, we completed a short-form merger of B6 Sigma into Sigma. As a result, B6 Sigma became part of Sigma and no longer exists as a subsidiary.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>B6 Sigma, Inc., incorporated February 5, 2010, was founded by a group of scientists, engineers and businessmen to develop and commercialize novel and unique manufacturing and materials technologies. The Company believes that some of these technologies will fundamentally redefine conventional quality assurance and process control practices by embedding them into the manufacturing processes in real time, enabling process intervention and ultimately leading to closed loop process control. The Company anticipates that its core technologies will allow its clientele to combine advanced manufacturing quality assurance and process control protocols with novel materials to achieve breakthrough product potential in many industries including aerospace, defense, oil and gas, bio-medical, and power generation.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>Basis of Presentation</B> &#8211;&nbsp;The accompanying financial statements have been prepared by the Company in accordance with Article 8 of U.S. Securities and Exchange Commission Regulation S-X. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2017 and 2016 and for the periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. The Company suggests these condensed financial statements be read in conjunction with the December 31, 2016 audited financial statements and notes thereto included in the Company&#8217;s Form 10-K. The results of operations for the periods ended September 30, 2017 and 2016 are not necessarily indicative of the operating results for the full year.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>Reclassification</B> &#8211;&nbsp;Certain amounts in prior-period financial statements have been reclassified for comparative purposes to conform to presentation in the current-period financial statements.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>Loss Per Share &#8211;&nbsp;</B>The computation of loss per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, &#8220;Earnings Per Share.&#8221;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>Recently Enacted Accounting Standards</B> &#8211;&nbsp;The FASB established the Accounting Standards Codification (&#8220;Codification&#8221; or &#8220;ASC&#8221;) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;). Rules and interpretive releases of the Securities and Exchange Commission (&#8220;SEC&#8221;) issued under authority of federal securities laws are also sources of GAAP for SEC registrants.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Recent Accounting Standards Updates (&#8220;ASU&#8221;) through ASU No. 2015-01 contain technical corrections to existing guidance or affects guidance to specialized industries or situations. The Company has evaluated recently issued technical pronouncements and has determined that these updates have no current applicability to the Company or their effect on the financial statements would not have been significant.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>Accounting Estimates</B> - The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowance for bad debts and inventory obsolescence.</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>6</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=justify style='font:10pt Times New Roman;margin:0'><B>NOTE 2 &#8211;&nbsp;Stockholders&#8217; Equity</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><B>Common Stock</B>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Effective March 17, 2016, our Amended and Restated Articles of Incorporation were amended pursuant to a Certificate of Change Pursuant to Nevada Revised Statutes 78.209 (the &#8220;Certificate of Change&#8221;) filed with the Nevada Secretary of State. The Certificate of Change provided for both a reverse stock split of the outstanding shares of our common stock on a 1-for-100 basis (the &#8220;Reverse Stock Split&#8221;), and a corresponding decrease in the number of shares of our common stock that we are authorized to issue (the &#8220;Share Decrease&#8221;). </P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>As a result of the Reverse Stock Split, the number of issued and outstanding shares of our common stock on March 17, 2016 decreased from 622,969,835 pre-Reverse Stock Split shares to 6,229,710 post-Reverse Stock Split shares (after adjustment for any fractional shares). Pursuant to the Share Decrease, the number of authorized shares of our common stock decreased from 750,000,000 to 7,500,000 shares of common stock. All amounts shown for common stock included in these financial statements are presented post-Reverse Stock Split. </P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>On April 28, 2016, the Company&#8217;s Amended and Restated Articles of Incorporation were amended to increase the number of authorized shares of the Company&#8217;s common stock from 7,500,000 to 15,000,000 shares of common stock. </P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Effective February 15, 2017, our Amended and Restated Articles of Incorporation were amended pursuant to a Certificate of Change Pursuant to Nevada Revised Statutes 78.209 (the &#8220;Certificate of Change&#8221;) filed with the Nevada Secretary of State. The Certificate of Change provided for both a reverse stock split of the outstanding shares of our common stock on a 1-for-2 basis (the &#8220;Reverse Stock Split&#8221;), and a corresponding decrease in the number of shares of our common stock that we are authorized to issue (the &#8220;Share Decrease&#8221;). </P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&#160;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>As a result of the Reverse Stock Split, the number of issued and outstanding shares of our common stock on February 15, 2017 decreased from 6,307,577 pre-Reverse Stock Split shares to 3,153,801 post-Reverse Stock Split shares (after adjustment for any fractional shares). Pursuant to the Share Decrease, the number of authorized shares of our common stock decreased from 15,000,000 to 7,500,000 shares of common stock, $0.001 par value per share. As of March 31, 2017, the Company had 7,500,000 shares of authorized common stock, $0.001 par value per share. </P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>In January, 2017, the Company issued 20,000 shares of common stock to two directors in equal amounts of 10,000 shares each, valued at $1.72 per share, or $34,404. </P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>In February, 2017, the Company issued 5,232 shares of common stock to a director valued at $3.25 per share, or $17,004.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-right:-2.7pt'>On February 14, 2017, The&#160;NASDAQ&#160;Stock Market LLC informed the Company that it had approved the listing of the Company&#8217;s common stock on The&#160;NASDAQ&#160;Capital Market, effective as of February 15, 2017. The Company&#8217;s common stock ceased trading on the OTCQB on February 15, 2017, and on such date the common stock commenced trading on The NASDAQ&#160;Capital Market under the ticker symbol &#8220;SGLB&#8221;.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>On August 8, 2017, the Company issued 7,489 shares of common stock to a director valued at $2.27 per share, or $17,000.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>On August 16, 2017, the Company issued 8,213 shares of common stock to a director valued at $2.07 per share, or $17,000.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>As of September 30, 2017 and December 31, 2016, there were 4,577,651 and 3,133,789 shares of common stock issued and outstanding, respectively.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><B>Preferred Stock</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>&#160;</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>The Company is authorized to issue 10,000,000 shares of preferred stock, $0.001 par value. No shares of preferred stock were issued and outstanding at September 30, 2017 and 2016.</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>7</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><B>Stock Options</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>On September 28, 2017, the Company granted to an officer (i) a five-year stock option to purchase up to 2,500 shares of common stock, at an exercise price equal to $1.91 per share, which was the closing market price of our common stock on September 28, 2017 (i.e., the date of grant), which option vested and became exercisable in full on the date of grant, and (ii) a five-year stock option to purchase up to 47,500 shares of common stock, at an exercise price equal to $1.91 per share (the closing market price of our common stock on the date of grant), which option is subject to vesting.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>The weighted average period over which total the compensation cost of the options of $90,723 ($11,937 in 2017) will be recognized is 4 years. The weighted average exercise price of all outstanding options as of September 30, 2017 is $3.58 and the weighted average fair value of the options on the grant dates was $2.88. The estimated fair value of the options was determined using the Black-Scholes pricing model using the following assumptions:</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR><TD valign=top style=width:102.35pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>Expected term:</P>
</TD><TD valign=top style=width:77.65pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:10pt Times New Roman;margin:0'>5 years</P>
</TD></TR>
<TR><TD valign=top style=width:102.35pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:77.65pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:102.35pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>Volatility:</P>
</TD><TD valign=top style=width:77.65pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:10pt Times New Roman;margin:0'>67.3 &#8211;&nbsp;155.62%</P>
</TD></TR>
<TR><TD valign=top style=width:102.35pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:77.65pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:102.35pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>Dividend yield:</P>
</TD><TD valign=top style=width:77.65pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:10pt Times New Roman;margin:0'>0.00%</P>
</TD></TR>
<TR><TD valign=top style=width:102.35pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:77.65pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:102.35pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>Risk-free interest rate:</P>
</TD><TD valign=top style=width:77.65pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:10pt Times New Roman;margin:0'>1.13 - 2.27%</P>
</TD></TR>
</TABLE>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><B>Warrants</B>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>As of September 30, 2017, the Company had outstanding warrants to purchase a total of 80,000 shares of common stock at an exercise price of $2.00 per share. Each warrant, prior to its amendment described below in Note 4, had an exercise price equal to $4.13. If not exercised, the warrants to purchase the 80,000 shares will expire on October 17, 2019. In addition, as of September 30, 2017, the Company had outstanding warrants to purchase a total of 1,621,500 shares of common stock at an exercise price of $4.00 per share. If not exercised, the warrants to purchase the 1,621,500 shares will expire on February 21, 2022. The 1,621,500 warrants trade on The NASDAQ&#160;Capital Market under the ticker symbol &#8220;SGLBW&#8221;.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><B>Unit Purchase Option</B>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>On February 15, 2017, Sigma Labs, Inc. (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Dawson James Securities, Inc., as underwriter (the &#8220;Underwriter&#8221;) in connection with a public offering (the &#8220;Offering&#8221;) of the Company&#8217;s securities. &#160;&nbsp;Pursuant to the Underwriting Agreement, the Company has granted the Underwriter the right to purchase from the Company 70,500 Units at an exercise price equal to 125% of the public offering price of the Units in the Offering, or $5.1625 per Unit. The Unit Purchase Option has a term of five years and is not redeemable by us. A &#8220;Unit&#8221; is defined as of one share of the Company&#8217;s common stock, par value $0.001 per share and one warrant to purchase one share of the Company&#8217;s common stock, par value $0.001 per share, at an exercise price of $4.00 per share.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>NOTE 3 &#8211;&nbsp;Note Receivable</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>On May 1, 2017, the Company completed funding a loan in the principal amount of $250,000 to Jaguar Precision Machine, LLC, a New Mexico limited liability company, pursuant to a Secured Convertible Promissory Note dated May 1, 2017 delivered by Jaguar to the Company. The loan bears interest at the rate of 7% per annum, is due and payable in full on May 1, 2018, is secured by certain assets of Jaguar, and is convertible at the Company&#8217;s option into 10% of the outstanding shares of the common stock of Jaguar unless Jaguar exercises its right under specified circumstances to repay all principal and accrued interest on the loan. The purpose of the loan is to provide working capital to Jaguar to, among other things, stand up a metallurgical laboratory and become ASM9100 certified for contracts related to AM of high-precision aerospace and defense components, in furtherance of our strategic alliance. Sigma will receive from Jaguar priority for use of certain machines and services of Jaguar. </P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>On March 27, 2017, the Company completed funding a loan in the principal amount of $500,000 to Morf3D, Inc., an Illinois corporation, pursuant to a Secured Convertible Promissory Note dated March 27, 2017 delivered by Morf3D to the Company. The loan bears interest at the rate of 7% per annum, is due and payable in full on March 27, 2018, is secured by certain assets of Morf3D, and is convertible at the Company&#8217;s option into 10% of the outstanding shares of the common stock of Morf3D unless Morf3D exercises its right under specified circumstances to repay all principal and accrued interest on the loan. The purpose of the loan is to provide working capital to Morf3D to, among other things, lease an EOS M 400 system for Morf3D for Morf3D to expand production for contracts related to AM of high-precision aerospace and defense components, in furtherance of our strategic alliance and in contemplation of a possible acquisition of or merger with Morf3D (although discussions regarding a possible acquisition of or merger with Morf3D are not currently ongoing).</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>8</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=justify style='font:10pt Times New Roman;margin:0'><B>NOTE 4</B> <B>&#8211; Notes Payable</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Effective October 17, 2016, the Company entered into a Securities Purchase Agreement with two accredited investors (the &#8220;Investors&#8221;) for the private placement by the Company of Secured Convertible Notes in the aggregate principal amount of $1,000,000 (the &#8220;Notes&#8221;) and warrants (the &#8220;Warrants&#8221;) to purchase up to 80,000 shares (the &#8220;Warrant Shares&#8221;) of the Company&#8217;s common stock (&#8220;Common Stock&#8221;) (subject to adjustment in certain circumstances), for aggregate gross proceeds, before expenses, to the Company of $900,000 (the &#8220;Financing Transaction&#8221;). The Notes carry a one-time upfront interest charge of a total of $100,000, which is being expensed to interest expense monthly over the 1-year term of the Notes and correspondingly increases in the Notes Payable balance each period. </P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>The Notes carry an interest rate of 10% per annum, calculated on the basis of a 360-day year, based on the $1 million Notes Payable effective balance. Such interest is payable every three months in cash, or, at the holder&#8217;s option, in unrestricted shares of Common Stock, if a registration statement is then in effect for such shares of common stock.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>In connection with the Financing Transaction, the Company entered into a Registration Rights Agreement, dated October 17, 2016, with the Investors, pursuant to which the Company filed a registration statement related to the Financing Transaction with the Securities and Exchange Commission (&#8220;SEC&#8221;) covering the resale of (i) the shares of Common Stock that will be issued to the Investors upon conversion of the Notes, and (ii) the Warrant Shares that will be issued to the Investors upon exercise of the Warrants. </P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>The Notes are secured by the assets of the Company pursuant to a Security Agreement, dated October 17, 2016, between the Company and the &#8220;collateral agent&#8221; (as defined in the Notes) for the benefit of itself and each of the Investors.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>The Notes , prior to their amendment described below, provided that they were convertible into shares of Common Stock at a conversion price equal to the lesser of (i) the final unit price of the Company&#8217;s proposed public offering initially filed with the SEC on July 28, 2016, and (ii) 150% of the closing price of the Common Stock as reported by the OTC Markets Group, Inc. on the date of issuance of the Notes (subject to adjustment as provided therein). As such, the conversion price of the Notes was $4.13, which is the final unit price of the Company&#8217;s public offering.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Each Warrant , prior to its amendment described below, had an exercise price equal to the lesser of (i) the final unit price of the Company&#8217;s proposed public offering initially filed with the SEC on February 17, 2017, and (ii) 150% of the closing price of the Common Stock as reported by the OTC Markets Group, Inc. on the date of issuance of the Warrants (subject to adjustment as provided therein), which Warrants may be exercised on a cashless basis as provided in the Warrants. As such, the exercise price of the Warrants was $4.13, which is the final unit price of the Company&#8217;s public offering.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>On September 29, 2017, the Company entered into amendments (the &#8220;Amendments&#8221;) to the Notes and Warrants pursuant to which, among other things set forth in the Amendments, (1) the exercise price of the Warrants was reduced from $4.13 per share to $2.00 per share, and (2) the conversion price of the Notes was reduced from $4.13 per share to $2.00 per share. Under the Amendments, Sigma paid the Investors an aggregate amount equal to $500,000 (representing 50% of the outstanding principal balance of the Notes) plus all accrued interest on the Notes on October 2, 2017. In consideration of the foregoing, the Investors agreed to, among other things, extend the payment date of the remaining 50% of the outstanding principal balance of the Notes from October 17, 2017 to the earlier of May 18, 2018 or the closing of the Company&#8217;s next underwritten public offering of securities in which the Company raises gross proceeds of at least $3,000,000 (should the Company elect to commence and close such an offering of securities).</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>As of September 30, 2017, the Notes Payable balance is $994,909 which balance was reduced to $500,000 on October 2, 2017.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>NOTE 5 - Continuing Operations</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-right:-2.7pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-right:-2.7pt'>The Company has sustained losses and has negative cash flows from operating activities since its inception. However, the Company has raised significant equity capital and is currently developing new product lines to increase future revenues. On February 21, 2017, the Company closed an underwritten public offering of equity securities resulting in net proceeds of approximately $5.25 million, after deducting underwriting discounts and commissions and other offering expenses payable by the Company. As such, the Company believes it has adequate working capital and cash to fund operations through 2017.&#160;</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>9</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=justify style='font:10pt Times New Roman;margin:0'><B>NOTE 6 &#8211;&nbsp;Loss Per Share</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>The following data show the amounts used in computing loss per share and the weighted average number of shares of dilutive potential common stock for the periods ended September 30, 2017 and 2016:</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR><TD valign=top style=width:159.95pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=3 valign=bottom style='width:169.9pt;padding-left:5.4pt;padding-right:5.4pt;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>9 Months Ending</P>
</TD></TR>
<TR><TD valign=top style=width:159.95pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-right:-18pt'>&nbsp;</P>
</TD><TD valign=top style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-right:-18pt'>&nbsp;</P>
</TD><TD valign=bottom style='width:77.05pt;padding-left:5.4pt;padding-right:5.4pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>9-30-17</P>
</TD><TD valign=bottom style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:77.05pt;padding-left:5.4pt;padding-right:5.4pt;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>9-30-16</P>
</TD></TR>
<TR><TD valign=top style=width:159.95pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:77.05pt;padding-left:5.4pt;padding-right:5.4pt;border-top:0.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:77.05pt;padding-left:5.4pt;padding-right:5.4pt;border-top:0.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:159.95pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>Loss from continuing</P>
</TD><TD valign=top style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:77.05pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:77.05pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:159.95pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>Operations available to </P>
</TD><TD valign=top style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:77.05pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:77.05pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:159.95pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-right:-18pt'>Common stockholders (numerator)</P>
</TD><TD valign=bottom style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0;margin-right:-3.6pt'>$</P>
</TD><TD valign=bottom style='width:77.05pt;padding-left:5.4pt;padding-right:5.4pt;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>(3,049,616)</P>
</TD><TD valign=bottom style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0;margin-right:-3.6pt'>$</P>
</TD><TD valign=bottom style='width:77.05pt;padding-left:5.4pt;padding-right:5.4pt;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>(1,931,833)</P>
</TD></TR>
<TR><TD valign=top style=width:159.95pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:77.05pt;padding-left:5.4pt;padding-right:5.4pt;border-top:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:77.05pt;padding-left:5.4pt;padding-right:5.4pt;border-top:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:159.95pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>Weighted average number of </P>
</TD><TD valign=bottom style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:77.05pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:77.05pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:159.95pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>common shares Outstanding </P>
</TD><TD valign=bottom style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:77.05pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:77.05pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:159.95pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>used in loss per share during </P>
</TD><TD valign=bottom style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:77.05pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:77.05pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:159.95pt;padding-left:5.4pt;padding-right:5.4pt><P align=justify style='font:10pt Times New Roman;margin:0'>the Period (denominator)</P>
</TD><TD valign=bottom style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:77.05pt;padding-left:5.4pt;padding-right:5.4pt;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>4,330,565</P>
</TD><TD valign=bottom style=width:15.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:77.05pt;padding-left:5.4pt;padding-right:5.4pt;border-bottom:3px double #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,121,821</P>
</TD></TR>
</TABLE>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Dilutive loss per share was not presented as the Company had no common equivalent shares for all periods presented that would affect the computation of diluted loss per share or its effect is anti-dilutive.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>NOTE 7</B> <B>&#8211; Subsequent Events</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>On October 6, 2017, <A name=_Toc478471069 />pursuant to an advisory agreement with the Underwriter, the Company issued to the Underwriter a total of 141,000 shares of the Company&#8217;s common stock in exchange for the surrender by the Underwriter of its Unit Purchase Option to acquire up to 70,500 Units.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>On October 13, 2017, the Company granted two employees five-year options to purchase an aggregate of 20,000 shares of common stock, with each option having an exercise price of $1.92 per share, and vesting over the four-year period following the date of grant.</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>10</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=justify style='font:10pt Times New Roman;margin:0'><B>ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B> </B>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>Forward-looking statements</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><B> </B>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><I>This Quarterly Report, including any documents which may be incorporated by reference into this Report, contains &#8220;Forward-Looking Statements.&#8221; All statements other than statements of historical fact are &#8220;Forward-Looking Statements&#8221; for purposes of these provisions, including any projections of revenue or other financial items, any statements of the plans and objectives of management for future operations, any statements concerning proposed new products or services, any statements regarding future economic conditions or performance, and any statements of assumptions underlying any of the foregoing. All Forward-Looking Statements included in this document are made as of the date hereof and are based on information available to us as of such date. We assume no obligation to update any Forward-Looking Statement. In some cases, Forward-Looking Statements can be identified by the use of terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;potential,&#8221; or &#8220;continue,&#8221; or the negative thereof or other comparable terminology. Although we believe that the expectations reflected in the Forward-Looking Statements contained herein are reasonable, there can be no assurance that such expectations or any of the Forward-Looking Statements will prove to be correct, and actual results could differ materially from those projected or assumed in the Forward-Looking Statements. Future financial condition and results of operations, as well as any Forward-Looking Statements are subject to inherent risks and uncertainties, including any other factors referred to in our press releases and reports filed with the Securities and Exchange Commission (&#8220;SEC&#8221;). All subsequent Forward-Looking Statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Additional factors that may have a direct bearing on our operating results are described under the caption &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the year ended December 31, 2016 and elsewhere in this report.</I></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><B><I> </I></B>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>Overview</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Sigma Labs, Inc. (the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;Sigma&#8221;) is a software company that has developed In-Process-Quality-Assurance (&#8220;IPQA&#8221;) software known as PrintRite3D&#174;. This technology is also sometimes referred to as Real-Time-Computer-Aided Inspection (&#8220;CAI&#8221;). &nbsp;Sigma believes that its PrintRite3D&#174; solves the major problem that has prevented large-scale metal part production using 3D printers. </P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>3D metal manufacturing is a technology that uses lasers to form or create parts out of welding powdered metals into a 3-dimensional (3D) object. The quality of these parts can vary from any given part to another on a single production run. Therefore, traditional after the fact quality inspection methods do not assure quality of 3D printed parts. Sigma believes that the best, indeed, only way to attain high yields for both manufacturing quality and cost efficiency is an IPQA&#174; approach that looks at each part in real time as it is being manufactured and determines in real time whether it meets quality specifications. </P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>GE Aviation has stated that it plans to commit $3.5 billion by 2020 to, among other things, build a metal 3D production facility for its Leap engine and other engines to produce Leap engine 3D printed metal parts. Since September 2016, GE has spent over $1 billion buying controlling interests in AM equipment manufacturers, Concept Laser and Arcam AB, and invested over $300 million creating AM manufacturing capability in both the United States and India. However, unless companies that utilize a 3D production facility like GE Aviation are able to effectively check each part for conforming attributes of shape, density, strength and consistency in real-time during the manufacturing process, we believe that such companies will be at risk of letting some substandard parts through and, also, be unable to improve the workflow and high-quality yields of 3D printing functional metal parts. We believe that our software, which can be positioned &#8220;inside&#8221; the 3D metal printer, solves these problems by assuring each part is being made to the quality specifications of the computer file as such part is being made. In essence, our software enables 3D prototyping to become 3D manufacturing. Instead of performing quality assurance (&#8220;QA&#8221;) post production or after the fact, our PrintRite3D&#174; software has been designed to fundamentally redefine traditional QA by embedding quality assurance and process control into the manufacturing process in real time. </P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>We have filed patent applications on our In-Process Quality Assurance&#8482; (&#8220;IPQA&#174;&#8221;) process and procedure for advanced manufacturing. In addition, we anticipate that our core PrintRite3D&#174; software will enable our customers to combine their digital manufacturing technologies with our 3D manufacturing QA to achieve both cost savings and more reliable parts. Vertical markets that we believe would benefit from our technology and software include aerospace, defense, bio-medical, power generation, and oil &amp; gas industries. We provide our software products to customers in the form of Software as a Service (&#8220;SaaS&#8221;).&#160;</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>11</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P style='font:10pt Times New Roman;margin:0'><B>About 3D Printing </B></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>3D printing (&#8220;3DP&#8221;) or additive manufacturing (&#8220;AM&#8221;) is changing the world by going directly from computer graphics to actual parts. 3D printing has been applied to the manufacture of plastic parts for decades. 3D manufacturing of metal parts involves directing a laser or other energy source at a layer of powdered metal and melting it. These layers become melted together from the bottom up. Worldwide revenues attributable to 3D manufacturing for metal products were $88.1 million in 2015 (Wohlers Report 2016, 3D Printing and Additive Manufacturing State of the Industry &#8211;&nbsp;Annual Worldwide Progress Report).</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>The application of 3D printing to high-tolerance, precision manufactured metal parts has only recently emerged. 3D printing of metal parts today represents only a minor percentage of all 3D manufacturing. However, we believe the greatest future growth for 3D printing appears to be in metal parts, given the interest and investment being made by Fortune 100 companies, Federal government laboratories and agencies as well as university-based institutions. Emphasis from these high-end manufacturers and technology leaders is strongly focused on helping the transformation of analog manufacturing of precision, high-tolerance parts in the U.S. today to a digital enterprise of tomorrow complete with automation, robotics and closed-loop process control. We believe that the on-going success of 3D printing for metal parts will be highly dependent upon the evolution of digital quality assurance procedures used, such as our PrintRite3D&#174; process control. </P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><B>About Quality Assurance in 3D Printing</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Current methods for providing quality in 3DP are generally either inaccurate due to use of procedures that do not recognize and measure the primary quality issues of 3D metal manufacturing or are cost prohibitive due to the expense of equipment required to examine the interior of complex dense parts such as 3D can create, and further, may be inaccurate due to misuse of statistically based assessments. &nbsp;After 3D-manufacture, costs are normally incurred by using non-destructive technologies such as ultrasound and non-traditional x-ray scanning technology on these parts, and old-fashioned visual inspection. Destructive testing of 3D parts is a mis-applied carryover from current Subtractive Manufacturing quality assurance practice in which the great consistency of CNC machines &nbsp;permits quality inspectors to infer the quality of a production run by cutting up and analyzing a statistically relevant number of parts. The test result of the parts that are destroyed and analyzed have been, at great time and expense, statistically demonstrated to be representative of the rest of the parts in the production lot. The underlying premise of quality assurance for Subtractive Manufactured parts is that if a machine is set up properly, then all parts it produces will be the same. This simple, effective and accurate quality system does not apply to Additive Manufacturing, in which each part is built in an average production lot of 5-20, and in which quality variance may occur from part to part and within any part notwithstanding that the AM machine settings are the same. Therefore, unable to rely on a traditional statistically based quality system, 3D Manufacturing&#8217;s optimum quality assurance system would evaluate the quality of each individual part. &nbsp;PrintRite3D&#174;&#8217;s in-process quality inspection approach of each part individually allows a manufacturer to use AM to form a single part, such as a hip replacement or one spare aircraft part needed on an aircraft carrier, or several lots of the same part, in large quality &#8211;&nbsp;each approved or rejected in real time and based upon 100% inspection during fabrication. We offer our customers&#8217; the ability to use real-time sensors to track individual scans of each layer, and our software continuously analyzes the part health so that when it is finished we can determine if it meets the production quality standard set by the customer. We believe our PrintRite3D&#174; software could reduce inspection costs by a factor of 10 and development time for new parts by 50% or more. Most importantly is the ability of our software to reduce risk associated with the qualification and certification of printed parts. </P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>By using PrintRite3D&#174; software, a high-precision manufacturer would have the ability to offer its customers product warranties and assurances that its printed parts were produced in compliance with stringent quality requirements. Orders for our software have been received from Honeywell Aerospace, Aerojet Rocketdyne, Woodward, Siemens Turbomachinery, Pratt and Whitney, and Solar Turbines. </P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>We believe there is potential for our PrintRite3D&#174; software to be incorporated into a majority of 3D metal printing devices made by companies like Electro-Optical Systems (&#8220;EOS&#8221;), Additive Industries, Concept Lasers, Trumpf Lasers, Renishaw, Sentrol, Farsoon, Desktop Metal and others.</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>12</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P style='font:10pt Times New Roman;margin:0'><B>Sigma&#8217;s Cloud-Based IIoT Solutions</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>The process of making a 3D printed part could start with our customers loading a computer aided design (&#8220;CAD&#8221;) model of the part into the Cloud as shown in &#8220;A&#8221; in Figure 1. Next, computer aided engineering (&#8220;CAE&#8221;) and/or computer aided manufacturing (&#8220;CAM&#8221;) instructions are sent to the 3D printer (see &#8220;B&#8221;, as shown in Figure 1). Metal powder in the machine is then deposited onto the build platform where a laser beam, or other energy source, focused onto the build platform melts each successive layer of powder in 20-60 micron increments. Our PrintRite3D SENSORPAK&#174; (see &#8220;C&#8221; in Figure 1) detects, records, analyzes and compares the part as it is being made layer-by-layer against the CAD/CAM specifications and physical reference points for quality assurance during manufacturing. Our PrintRite3D INSPECT&#174;, Version 3.0 software determines compliance of each part for its metallurgical quality. Our alpha version of PrintRite3D CONTOUR&#174; software determines the shape and conformity of a part in real-time manufacture with its geometric design specification.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Our <A name=_Hlk497636573 />P<A name=_Hlk497636900 />rintRite3D&#174; CAI web-based software suite (see &#8220;D&#8221; in Figure 1) resides in situ and/or in the Cloud (see &#8220;A&#8221; in Figure 1) of the Industrial Internet of Things (&#8220;IIoT&#8221;). We enable manufacturing engineers to assure the part quality layer-by-layer, provide for manufacturing statistical process control and harvest, aggregate, and analyze Big Data from the manufacturing real-time data collected from our PrintRite3D SENSORPAK&#174; (see &#8220;C&#8221; in Figure 1), as well as post-process manufacturing data collected by our customers (see &#8220;E&#8221; in Figure 1).</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Our specialized sensor suite (see &#8220;C&#8221; in Figure 1), known as PrintRite3D SENSORPAK&#174;, is an edge computing device. It contains the modular hardware and software necessary to connect to &#8220;cyber-physical&#8221; objects (see &#8220;B&#8221; in Figure 1) living on the manufacturing floor. It allows for bi-directional information flow between the manufacturing floor and the Cloud (see &#8220;A&#8221; in Figure 1). It starts a million-fold data reduction that finishes with our PrintRite3D&#174; Digital Quality Record (&#8220;DQR&#8221;) and report, which provides customers with product guarantees and assurances that parts were produced in compliance with stringent quality standards. It can collect, analyze, aggregate, filter, and then further communicate data from the manufacturing floor to the Cloud (see &#8220;A&#8221; in Figure 1) and enable links to other areas (see &#8220;F&#8221; in Figure 1) of the IIoT.</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><IMG src=f10q093017_10q1.jpg width=392 height=302 alt='Picture 1' title='Picture 1'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>Figure 1. Sigma&#8217;s Industrial IoT<B> / </B>PrintRite3D&#174; Cloud Architecture</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><B>Business Activities and Industry Applications</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Our principal business activities include the continued development and commercialization of our PrintRite3D&#174; suite of software applications, with our main focus currently on the 3DP and the AM industry, as well as further developing our contract additive manufacturing business for metal 3DP to be a customer prototype center available for cutting edge 3D challenges and a concurrent means of demonstrating and proving the merit of PrintRite3D&#174; for customers&#8217; parts or application. Our strategy is to continue to leverage our advanced manufacturing knowledge, experience and capabilities through the following means: </P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>13</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD>Identify, develop and commercialize our quality assurance software Apps for advanced manufacturing technologies designed to assure part quality in real time as the part is being made and improve process control practices for a variety of industries;&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD>Provide materials and process engineering consulting services in respect of our PrintRite3D&#174; CAI quality assurance software Apps for advanced manufacturing to customers that have needs in developing next-generation technologies for digital manufacturing technologies; and&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD>Build and run a prototype and small lot contract manufacturing and demonstration division for metal 3DP beginning with our EOS M290 state-of-the-art metal printer. &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>We are presently engaged in the following industry sectors:</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD>Aerospace and defense manufacturing; and&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD>Energy and power generation.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-left:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>We also seek to be engaged in the following industry sectors and have begun to develop relationships with leading manufacturers in each such sector:</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD>Bio-medical manufacturing;&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD>Automotive manufacturing; and&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD>Other markets such as firearms and recreational equipment.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>We generate revenues through PrintRite3D&#174; hardware and CAI software licensing of our PrintRite3D&#174; technology to customers that seek to improve their manufacturing production processes, and through ongoing annual software upgrades and maintenance fees. Additionally, we generate revenues from our contract manufacturing activities in metal AM. By running a contract AM services operation, we are able to understand the current needs of our customers and where they are going with their next-generation product development efforts. Contract AM further allows us a means for continuing/self-funding our IPQA&#174;-enabled R&amp;D and product development activities for CAI software. We provide our AM contract manufacturing services to customers in the form of Quality as a Service (&#8220;QaaS&#8221;). Starting with our PrintRite3D&#174; cloud-based SaaS model, customers will contract with us for CAE, CAM and CAI services to generate and establish a DQR for AM built parts. Each DQR is cloud-based and allows for archiving and storage of quality data, access to our big data ANALYTICS&#8482; software App for continuous quality monitoring and improvement, and automatic industry benchmarking while maintaining firewalls between company-specific data.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>In late 2015, we launched two programs &#8722;&nbsp;an Early Adopter Program (&#8220;EAP&#8221;) and an Original Equipment Manufacturer (&#8220;OEM&#8221;) Partner Program &#8722;&nbsp;designed to broaden our market presence and speed adoption of our PrintRite3D&#174; technology. The EAP was designed to attract end user customers who have an existing, installed base of 3D metal printers and to offer them incentivized pricing in return for feedback on engineering and beta releases of our PrintRite3D&#174; software Apps. Our OEM Partner Program was specifically designed for AM machine manufacturers seeking to embed our PrintRite3D&#174; quality assurance software Apps directly into their machines for customers purchasing a turnkey solution for their new AM machine purchases.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>We possess the resident expertise to provide manufacturing materials and process (&#8220;M&amp;P&#8221;) engineering services and support to companies using our PrintRite3D&#174; software Apps for metal AM. Accordingly, in addition to our primary business focus, we intend to generate revenues by providing such engineering services and support to businesses licensing our PrintRite3D&#174; software Apps.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Our President and Chief Technology Officer has worked at or with the Edison Welding Institute, the United States Department of Energy (&#8220;DOE&#8221;) national laboratories (including the Knolls Atomic Power Laboratory, Bettis Atomic Power Laboratory, Los Alamos National Laboratory and Sandia National Laboratory) over the past 34 years. Due to his work with the DOE, our President and Chief Technology Officer has developed extensive relationships with the DOE and its network of national laboratories. Accordingly, we expect to leverage these relationships in connection with licensing and developing technologies created at such national laboratories for commercialization in the private sector.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><B>Corporate Information</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><B> </B>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Our principal executive offices are located at 3900 Paseo del Sol, Santa Fe, New Mexico 87507, and our current telephone number at that address is (505) 438-2576. Our website address is www.sigmalabsinc.com. The Company&#8217;s annual reports, quarterly reports, current reports on Form 8-K and amendments to such reports filed or furnished pursuant to section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;), and other information related to the Company, are available, free of charge, on that website as soon as we electronically file those documents with, or otherwise furnish them to, the SEC. The Company&#8217;s website and the information contained therein, or connected thereto, are not and are not intended to be incorporated into this Quarterly Report on Form 10-Q.</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>14</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>We incorporated as Messidor Limited in Nevada on December 23, 1985 and changed our name to Framewaves Inc. in 2001. On September 27, 2010, we changed our name from Framewaves Inc. to Sigma Labs, Inc.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>Recent Developments (in reverse chronological order)</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>On November 9, 2017, we announced that the Company and 3DSIM have partnered to bring their customers closer to the reality of full process control over the metal additive manufacturing (AM) process which has been a challenge for AM part designers and manufacturers. 3DSIM, an AM simulation leader, has jointly developed with the Company, a new capability for 3DSIM&#8217;s FLEX<SUP>TM</SUP> software that simulates the thermal sensors&#8217; response to the metal AM process. FLEX<SUP>TM</SUP> is the newest software from 3DSIM, the full commercial version of which is scheduled to be released in early 2018.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>On October 16, 2017, we announced that we will unveil our PrintRite3D&#174; INSPECT&#8482; V3.0 quality assurance software at the international Formnext 2017 to be held from November 14-17, 2017, which will showcase current and future cutting-edge applications of additive technologies.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>On October 12, 2017, we announced that John Rice, our interim Chief Executive Officer, was to be a featured presenter at the 3rd Annual Dawson James Small Cap Growth Conference on October 19, 2017 in Jupiter, Florida, and on September 29, 2017, we announced that Mr. Rice was to present at The MicroCap Conference in New York City on October 5, 2017.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>On September 5, 2017, we announced that our cloud-based PrintRite3D&#174; INSPECT&#174; software Version 2.0 was recently installed at the advanced additive manufacturing facility operated by Siemens Industrial Turbomachinery AB in Sweden.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>On August 25, 2017, we announced that the Company received an invitation to speak at the Third Joint FAA &#8211;&nbsp;USAF Workshop on Qualification and Certification of Additively Manufactured Parts, at which Mark Cola, our President and CTO, presented, &#8220;In-situ Monitoring for Additive Manufacturing:&#160; Implications for the Digital Manufacturing Age,&#8221; on August 31, 2017 at the University of Dayton River Campus.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>On August 22, 2017, we announced that we entered into an agreement with Digital-CAN Tech Co., LTD to serve as our non-exclusive sales agent in Taiwan. Digital-CAN has experience in a variety of industries such as aerospace, medical, tooling, industrial manufacturing 4.0 applications, architecture, product design, automotive design, and lifestyle applications. We agreed to pay Digital-CAN a commission tied to revenue generated by us as a result of customers identified by Digital-CAN. As of the date of this Quarterly Report on Form 10-Q, Digital-CAN has not earned any commissions. </P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>On August 10, 2017, we announced that our cloud-based PrintRite3D&#174; INSPECT&#174; software Version 2.0 was installed at Woodward Inc. Aircraft Turbine Systems group at its Zeeland, MI location. Our PrintRite3D&#174; software is part of Woodward&#8217;s additive manufacturing strategies to ensure that their aerospace and industrial customers receive quality product.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>On August 3, 2017, we announced signing Jeta Enterprises as a new manufacturer&#8217;s representative for sales of Sigma contract printing and AM services in the Northwest region of the U.S., including Oregon and Washington states. Jeta&#8217;s strong customer base in Aerospace and Medical Devices coupled with its expertise in custom-engineered components positions it to serve a growing base of demand for advanced component manufacturing with Sigma&#8217;s suite of products and services. As of the date of this Quarterly Report on Form 10-Q, Jeta has not earned any commissions.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>On July 27, 2017, we announced changes in senior management. Mr. Cola, who serves as President, was appointed as Sigma&#8217;s Chief Technology Officer, responsible for building and implementing the Sigma technological strategy and guiding key technical advancements towards digitalization in the context of the Industrial Internet of Things (IIoT). Together with our executive team members, Mr. Cola will seek to expand and grow the Company through next-generation products and key customer development in a broad range of industries. John Rice, who has served as Chairman of the Board of the Company since his appointment in April 2017, replaced Mr. Cola as Chief Executive Officer effective as of July 24, 2017. As Chairman of the Board and interim Chief Executive Officer, Mr. Rice oversees our implementation of internal and external growth, with an emphasis on internal focus technology, sales, and efficiency, and externally, reaching into the marketplace to expand the Company&#8217;s digital technical bandwidth with respect to our IPQA&#174; technology and additive manufacturing. Mr. Rice brings substantial operating and investment experience to these tasks, including with respect to operations of startup and emerging companies, corporate finance, and mergers and acquisitions. </P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>On July 20, 2017, we announced the June 30, 2016 publication of our U.S. Patent Application No. US 2016/0185048; Multi-Sensor Quality Inference and Control For Additive Manufacturing Processes. This patent application is related to real-time quality analysis during AM processes and the characterization of material properties using acoustic signals emitted during AM which can be used in addition to optical signals to simplify the qualification of printed parts.</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>15</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>On July 6, 2017, we announced that the Company has signed a Technology Development Agreement (&#8220;TDA&#8221;) with OXYS Corporation, a technology company in Cambridge, MA working in the Industrie 4.0 space. The first project to be executed under the TDA will be a new architecture platform for the Company&#8217;s PrintRite3D&#174; INSPECT. The Company expects that the completed project will allow for miniaturization of the sensor/hardware PrintRite3D&#174; product, enhancements to the level of hardware/software integration moving it towards board-level integration, as well as broaden the market reach of the Company&#8217;s PrintRite3D&#174; technology to the Smart Factory and the larger Digital Enterprise, including polymer-based 3D printing.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>Critical Accounting Policies</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><B> </B>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts in the accompanying consolidated financial statements and related notes. These estimates and assumptions have a significant impact on our consolidated financial statements. Actual results could differ materially from those estimates. Critical accounting policies are those that require the most subjective and complex judgments, often employing the use of estimates about the effect of matters that are inherently uncertain. Our significant accounting policies are disclosed in Note 1 to the Financial Statements included in this Quarterly Report on Form 10-Q. However, we do not believe that there are any alternative methods of accounting for our operations that would have a material effect on our financial statements.</P>
<P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>Results of Operations</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B> </B>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>We expect to generate revenue primarily by selling and licensing our manufacturing and materials technologies to businesses that seek to improve their manufacturing production processes and/or manipulate and improve the most functional characteristics of the materials and other input components used in their business operations. We also expect to generate revenues though contract AM manufacturing using our in-house metal 3D printing capability. However, we presently make limited sales of these technologies and services, which include limited sales of non-exclusive licenses to use our PrintRite3D&#174; technologies, including under our Early Adopter Program and OEM Partner Program, as described above. Our ability to generate revenues in the future will depend on our ability to further commercialize and increase market presence of our PrintRite3D&#174; technologies.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>During the three and nine months ended September 30, 2017, we recognized revenue of $78,046 and $518,802, respectively, as compared to $189,952 and $642,230 in revenue recognized during the same periods in 2016. The decrease in revenue was primarily due to reduced programmatic sales, the revenue from which was only partially replaced by new EAP and OEM Partner Program sales due to the incentivized pricing associated with those two programs. We financed our operations during the three and nine months ended September 30, 2017 and 2016 primarily from PrintRite3D&#174; system sales, DARPA and Aerojet programs, engineering consulting services we provided to third parties during these periods and through sales of our common stock and debt securities. We anticipate that our revenue will increase in future periods as we seek to further commercialize and expand our market presence for our PrintRite3D&#174;-related technologies, and obtain new contract manufacturing orders in connection with our EOS M290 metal printer, as well as further perform on our engineering consulting contracts for the Aerojet Rocketdyne Booster Propulsion program and Honeywell Aerospace for the DARPA Phase III and Plus up efforts. Our Cost of Revenue for the three and nine months ended September 30, 2017 was $81,214 and $267,160, respectively, as compared to $69,259 and $207,744 for the same periods in 2016. The increases are attributable to the additional costs associated with implementation of the EAP and OEM programs.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Our General and Administrative Expenses for the three and nine months ended September 30, 2017, were $576,855 and $1,814,843, respectively, as compared to $437,870 and $1,314,055 for the same periods in 2016. Our payroll expenses for the three and nine months ended September 30, 2017 were $295,890 and $973,172, respectively, as compared to $259,011 and $727,494 for the same periods in 2016. Our expenses relating to stock-based compensation for the three and nine months ended September 30, 2017 were $199,225 and $505,630, respectively, as compared to $105,641 and $236,554, respectively, for the same periods in 2016. Our research and development expenses for the three and nine months ended September 30, 2017 were $57,947 and $225,562, respectively, as compared to $37,526 and $88,504 for the same periods in 2016.<A name=eolPage17 /></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>16</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><A name=_Hlk498094692 />General and Administrative Expenses principally include internal operating and sales expenses and outside service fees, the largest component of which consists of services in connection with our obligations as an SEC reporting company. The increase in General and Administrative Expenses for the three and nine months ended September 30, 2017 as compared to the same period in 2016 is principally the result of fees relating to and as a consequence of our February 2017 public offering that resulted in net proceeds of approximately $5,225,650, fees incurred in connection with investing in strategic partners, the increase in interest and finance costs on the $1,000,000 note originated in October of 2016, along with the continued development of our IPQA&#174;-enabled PrintRite3D&#174; technologies and our related efforts to expand our services. The increase in payroll expenses for the three and nine months ended September 30, 2017 as compared to the same periods in 2016 is principally the result of our hiring of additional software development staff to assist in acceleration of our IPQA&#174;-enabled PrintRite3D&#174; technologies and 2017 increases in administrative salaries. The increase in research and development expenses for the three and nine months ended September 30, 2017 as compared to the same periods in 2016 is principally the result of increased contract consulting combined with software and hardware upgrades required for the continued development and improvement of our software and technology. The increase in stock-based compensation costs is due to the fact that the majority of stock options were granted after September 30, 2016, thus more stock option vesting occurred in each quarter of 2017 than in the same periods of 2016.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><A name=_Hlk498094409 />Our General and Administrative expenses are expected to continue to increase as we seek further commercialization of our IPQA&#174;-enabled PrintRite3D&#174; technologies through increased marketing and sales efforts. Similarly, we anticipate that our payroll and non-cash compensation expenses will continue to increase as we engage more employees and other service providers to support our efforts to grow our business.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Our net loss for the three and nine months ended September 30, 2017 increased over each of the prior year comparative periods and totaled $1,116,910 and $3,049,616, respectively, as compared to $719,320 and $1,931,833 for the same periods in 2016. This increase in net loss was attributable to a decrease in revenue and an increase in expenses as noted above. </P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>Liquidity and Capital Resources</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><B> </B>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>As of September 30, 2017, we had $2,691,487 in cash and had a working capital surplus of $2,482,056, as compared with $398,391 in cash and a working capital surplus of $110,799 as of December 31, 2016. </P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>On February 21, 2017, the Company closed an underwritten public offering of equity securities resulting in net proceeds of approximately $5,225,650, after deducting underwriting discounts and commissions and other offering expenses payable by the Company.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>We expect to generate revenue primarily by licensing our manufacturing and materials technologies to businesses that seek to improve their manufacturing production processes and/or manipulate and improve the most functional characteristics of the materials and other input components used in their business operations. We also expect to generate revenues by providing contract AM services using our EOS M290 metal AM system. However, for the period from our inception through September 30, 2017, we generated revenue and financed our operations primarily from PrintRite3D&#174;-enabled engineering consulting services as well as thru the programmatic work performed on both the DARPA Phase II and Aerojet programs we provided during this period and through sales of Sigma common stock and debt securities. We expect to further ramp up our operations and our commercialization and marketing efforts, which we anticipate will increase the amount of cash we will use in our operations.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>We expect that our continued development of our IPQA&#174;-enabled PrintRite3D&#174; technology will enable us to further commercialize this technology for the AM metal market in the remainder of 2017. However, until commercialization of our full suite of PrintRite3D&#174; technologies, we plan to continue funding our development activities and operating expenses by licensing our PrintRite3D&#174; systems and conducting supporting field services, as applicable, and providing PrintRite3D&#174;-enabled engineering consulting services concerning our areas of expertise (materials and manufacturing quality assurance and process control technologies) and contract manufacturing for metal AM, and through the use of proceeds from sales of our securities.<A name=eolPage23 /> </P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Cash used in operating activities increased a net of $479,203 during the nine months ended September 30, 2017, to $1,801,569 from $1,322,366 during the same period in 2016. &nbsp;This increase was primarily due to the increases in general and administrative, payroll and research and development expenses noted above which were partially offset by the net effect of changes in accounts receivable, notes payable, and accrued expenses during the period. Cash used in investing activities increased during the nine months ended September 30, 2017 to $829,146, as compared to $79,741 during the same period in 2016, due primarily to the $775,267 increase in notes receivables related to our loans to Morf3D and Jaguar Precision Machine in conjunction with our strategic alliances. Cash flows provided by financing activities during the nine months ended September 30, 2017 increased a net of $4,923,811 from $0 during the same period in 2016. There were no cash flows used or provided by financing activities in 2016.</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>17</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Some of our engineering consulting contracts, including the contracts from Honeywell Aerospace, Bendix King, Siemens, EOS, Solar Turbines, Pratt &amp; Whitney and Aerojet Rocketdyne, are fixed-price contracts, for which we will be entitled to receive a specified fee regardless of our cost to perform under such contract. In connection with entering into these fixed-contract consulting arrangements, we are required to estimate our costs of performance. To actually earn a profit on these contracts, we must accurately estimate costs involved and assess the probability of meeting the specified objectives, realizing the expected units of work or completing individual transactions, within the contracted time period. Accordingly, if we under-estimate the cost to complete a contract, we remain obligated to complete the work based on our initial cost estimate, which would reduce the amount of profit actually earned under the contract.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>We do not have any material commitments for capital expenditures during the next twelve months. Pursuant to the September 29, 2017 amendments to the Notes and Warrants discussed in Note 4 to our financial statements above, Sigma paid an aggregate amount equal to $500,000 plus all accrued interest on the Notes on October 2, 2017. In consideration of the foregoing, the Investors agreed to, among other things, extend the payment date of the remaining 50% of the outstanding principal balance of the Notes from October 17, 2017 to the earlier of May 18, 2018 or the closing of the Company&#8217;s next underwritten public offering of securities in which the Company raises gross proceeds of at least $3,000,000 (should the Company elect to commence and close such an offering of securities).</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Based on the funds we have as of November 14, 2017, and the proceeds we expect to receive under our PrintRite3D&#174;-enabled engineering consulting agreements, from selling or licensing our PrintRite3D&#174; systems and software, and sales of contract AM manufacturing for metal AM parts, we believe that we will have sufficient funds to pay our administrative and other operating expenses through 2017. Until we are able to generate significant revenues and royalties from selling or licensing our PrintRite3D&#174;-enabled technologies and our contact AM manufacturing services, our ability to continue to fund our liquidity and working capital needs will be dependent upon revenues from existing and future PrintRite3D&#174;-enabled engineering consulting contracts, strategic partnerships, contract manufacturing orders in connection with our EOS M290 metal printer, and proceeds received from sales of our securities. Revenue we generate from licensing our technologies is not expected to increase significantly during 2017 and<B> </B>we also anticipate that there will be an increase in the amount of cash we will use during the remainder of 2017 in connection with our efforts to identify compatible businesses to possibly acquire that will be synergistic with our business (although there is no assurance than any acquisition will be consummated). Accordingly, we will have to obtain additional capital from the sale of additional securities or by borrowing funds from lenders to fulfill our business plans. If we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. There is no assurance that we will be successful in obtaining additional financing. Such financing, if in the form of equity, may be highly dilutive to our existing stockholders and may otherwise include onerous terms. Such financing, if in the form of debt, may include debt covenants and repayment obligations that are onerous and that adversely affect our business operations. If adequate funds are not available to us, we may be required to delay, limit or terminate our business operations If we fail to obtain sufficient funding when needed, we may be forced to delay, scale back or eliminate all or a portion of our commercialization efforts and operations.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Inflation and changing prices have had no effect on our continuing operations over our two most recent fiscal years.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>We have no off-balance sheet arrangements as defined in Item 303(a) of Regulation S-K.<A name=FIS_MARKET_RISK /><A name=V438343_10Q_HTM_A_021 /></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><B>ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><B> </B>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Not applicable.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> <A name=FIS_CONTROL_AND_PROCEDURES />&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><A name=V438343_10Q_HTM_A_022 /><B>ITEM 4. CONTROLS AND PROCEDURES.</B></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><B> </B>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Rule 13a-15(e) under the Exchange Act defines the term &#8220;disclosure controls and procedures&#8221; as those controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and that such information is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Based upon an evaluation of the effectiveness of our disclosure controls and procedures performed by our management, with the participation of our Chief Executive Officer, and Principal Financial and Accounting Officer, as of the end of the period covered by this quarterly report, our management concluded that our disclosure controls and procedures are effective at a reasonable assurance level in ensuring that information required to be disclosed by us in our reports is recorded, processed, summarized and reported within the required time periods. In addition, no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) occurred during the quarter ended September 30, 2017 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>18</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><A name=FIS_PART_III /><A name=FIS_PART_II /><A name=V438343_10Q_HTM_A_023 /><B>PART II</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>OTHER INFORMATION</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B> </B><A name=FIS_LEGAL_PROCEEDING />&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><A name=V438343_10Q_HTM_A_024 /><B>ITEM 1. LEGAL PROCEEDINGS.</B></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><B> </B>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Not applicable.</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'> <A name=FIS_RISK_FACTORS />&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><A name=V438343_10Q_HTM_A_025 /><B>ITEM 1A. RISK FACTORS.</B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>The &#8220;Risk Factors&#8221; included under Item&#160;1A of our Annual Report on Form 10-K for the year ended December&#160;31, 2016 filed with the SEC on March&#160;31, 2017 should be considered. There have been no material changes to those Risk Factors.</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><A name=FIS_CHANGES_IN_SECURITIES /><A name=V438343_10Q_HTM_A_026 /><B>ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.</B></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><B> </B>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>None</P>
<P style='font:10pt Times New Roman;margin:0'><A name=FIS_DEFAULT_SECURITIES />&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><A name=V438343_10Q_HTM_A_027 /><B>ITEM 3. DEFAULTS UPON SENIOR SECURITIES.</B></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><B> </B>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Not applicable.</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'> <A name=FIS_MINE_SAFETY_DISCLOSURE />&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><A name=V438343_10Q_HTM_A_028 /><B>ITEM 4. MINE SAFETY DISCLOSURES.</B></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><B> </B>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Not applicable.</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'> <A name=FIS_OTHER_INFORMATION />&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><A name=V438343_10Q_HTM_A_029 /><B>ITEM 5. OTHER INFORMATION.</B></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><B> </B>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><A name=FIS_EXHIBITS_REPORTS /><A name=V438343_10Q_HTM_A_030 /><KBD style=margin-left:36pt></KBD>Not applicable.&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><B>ITEM 6. EXHIBITS.</B><A name=FIS_UNIDENTIFIED_TABLE_4 /></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse><TR><TD valign=top style=width:52.45pt><P style='font:10pt Times New Roman;margin:0'><A href=f10q093017_ex3z1.htm style=text-decoration:none><FONT style='color:#0000FF;border-bottom:1px solid #0000FF'>3.1</FONT></A></P>
</TD><TD valign=top style=width:483.05pt><P style='font:10pt Times New Roman;margin:0'><A name=BM002 />Amended and Restated Bylaws, as amended of Sigma Labs, Inc.**</P>
</TD></TR>
<TR><TD valign=top style=width:52.45pt><P style='font:10pt Times New Roman;margin:0'>10.1</P>
</TD><TD valign=top style=width:483.05pt><P style='font:10pt Times New Roman;margin:0'>Amended and Restated Employment Agreement, dated as of July 24, 2017, between Sigma Labs, Inc. and Mark J. Cola. (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed July 27, 2017 and incorporated herein by reference).*</P>
</TD></TR>
<TR><TD valign=top style=width:52.45pt><P style='font:10pt Times New Roman;margin:0'><A href=f10q093017_ex10z2.htm style=text-decoration:none><FONT style='color:#0000FF;border-bottom:1px solid #0000FF'>10.2</FONT></A></P>
</TD><TD valign=top style=width:483.05pt><P style='font:10pt Times New Roman;margin:0'>Summary of unwritten Employment Agreement between Sigma Labs, Inc. and John Rice entered into on August 8, 2017.* &nbsp;**</P>
</TD></TR>
<TR style=height:27.9pt><TD valign=top style=width:52.45pt><P style='font:10pt Times New Roman;margin:0'>10.3</P>
</TD><TD valign=top style=width:483.05pt><P style='font:10pt Times New Roman;margin:0'>Employment Letter Agreement, effective as of September 28, 2017, between Sigma Labs, Inc. and Nannette Toups (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on September 20, 2017 and incorporated herein by reference).*</P>
</TD></TR>
<TR style=height:27.9pt><TD valign=top style=width:52.45pt><P style='font:10pt Times New Roman;margin:0'>10.4</P>
</TD><TD valign=top style=width:483.05pt><P style='font:10pt Times New Roman;margin:0'>Amendment No. 1, dated September 18, 2017, to Employment Offer Letter Agreement, effective August 10, 2015, between Sigma Labs, Inc. and Ronald Fisher (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on September 20, 2017 and incorporated herein by reference).*</P>
</TD></TR>
<TR style=height:27.9pt><TD valign=top style=width:52.45pt><P style='font:10pt Times New Roman;margin:0'>10.5</P>
</TD><TD valign=top style=width:483.05pt><P style='font:10pt Times New Roman;margin:0'>Form of Amendment of Warrant and Note, entered into as of September 29, 2017, between the Company and the Holders named therein (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on October 5, 2017 and incorporated herein by reference). </P>
</TD></TR>
<TR style=height:27.9pt><TD valign=top style=width:52.45pt><P style='font:10pt Times New Roman;margin:0'><A href=f10q093017_ex31z1.htm style=text-decoration:none><FONT style='border-bottom:1px solid #000000'>31.1 </FONT></A></P>
</TD><TD valign=top style=width:483.05pt><P style='font:10pt Times New Roman;margin:0'>Rule 13a-14(a) Certification of Principal Executive Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.**</P>
</TD></TR>
<TR><TD valign=top style=width:52.45pt><P style='font:10pt Times New Roman;margin:0'><A href=f10q093017_ex31z2.htm style=text-decoration:none><FONT style='border-bottom:1px solid #000000'>31.2 </FONT></A></P>
</TD><TD valign=top style=width:483.05pt><P style='font:10pt Times New Roman;margin:0'>Rule 13a-14(a) Certification of Principal Financial Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.**</P>
</TD></TR>
<TR><TD valign=top style=width:52.45pt><P style='font:10pt Times New Roman;margin:0'><A href=f10q093017_ex32z1.htm style=text-decoration:none><FONT style='border-bottom:1px solid #000000'>32.1</FONT></A></P>
</TD><TD valign=top style=width:483.05pt><P style='font:10pt Times New Roman;margin:0'>Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**</P>
</TD></TR>
<TR><TD valign=top style=width:52.45pt><P style='font:10pt Times New Roman;margin:0'>101.INS</P>
</TD><TD valign=top style=width:483.05pt><P style='font:10pt Times New Roman;margin:0'>XBRL Instance Document.**</P>
</TD></TR>
<TR><TD valign=top style=width:52.45pt><P style='font:10pt Times New Roman;margin:0'>101.SCH</P>
</TD><TD valign=top style=width:483.05pt><P style='font:10pt Times New Roman;margin:0'>XBRL Schema Document.**</P>
</TD></TR>
<TR><TD valign=top style=width:52.45pt><P style='font:10pt Times New Roman;margin:0'>101.CAL</P>
</TD><TD valign=top style=width:483.05pt><P style='font:10pt Times New Roman;margin:0'>XBRL Calculation Linkbase Document.**</P>
</TD></TR>
<TR><TD valign=top style=width:52.45pt><P style='font:10pt Times New Roman;margin:0'>101.DEF </P>
</TD><TD valign=top style=width:483.05pt><P style='font:10pt Times New Roman;margin:0'>XBRL Definition Linkbase Document.**</P>
</TD></TR>
<TR><TD valign=top style=width:52.45pt><P style='font:10pt Times New Roman;margin:0'>101.LAB </P>
</TD><TD valign=top style=width:483.05pt><P style='font:10pt Times New Roman;margin:0'>XBRL Labels Linkbase Document.**</P>
</TD></TR>
<TR><TD valign=top style=width:52.45pt><P style='font:10pt Times New Roman;margin:0'>101.PRE </P>
</TD><TD valign=top style=width:483.05pt><P style='font:10pt Times New Roman;margin:0'>XBRL Presentation Linkbase Document.**</P>
</TD></TR>
</TABLE>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>* Indicates a management contract or compensatory plan or arrangement.</P>
<P style='font:10pt Times New Roman;margin:0'>** Filed herewith.<A name=eolPage20 /><A name=FIS_SIGNATURES /><A name=V438343_10Q_HTM_A_031 /></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>19</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'><B>SIGNATURES</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B> </B>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<TABLE style=border-collapse:collapse><TR><TD valign=middle style=width:287.25pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=middle style=width:29.25pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=middle style=width:218.25pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:287.25pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD colspan=2 valign=top style=width:247.5pt><P style='font:10pt Times New Roman;margin:0'>SIGMA LABS, INC.</P>
</TD></TR>
<TR><TD valign=top style=width:287.25pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:29.25pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:218.25pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:287.25pt><P style='font:10pt Times New Roman;margin:0'>November 14, 2017</P>
</TD><TD valign=top style=width:29.25pt><P style='font:10pt Times New Roman;margin:0'>By: </P>
</TD><TD valign=top style='width:218.25pt;border-bottom:1pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>/s/ John Rice</I></P>
</TD></TR>
<TR><TD valign=top style=width:287.25pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:29.25pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:218.25pt><P style='font:10pt Times New Roman;margin:0'>John Rice</P>
</TD></TR>
<TR><TD valign=top style=width:287.25pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:29.25pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:218.25pt><P style='font:10pt Times New Roman;margin:0'>Chairman of the Board and Interim Chief Executive Officer (Interim Principal Executive Officer)</P>
</TD></TR>
<TR><TD valign=top style=width:287.25pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:29.25pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:218.25pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:287.25pt><P style='font:10pt Times New Roman;margin:0'>November 14, 2017</P>
</TD><TD valign=top style=width:29.25pt><P style='font:10pt Times New Roman;margin:0'>By:</P>
</TD><TD valign=top style='width:218.25pt;border-bottom:1pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>/s/ Nannette Toups</I></P>
</TD></TR>
<TR><TD valign=top style=width:287.25pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:29.25pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:218.25pt><P style='font:10pt Times New Roman;margin:0'>Nannette Toups</P>
</TD></TR>
<TR><TD valign=top style=width:287.25pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:29.25pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:218.25pt><P style='font:10pt Times New Roman;margin:0'>Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer)</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>20</P>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>f10q093017_ex3z1.htm
<DESCRIPTION>EXHIBIT 3.1 AMENDED AND RESTATED BYLAWS
<TEXT>
<HTML>
<!-- Produced by Justeene Blankenship using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2017 [PPXAC8S3T1P2VKXCJE4E]. www.edgarsuite.com -->
<HEAD>
<TITLE>Exhibit 3.1 Amended and Restated Bylaws</TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:36pt;width:540pt><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>AMENDED AND RESTATED </B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>BY-LAWS</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>OF</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>SIGMA LABS, INC.</B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>ARTICLE I</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>OFFICES</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 1.</KBD><KBD style=margin-left:72pt></KBD>The Corporation may have offices at such places both within and without the State of Nevada as the Board of Directors may from time to time determine or the business of the Corporation may require. &nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>ARTICLE II</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>MEETINGS OF STOCKHOLDERS</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 1.</KBD><KBD style=margin-left:72pt></KBD>All meetings of the stockholders shall be held at any place within or outside the State of Nevada as shall be designated from time to time by the Board of Directors. In the absence of any such designation, stockholders' meetings shall be held at the principal executive office of the Corporation.&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 2.</KBD><KBD style=margin-left:72pt></KBD>The annual meeting of stockholders shall be held on such date and at such time and place as may be fixed by the Board of Directors and stated in the notice of the meeting, for the purpose of electing directors and for the transaction of such other business as<I> </I>is properly brought before the meeting in accordance with these By-Laws.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>To be properly brought before the annual meeting, business must be either (i) specified in the notice of annual meeting (or any supplement or amendment thereto) signed by the President or Vice President, or the Secretary, or an Assistant Secretary, or by such other person or persons as the Board of Directors shall designate, (ii) otherwise brought before the annual meeting by or at the direction of the Board of Directors, or (iii) otherwise properly brought before the annual meeting by a stockholder. Except as provided in Article III, Section 1 of these By-Laws with respect to stockholder nominations of director candidates, any stockholder entitled to vote in the election of directors may propose any action or actions for consideration by the stockholders at any meeting of stockholders only if notice is timely given in writing to the Secretary of the Corporation. To be timely, written notice of such stockholder&#8217;s intent to propose such action or actions for consideration by the stockholders must be given, either by personal delivery or by registered or certified mail, to the Secretary of the Corporation, by the date specified under Rule 14a-8(e) of the Securities Exchange Act of 1934, as amended (the &#8220;<FONT style='border-bottom:1px solid #000000'>Exchange Act</FONT>&#8221;) (or any amendment or successor to such rule) as the deadline for submitting stockholder proposals.</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>A stockholder&#8217;s notice to the Secretary shall set forth as to each matter the stockholder proposes to bring before the annual meeting: (i) a brief description of the business desired to be brought before the annual meeting and the reasons for conducting such business at the annual meeting, (ii) the name and address, as they appear on the Corporation&#8217;s books, of the stockholder proposing such business, (iii) the class and number of shares of the Corporation which are beneficially owned by the stockholder, (iv) any material interest of the stockholder in such business, and (v) any other information that is required to be provided by the stockholder pursuant to Regulation 14A under the Exchange Act, in his capacity as a proponent to a stockholder proposal. Notwithstanding anything in these By-Laws to the contrary, no business shall be conducted at any annual meeting except in accordance with the procedures set forth in this Section 2. The chairman of the annual meeting shall, if the facts warrant, determine and declare at the meeting that business was not properly brought before the meeting and in accordance with the provisions of this Section 2, and, if he should so determine, he shall so declare at the meeting that any such business not properly brought before the meeting shall not be transacted.</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 3.</KBD><KBD style=margin-left:72pt></KBD>The holders of a majority of the voting power of the Corporation&#8217;s stock at any meeting of stockholders, which are present in person or represented by proxy, shall constitute a quorum for the transaction of business except as otherwise provided by law, by the Articles of Incorporation, or by these By-Laws. A quorum, once established, shall not be broken by the withdrawal of enough votes to leave less than a quorum and the votes present may continue to transact business until adjournment. If, however, such quorum shall not be present or represented at any meeting of the stockholders, a majority of the voting stock represented in person or by proxy may adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum shall be present or represented. At such adjourned meeting at which a quorum shall be present or represented, any business may be transacted which might have been transacted at the meeting as originally notified. If the adjournment is for more than thirty days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote thereat.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 4.</KBD><KBD style=margin-left:72pt></KBD>When a quorum is present at any meeting, action by the stockholders on a matter other than the election of directors is approved if the number of votes cast in favor of the action exceeds the number of votes cast in opposition to the action, unless the matter is one upon which, by express provisions of the statutes of Nevada or the Articles of Incorporation, a different vote is required, in which case such express provision shall govern and control.&nbsp;</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 5. </KBD><KBD style=margin-left:72pt></KBD>At each meeting of the stockholders, each stockholder having the right to vote may vote in person or may authorize another person or persons to act for him by proxy appointed in a reasonable manner as may be permitted by law, including, without limitation, a signed writing, telegram, facsimile, and electronic communication. All proxies must be filed with the Secretary of the Corporation at the beginning of each meeting in order to be counted in any vote at the meeting. Each stockholder shall have one vote for each share of stock having voting power, registered in his name on the books of the Corporation on the record date set by the Board of Directors.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 6.</KBD><KBD style=margin-left:72pt></KBD>No stockholder shall be permitted to cumulate his votes in the election of directors or for any other matter voted upon by stockholders.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 7.</KBD><KBD style=margin-left:72pt></KBD>Special meetings of the stockholders, for any purpose, or purposes, unless otherwise prescribed by statute or by the Articles of Incorporation, may be called only by the Chairman of the Board, the Chief Executive Officer, the President or the Board of Directors. Such request shall state the purpose or purposes of the proposed meeting. Business transacted at any special meeting of stockholders shall be limited to the purposes stated in the notice.&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 8.</KBD><KBD style=margin-left:72pt></KBD>Whenever stockholders are required or permitted to take any action at a meeting, a written notice of the meeting shall be given which notice shall state the place, date and hour of the meeting and the purpose or purposes for which the meeting is called. The written notice of any meeting shall be given to each stockholder entitled to vote at such meeting not less than ten (10) nor more than sixty (60) days before the date of the meeting. If mailed, notice is given when deposited in the United States mail, postage prepaid, directed to the stockholder at his address as it appears on the records of the Corporation.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 9.</KBD><KBD style=margin-left:72pt></KBD>The officer who has charge of the stock ledger of the Corporation shall prepare and make, at least ten days before every meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting, during ordinary business hours, for a period of at least ten days prior to the meeting, either at a place within the city where the meeting is to be held, which place shall be specified in the notice of the meeting, or, if not so specified, at the place where the meeting is to be held. The list shall also be produced and kept at the time and place of the meeting during the whole time thereof, and may be inspected by any stockholder who is present.&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 10.</KBD><KBD style=margin-left:72pt></KBD>Any action required or permitted to be taken by the stockholders of the Corporation must be effected at a duly called annual or special meeting of stockholders of the Corporation and may not be effected by any consent in writing by such stockholders.&nbsp;</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>ARTICLE III</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>DIRECTORS</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 1.</KBD><KBD style=margin-left:72pt></KBD>Subject to any limitations in the laws of the State of Nevada, the Articles of Incorporation or these By-Laws, the authorized number of directors of the Corporation shall be not less than one (1) nor more than seven (7) as fixed from time to time by resolution of the Board of Directors; provided that no decrease in the number of directors shall shorten the term of any incumbent directors. A director need not be a stockholder of the Corporation. Nominations of persons for election to the Board of Directors of the Corporation at the annual meeting may be made at such meeting by or at the direction of the Board of Directors, by any committee or persons appointed by the Board of Directors or by any stockholder of the Corporation entitled to vote for the election of directors at the meeting who complies with the notice procedures set forth in this Article III, Section 1. A nomination may be made by a stockholder only if written notice of the nomination has been given to the Secretary of the corporation, either by personal delivery or registered or certified mail, not less than the date specified under Rule 14a-8 of the Securities Exchange Act of 1934 (or any amendment or successor to such rule) as the deadline for submitting stockholder proposals for any meeting of stockholders called for purposes of electing directors. Such stockholder&#8217;s notice to the Secretary shall set forth (i) as to each person whom the stockholder proposes to nominate for election or reelection as a director, (a) the name, age, business address and residence address of the person, (b) the principal occupation or employment of the person, (c) the class and number of shares of capital stock of the Corporation which are beneficially owned by the person, and (d) any other information relating to the person that is required to be disclosed in solicitations for proxies for election of directors pursuant to the Rules and Regulations of the Securities and Exchange Commission under Section 14 of the Securities Exchange Act of 1934; and (ii) as to the stockholder giving the notice (a) the name and record address of the stockholder and (b) the class and number of shares of capital stock of the Corporation which are beneficially owned by the stockholder. The Corporation may require any proposed nominee to furnish such other information as may reasonably be required by the Corporation to determine the eligibility of such proposed nominee to serve as a director of the Corporation. No person shall be eligible for election as a director of the Corporation unless nominated in accordance with the procedures set forth herein. The officer of the Corporation presiding at an annual meeting shall, if the facts warrant, determine and declare to the meeting that a nomination was not made in accordance with the foregoing procedure, and if he should so determine, he shall so declare to the meeting and the defective nomination shall be disregarded. The directors shall be elected at the annual meeting of the stockholders, except as provided in Section 2 of this Article III, and each director elected shall hold office until his successor is elected and qualified; provided, however, that unless otherwise restricted by the Articles of Incorporation or law, any director or the entire Board of Directors may be removed, either with or without cause, from the Board of Directors at any meeting of stockholders by the holders of two-thirds of the voting power of the Corporation&#8217;s stock.&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 2.</KBD><KBD style=margin-left:72pt></KBD>Commencing with the election of directors at the 2017 annual meeting of stockholders, the directors shall be divided into three classes designated as Class I, Class II and Class III. Each class shall consist, as nearly as is possible, of one-third of the number of directors constituting the entire Board of Directors. Initial class assignments shall be determined by the Board of Directors. At each annual meeting of stockholders, successors to the directors whose terms expired at that annual meeting shall be elected for a three-year term, except that, the director or directors elected to Class I will be subject to election for a three-year term at the annual meeting of stockholders in 2018 and the director or directors elected to Class II will be subject to election for a three-year term at the annual meeting of stockholders in 2019. If the number of directors changes, any increase or decrease shall be apportioned among the classes such that the number of directors in each class shall remain as nearly equal as possible, but in no case will a decrease in the number of directors shorten the term of any incumbent director. A director shall hold office until the annual meeting for the year in which his term expires and until his successor shall be elected and qualified, subject, however, to such director&#8217;s prior death, resignation, retirement, disqualification or removal from office. Subject to the rights of the holders of any one or more series of preferred stock then outstanding, newly created directorships resulting from any increase in the authorized number of directors or any vacancies in the Board of Directors resulting from death, resignation, retirement, disqualification, removal from office, or other cause shall, unless otherwise provided by law, be filled solely by the affirmative vote of a majority of the remaining directors then in office, although less than a quorum, or by a sole remaining director. Any director so chosen shall hold office until the next annual election of the class for which such director shall have been chosen and until his successor shall be elected and qualified. No decrease in the authorized number of directors shall shorten the term of any incumbent director. In the event of a vacancy on the Board of Directors, the remaining directors, except as otherwise provided by law, may exercise the powers of the full Board of Directors until the vacancy is filled.&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 3.</KBD><KBD style=margin-left:72pt></KBD>The property and business of the Corporation shall be managed by or under the direction of its Board of Directors. In addition to the powers and authorities by these By-Laws expressly conferred upon them, the Board may exercise all such powers of the Corporation and do all such lawful acts and things as are not by statute or by the Articles of Incorporation or by these By-Laws directed or required to be exercised or done by the stockholders.&nbsp;</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>ARTICLE IV</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>MEETINGS OF THE BOARD OF DIRECTORS</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 1.</KBD><KBD style=margin-left:72pt></KBD>The directors may hold their meetings and have one or more offices, and keep the books of the Corporation outside of the State of Nevada.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 2.</KBD><KBD style=margin-left:72pt></KBD>Regular meetings of the Board of Directors may be held without notice at such time and place as shall from time to time be determined by the Board.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 3.</KBD><KBD style=margin-left:72pt></KBD>Special meetings of the Board of Directors may be called by the Chairman of the Board or President on twenty-four hours&#8217; notice to each director, either personally, by telephone, by facsimile, by e-mail, by mail or by telegram; special meetings shall be called by the President or the Secretary in like manner and on like notice on the written request of two directors unless the Board consists of only one director; in which case special meetings shall be called by the President or Secretary in like manner or on like notice on the written request of the sole director.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 4.</KBD><KBD style=margin-left:72pt></KBD>At all meetings of the Board of Directors a majority of the authorized number of directors shall be necessary and sufficient to constitute a quorum for the transaction of business, and the vote of a majority of the directors present at any meeting at which there is a quorum, shall be the act of the Board of Directors, except as may be otherwise specifically provided by statute, by the Articles of Incorporation or by these By-Laws. If a quorum shall not be present at any meeting of the Board of Directors the directors present thereat may adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum shall be present. &nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 5.</KBD><KBD style=margin-left:72pt></KBD>Unless otherwise restricted by the Articles of Incorporation or these By-Laws, any action required or permitted to be taken at any meeting of the Board of Directors or of any committee thereof may be taken without a meeting, if all members of the Board or committee, as the case may be, consent thereto in writing, and the writing or writings are filed with the minutes of proceedings of the Board or committee.&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 6.</KBD><KBD style=margin-left:72pt></KBD>Unless otherwise restricted by the Articles of Incorporation or these By-Laws, members of the Board of Directors, or any committee designated by the Board of Directors, may participate in a meeting of the Board of Directors, or any committee, by means of conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other, and such participation in a meeting shall constitute presence in person at such meeting.&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>ARTICLE V</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>COMMITTEES OF DIRECTORS</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 1.</KBD><KBD style=margin-left:72pt></KBD>The Board of Directors may, by resolution passed by a majority of the whole Board, designate one or more committees, each such committee to consist of one or more of the directors of the Corporation. The Board may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee. In the absence or disqualification of a member of a committee, the member or members thereof present at any meeting and not disqualified from voting, whether or not he or they constitute a quorum, may unanimously appoint another member of the Board of Directors to act at the meeting in the place of any such absent or disqualified member. Any such committee, to the extent provided in the resolution of the Board of Directors, shall have and may exercise all the powers of the Board of Directors in the management of the business and affairs of the Corporation, and may authorize the seal of the Corporation to be affixed to all papers which may require it; but no such committee shall have the power in reference to amending the Articles of Incorporation (except that a committee may, to the extent authorized in the resolution or resolutions providing for the issuance of shares of stock adopted by the Board of Directors, fix<I> </I>the designations and any of the preferences or rights of such shares relating to dividends, redemption, dissolution, any distribution of assets of the Corporation or the conversion into, or the exchange of such shares for, shares of any other class or classes or any other series of the same or any other class or classes of stock of the Corporation or fix the number of shares of any series of stock or authorize the increase or decrease of the shares of any series), adopting an agreement of merger or consolidation, recommending to the stockholders the sale, lease or exchange of all or substantially all of the Corporation's property and assets, recommending to the stockholders a dissolution of the Corporation or a revocation of a dissolution, or amending the By-Laws of the Corporation; and, unless the resolution, By-Laws, or the Articles of Incorporation expressly so provide, no such committee shall have the power or authority to declare a dividend to authorize the issuance of stock, or to adopt Articles of Merger.&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 2.</KBD><KBD style=margin-left:72pt></KBD>Each committee shall keep regular minutes of its meetings and report the same to the Board of Directors when required.&nbsp;</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>ARTICLE VI</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>COMPENSATION OF DIRECTORS</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 1.</KBD><KBD style=margin-left:72pt></KBD>Unless otherwise restricted by the Articles of Incorporation or these By-Laws, the Board of Directors shall have the authority to fix the compensation of directors. The directors may be paid their expenses, if any, of attendance at each meeting of the Board of Directors and may be paid a fixed sum for attendance at each meeting of the Board of Directors or a stated salary as director. No such payment shall preclude any director from serving the Corporation in any other capacity and receiving compensation therefor. Members of special or standing committees may be allowed like compensation for attending committee meetings.&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>ARTICLE VII</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>INDEMNIFICATION</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 1.</KBD><KBD style=margin-left:72pt></KBD>The Corporation shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, except an action by or in the right of the Corporation, by reason of the fact that he is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another Corporation, partnership, joint venture, trust or other enterprise, against expenses, including attorneys&#8217; fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection with the action, suit or proceeding if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, does not, of itself, create a presumption that the person did not act in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that his conduct was unlawful.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 2.</KBD><KBD style=margin-left:72pt></KBD>The Corporation shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the Corporation to procure a judgment in its favor by reason of the fact that he is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another Corporation, partnership, joint venture, trust or other enterprise against expenses, including amounts paid in settlement and attorneys&#8217; fees actually and reasonably incurred by him in connection with the defense or settlement of the action or suit if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Corporation. Indemnification shall not be made for any claim, issue or matter as to which such a person has been adjudged by a court of competent jurisdiction, after exhaustion of all appeals therefrom, to be liable to the Corporation or for amounts paid in settlement to the Corporation unless and only to the extent that the court in which such action or suit was brought or other court of competent jurisdiction determines upon application that in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 3.</KBD><KBD style=margin-left:72pt></KBD>To the extent that a director, officer, employee or agent of the Corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in Sections 1 and 2, or in defense of any claim, issue or matter therein, he must be indemnified by the Corporation against expenses, including attorneys&#8217; fees, actually and reasonably incurred by him in connection with the defense.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 4.</KBD><KBD style=margin-left:72pt></KBD>Any indemnification under Sections 1 and 2, unless ordered by a court or advanced pursuant to Section 5, shall be made by the Corporation only as authorized in the specific case upon a determination that indemnification of the director, officer, employee or agent is proper in the circumstances. The determination shall be made (1) by the holders of a majority of the voting power of the corporation&#8217;s stock, (2) by the Board of Directors by majority vote of a quorum consisting of directors who were not parties to the action, suit or proceeding, (3) if a majority vote of a quorum consisting of directors who are not parties to the action, suit or proceeding so order, by independent legal counsel in a written opinion, or (4) if a quorum consisting of directors who were not parties to the action, suit or proceeding cannot be obtained, by independent legal counsel in a written opinion.&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 5.</KBD><KBD style=margin-left:72pt></KBD>Expenses incurred by an officer or director in defending a civil or criminal action, suit or proceeding shall be paid by the Corporation as they are incurred and in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall ultimately be determined that he is not entitled to be indemnified by the Corporation. Such expenses incurred by other employees and agents may be so paid upon such terms and conditions, if any, as the Board of Directors deems appropriate.&nbsp;</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;margin-left:36pt;text-indent:0'>Section 6.</KBD><KBD style=margin-left:108pt></KBD>The indemnification and advancement of expenses authorized in or ordered by a court pursuant to the other paragraphs of this Article VII, (i) does not exclude any other rights to which a person seeking indemnification or advancement of expenses may be entitled under any By-Law, agreement, vote of stockholders or disinterested directors or otherwise, for either an action in his official capacity or an action in another capacity while holding his office except that indemnification, unless ordered by a court pursuant to Section 78.7502 of the Nevada Revised Statutes or for the advancement of expenses made pursuant to Section 5, may not be made to or on behalf of any director or officer if a final adjudication establishes that his acts or omissions involved intentional misconduct, fraud or a knowing violation of the law and was material to the cause of action; and (ii) continues for a person who has ceased to be a director, officer, employee or agent and inures to the benefit of the heirs, executors and administrators of such a person. If a claim for indemnification or payment of expenses under this Section 1 is not paid in full within ninety (90) days after a written claim therefor has been received by the Corporation, the claimant may file suit to recover the unpaid amount of such claim and, if successful in whole or in part, shall be entitled to be paid the expense of prosecuting such claim. In any such action the Corporation shall have the burden of proving that the claimant was not entitled to the requested indemnification or payment of expenses under applicable law.&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 7.</KBD><KBD style=margin-left:72pt></KBD>The Board of Directors may authorize, by a vote of a majority of a quorum of the Board of Directors, the Corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another Corporation, partnership, joint venture, trust or other enterprise against any liability asserted against him and incurred by him in any such capacity, or arising out of his status as such, whether or not the Corporation would have the power to indemnify him against such liability under the provisions of this Article VII.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 8.</KBD><KBD style=margin-left:72pt></KBD>The Board of Directors may authorize the Corporation to enter into a contract with any person who is or was a director, officer, employee or agent of the Corporation or is or was serving at the request of the Corporation as a director, officer, employee or agent of another partnership, joint venture, trust or other enterprise providing for indemnification rights equivalent to or, if the Board of Directors so determines, greater than those provided for in this Article VII.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 9.</KBD><KBD style=margin-left:72pt></KBD>For the purposes of this Article VII, references to &#8220;the Corporation&#8221; shall include, in addition to the resulting Corporation, any constituent Corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, and employees or agents, so that any person who is or was a director, officer, employee or agent of such constituent Corporation, or is or was serving at the request of such constituent Corporation as a director, officer, employee or agent of another Corporation, partnership, joint venture, trust or other enterprise, shall stand in the same position under the provisions of this Section with respect to the resulting or surviving Corporation as he would have with respect to such constituent Corporation if its separate existence had continued.&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 10.</KBD><KBD style=margin-left:72pt></KBD>For purposes of this section, references to &#8220;other enterprises&#8221; shall include employee benefit plans; references to &#8220;fines&#8221; shall include any excise taxes assessed on a person with respect to an employee benefit plan; and references to &#8220;serving at the request of the Corporation&#8221; shall include service as a director, officer, employee or agent of the Corporation which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner he reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner &#8220;not opposed to the best interests of the Corporation&#8221; as referred to in this section.&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>ARTICLE VIII</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>OFFICERS</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 1.</KBD><KBD style=margin-left:72pt></KBD>The officers of this Corporation shall be chosen by the Board of Directors and shall include a President, a Secretary and a Treasurer. The Corporation may also have at the discretion of the Board of Directors such other officers as are desired, including a Chief Executive Officer, Chairman of the Board, one or more Vice Presidents, one or more Assistant Secretaries and Assistant Treasurers, and such other officers as may be appointed in accordance with the provisions of Section 3 hereof. In the event there are two or more Vice Presidents, then one or more may be designated as Executive Vice President, Senior Vice President, or other similar or dissimilar title. At the time of the election of officers, the directors may by resolution determine the order of their rank. Any number of offices may be held by the same person, unless the Articles of Incorporation or these By-Laws otherwise provide.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 2.</KBD><KBD style=margin-left:72pt></KBD>The Board of Directors, at its first meeting after each annual meeting of stockholders, shall choose the officers of the Corporation.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 3.</KBD><KBD style=margin-left:72pt></KBD>The Board of Directors may appoint such other officers and agents as it shall deem necessary who shall hold their offices for such terms and shall exercise such powers and perform such duties as shall be determined from time to time by the Board.&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 4.</KBD><KBD style=margin-left:72pt></KBD>The salaries of all officers and agents of the Corporation may be fixed by the Board of Directors.&nbsp;</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 5.</KBD><KBD style=margin-left:72pt></KBD>The officers of the Corporation shall hold office until their successors are chosen and qualify in their stead. Any officer elected or appointed by the Board of Directors may be removed at any time by the affirmative vote of a majority of the Board of Directors. If the office of any officer or officers becomes vacant for any reason, the vacancy shall be filled by the Board of Directors.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 6.</KBD><KBD style=margin-left:72pt></KBD>The Chairman of the Board, if such an officer be elected, shall, if present, preside at all meetings of the Board of Directors and exercise and perform such other powers and duties as may be from time to time assigned to him by the Board of Directors or prescribed by these By-Laws. &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 7.</KBD><KBD style=margin-left:72pt></KBD>Subject to such supervisory powers, if any, as may be given by the Board of Directors to the Chairman of the Board, if there be such an officer, the President shall, subject to the control of the Board of Directors, have general supervision, direction and control of the business and officers of the Corporation. He shall preside at all meetings of the stockholders, and in the absence of the Chairman of the Board, at all meetings of the Board of Directors. He shall have the general powers and duties of management usually vested in the office of president of a corporation, and shall have such other powers and duties as may be prescribed by the Board of Directors or by the By-Laws.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 8.</KBD><KBD style=margin-left:72pt></KBD>In the absence or disability of the President, the Vice Presidents in order of their rank as fixed by the Board of Directors, or if not ranked, the Vice President designated by the Board of Directors, shall perform all the duties of the President, and when so acting shall have all the powers of and be subject to all the restrictions upon the President. The Vice Presidents shall have such other duties as from time to time may be prescribed for them, respectively, by the Board of Directors.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 9.</KBD><KBD style=margin-left:72pt></KBD>The Secretary shall attend all sessions of the Board of Directors and all meetings of the stockholders and record all votes and the minutes of all proceedings in a book to be kept for that purpose; and shall perform like duties for the standing committees when required by the Board of Directors. Except as otherwise provided herein, the Secretary shall give, or cause to be given, notice of all meetings of the stockholders and of the Board of Directors, and shall perform such other duties as may be prescribed by the Board of Directors or these By-Laws. The Secretary shall keep in safe custody the seal of the Corporation, and affix the same to any instrument requiring it, and when so affixed it shall be attested by his signature or by the signature of an Assistant Secretary. The Board of Directors may give general authority to any other officer to affix<I> </I>the seal of the Corporation and to attest the affixing by his signature.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 10.</KBD><KBD style=margin-left:72pt></KBD>The Assistant Secretary, or if there be more than one, the Assistant Secretaries in the order determined by the Board of Directors, or if there be no such determination, the Assistant Secretary designated by the Board of Directors, shall, in the absence or disability of the Secretary perform the duties and exercise the powers of the Secretary and shall perform such other duties and have such other powers as the Board of Directors may from time to time prescribe.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 11.</KBD><KBD style=margin-left:72pt></KBD>The Treasurer shall have the custody of the corporate funds and securities and shall keep full and accurate accounts of receipts and disbursements in books belonging to the Corporation and shall deposit all moneys, and other valuable effects in the name and to the credit of the Corporation, in such depositories as may be designated by the Board of Directors. He shall disburse the funds of the Corporation as may be ordered by the Board of Directors, taking proper vouchers for such disbursements, and shall render to the Board of Directors, at its regular meetings, or when the Board of Directors so requires, an account of all his transactions as Treasurer and of the financial condition of the Corporation. If required by the Board of Directors, he shall give the Corporation a bond, in such sum and with such surety or sureties as shall be satisfactory to the Board of Directors, for the faithful performance of the duties of his office and for the restoration to the Corporation, in case of his death, resignation, retirement or removal from office, of all books, papers, vouchers, money and other property of whatever kind in his possession or under his control belonging to the Corporation.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 12.</KBD><KBD style=margin-left:72pt></KBD>The Assistant Treasurer, or if there shall be more than one, the Assistant Treasurers in the order determined by the Board of Directors, or if there be no such determination, the Assistant Treasurer designated by the Board of Directors, shall, in the absence or disability of the Treasurer, perform the duties and exercise the powers of the Treasurer and shall perform such other duties and have such other powers as the Board of Directors may from time to time prescribe.&nbsp;</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>ARTICLE IX</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>CERTIFICATES OF STOCK</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 1.</KBD><KBD style=margin-left:72pt></KBD>Shares of the capital stock of the Corporation may be certificated or uncertificated, as provided under the General Corporation Law of the State of Nevada. Each stockholder, upon written request to the transfer agent or registrar of the Corporation, shall be entitled to a certificate of the capital stock of the Corporation in such form as may from time to time be prescribed by the Board of Directors. Such certificate shall be signed by the Chairman of the Board, the President or a Vice President and by the Treasurer or an Assistant Treasurer or the Secretary or an Assistant Secretary. The Corporation seal, if applied, and the signatures by corporation officers may be facsimiles if the certificate is manually countersigned by an authorized person on behalf of a transfer agent or registrar other than the Corporation or its employee. In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed on such certificate shall have ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be issued by the Corporation with the same effect as if such officer, transfer agent or registrar were such officer, transfer agent or registrar at the time of its issue. Every certificate for shares of stock which are subject to any restriction on transfer and every certificate issued when the Corporation is authorized to issue more than one class or series of stock shall contain such legend with respect thereto as is required by law. The Corporation shall be permitted to issue fractional shares.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 2.</KBD><KBD style=margin-left:72pt></KBD>If the Corporation shall be authorized to issue more than one class of stock or more than one series of any class, the voting powers, designations, preferences, limitations, restrictions and relative rights of each class of stock or series thereof and the qualification, limitations or restrictions of such preferences and/or rights shall be set forth in full or summarized on the face or back of the certificate which the Corporation shall issue to represent such class or series of stock, provided that, except as otherwise provided in section 78.195 of the Revised Nevada Statutes, in lieu of the foregoing requirements, there may be set forth on the face or back of the certificate which the Corporation shall issue a statement setting forth the office or agency of the Corporation from which the stockholders may obtain a copy of a statement setting forth in full or summarizing the voting powers, designations, preferences, limitations, restrictions and relative rights of each class of stock or series thereof that the Corporation will furnish without charge to each stockholder who so requests.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 3.</KBD><KBD style=margin-left:72pt></KBD>The Board of Directors may direct a new certificate or certificates to be issued in place of any certificate or certificates theretofore issued by the Corporation alleged to have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the person claiming the certificate of stock to be lost, stolen or destroyed. When authorizing such issue of a new certificate or certificates, the Board of Directors may, in its discretion and as a condition precedent to the issuance thereof, require the owner of such lost, stolen or destroyed certificate or certificates, or his legal representative, to advertise the same in such manner as it shall require and/or to give the Corporation a bond in such sum as it may direct as indemnity against any claim that may be made against the Corporation with respect to the certificate alleged to have been lost, stolen or destroyed.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 4.</KBD><KBD style=margin-left:72pt></KBD>Subject to any restrictions on transfer and unless otherwise provided by the Board of Directors, shares of stock may be transferred only on the books of the Corporation, if such shares are certificated, by the surrender to the Corporation or its transfer agent of the certificate therefore properly endorsed or accompanied by a written assignment or power of attorney properly executed, or upon proper instructions from the holder of uncertificated shares, in each case with such proof of the authenticity of signature as the Corporation or its transfer agent may reasonably require.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 5.</KBD><KBD style=margin-left:72pt></KBD>The Corporation shall be entitled to treat the holder of record of any share or shares of stock as the holder in fact thereof and accordingly shall not be bound to recognize any equitable or other claim or interest in such share on the part of any other person, whether or not it shall have express or other notice thereof, save as expressly provided by the laws of the State of Nevada.&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>ARTICLE X</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>GENERAL PROVISIONS</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 1.</KBD><KBD style=margin-left:72pt></KBD><FONT style='border-bottom:1px solid #000000'>Distributions</FONT>.&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:108pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>(a)</KBD><KBD style=margin-left:36pt></KBD>Distributions upon the capital stock of the Corporation, subject to the provisions of the Articles of Incorporation, if any, may be declared by the Board of Directors at any regular or special meeting, pursuant to law.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:108pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>(b)</KBD><KBD style=margin-left:36pt></KBD>Before payment of any distribution there may be set aside out of any funds of the Corporation available for distributions such sum or sums as the directors from time to time, in their absolute discretion, think proper as a reserve fund to meet contingencies, or for equalizing distributions, or for repairing or maintaining any property of the Corporation, or for such other purpose as the directors shall think conducive to the interests of the Corporation, and the directors may abolish any such reserve.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:108pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 2.</KBD><KBD style=margin-left:72pt></KBD><FONT style='border-bottom:1px solid #000000'>Checks</FONT>. All checks or demands for money and notes of the Corporation shall be signed by such officer or officers, or such other persons, as the Board of Directors may from time to time designate.&nbsp;</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 3.</KBD><KBD style=margin-left:72pt></KBD><FONT style='border-bottom:1px solid #000000'>Seal</FONT>. The corporate seal shall have inscribed thereon the name of the Corporation and the words &#8220;Corporate Seal, Nevada&#8221;. Said seal may be used by causing it or a facsimile thereof to be impressed or affixed or reproduced or otherwise.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 4.</KBD><KBD style=margin-left:72pt></KBD><FONT style='border-bottom:1px solid #000000'>Notices</FONT>. Whenever, under the provisions of the statutes or of the Articles of Incorporation or of these By-Laws, notice is required to be given to any director or stockholder, it shall not be construed to mean personal notice, but such notice may be given in writing, addressed to such director or stockholder, at the stockholder&#8217;s address as it appears on the records of the Corporation, with postage thereon prepaid, and such notice shall be deemed to be given at the time when the same shall be deposited in the United States mail. Notice to any director may be by any reasonable means, including, without limitation, mail, personal delivery, facsimile, or electronic communication. All notices shall be deemed given when sent.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 5.</KBD><KBD style=margin-left:72pt></KBD><FONT style='border-bottom:1px solid #000000'>Waiver</FONT>. Whenever any notice is required to be given under the provisions of the statutes or of the Articles of Incorporation or of these By-Laws, a waiver thereof in writing, signed by the person or persons entitled to said notice, whether before or after the time stated therein, shall be deemed equivalent thereto.&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>ARTICLE XI</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>AMENDMENTS</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>Section 1.</KBD><KBD style=margin-left:72pt></KBD>Except as otherwise restricted in the Articles of Incorporation or these By-Laws:&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:108pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>(a)</KBD><KBD style=margin-left:36pt></KBD>Any provision of these By-Laws may be altered, amended or repealed at the annual or any regular meeting of the Board of Directors without prior notice, or at any special meeting of the Board of Directors if notice of such alteration or repeal be contained in the notice of such special meeting. Any such alteration, amendment or repeal shall not require stockholder approval.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:108pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'>(b)</KBD><KBD style=margin-left:36pt></KBD>The stockholders may not adopt, amend, alter or repeal these By-Laws unless such action is approved at a duly convened meeting of the stockholders by the affirmative vote of the holders of at least two-thirds of the voting power of the Corporation&#8217;s stock.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:108pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>I, Amanda Cola, hereby certify that the forgoing Amended and Restated By-Laws of Sigma Labs, Inc. were duly adopted by written consent of the Board of Directors of Sigma Labs, Inc., effective as of February 15, 2017. </P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR style=height:27.9pt><TD valign=top style=width:232.65pt><P align=justify style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:235.35pt><P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><I>/s/ Amanda Cola </I></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Name: Amanda Cola, </P>
<P align=justify style='font:10pt Times New Roman;margin:0'>Secretary</P>
</TD></TR>
</TABLE>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=center style='font:10pt Times New Roman;margin:0'><B>Amendment Number One to Amended and Restated Bylaws of Sigma Labs, Inc.</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>(A Nevada Corporation)</B></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>The Amended and Restated Bylaws (the &#8220;Bylaws&#8221;) of Sigma Labs, Inc. are hereby amended as follows:</P>
<P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'>1.</KBD><KBD style=margin-left:36pt></KBD>The first sentence of the second paragraph of Article II, Section 2 of the Bylaws is hereby amended and restated to read in its entirety as follows: &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-left:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&#8220;To be properly brought before the annual meeting, business must be either (i) specified in the notice of annual meeting (or any supplement or amendment thereto) signed by the Chief Executive Officer or by such other person or persons as the Board of Directors shall designate, (ii) otherwise brought before the annual meeting by or at the direction of the Board of Directors, or (iii) otherwise properly brought before the annual meeting by a stockholder.&#8221;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'>2.</KBD><KBD style=margin-left:36pt></KBD>The first sentence of Article II, Section 7 of the Bylaws is hereby amended and restated to read in its entirety as follows: &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-left:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&#8220;Special meetings of the stockholders, for any purpose, or purposes, unless otherwise prescribed by statute or by the Articles of Incorporation, may be called only by the Chairman of the Board, the Chief Executive Officer, the Board of Directors or, in the absence of a Chief Executive Officer, the President.&#8221;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'>3.</KBD><KBD style=margin-left:36pt></KBD>Article IV, Section 3 of the Bylaws is hereby amended and restated to read in its entirety as follows: &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-left:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&#8220;Special meetings of the Board of Directors may be called by the Chairman of the Board, the Chief Executive Officer or, in the absence of a Chief Executive Officer, the President, on twenty-four hours&#8217; notice to each director, either personally, by telephone, by facsimile, by e-mail, by mail or by telegram; special meetings shall be called by the Chief Executive Officer, in the absence of a Chief Executive Officer, the President, or the Secretary in like manner and on like notice on the written request of two directors unless the Board consists of only one director, in which case special meetings shall be called by the Chief Executive Officer, in the absence of a Chief Executive Officer, the President, or the Secretary in like manner or on like notice on the written request of the sole director.&#8221;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'>4.</KBD><KBD style=margin-left:36pt></KBD>Article VIII, Section 1 of the Bylaws is hereby amended and restated to read in its entirety as follows: &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-left:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&#8220;The officers of this Corporation shall be chosen by the Board of Directors and shall include a Chief Executive Officer, a President, a Secretary and a Treasurer. The Corporation may also have at the discretion of the Board of Directors such other officers as are desired, including a Chairman of the Board, one or more Vice Presidents, one or more Assistant Secretaries and Assistant Treasurers, and such other officers as may be appointed in accordance with the provisions of Section 3 hereof. In the event there are two or more Vice Presidents, then one or more may be designated as Executive Vice President, Senior Vice President, or other similar or dissimilar title. At the time of the election of officers, the directors may by resolution determine the order of their rank. Any number of offices may be held by the same person, unless the Articles of Incorporation or these By-Laws otherwise provide.&#8221;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'>5.</KBD><KBD style=margin-left:36pt></KBD>Article VIII, Section 7 of the Bylaws is hereby amended and restated to read in its entirety as follows: &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-left:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&#8220;Subject to such supervisory powers, if any, as may be given by the Board of Directors to the Chairman of the Board, if there be such an officer, the Chief Executive Officer shall, subject to the control of the Board of Directors, have general supervision, direction and control of the business and officers of the Corporation. He shall preside at all meetings of the stockholders, and in the absence of the Chairman of the Board, at all meetings of the Board of Directors. He shall have the general powers and duties of management usually vested in the office of chief executive officer of a corporation, and shall have such other powers and duties as may be prescribed by the Board of Directors or by the By-Laws.&#8221;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'>6.</KBD><KBD style=margin-left:36pt></KBD>Article VIII, Section 8 of the Bylaws is hereby amended and restated to read in its entirety as follows: &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-left:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&quot;In the absence or disability of the Chief Executive Officer, the President shall perform all the duties of the Chief Executive Officer, and when so acting shall have all the powers of and be subject to all the restrictions upon the Chief Executive Officer. The President shall have such other duties as from time to time may be prescribed for him or her by the Board of Directors.&quot;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'>7.</KBD><KBD style=margin-left:36pt></KBD>A new Section 13 is added to the end of Article VIII of the Bylaws to read in its entirety as follows: &#8220;Section 13. &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-left:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&#8220;The President shall perform all duties and have all powers which are delegated to him or her by the Board of Directors.&#8221; </P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=justify style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'>8.</KBD><KBD style=margin-left:36pt></KBD>The third sentence of Article IX, Section 1 of the Bylaws is hereby amended and restated to read in its entirety as follows: &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-left:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&#8220;Such certificate shall be signed by the Chairman of the Board or the Chief Executive Officer or, in the absence of a Chief Executive Officer, the President, or a Vice President, and by the Treasurer or an Assistant Treasurer or the Secretary or an Assistant Secretary.&#8221; </P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Except as amended hereby, the Amended and Restated Bylaws of Sigma Labs, Inc. shall remain in full force and effect.</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>I, Amanda Cola, hereby certify that the forgoing Amendment Number One to Amended and Restated Bylaws of Sigma Labs, Inc.<B> </B>was duly adopted by written consent of the Board of Directors of Sigma Labs, Inc., effective as of July 24, 2017. </P>
<P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR style=height:7.2pt><TD valign=top style=width:232.55pt;padding:0.75pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:235.45pt;padding:0.75pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><I>/s/ Amanda Cola</I></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>Name: Amanda Cola,</P>
<P style='font:10pt Times New Roman;margin:0'>Secretary</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>f10q093017_ex10z2.htm
<DESCRIPTION>EXHIBIT 10.2 SUMMARY OF UNWRITTEN EMPLOYMENT ARRANGEMENT WITH JOHN RICE
<TEXT>
<HTML>
<!-- Produced by Justeene Blankenship using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2017 [PPXAC8S3T1P2VKXCJE4E]. www.edgarsuite.com -->
<HEAD>
<TITLE>Exhibit 10.2 Summary of Unwritten Employment Arrangement with John Rice</TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:36pt;width:540pt><P align=right style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=right style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Exhibit 10.2</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Summary of Unwritten Employment Arrangement with John Rice</FONT></P>
<P style='font:12pt Times New Roman;margin-top:0pt;margin-bottom:12pt;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><A name=_DV_M10 /><KBD style=margin-left:36pt></KBD>On August 8, 2017, Sigma Labs, Inc., a Nevada corporation (the &quot;Company&quot;), entered into an &#8220;at will&#8221; unwritten employment arrangement with John Rice, effective as of August 1, 2017, pursuant to which Mr. Rice serves as the Company's interim Chief Executive Officer and interim principal executive officer. Under the employment arrangement, Mr. Rice is entitled to receive a monthly salary of $9,000, and he is eligible to receive medical and dental benefits, life insurance, and long term and short term disability coverage. Further, Mr. Rice is eligible under his employment arrangement to participate in the Company&#8217;s 2013 Equity Incentive Plan, with equity compensation to Mr. Rice to be determined by the Company's Compensation Committee at a later date.&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>f10q093017_ex31z1.htm
<DESCRIPTION>EXHIBIT 31.1 SECTION 302 CERTIFICATION
<TEXT>
<HTML>
<!-- Produced by Justeene Blankenship using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2017 [PPXAC8S3T1P2VKXCJE4E]. www.edgarsuite.com -->
<HEAD>
<TITLE>Exhibit 31.1 Section 302 Certification</TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:36pt;width:540pt><P align=center style='font:10pt Times New Roman;margin:0;margin-left:396pt'>&nbsp;</P>
<P align=right style='font:10pt Times New Roman;margin:0;margin-left:396pt'><B>Exhibit 31.1</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B> </B>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>I, John Rice, certify that:</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>1. I have reviewed this Quarterly Report on Form 10-Q of Sigma Labs, Inc.;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</P>
<P align=center style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>Date: November 14, 2017</P>
<TABLE style=border-collapse:collapse;width:549pt><TR><TD valign=middle style=width:247.2pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=middle style=width:27.3pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=middle style=width:274.5pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:247.2pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
</TD><TD valign=top style=width:27.3pt><P style='font:10pt Times New Roman;margin:0'>By:</P>
</TD><TD valign=top style='width:274.5pt;border-bottom:1pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>/s/ John Rice</I></P>
</TD></TR>
<TR><TD valign=top style=width:247.2pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:27.3pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:274.5pt><P style='font:10pt Times New Roman;margin:0'>Name: John Rice</P>
</TD></TR>
<TR><TD valign=top style=width:247.2pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:27.3pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:274.5pt><P style='font:10pt Times New Roman;margin:0'>Title: Chairman of the Board and Interim Chief Executive Officer</P>
</TD></TR>
<TR><TD valign=top style=width:247.2pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:27.3pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:274.5pt><P style='font:10pt Times New Roman;margin:0'>(Interim Principal Executive Officer)</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>f10q093017_ex31z2.htm
<DESCRIPTION>EXHIBIT 31.2 SECTION 302 CERTIFICATION
<TEXT>
<HTML>
<!-- Produced by Justeene Blankenship using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2017 [PPXAC8S3T1P2VKXCJE4E]. www.edgarsuite.com -->
<HEAD>
<TITLE>Exhibit 31.2 Section 302 Certification</TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:36pt;width:540pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=right style='font:10pt Times New Roman;margin:0'><B>Exhibit 31.2</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B> </B>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>I, Nannette Toups, certify that:</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>1. I have reviewed this Quarterly Report on Form 10-Q of Sigma Labs, Inc.;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</P>
<P align=center style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>Date: November 14, 2017</P>
<TABLE style=border-collapse:collapse><TR><TD valign=middle style=width:265.5pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=middle style=width:27.15pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=middle style=width:196.55pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:265.5pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
</TD><TD valign=top style=width:27.15pt><P style='font:10pt Times New Roman;margin:0'>By:</P>
</TD><TD valign=top style='width:196.55pt;border-bottom:1pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>/s/ Nannette Toups</I></P>
</TD></TR>
<TR><TD valign=top style=width:265.5pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:27.15pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:196.55pt><P style='font:10pt Times New Roman;margin:0'>Name: Nannette Toups</P>
</TD></TR>
<TR><TD valign=top style=width:265.5pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:27.15pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:196.55pt><P style='font:10pt Times New Roman;margin:0'>Title: Chief Financial Officer, Treasurer (Principal Financial and Accounting Officer)</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>f10q093017_ex32z1.htm
<DESCRIPTION>EXHIBIT 32.1 SECTION 906 CERTIFICATION
<TEXT>
<HTML>
<!-- Produced by Justeene Blankenship using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2017 [PPXAC8S3T1P2VKXCJE4E]. www.edgarsuite.com -->
<HEAD>
<TITLE>Exhibit 32.1 Section 906 Certification</TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:36pt;width:540pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=right style='font:10pt Times New Roman;margin:0'><B>Exhibit 32.1</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B> </B><A name=FIS_CERTIFICATION_3 />&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Certification Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B> </B>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, John Rice, the Interim Chief Executive Officer, and Nannette Toups, the Chief Financial Officer, of Sigma Labs, Inc. (the &quot;Company&quot;), hereby certify, that, to their knowledge:</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>1. The Quarterly Report on Form 10-Q for the period ended September 30, 2017 (the &quot;Report&quot;) of the Company fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934; and</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'> &nbsp;</P>
<TABLE style=border-collapse:collapse;width:540pt><TR><TD valign=middle style=width:252pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=middle style=width:18pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=middle style=width:270pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style='width:252pt;border-bottom:1pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>/s/ John Rice</I></P>
</TD><TD valign=bottom style=width:18pt><P style='font:10pt Times New Roman;margin:0'><I> </I>&nbsp;</P>
</TD><TD valign=top style='width:270pt;border-bottom:1pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>/s/ Nannette Toups</I></P>
</TD></TR>
<TR><TD valign=top style=width:252pt><P style='font:10pt Times New Roman;margin:0'>John Rice</P>
</TD><TD valign=bottom style=width:18pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:270pt><P style='font:10pt Times New Roman;margin:0'>Nannette Toups</P>
</TD></TR>
<TR><TD valign=top style=width:252pt><P style='font:10pt Times New Roman;margin:0'>Chairman of the Board and Interim Chief Executive Officer </P>
<P style='font:10pt Times New Roman;margin:0'>(Interim Principal Executive Officer)</P>
</TD><TD valign=bottom style=width:18pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:270pt><P style='font:10pt Times New Roman;margin:0'>Chief Financial Officer, Treasurer </P>
<P style='font:10pt Times New Roman;margin:0'>(Principal Financial and Accounting Officer)</P>
</TD></TR>
<TR><TD valign=top style=width:252pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:18pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:270pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom style=width:252pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=bottom style=width:18pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=bottom style=width:270pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:252pt><P style='font:10pt Times New Roman;margin:0'>November 14, 2017</P>
</TD><TD valign=bottom style=width:18pt><P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
</TD><TD valign=top style=width:270pt><P style='font:10pt Times New Roman;margin:0'>November 14, 2017</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'> &nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>sglb-20170930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by edgar-services.com using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2017 [PPXK2X91H1YFVLAJKX0D]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://www.sigmalabs.com/20170930"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_CondensedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_CondensedBalanceSheetsUnaudited"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_CondensedBalanceSheetsUnaudited">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_CashAndCashEquivalentsAtCarryingValue' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent' xlink:label='us-gaap_AccountsReceivableNetCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_AccountsReceivableNetCurrent' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent' xlink:label='us-gaap_NotesAndLoansReceivableNetCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_NotesAndLoansReceivableNetCurrent' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet' xlink:label='us-gaap_InventoryNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_InventoryNet' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseCurrent' xlink:label='us-gaap_PrepaidExpenseCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsCurrent' xlink:to='us-gaap_PrepaidExpenseCurrent' use='optional' order='5.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_AssetsCurrent' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsNoncurrent' xlink:label='us-gaap_AssetsNoncurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Assets' xlink:to='us-gaap_AssetsNoncurrent' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsNoncurrent' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:label='us-gaap_IntangibleAssetsNetExcludingGoodwill'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsNoncurrent' xlink:to='us-gaap_IntangibleAssetsNetExcludingGoodwill' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAssetNoncurrent' xlink:label='us-gaap_BusinessCombinationContingentConsiderationAssetNoncurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsNoncurrent' xlink:to='us-gaap_BusinessCombinationContingentConsiderationAssetNoncurrent' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseOtherNoncurrent' xlink:label='us-gaap_PrepaidExpenseOtherNoncurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_AssetsNoncurrent' xlink:to='us-gaap_PrepaidExpenseOtherNoncurrent' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent' xlink:label='us-gaap_AccountsPayableCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_AccountsPayableCurrent' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnsecuredDebtCurrent' xlink:label='us-gaap_UnsecuredDebtCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_UnsecuredDebtCurrent' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='us-gaap_AccruedLiabilitiesCurrent' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Liabilities' xlink:to='us-gaap_LiabilitiesCurrent' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrent' xlink:label='us-gaap_LiabilitiesNoncurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_Liabilities' xlink:to='us-gaap_LiabilitiesNoncurrent' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent' xlink:label='us-gaap_DerivativeLiabilitiesCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesNoncurrent' xlink:to='us-gaap_DerivativeLiabilitiesCurrent' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_Liabilities' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' xlink:label='us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue' xlink:label='us-gaap_PreferredStockValue'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' xlink:to='us-gaap_PreferredStockValue' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' xlink:to='us-gaap_CommonStockValue' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital' xlink:label='us-gaap_AdditionalPaidInCapital'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' xlink:to='us-gaap_AdditionalPaidInCapital' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' xlink:to='us-gaap_RetainedEarningsAccumulatedDeficit' use='optional' order='4.0' weight='1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_CondensedStatementOfOperationsUnaudited" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_CondensedStatementOfOperationsUnaudited"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_CondensedStatementOfOperationsUnaudited">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit' xlink:label='us-gaap_GrossProfit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNet' xlink:label='us-gaap_SalesRevenueNet'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_GrossProfit' xlink:to='us-gaap_SalesRevenueNet' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenue' xlink:label='us-gaap_CostOfRevenue'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_GrossProfit' xlink:to='us-gaap_CostOfRevenue' use='optional' order='2.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:to='us-gaap_GrossProfit' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpenses' xlink:label='us-gaap_OperatingExpenses'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:to='us-gaap_OperatingExpenses' use='optional' order='2.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonoperatingIncomeExpense' xlink:label='us-gaap_NonoperatingIncomeExpense'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:to='us-gaap_NonoperatingIncomeExpense' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense' xlink:label='us-gaap_GeneralAndAdministrativeExpense'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_OperatingExpenses' xlink:to='us-gaap_GeneralAndAdministrativeExpense' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LaborAndRelatedExpense' xlink:label='us-gaap_LaborAndRelatedExpense'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_OperatingExpenses' xlink:to='us-gaap_LaborAndRelatedExpense' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation' xlink:label='us-gaap_ShareBasedCompensation'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_OperatingExpenses' xlink:to='us-gaap_ShareBasedCompensation' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense' xlink:label='us-gaap_ResearchAndDevelopmentExpense'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_OperatingExpenses' xlink:to='us-gaap_ResearchAndDevelopmentExpense' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentIncomeInterest' xlink:label='us-gaap_InvestmentIncomeInterest'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NonoperatingIncomeExpense' xlink:to='us-gaap_InvestmentIncomeInterest' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncome' xlink:label='us-gaap_OtherNonoperatingIncome'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NonoperatingIncomeExpense' xlink:to='us-gaap_OtherNonoperatingIncome' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax' xlink:label='us-gaap_GainLossOnDerivativeInstrumentsNetPretax'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NonoperatingIncomeExpense' xlink:to='us-gaap_GainLossOnDerivativeInstrumentsNetPretax' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingExpense' xlink:label='us-gaap_OtherNonoperatingExpense'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NonoperatingIncomeExpense' xlink:to='us-gaap_OtherNonoperatingExpense' use='optional' order='4.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-gaap_NetIncomeLoss'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetIncomeLoss' xlink:to='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit' xlink:label='us-gaap_IncomeTaxExpenseBenefit'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetIncomeLoss' xlink:to='us-gaap_IncomeTaxExpenseBenefit' use='optional' order='2.0' weight='-1.0'/>
	</link:calculationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_CondensedStatementsOfCashFlowsUnaudited" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_CondensedStatementsOfCashFlowsUnaudited"/>
	<link:calculationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_CondensedStatementsOfCashFlowsUnaudited">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-gaap_ProfitLoss'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:to='us-gaap_ProfitLoss' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentForAmortization' xlink:label='us-gaap_AdjustmentForAmortization'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:to='us-gaap_AdjustmentForAmortization' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation' xlink:label='us-gaap_Depreciation'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:to='us-gaap_Depreciation' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims' xlink:label='us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:to='us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims' use='optional' order='4.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RecognitionOfDeferredRevenue' xlink:label='us-gaap_RecognitionOfDeferredRevenue'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:to='us-gaap_RecognitionOfDeferredRevenue' use='optional' order='5.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProvisionForLoanAndLeaseLosses' xlink:label='us-gaap_ProvisionForLoanAndLeaseLosses'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:to='us-gaap_ProvisionForLoanAndLeaseLosses' use='optional' order='6.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProvisionForOtherLosses' xlink:label='us-gaap_ProvisionForOtherLosses'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:to='us-gaap_ProvisionForOtherLosses' use='optional' order='7.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:label='us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:to='us-gaap_IncreaseDecreaseInAccountsReceivable' use='optional' order='8.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories' xlink:label='us-gaap_IncreaseDecreaseInInventories'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:to='us-gaap_IncreaseDecreaseInInventories' use='optional' order='9.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:label='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:to='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' use='optional' order='10.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade' xlink:label='us-gaap_IncreaseDecreaseInAccountsPayableTrade'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:to='us-gaap_IncreaseDecreaseInAccountsPayableTrade' use='optional' order='11.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInNotesPayableCurrent' xlink:label='us-gaap_IncreaseDecreaseInNotesPayableCurrent'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:to='us-gaap_IncreaseDecreaseInNotesPayableCurrent' use='optional' order='12.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:to='us-gaap_IncreaseDecreaseInAccruedLiabilities' use='optional' order='13.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect' xlink:label='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect' xlink:to='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivities' use='optional' order='2.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect' xlink:to='us-gaap_NetCashProvidedByUsedInFinancingActivities' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireFurnitureAndFixtures' xlink:label='us-gaap_PaymentsToAcquireFurnitureAndFixtures'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='us-gaap_PaymentsToAcquireFurnitureAndFixtures' use='optional' order='1.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets' xlink:label='us-gaap_PaymentsToAcquireIntangibleAssets'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='us-gaap_PaymentsToAcquireIntangibleAssets' use='optional' order='2.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromCollectionOfLoansReceivable' xlink:label='us-gaap_ProceedsFromCollectionOfLoansReceivable'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='us-gaap_ProceedsFromCollectionOfLoansReceivable' use='optional' order='3.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherPaymentsToAcquireBusinesses' xlink:label='us-gaap_OtherPaymentsToAcquireBusinesses'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='us-gaap_OtherPaymentsToAcquireBusinesses' use='optional' order='4.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries' xlink:label='us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries' use='optional' order='5.0' weight='-1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock' xlink:label='us-gaap_ProceedsFromIssuanceOfCommonStock'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='us-gaap_ProceedsFromIssuanceOfCommonStock' use='optional' order='1.0' weight='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities' xlink:label='us-gaap_ProceedsFromPaymentsForOtherFinancingActivities'/>
		<link:calculationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/summation-item' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='us-gaap_ProceedsFromPaymentsForOtherFinancingActivities' use='optional' order='2.0' weight='1.0'/>
	</link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>sglb-20170930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by edgar-services.com using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2017 [PPXK2X91H1YFVLAJKX0D]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://www.sigmalabs.com/20170930"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DocumentDocumentAndEntityInformation"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_CondensedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_CondensedBalanceSheetsUnaudited"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_CondensedBalanceSheetsUnaudited"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_CondensedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_CondensedBalanceSheetsUnauditedParenthetical"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_CondensedBalanceSheetsUnauditedParenthetical"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_CondensedStatementOfOperationsUnaudited" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_CondensedStatementOfOperationsUnaudited"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_CondensedStatementOfOperationsUnaudited"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_CondensedStatementsOfCashFlowsUnaudited" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_CondensedStatementsOfCashFlowsUnaudited"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_CondensedStatementsOfCashFlowsUnaudited"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE1SummaryOfSignificantAccountingPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPolicies"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquity" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE2StockholdersEquity"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquity"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE3NoteReceivable" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE3NoteReceivable"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE3NoteReceivable"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE4NotesPayable" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE4NotesPayable"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE4NotesPayable"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE5ContinuingOperations" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE5ContinuingOperations"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE5ContinuingOperations"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShare" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE6LossPerShare"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShare"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE7SubsequentEvents" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE7SubsequentEvents"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE7SubsequentEvents"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessPolicies" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessPolicies"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesBasisOfPresentationPolicies" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesBasisOfPresentationPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesBasisOfPresentationPolicies"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesReclassificationPolicies" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesReclassificationPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesReclassificationPolicies"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesLossPerSharePolicies" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesLossPerSharePolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesLossPerSharePolicies"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesRecentlyEnactedAccountingStandardsPolicies" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesRecentlyEnactedAccountingStandardsPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesRecentlyEnactedAccountingStandardsPolicies"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesAccountingEstimatesPolicies" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesAccountingEstimatesPolicies"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesAccountingEstimatesPolicies"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesTables" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesTables"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedTables" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedTables"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedTables"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessDetails" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessDetails"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityDetails" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE2StockholdersEquityDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_TimeReferenceAxis' xlink:label='fil_TimeReferenceAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='fil_TimeReferenceAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_TimeReferenceDomain' xlink:label='fil_TimeReferenceDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='fil_TimeReferenceAxis' xlink:to='fil_TimeReferenceDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_TimeReferenceDomain' xlink:label='fil_TimeReferenceDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='fil_TimeReferenceAxis' xlink:to='fil_TimeReferenceDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_InJanuary2017Member' xlink:label='fil_InJanuary2017Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='fil_TimeReferenceDomain' xlink:to='fil_InJanuary2017Member' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_InFebruary2017Member' xlink:label='fil_InFebruary2017Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='fil_TimeReferenceDomain' xlink:to='fil_InFebruary2017Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding' xlink:label='us-gaap_CommonStockSharesOutstanding'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockSharesOutstanding' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued' xlink:label='us-gaap_CommonStockSharesIssued'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockSharesIssued' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized' xlink:label='us-gaap_CommonStockSharesAuthorized'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockSharesAuthorized' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare' xlink:label='us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockParOrStatedValuePerShare' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther' xlink:label='us-gaap_StockIssuedDuringPeriodSharesOther'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodSharesOther' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesIssued' xlink:label='us-gaap_SharesIssued'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SharesIssued' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharePrice' xlink:label='us-gaap_SharePrice'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SharePrice' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockValue' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized' xlink:label='us-gaap_PreferredStockSharesAuthorized'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockSharesAuthorized' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare' xlink:label='us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockParOrStatedValuePerShare' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued' xlink:label='us-gaap_PreferredStockSharesIssued'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockSharesIssued' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesOutstanding' xlink:label='us-gaap_PreferredStockSharesOutstanding'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockSharesOutstanding' use='optional' order='12.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis' xlink:label='us-gaap_RangeAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_RangeAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember' xlink:label='us-gaap_RangeMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_RangeAxis' xlink:to='us-gaap_RangeMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember' xlink:label='us-gaap_RangeMember_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_RangeAxis' xlink:to='us-gaap_RangeMember_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember' xlink:label='us-gaap_MinimumMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_RangeMember' xlink:to='us-gaap_MinimumMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember' xlink:label='us-gaap_MaximumMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_RangeMember' xlink:to='us-gaap_MaximumMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1' xlink:label='us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum' use='optional' order='6.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE3NoteReceivableDetails" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE3NoteReceivableDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE3NoteReceivableDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CounterpartyNameAxis' xlink:label='us-gaap_CounterpartyNameAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_CounterpartyNameAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain' xlink:label='us-gaap_RepurchaseAgreementCounterpartyNameDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_CounterpartyNameAxis' xlink:to='us-gaap_RepurchaseAgreementCounterpartyNameDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain' xlink:label='us-gaap_RepurchaseAgreementCounterpartyNameDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_CounterpartyNameAxis' xlink:to='us-gaap_RepurchaseAgreementCounterpartyNameDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_AguarPrecisionMachineLlcMember' xlink:label='fil_AguarPrecisionMachineLlcMember'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_RepurchaseAgreementCounterpartyNameDomain' xlink:to='fil_AguarPrecisionMachineLlcMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesAndLoansReceivableGrossNoncurrent' xlink:label='us-gaap_NotesAndLoansReceivableGrossNoncurrent'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_NotesAndLoansReceivableGrossNoncurrent' use='optional' order='1.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE4NotesPayableDetails" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE4NotesPayableDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE4NotesPayableDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis' xlink:label='us-gaap_DebtInstrumentAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_DebtInstrumentAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain' xlink:label='us-gaap_DebtInstrumentNameDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_DebtInstrumentAxis' xlink:to='us-gaap_DebtInstrumentNameDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain' xlink:label='us-gaap_DebtInstrumentNameDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_DebtInstrumentAxis' xlink:to='us-gaap_DebtInstrumentNameDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_Note1Member' xlink:label='fil_Note1Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_DebtInstrumentNameDomain' xlink:to='fil_Note1Member' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_Note2Member' xlink:label='fil_Note2Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_DebtInstrumentNameDomain' xlink:to='fil_Note2Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentIssuanceDate1' xlink:label='us-gaap_DebtInstrumentIssuanceDate1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentIssuanceDate1' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentDescription' xlink:label='us-gaap_DebtInstrumentDescription'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentDescription' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFaceAmount' xlink:label='us-gaap_DebtInstrumentFaceAmount'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentFaceAmount' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage' xlink:label='us-gaap_DebtInstrumentInterestRateStatedPercentage'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentInterestRateStatedPercentage' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentCollateral' xlink:label='us-gaap_DebtInstrumentCollateral'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentCollateral' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature' xlink:label='us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature' use='optional' order='6.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails"/>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE7SubsequentEventsDetails" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE7SubsequentEventsDetails"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE7SubsequentEventsDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis' xlink:label='us-gaap_SubsequentEventTypeAxis'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/hypercube-dimension' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_SubsequentEventTypeAxis' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain' xlink:label='us-gaap_SubsequentEventTypeDomain'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-domain' xlink:from='us-gaap_SubsequentEventTypeAxis' xlink:to='us-gaap_SubsequentEventTypeDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain' xlink:label='us-gaap_SubsequentEventTypeDomain_1'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/dimension-default' xlink:from='us-gaap_SubsequentEventTypeAxis' xlink:to='us-gaap_SubsequentEventTypeDomain_1' use='optional' order='1.0' xbrldt:contextElement='segment'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_Event1Member' xlink:label='fil_Event1Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_SubsequentEventTypeDomain' xlink:to='fil_Event1Member' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_Event2Member' xlink:label='fil_Event2Member'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_SubsequentEventTypeDomain' xlink:to='fil_Event2Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsDate' xlink:label='us-gaap_SubsequentEventsDate'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SubsequentEventsDate' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventDescription' xlink:label='us-gaap_SubsequentEventDescription'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/domain-member' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SubsequentEventDescription' use='optional' order='2.0'/>
		<link:definitionArc xlink:type='arc' xlink:arcrole='http://xbrl.org/int/dim/arcrole/all' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StatementTable' order='0.5' xbrldt:closed='true' xbrldt:contextElement='segment' use='optional'/>
	</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>9
<FILENAME>sglb-20170930.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by edgar-services.com using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2017 [PPXK2X91H1YFVLAJKX0D]. www.edgarsuite.com -->
<xbrl xmlns:nonnum='http://www.xbrl.org/dtr/type/non-numeric' xmlns='http://www.xbrl.org/2003/instance' xmlns:us-gaap='http://fasb.org/us-gaap/2017-01-31' xmlns:xbrldi='http://xbrl.org/2006/xbrldi' xmlns:dei='http://xbrl.sec.gov/dei/2014-01-31' xmlns:fil='http://www.sigmalabs.com/20170930' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:utr='http://www.xbrl.org/2009/utr' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:iso4217='http://www.xbrl.org/2003/iso4217' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns:xbrli='http://www.xbrl.org/2003/instance'>
	<link:schemaRef xlink:type='simple' xlink:href='sglb-20170930.xsd' />
	<dei:EntityRegistrantName contextRef='D170101_170930'>SIGMA LABS, INC.</dei:EntityRegistrantName>
	<dei:EntityCentralIndexKey contextRef='D170101_170930'>0000788611</dei:EntityCentralIndexKey>
	<dei:CurrentFiscalYearEndDate contextRef='D170101_170930'>--12-31</dei:CurrentFiscalYearEndDate>
	<dei:TradingSymbol contextRef='D170101_170930'>sglb</dei:TradingSymbol>
	<dei:EntityCurrentReportingStatus contextRef='D170101_170930'>Yes</dei:EntityCurrentReportingStatus>
	<dei:EntityVoluntaryFilers contextRef='D170101_170930'>No</dei:EntityVoluntaryFilers>
	<dei:EntityWellKnownSeasonedIssuer contextRef='D170101_170930'>No</dei:EntityWellKnownSeasonedIssuer>
	<dei:AmendmentFlag contextRef='D170101_170930'>false</dei:AmendmentFlag>
	<dei:DocumentFiscalYearFocus contextRef='D170101_170930'>2017</dei:DocumentFiscalYearFocus>
	<dei:DocumentFiscalPeriodFocus contextRef='D170101_170930'>Q3</dei:DocumentFiscalPeriodFocus>
	<dei:DocumentType contextRef='D170101_170930'>10-Q</dei:DocumentType>
	<dei:DocumentPeriodEndDate contextRef='D170101_170930'>2017-09-30</dei:DocumentPeriodEndDate>
	<dei:EntityTaxIdentificationNumber contextRef='D170101_170930'>271865814</dei:EntityTaxIdentificationNumber>
	<dei:EntityAddressAddressLine1 contextRef='D170101_170930'>3900 Paseo del Sol</dei:EntityAddressAddressLine1>
	<dei:EntityAddressCityOrTown contextRef='D170101_170930'>Santa Fe</dei:EntityAddressCityOrTown>
	<dei:EntityAddressStateOrProvince contextRef='D170101_170930'>NM</dei:EntityAddressStateOrProvince>
	<dei:EntityAddressPostalZipCode contextRef='D170101_170930'>87507</dei:EntityAddressPostalZipCode>
	<dei:CityAreaCode contextRef='D170101_170930'>505</dei:CityAreaCode>
	<dei:LocalPhoneNumber contextRef='D170101_170930'>438-2576</dei:LocalPhoneNumber>
	<dei:EntityFilerCategory contextRef='D170101_170930'>Smaller Reporting Company</dei:EntityFilerCategory>
	<dei:EntityCommonStockSharesOutstanding decimals='INF' contextRef='I170814' unitRef='Shares'>4718651</dei:EntityCommonStockSharesOutstanding>
	<us-gaap:AccountsReceivableNetCurrent decimals='INF' contextRef='E17Q3' unitRef='USD'>105725</us-gaap:AccountsReceivableNetCurrent>
	<us-gaap:AccountsReceivableNetCurrent decimals='INF' contextRef='E16' unitRef='USD'>288236</us-gaap:AccountsReceivableNetCurrent>
	<us-gaap:NotesAndLoansReceivableNetCurrent decimals='INF' contextRef='E17Q3' unitRef='USD'>775267</us-gaap:NotesAndLoansReceivableNetCurrent>
	<us-gaap:NotesAndLoansReceivableNetCurrent decimals='INF' contextRef='E16' unitRef='USD'>0</us-gaap:NotesAndLoansReceivableNetCurrent>
	<us-gaap:InventoryNet decimals='INF' contextRef='E17Q3' unitRef='USD'>188907</us-gaap:InventoryNet>
	<us-gaap:InventoryNet decimals='INF' contextRef='E16' unitRef='USD'>187241</us-gaap:InventoryNet>
	<us-gaap:PrepaidExpenseCurrent decimals='INF' contextRef='E17Q3' unitRef='USD'>49896</us-gaap:PrepaidExpenseCurrent>
	<us-gaap:PrepaidExpenseCurrent decimals='INF' contextRef='E16' unitRef='USD'>36056</us-gaap:PrepaidExpenseCurrent>
	<us-gaap:AssetsCurrent decimals='INF' contextRef='E17Q3' unitRef='USD'>3811282</us-gaap:AssetsCurrent>
	<us-gaap:AssetsCurrent decimals='INF' contextRef='E16' unitRef='USD'>909924</us-gaap:AssetsCurrent>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E17Q3' unitRef='USD'>446449</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet decimals='INF' contextRef='E16' unitRef='USD'>564933</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill decimals='INF' contextRef='E17Q3' unitRef='USD'>261660</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill decimals='INF' contextRef='E16' unitRef='USD'>226450</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:BusinessCombinationContingentConsiderationAssetNoncurrent decimals='INF' contextRef='E17Q3' unitRef='USD'>500</us-gaap:BusinessCombinationContingentConsiderationAssetNoncurrent>
	<us-gaap:BusinessCombinationContingentConsiderationAssetNoncurrent decimals='INF' contextRef='E16' unitRef='USD'>500</us-gaap:BusinessCombinationContingentConsiderationAssetNoncurrent>
	<us-gaap:PrepaidExpenseOtherNoncurrent decimals='INF' contextRef='E17Q3' unitRef='USD'>49528</us-gaap:PrepaidExpenseOtherNoncurrent>
	<us-gaap:PrepaidExpenseOtherNoncurrent decimals='INF' contextRef='E16' unitRef='USD'>167562</us-gaap:PrepaidExpenseOtherNoncurrent>
	<us-gaap:AssetsNoncurrent decimals='INF' contextRef='E17Q3' unitRef='USD'>758137</us-gaap:AssetsNoncurrent>
	<us-gaap:AssetsNoncurrent decimals='INF' contextRef='E16' unitRef='USD'>959445</us-gaap:AssetsNoncurrent>
	<us-gaap:Assets decimals='INF' contextRef='E17Q3' unitRef='USD'>4569419</us-gaap:Assets>
	<us-gaap:Assets decimals='INF' contextRef='E16' unitRef='USD'>1869369</us-gaap:Assets>
	<us-gaap:AccountsPayableCurrent decimals='INF' contextRef='E17Q3' unitRef='USD'>114747</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccountsPayableCurrent decimals='INF' contextRef='E16' unitRef='USD'>112175</us-gaap:AccountsPayableCurrent>
	<fil:CostOfGoodsSoldDiscontinuedOperations decimals='INF' contextRef='E17Q3' unitRef='USD'>5091</fil:CostOfGoodsSoldDiscontinuedOperations>
	<fil:CostOfGoodsSoldDiscontinuedOperations decimals='INF' contextRef='E16' unitRef='USD'>69703</fil:CostOfGoodsSoldDiscontinuedOperations>
	<fil:NotesPayableDebtDiscount decimals='INF' contextRef='E16' unitRef='USD'>358280</fil:NotesPayableDebtDiscount>
	<us-gaap:UnsecuredDebtCurrent decimals='INF' contextRef='E17Q3' unitRef='USD'>994909</us-gaap:UnsecuredDebtCurrent>
	<us-gaap:UnsecuredDebtCurrent decimals='INF' contextRef='E16' unitRef='USD'>561834</us-gaap:UnsecuredDebtCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E17Q3' unitRef='USD'>219570</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent decimals='INF' contextRef='E16' unitRef='USD'>125116</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent decimals='INF' contextRef='E17Q3' unitRef='USD'>1329226</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent decimals='INF' contextRef='E16' unitRef='USD'>799125</us-gaap:LiabilitiesCurrent>
	<us-gaap:DerivativeLiabilitiesCurrent decimals='INF' contextRef='E17Q3' unitRef='USD'>0</us-gaap:DerivativeLiabilitiesCurrent>
	<us-gaap:DerivativeLiabilitiesCurrent decimals='INF' contextRef='E16' unitRef='USD'>93206</us-gaap:DerivativeLiabilitiesCurrent>
	<us-gaap:LiabilitiesNoncurrent decimals='INF' contextRef='E17Q3' unitRef='USD'>0</us-gaap:LiabilitiesNoncurrent>
	<us-gaap:LiabilitiesNoncurrent decimals='INF' contextRef='E16' unitRef='USD'>93206</us-gaap:LiabilitiesNoncurrent>
	<us-gaap:Liabilities decimals='INF' contextRef='E17Q3' unitRef='USD'>1329226</us-gaap:Liabilities>
	<us-gaap:Liabilities decimals='INF' contextRef='E16' unitRef='USD'>892331</us-gaap:Liabilities>
	<us-gaap:PreferredStockParOrStatedValuePerShare decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockSharesAuthorized decimals='INF' contextRef='E16' unitRef='Shares'>10000000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesIssued decimals='INF' contextRef='E16' unitRef='Shares'>0</us-gaap:PreferredStockSharesIssued>
	<us-gaap:PreferredStockSharesOutstanding decimals='INF' contextRef='E16' unitRef='Shares'>0</us-gaap:PreferredStockSharesOutstanding>
	<us-gaap:PreferredStockValue decimals='INF' contextRef='E17Q3' unitRef='USD'>0</us-gaap:PreferredStockValue>
	<us-gaap:PreferredStockValue decimals='INF' contextRef='E16' unitRef='USD'>0</us-gaap:PreferredStockValue>
	<us-gaap:CommonStockParOrStatedValuePerShare decimals='INF' contextRef='E17Q3' unitRef='UsdPerShare'>0.001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare decimals='INF' contextRef='E16' unitRef='UsdPerShare'>0.001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockSharesAuthorized decimals='INF' contextRef='E17Q3' unitRef='Shares'>7500000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesAuthorized decimals='INF' contextRef='E16' unitRef='Shares'>7500000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesIssued decimals='INF' contextRef='E16' unitRef='Shares'>3133789</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesOutstanding decimals='INF' contextRef='E16' unitRef='Shares'>3133789</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockValue decimals='INF' contextRef='E17Q3' unitRef='USD'>4578</us-gaap:CommonStockValue>
	<us-gaap:CommonStockValue decimals='INF' contextRef='E16' unitRef='USD'>3135</us-gaap:CommonStockValue>
	<us-gaap:AdditionalPaidInCapital decimals='INF' contextRef='E17Q3' unitRef='USD'>16046185</us-gaap:AdditionalPaidInCapital>
	<us-gaap:AdditionalPaidInCapital decimals='INF' contextRef='E16' unitRef='USD'>10734857</us-gaap:AdditionalPaidInCapital>
	<us-gaap:RetainedEarningsAccumulatedDeficit decimals='INF' contextRef='E17Q3' unitRef='USD'>-12810570</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RetainedEarningsAccumulatedDeficit decimals='INF' contextRef='E16' unitRef='USD'>-9760954</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest decimals='INF' contextRef='E17Q3' unitRef='USD'>3240193</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest decimals='INF' contextRef='E16' unitRef='USD'>977038</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
	<us-gaap:LiabilitiesAndStockholdersEquity decimals='INF' contextRef='E17Q3' unitRef='USD'>4569419</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity decimals='INF' contextRef='E16' unitRef='USD'>1869369</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:SalesRevenueNet decimals='INF' contextRef='Y17Q3' unitRef='USD'>78046</us-gaap:SalesRevenueNet>
	<us-gaap:SalesRevenueNet decimals='INF' contextRef='Y16Q3' unitRef='USD'>189952</us-gaap:SalesRevenueNet>
	<us-gaap:SalesRevenueNet decimals='INF' contextRef='D170101_170930' unitRef='USD'>518802</us-gaap:SalesRevenueNet>
	<us-gaap:SalesRevenueNet decimals='INF' contextRef='D160101_160930' unitRef='USD'>642230</us-gaap:SalesRevenueNet>
	<us-gaap:CostOfRevenue decimals='INF' contextRef='Y17Q3' unitRef='USD'>81214</us-gaap:CostOfRevenue>
	<us-gaap:CostOfRevenue decimals='INF' contextRef='Y16Q3' unitRef='USD'>69259</us-gaap:CostOfRevenue>
	<us-gaap:CostOfRevenue decimals='INF' contextRef='D170101_170930' unitRef='USD'>267160</us-gaap:CostOfRevenue>
	<us-gaap:CostOfRevenue decimals='INF' contextRef='D160101_160930' unitRef='USD'>207744</us-gaap:CostOfRevenue>
	<us-gaap:GrossProfit decimals='INF' contextRef='Y17Q3' unitRef='USD'>-3168</us-gaap:GrossProfit>
	<us-gaap:GrossProfit decimals='INF' contextRef='Y16Q3' unitRef='USD'>120693</us-gaap:GrossProfit>
	<us-gaap:GrossProfit decimals='INF' contextRef='D170101_170930' unitRef='USD'>251642</us-gaap:GrossProfit>
	<us-gaap:GrossProfit decimals='INF' contextRef='D160101_160930' unitRef='USD'>434486</us-gaap:GrossProfit>
	<us-gaap:GeneralAndAdministrativeExpense decimals='INF' contextRef='Y17Q3' unitRef='USD'>576855</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense decimals='INF' contextRef='Y16Q3' unitRef='USD'>437870</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense decimals='INF' contextRef='D170101_170930' unitRef='USD'>1814843</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense decimals='INF' contextRef='D160101_160930' unitRef='USD'>1314055</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:LaborAndRelatedExpense decimals='INF' contextRef='Y17Q3' unitRef='USD'>295890</us-gaap:LaborAndRelatedExpense>
	<us-gaap:LaborAndRelatedExpense decimals='INF' contextRef='Y16Q3' unitRef='USD'>259010</us-gaap:LaborAndRelatedExpense>
	<us-gaap:LaborAndRelatedExpense decimals='INF' contextRef='D170101_170930' unitRef='USD'>973172</us-gaap:LaborAndRelatedExpense>
	<us-gaap:LaborAndRelatedExpense decimals='INF' contextRef='D160101_160930' unitRef='USD'>727494</us-gaap:LaborAndRelatedExpense>
	<us-gaap:ShareBasedCompensation decimals='INF' contextRef='Y17Q3' unitRef='USD'>199225</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation decimals='INF' contextRef='Y16Q3' unitRef='USD'>105641</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation decimals='INF' contextRef='D170101_170930' unitRef='USD'>505630</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation decimals='INF' contextRef='D160101_160930' unitRef='USD'>236554</us-gaap:ShareBasedCompensation>
	<us-gaap:ResearchAndDevelopmentExpense decimals='INF' contextRef='Y17Q3' unitRef='USD'>57947</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:ResearchAndDevelopmentExpense decimals='INF' contextRef='Y16Q3' unitRef='USD'>37526</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:ResearchAndDevelopmentExpense decimals='INF' contextRef='D170101_170930' unitRef='USD'>225562</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:ResearchAndDevelopmentExpense decimals='INF' contextRef='D160101_160930' unitRef='USD'>88504</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:OperatingExpenses decimals='INF' contextRef='Y17Q3' unitRef='USD'>1129917</us-gaap:OperatingExpenses>
	<us-gaap:OperatingExpenses decimals='INF' contextRef='Y16Q3' unitRef='USD'>840047</us-gaap:OperatingExpenses>
	<us-gaap:OperatingExpenses decimals='INF' contextRef='D170101_170930' unitRef='USD'>3519207</us-gaap:OperatingExpenses>
	<us-gaap:OperatingExpenses decimals='INF' contextRef='D160101_160930' unitRef='USD'>2366607</us-gaap:OperatingExpenses>
	<us-gaap:InvestmentIncomeInterest decimals='INF' contextRef='Y17Q3' unitRef='USD'>13675</us-gaap:InvestmentIncomeInterest>
	<us-gaap:InvestmentIncomeInterest decimals='INF' contextRef='Y16Q3' unitRef='USD'>35</us-gaap:InvestmentIncomeInterest>
	<us-gaap:InvestmentIncomeInterest decimals='INF' contextRef='D170101_170930' unitRef='USD'>26616</us-gaap:InvestmentIncomeInterest>
	<us-gaap:InvestmentIncomeInterest decimals='INF' contextRef='D160101_160930' unitRef='USD'>288</us-gaap:InvestmentIncomeInterest>
	<us-gaap:OtherNonoperatingIncome decimals='INF' contextRef='Y17Q3' unitRef='USD'>2500</us-gaap:OtherNonoperatingIncome>
	<us-gaap:OtherNonoperatingIncome decimals='INF' contextRef='Y16Q3' unitRef='USD'>0</us-gaap:OtherNonoperatingIncome>
	<us-gaap:OtherNonoperatingIncome decimals='INF' contextRef='D170101_170930' unitRef='USD'>154568</us-gaap:OtherNonoperatingIncome>
	<us-gaap:OtherNonoperatingIncome decimals='INF' contextRef='D160101_160930' unitRef='USD'>0</us-gaap:OtherNonoperatingIncome>
	<us-gaap:GainLossOnDerivativeInstrumentsNetPretax decimals='INF' contextRef='Y17Q3' unitRef='USD'>0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
	<us-gaap:GainLossOnDerivativeInstrumentsNetPretax decimals='INF' contextRef='Y16Q3' unitRef='USD'>0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
	<us-gaap:GainLossOnDerivativeInstrumentsNetPretax decimals='INF' contextRef='D170101_170930' unitRef='USD'>93206</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
	<us-gaap:GainLossOnDerivativeInstrumentsNetPretax decimals='INF' contextRef='D160101_160930' unitRef='USD'>0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
	<us-gaap:OtherNonoperatingExpense decimals='INF' contextRef='Y17Q3' unitRef='USD'>0</us-gaap:OtherNonoperatingExpense>
	<us-gaap:OtherNonoperatingExpense decimals='INF' contextRef='Y16Q3' unitRef='USD'>0</us-gaap:OtherNonoperatingExpense>
	<us-gaap:OtherNonoperatingExpense decimals='INF' contextRef='D170101_170930' unitRef='USD'>56441</us-gaap:OtherNonoperatingExpense>
	<us-gaap:OtherNonoperatingExpense decimals='INF' contextRef='D160101_160930' unitRef='USD'>0</us-gaap:OtherNonoperatingExpense>
	<us-gaap:NonoperatingIncomeExpense decimals='INF' contextRef='Y17Q3' unitRef='USD'>16175</us-gaap:NonoperatingIncomeExpense>
	<us-gaap:NonoperatingIncomeExpense decimals='INF' contextRef='Y16Q3' unitRef='USD'>35</us-gaap:NonoperatingIncomeExpense>
	<us-gaap:NonoperatingIncomeExpense decimals='INF' contextRef='D170101_170930' unitRef='USD'>217949</us-gaap:NonoperatingIncomeExpense>
	<us-gaap:NonoperatingIncomeExpense decimals='INF' contextRef='D160101_160930' unitRef='USD'>288</us-gaap:NonoperatingIncomeExpense>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest decimals='INF' contextRef='Y17Q3' unitRef='USD'>-1116910</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest decimals='INF' contextRef='Y16Q3' unitRef='USD'>-719320</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
	<us-gaap:IncomeTaxExpenseBenefit decimals='INF' contextRef='Y17Q3' unitRef='USD'>0</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit decimals='INF' contextRef='Y16Q3' unitRef='USD'>0</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit decimals='INF' contextRef='D170101_170930' unitRef='USD'>0</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit decimals='INF' contextRef='D160101_160930' unitRef='USD'>0</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='Y17Q3' unitRef='USD'>-1116910</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='Y16Q3' unitRef='USD'>-719320</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='D170101_170930' unitRef='USD'>-3049616</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss decimals='INF' contextRef='D160101_160930' unitRef='USD'>-1931833</us-gaap:NetIncomeLoss>
	<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='Y17Q3' unitRef='UsdPerShare'>-0.24</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='Y16Q3' unitRef='UsdPerShare'>-0.23</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='D170101_170930' unitRef='UsdPerShare'>-0.70</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:EarningsPerShareBasicAndDiluted decimals='INF' contextRef='D160101_160930' unitRef='UsdPerShare'>-0.62</us-gaap:EarningsPerShareBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted decimals='INF' contextRef='Y17Q3' unitRef='Shares'>4574460</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted decimals='INF' contextRef='Y16Q3' unitRef='Shares'>3129675</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:ProfitLoss decimals='INF' contextRef='D170101_170930' unitRef='USD'>-3049616</us-gaap:ProfitLoss>
	<us-gaap:ProfitLoss decimals='INF' contextRef='D160101_160930' unitRef='USD'>-1931833</us-gaap:ProfitLoss>
	<us-gaap:AdjustmentForAmortization decimals='INF' contextRef='D170101_170930' unitRef='USD'>2289</us-gaap:AdjustmentForAmortization>
	<us-gaap:AdjustmentForAmortization decimals='INF' contextRef='D160101_160930' unitRef='USD'>6526</us-gaap:AdjustmentForAmortization>
	<us-gaap:Depreciation decimals='INF' contextRef='D170101_170930' unitRef='USD'>134865</us-gaap:Depreciation>
	<us-gaap:Depreciation decimals='INF' contextRef='D160101_160930' unitRef='USD'>131879</us-gaap:Depreciation>
	<us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims decimals='INF' contextRef='D170101_170930' unitRef='USD'>506994</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
	<us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims decimals='INF' contextRef='D160101_160930' unitRef='USD'>240756</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
	<us-gaap:RecognitionOfDeferredRevenue decimals='INF' contextRef='D170101_170930' unitRef='USD'>93206</us-gaap:RecognitionOfDeferredRevenue>
	<us-gaap:RecognitionOfDeferredRevenue decimals='INF' contextRef='D160101_160930' unitRef='USD'>0</us-gaap:RecognitionOfDeferredRevenue>
	<us-gaap:ProvisionForLoanAndLeaseLosses decimals='INF' contextRef='D170101_170930' unitRef='USD'>74794</us-gaap:ProvisionForLoanAndLeaseLosses>
	<us-gaap:ProvisionForLoanAndLeaseLosses decimals='INF' contextRef='D160101_160930' unitRef='USD'>0</us-gaap:ProvisionForLoanAndLeaseLosses>
	<us-gaap:ProvisionForOtherLosses decimals='INF' contextRef='D170101_170930' unitRef='USD'>56441</us-gaap:ProvisionForOtherLosses>
	<us-gaap:ProvisionForOtherLosses decimals='INF' contextRef='D160101_160930' unitRef='USD'>0</us-gaap:ProvisionForOtherLosses>
	<us-gaap:IncreaseDecreaseInAccountsReceivable decimals='INF' contextRef='D170101_170930' unitRef='USD'>-182511</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInAccountsReceivable decimals='INF' contextRef='D160101_160930' unitRef='USD'>-160623</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInInventories decimals='INF' contextRef='D170101_170930' unitRef='USD'>1666</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInInventories decimals='INF' contextRef='D160101_160930' unitRef='USD'>64530</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets decimals='INF' contextRef='D170101_170930' unitRef='USD'>13840</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
	<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets decimals='INF' contextRef='D160101_160930' unitRef='USD'>-4590</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
	<us-gaap:IncreaseDecreaseInAccountsPayableTrade decimals='INF' contextRef='D170101_170930' unitRef='USD'>2572</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
	<us-gaap:IncreaseDecreaseInAccountsPayableTrade decimals='INF' contextRef='D160101_160930' unitRef='USD'>104824</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
	<us-gaap:IncreaseDecreaseInNotesPayableCurrent decimals='INF' contextRef='D170101_170930' unitRef='USD'>301839</us-gaap:IncreaseDecreaseInNotesPayableCurrent>
	<us-gaap:IncreaseDecreaseInNotesPayableCurrent decimals='INF' contextRef='D160101_160930' unitRef='USD'>0</us-gaap:IncreaseDecreaseInNotesPayableCurrent>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities decimals='INF' contextRef='D170101_170930' unitRef='USD'>94454</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities decimals='INF' contextRef='D160101_160930' unitRef='USD'>24799</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations decimals='INF' contextRef='D170101_170930' unitRef='USD'>-1801569</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
	<us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations decimals='INF' contextRef='D160101_160930' unitRef='USD'>-1322366</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
	<us-gaap:PaymentsToAcquireFurnitureAndFixtures decimals='INF' contextRef='D170101_170930' unitRef='USD'>16381</us-gaap:PaymentsToAcquireFurnitureAndFixtures>
	<us-gaap:PaymentsToAcquireFurnitureAndFixtures decimals='INF' contextRef='D160101_160930' unitRef='USD'>26907</us-gaap:PaymentsToAcquireFurnitureAndFixtures>
	<us-gaap:PaymentsToAcquireIntangibleAssets decimals='INF' contextRef='D170101_170930' unitRef='USD'>37498</us-gaap:PaymentsToAcquireIntangibleAssets>
	<us-gaap:PaymentsToAcquireIntangibleAssets decimals='INF' contextRef='D160101_160930' unitRef='USD'>61556</us-gaap:PaymentsToAcquireIntangibleAssets>
	<us-gaap:ProceedsFromCollectionOfLoansReceivable decimals='INF' contextRef='D170101_170930' unitRef='USD'>-775267</us-gaap:ProceedsFromCollectionOfLoansReceivable>
	<us-gaap:ProceedsFromCollectionOfLoansReceivable decimals='INF' contextRef='D160101_160930' unitRef='USD'>0</us-gaap:ProceedsFromCollectionOfLoansReceivable>
	<us-gaap:OtherPaymentsToAcquireBusinesses decimals='INF' contextRef='D170101_170930' unitRef='USD'>0</us-gaap:OtherPaymentsToAcquireBusinesses>
	<us-gaap:OtherPaymentsToAcquireBusinesses decimals='INF' contextRef='D160101_160930' unitRef='USD'>-8617</us-gaap:OtherPaymentsToAcquireBusinesses>
	<us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries decimals='INF' contextRef='D170101_170930' unitRef='USD'>0</us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries>
	<us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries decimals='INF' contextRef='D160101_160930' unitRef='USD'>-105</us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities decimals='INF' contextRef='D170101_170930' unitRef='USD'>-829146</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities decimals='INF' contextRef='D160101_160930' unitRef='USD'>-79741</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:ProceedsFromIssuanceOfCommonStock decimals='INF' contextRef='D170101_170930' unitRef='USD'>5225650</us-gaap:ProceedsFromIssuanceOfCommonStock>
	<us-gaap:ProceedsFromIssuanceOfCommonStock decimals='INF' contextRef='D160101_160930' unitRef='USD'>0</us-gaap:ProceedsFromIssuanceOfCommonStock>
	<us-gaap:ProceedsFromPaymentsForOtherFinancingActivities decimals='INF' contextRef='D170101_170930' unitRef='USD'>-301839</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
	<us-gaap:ProceedsFromPaymentsForOtherFinancingActivities decimals='INF' contextRef='D160101_160930' unitRef='USD'>0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities decimals='INF' contextRef='D170101_170930' unitRef='USD'>4923811</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities decimals='INF' contextRef='D160101_160930' unitRef='USD'>0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect decimals='INF' contextRef='D170101_170930' unitRef='USD'>2293096</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect decimals='INF' contextRef='D160101_160930' unitRef='USD'>-1402107</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF' contextRef='E16' unitRef='USD'>398391</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF' contextRef='E15' unitRef='USD'>1539809</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF' contextRef='E17Q3' unitRef='USD'>2691487</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue decimals='INF' contextRef='E16Q3' unitRef='USD'>137702</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:InterestPaid decimals='INF' contextRef='D170101_170930' unitRef='USD'>50418</us-gaap:InterestPaid>
	<us-gaap:InterestPaid decimals='INF' contextRef='D160101_160930' unitRef='USD'>0</us-gaap:InterestPaid>
	<us-gaap:IncomeTaxesPaidNet decimals='INF' contextRef='D170101_170930' unitRef='USD'>0</us-gaap:IncomeTaxesPaidNet>
	<us-gaap:IncomeTaxesPaidNet decimals='INF' contextRef='D160101_160930' unitRef='USD'>0</us-gaap:IncomeTaxesPaidNet>
	<us-gaap:StockIssuedDuringPeriodValueIssuedForServices decimals='INF' contextRef='D170101_170930' unitRef='USD'>85408</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
	<us-gaap:StockIssuedDuringPeriodValueIssuedForServices decimals='INF' contextRef='D160101_160930' unitRef='USD'>152265</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
	<us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 decimals='INF' contextRef='D170101_170930' unitRef='USD'>-301839</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
	<us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 decimals='INF' contextRef='D160101_160930' unitRef='USD'>0</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
	<us-gaap:SignificantAccountingPoliciesTextBlock contextRef='D170101_170930'>&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;NOTE 1 &amp;#150; Summary of Significant Accounting Policies&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;Nature of Business &amp;#150; &lt;/b&gt;On September 13, 2010 Sigma Labs, Inc., formerly named Framewaves, Inc., a Nevada corporation, acquired 100% of the shares of B6 Sigma, Inc. by exchanging 6.67 shares of Framewaves, Inc. restricted common stock for each issued and outstanding share of B6 Sigma, Inc. The acquisition has been accounted for as a &amp;#147;reverse merger&amp;#148; and, accordingly, the operations of Framewaves, Inc. prior to the date of acquisition have been eliminated. Unless otherwise indicated or the context otherwise requires, the term &amp;#147;B6 Sigma&amp;#148; refers to B6 Sigma, Inc., a Delaware corporation, which, until the short-form merger referenced below, was our wholly-owned, operating company acquired in September 2010; the terms the &amp;#147;Company,&amp;#148; &amp;#147;Sigma,&amp;#148; &amp;#147;we,&amp;#148; &amp;#147;us&amp;#148; and &amp;#147;our&amp;#148; refer to Sigma Labs, Inc., together with B6 Sigma, Inc. Prior to December 29, 2015, we conducted substantially all of our operations through B6 Sigma. On December 29, 2015, we completed a short-form merger of B6 Sigma into Sigma. As a result, B6 Sigma became part of Sigma and no longer exists as a subsidiary.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none&apos;&gt;B6 Sigma, Inc., incorporated February 5, 2010, was founded by a group of scientists, engineers and businessmen to develop and commercialize novel and unique manufacturing and materials technologies. The Company believes that some of these technologies will fundamentally redefine conventional quality assurance and process control practices by embedding them into the manufacturing processes in real time, enabling process intervention and ultimately leading to closed loop process control. The Company anticipates that its core technologies will allow its clientele to combine advanced manufacturing quality assurance and process control protocols with novel materials to achieve breakthrough product potential in many industries including aerospace, defense, oil and gas, bio-medical, and power generation.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:none&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt; &amp;#150; The accompanying financial statements have been prepared by the Company in accordance with Article 8 of U.S. Securities and Exchange Commission Regulation S-X. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2017 and 2016 and for the periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. The Company suggests these condensed financial statements be read in conjunction with the December 31, 2016 audited financial statements and notes thereto included in the Company&amp;#146;s Form 10-K. The results of operations for the periods ended September 30, 2017 and 2016 are not necessarily indicative of the operating results for the full year.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;Reclassification&lt;/b&gt; &amp;#150; Certain amounts in prior-period financial statements have been reclassified for comparative purposes to conform to presentation in the current-period financial statements.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;Loss Per Share &amp;#150; &lt;/b&gt;The computation of loss per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, &amp;#147;Earnings Per Share.&amp;#148;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;Recently Enacted Accounting Standards&lt;/b&gt; &amp;#150; The FASB established the Accounting Standards Codification (&amp;#147;Codification&amp;#148; or &amp;#147;ASC&amp;#148;) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States (&amp;#147;GAAP&amp;#148;). Rules and interpretive releases of the Securities and Exchange Commission (&amp;#147;SEC&amp;#148;) issued under authority of federal securities laws are also sources of GAAP for SEC registrants.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Recent Accounting Standards Updates (&amp;#147;ASU&amp;#148;) through ASU No. 2015-01 contain technical corrections to existing guidance or affects guidance to specialized industries or situations. The Company has evaluated recently issued technical pronouncements and has determined that these updates have no current applicability to the Company or their effect on the financial statements would not have been significant.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;Accounting Estimates&lt;/b&gt; - The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowance for bad debts and inventory obsolescence.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
	<us-gaap:NatureOfOperations contextRef='D170101_170930'>&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;Nature of Business &amp;#150; &lt;/b&gt;On September 13, 2010 Sigma Labs, Inc., formerly named Framewaves, Inc., a Nevada corporation, acquired 100% of the shares of B6 Sigma, Inc. by exchanging 6.67 shares of Framewaves, Inc. restricted common stock for each issued and outstanding share of B6 Sigma, Inc. The acquisition has been accounted for as a &amp;#147;reverse merger&amp;#148; and, accordingly, the operations of Framewaves, Inc. prior to the date of acquisition have been eliminated. Unless otherwise indicated or the context otherwise requires, the term &amp;#147;B6 Sigma&amp;#148; refers to B6 Sigma, Inc., a Delaware corporation, which, until the short-form merger referenced below, was our wholly-owned, operating company acquired in September 2010; the terms the &amp;#147;Company,&amp;#148; &amp;#147;Sigma,&amp;#148; &amp;#147;we,&amp;#148; &amp;#147;us&amp;#148; and &amp;#147;our&amp;#148; refer to Sigma Labs, Inc., together with B6 Sigma, Inc. Prior to December 29, 2015, we conducted substantially all of our operations through B6 Sigma. On December 29, 2015, we completed a short-form merger of B6 Sigma into Sigma. As a result, B6 Sigma became part of Sigma and no longer exists as a subsidiary.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none&apos;&gt;B6 Sigma, Inc., incorporated February 5, 2010, was founded by a group of scientists, engineers and businessmen to develop and commercialize novel and unique manufacturing and materials technologies. The Company believes that some of these technologies will fundamentally redefine conventional quality assurance and process control practices by embedding them into the manufacturing processes in real time, enabling process intervention and ultimately leading to closed loop process control. The Company anticipates that its core technologies will allow its clientele to combine advanced manufacturing quality assurance and process control protocols with novel materials to achieve breakthrough product potential in many industries including aerospace, defense, oil and gas, bio-medical, and power generation.&lt;/p&gt;</us-gaap:NatureOfOperations>
	<dei:EntityInformationDateToChangeFormerLegalOrRegisteredName contextRef='D170101_170930'>2010-09-13</dei:EntityInformationDateToChangeFormerLegalOrRegisteredName>
	<dei:EntityInformationFormerLegalOrRegisteredName contextRef='D170101_170930'>Framewaves, Inc.</dei:EntityInformationFormerLegalOrRegisteredName>
	<dei:EntityIncorporationStateCountryName contextRef='D170101_170930'>Nevada</dei:EntityIncorporationStateCountryName>
	<us-gaap:BasisOfAccounting contextRef='D170101_170930'>&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt; &amp;#150; The accompanying financial statements have been prepared by the Company in accordance with Article 8 of U.S. Securities and Exchange Commission Regulation S-X. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2017 and 2016 and for the periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. The Company suggests these condensed financial statements be read in conjunction with the December 31, 2016 audited financial statements and notes thereto included in the Company&amp;#146;s Form 10-K. The results of operations for the periods ended September 30, 2017 and 2016 are not necessarily indicative of the operating results for the full year.&lt;/p&gt;</us-gaap:BasisOfAccounting>
	<us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef='D170101_170930'>&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;Reclassification&lt;/b&gt; &amp;#150; Certain amounts in prior-period financial statements have been reclassified for comparative purposes to conform to presentation in the current-period financial statements.&lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
	<us-gaap:EarningsPerSharePolicyTextBlock contextRef='D170101_170930'>&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;Loss Per Share &amp;#150; &lt;/b&gt;The computation of loss per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, &amp;#147;Earnings Per Share.&amp;#148;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
	<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef='D170101_170930'>&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;Recently Enacted Accounting Standards&lt;/b&gt; &amp;#150; The FASB established the Accounting Standards Codification (&amp;#147;Codification&amp;#148; or &amp;#147;ASC&amp;#148;) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States (&amp;#147;GAAP&amp;#148;). Rules and interpretive releases of the Securities and Exchange Commission (&amp;#147;SEC&amp;#148;) issued under authority of federal securities laws are also sources of GAAP for SEC registrants.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Recent Accounting Standards Updates (&amp;#147;ASU&amp;#148;) through ASU No. 2015-01 contain technical corrections to existing guidance or affects guidance to specialized industries or situations. The Company has evaluated recently issued technical pronouncements and has determined that these updates have no current applicability to the Company or their effect on the financial statements would not have been significant.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
	<us-gaap:UseOfEstimates contextRef='D170101_170930'>&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;Accounting Estimates&lt;/b&gt; - The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowance for bad debts and inventory obsolescence.&lt;/p&gt;</us-gaap:UseOfEstimates>
	<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef='D170101_170930'>&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;NOTE 2 &amp;#150; Stockholders&amp;#146; Equity&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Common Stock&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Effective March 17, 2016, our Amended and Restated Articles of Incorporation were amended pursuant to a Certificate of Change Pursuant to Nevada Revised Statutes 78.209 (the &amp;#147;Certificate of Change&amp;#148;) filed with the Nevada Secretary of State. The Certificate of Change provided for both a reverse stock split of the outstanding shares of our common stock on a 1-for-100 basis (the &amp;#147;Reverse Stock Split&amp;#148;), and a corresponding decrease in the number of shares of our common stock that we are authorized to issue (the &amp;#147;Share Decrease&amp;#148;).&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;As a result of the Reverse Stock Split, the number of issued and outstanding shares of our common stock on March 17, 2016 decreased from 622,969,835 pre-Reverse Stock Split shares to 6,229,710 post-Reverse Stock Split shares (after adjustment for any fractional shares). Pursuant to the Share Decrease, the number of authorized shares of our common stock decreased from 750,000,000 to 7,500,000 shares of common stock. All amounts shown for common stock included in these financial statements are presented post-Reverse Stock Split.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;On April 28, 2016, the Company&amp;#146;s Amended and Restated Articles of Incorporation were amended to increase the number of authorized shares of the Company&amp;#146;s common stock from 7,500,000 to 15,000,000 shares of common stock.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Effective February 15, 2017, our Amended and Restated Articles of Incorporation were amended pursuant to a Certificate of Change Pursuant to Nevada Revised Statutes 78.209 (the &amp;#147;Certificate of Change&amp;#148;) filed with the Nevada Secretary of State. The Certificate of Change provided for both a reverse stock split of the outstanding shares of our common stock on a 1-for-2 basis (the &amp;#147;Reverse Stock Split&amp;#148;), and a corresponding decrease in the number of shares of our common stock that we are authorized to issue (the &amp;#147;Share Decrease&amp;#148;).&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;As a result of the Reverse Stock Split, the number of issued and outstanding shares of our common stock on February 15, 2017 decreased from 6,307,577 pre-Reverse Stock Split shares to 3,153,801 post-Reverse Stock Split shares (after adjustment for any fractional shares). Pursuant to the Share Decrease, the number of authorized shares of our common stock decreased from 15,000,000 to 7,500,000 shares of common stock, $0.001 par value per share. As of March 31, 2017, the Company had 7,500,000 shares of authorized common stock, $0.001 par value per share.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;In January, 2017, the Company issued 20,000 shares of common stock to two directors in equal amounts of 10,000 shares each, valued at $1.72 per share, or $34,404.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;In February, 2017, the Company issued 5,232 shares of common stock to a director valued at $3.25 per share, or $17,004.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;margin-top:0in;margin-right:-2.7pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-indent:0in&apos;&gt;On February 14, 2017, The&amp;nbsp;NASDAQ&amp;nbsp;Stock Market LLC informed the Company that it had approved the listing of the Company&amp;#146;s common stock on The&amp;nbsp;NASDAQ&amp;nbsp;Capital Market, effective as of February 15, 2017. The Company&amp;#146;s common stock ceased trading on the OTCQB on February 15, 2017, and on such date the common stock commenced trading on The NASDAQ&amp;nbsp;Capital Market under the ticker symbol &amp;#147;SGLB&amp;#148;.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;On August 8, 2017, the Company issued 7,489 shares of common stock to a director valued at $2.27 per share, or $17,000.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;On August 16, 2017, the Company issued 8,213 shares of common stock to a director valued at $2.07 per share, or $17,000.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;As of September 30, 2017 and December 31, 2016, there were 4,577,651 and 3,133,789 shares of common stock issued and outstanding, respectively.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-indent:.5in;text-autospace:none&apos;&gt;&lt;b&gt;Preferred Stock&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:none&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none&apos;&gt;The Company is authorized to issue 10,000,000 shares of preferred stock, $0.001 par value. No shares of preferred stock were issued and outstanding at September 30, 2017 and 2016.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-indent:.5in&apos;&gt;&lt;b&gt;Stock Options&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-indent:.5in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;On September 28, 2017, the Company granted to an officer (i) a five-year stock option to purchase up to 2,500 shares of common stock, at an exercise price equal to $1.91 per share, which was the closing market price of our common stock on September 28, 2017 (i.e., the date of grant), which option vested and became exercisable in full on the date of grant, and (ii) a five-year stock option to purchase up to 47,500 shares of common stock, at an exercise price equal to $1.91 per share (the closing market price of our common stock on the date of grant), which option is subject to vesting.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;The weighted average period over which total the compensation cost of the options of $90,723 ($11,937 in 2017) will be recognized is 4 years. The weighted average exercise price of all outstanding options as of September 30, 2017 is $3.58 and the weighted average fair value of the options on the grant dates was $2.88. The estimated fair value of the options was determined using the Black-Scholes pricing model using the following assumptions:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border:solid black 1.0pt;border-collapse:collapse;border:none&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;136&quot; valign=&quot;top&quot; style=&apos;width:102.35pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Expected term:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;104&quot; valign=&quot;top&quot; style=&apos;width:77.65pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;5 years&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;136&quot; valign=&quot;top&quot; style=&apos;width:102.35pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;104&quot; valign=&quot;top&quot; style=&apos;width:77.65pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;136&quot; valign=&quot;top&quot; style=&apos;width:102.35pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Volatility:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;104&quot; valign=&quot;top&quot; style=&apos;width:77.65pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;67.3 &amp;#150; 155.62%&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;136&quot; valign=&quot;top&quot; style=&apos;width:102.35pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;104&quot; valign=&quot;top&quot; style=&apos;width:77.65pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;136&quot; valign=&quot;top&quot; style=&apos;width:102.35pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Dividend yield:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;104&quot; valign=&quot;top&quot; style=&apos;width:77.65pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;0.00%&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;136&quot; valign=&quot;top&quot; style=&apos;width:102.35pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;104&quot; valign=&quot;top&quot; style=&apos;width:77.65pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;136&quot; valign=&quot;top&quot; style=&apos;width:102.35pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Risk-free interest rate:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;104&quot; valign=&quot;top&quot; style=&apos;width:77.65pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;1.13 - 2.27%&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;b&gt;Warrants&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;As of September 30, 2017, the Company had outstanding warrants to purchase a total of 80,000 shares of common stock at an exercise price of $2.00 per share. Each warrant, prior to its amendment described below in Note 4, had an exercise price equal to $4.13. If not exercised, the warrants to purchase the 80,000 shares will expire on October 17, 2019. In addition, as of September 30, 2017, the Company had outstanding warrants to purchase a total of 1,621,500 shares of common stock at an exercise price of $4.00 per share. If not exercised, the warrants to purchase the 1,621,500 shares will expire on February 21, 2022. The 1,621,500 warrants trade on The NASDAQ&amp;nbsp;Capital Market under the ticker symbol &amp;#147;SGLBW&amp;#148;.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;b&gt;Unit Purchase Option&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;On February 15, 2017, Sigma Labs, Inc. (the &amp;#147;Company&amp;#148;) entered into an underwriting agreement (the &amp;#147;Underwriting Agreement&amp;#148;) with Dawson James Securities, Inc., as underwriter (the &amp;#147;Underwriter&amp;#148;) in connection with a public offering (the &amp;#147;Offering&amp;#148;) of the Company&amp;#146;s securities. &amp;nbsp; Pursuant to the Underwriting Agreement, the Company has granted the Underwriter the right to purchase from the Company 70,500 Units at an exercise price equal to 125% of the public offering price of the Units in the Offering, or $5.1625 per Unit. The Unit Purchase Option has a term of five years and is not redeemable by us. A &amp;#147;Unit&amp;#148; is defined as of one share of the Company&amp;#146;s common stock, par value $0.001 per share and one warrant to purchase one share of the Company&amp;#146;s common stock, par value $0.001 per share, at an exercise price of $4.00 per share.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
	<us-gaap:CommonStockSharesOutstanding decimals='INF' contextRef='I160317' unitRef='Shares'>6229710</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockSharesIssued decimals='INF' contextRef='I160317' unitRef='Shares'>6229710</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesAuthorized decimals='INF' contextRef='I160317' unitRef='Shares'>7500000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesAuthorized decimals='INF' contextRef='I160428' unitRef='Shares'>15000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesOutstanding decimals='INF' contextRef='I170215' unitRef='Shares'>3153801</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockSharesIssued decimals='INF' contextRef='I170215' unitRef='Shares'>3153801</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesAuthorized decimals='INF' contextRef='I170215' unitRef='Shares'>7500000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockParOrStatedValuePerShare decimals='INF' contextRef='I170215' unitRef='UsdPerShare'>0.001</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:StockIssuedDuringPeriodSharesOther decimals='INF' contextRef='D170101_170930_TimeReference-InJanuary2017' unitRef='Shares'>20000</us-gaap:StockIssuedDuringPeriodSharesOther>
	<us-gaap:StockIssuedDuringPeriodSharesOther decimals='INF' contextRef='D170101_170930_TimeReference-InFebruary2017' unitRef='Shares'>5232</us-gaap:StockIssuedDuringPeriodSharesOther>
	<us-gaap:SharesIssued decimals='INF' contextRef='I170808' unitRef='Shares'>7489</us-gaap:SharesIssued>
	<us-gaap:SharePrice decimals='INF' contextRef='I170808' unitRef='UsdPerShare'>2.27</us-gaap:SharePrice>
	<us-gaap:CommonStockValue decimals='INF' contextRef='I170808' unitRef='USD'>-17000</us-gaap:CommonStockValue>
	<us-gaap:SharesIssued decimals='INF' contextRef='I170816' unitRef='Shares'>8213</us-gaap:SharesIssued>
	<us-gaap:SharePrice decimals='INF' contextRef='I170816' unitRef='UsdPerShare'>2.07</us-gaap:SharePrice>
	<us-gaap:CommonStockValue decimals='INF' contextRef='I170816' unitRef='USD'>-17000</us-gaap:CommonStockValue>
	<us-gaap:CommonStockSharesIssued decimals='INF' contextRef='E17Q3' unitRef='Shares'>4577651</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesOutstanding decimals='INF' contextRef='E17Q3' unitRef='Shares'>4577651</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockSharesIssued decimals='INF' contextRef='E16Q3' unitRef='Shares'>3133789</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesOutstanding decimals='INF' contextRef='E16Q3' unitRef='Shares'>3133789</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:PreferredStockSharesAuthorized decimals='INF' contextRef='E17Q3' unitRef='Shares'>10000000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesAuthorized decimals='INF' contextRef='E16Q3' unitRef='Shares'>10000000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockParOrStatedValuePerShare decimals='INF' contextRef='E17Q3' unitRef='UsdPerShare'>0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockParOrStatedValuePerShare decimals='INF' contextRef='E16Q3' unitRef='UsdPerShare'>0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockSharesIssued decimals='INF' contextRef='E17Q3' unitRef='Shares'>0</us-gaap:PreferredStockSharesIssued>
	<us-gaap:PreferredStockSharesIssued decimals='INF' contextRef='E16Q3' unitRef='Shares'>0</us-gaap:PreferredStockSharesIssued>
	<us-gaap:PreferredStockSharesOutstanding decimals='INF' contextRef='E17Q3' unitRef='Shares'>0</us-gaap:PreferredStockSharesOutstanding>
	<us-gaap:PreferredStockSharesOutstanding decimals='INF' contextRef='E16Q3' unitRef='Shares'>0</us-gaap:PreferredStockSharesOutstanding>
	<us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef='D170101_170930'>&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border:solid black 1.0pt;border-collapse:collapse;border:none&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;136&quot; valign=&quot;top&quot; style=&apos;width:102.35pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Expected term:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;104&quot; valign=&quot;top&quot; style=&apos;width:77.65pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;5 years&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;136&quot; valign=&quot;top&quot; style=&apos;width:102.35pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;104&quot; valign=&quot;top&quot; style=&apos;width:77.65pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;136&quot; valign=&quot;top&quot; style=&apos;width:102.35pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Volatility:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;104&quot; valign=&quot;top&quot; style=&apos;width:77.65pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;67.3 &amp;#150; 155.62%&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;136&quot; valign=&quot;top&quot; style=&apos;width:102.35pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;104&quot; valign=&quot;top&quot; style=&apos;width:77.65pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;136&quot; valign=&quot;top&quot; style=&apos;width:102.35pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Dividend yield:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;104&quot; valign=&quot;top&quot; style=&apos;width:77.65pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;0.00%&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;136&quot; valign=&quot;top&quot; style=&apos;width:102.35pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;104&quot; valign=&quot;top&quot; style=&apos;width:77.65pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;136&quot; valign=&quot;top&quot; style=&apos;width:102.35pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Risk-free interest rate:&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;104&quot; valign=&quot;top&quot; style=&apos;width:77.65pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;1.13 - 2.27%&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef='D170101_170930'>P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum decimals='INF' contextRef='D170101_170930' unitRef='Pure'>0.6730</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum decimals='INF' contextRef='D170101_170930' unitRef='Pure'>1.5562</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate decimals='INF' contextRef='D170101_170930' unitRef='Pure'>0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum decimals='INF' contextRef='D170101_170930' unitRef='Pure'>0.0113</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum decimals='INF' contextRef='D170101_170930' unitRef='Pure'>0.0227</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
	<us-gaap:FinancingReceivablesTextBlock contextRef='D170101_170930'>&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;NOTE 3 &amp;#150; Note Receivable&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;On May 1, 2017, the Company completed funding a loan in the principal amount of $250,000 to Jaguar Precision Machine, LLC, a New Mexico limited liability company, pursuant to a Secured Convertible Promissory Note dated May 1, 2017 delivered by Jaguar to the Company. The loan bears interest at the rate of 7% per annum, is due and payable in full on May 1, 2018, is secured by certain assets of Jaguar, and is convertible at the Company&amp;#146;s option into 10% of the outstanding shares of the common stock of Jaguar unless Jaguar exercises its right under specified circumstances to repay all principal and accrued interest on the loan. The purpose of the loan is to provide working capital to Jaguar to, among other things, stand up a metallurgical laboratory and become ASM9100 certified for contracts related to AM of high-precision aerospace and defense components, in furtherance of our strategic alliance. Sigma will receive from Jaguar priority for use of certain machines and services of Jaguar.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;On March 27, 2017, the Company completed funding a loan in the principal amount of $500,000 to Morf3D, Inc., an Illinois corporation, pursuant to a Secured Convertible Promissory Note dated March 27, 2017 delivered by Morf3D to the Company. The loan bears interest at the rate of 7% per annum, is due and payable in full on March 27, 2018, is secured by certain assets of Morf3D, and is convertible at the Company&amp;#146;s option into 10% of the outstanding shares of the common stock of Morf3D unless Morf3D exercises its right under specified circumstances to repay all principal and accrued interest on the loan. The purpose of the loan is to provide working capital to Morf3D to, among other things, lease an EOS M 400 system for Morf3D for Morf3D to expand production for contracts related to AM of high-precision aerospace and defense components, in furtherance of our strategic alliance and in contemplation of a possible acquisition of or merger with Morf3D (although discussions regarding a possible acquisition of or merger with Morf3D are not currently ongoing).&lt;/p&gt;</us-gaap:FinancingReceivablesTextBlock>
	<us-gaap:NotesAndLoansReceivableGrossNoncurrent decimals='INF' contextRef='E17Q3_CounterpartyName-AguarPrecisionMachineLlc' unitRef='USD'>250000</us-gaap:NotesAndLoansReceivableGrossNoncurrent>
	<us-gaap:DebtDisclosureTextBlock contextRef='D170101_170930'>&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;NOTE 4&lt;/b&gt; &lt;b&gt;&amp;#150; Notes Payable&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:none&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;margin-bottom:0in;margin-bottom:.0001pt;text-align:justify;text-indent:0in&apos;&gt;Effective October 17, 2016, the Company entered into a Securities Purchase Agreement with two accredited investors (the &amp;#147;Investors&amp;#148;) for the private placement by the Company of Secured Convertible Notes in the aggregate principal amount of $1,000,000 (the &amp;#147;Notes&amp;#148;) and warrants (the &amp;#147;Warrants&amp;#148;) to purchase up to 80,000 shares (the &amp;#147;Warrant Shares&amp;#148;) of the Company&amp;#146;s common stock (&amp;#147;Common Stock&amp;#148;) (subject to adjustment in certain circumstances), for aggregate gross proceeds, before expenses, to the Company of $900,000 (the &amp;#147;Financing Transaction&amp;#148;). The Notes carry a one-time upfront interest charge of a total of $100,000, which is being expensed to interest expense monthly over the 1-year term of the Notes and correspondingly increases in the Notes Payable balance each period.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;margin-bottom:0in;margin-bottom:.0001pt;text-indent:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;margin-bottom:0in;margin-bottom:.0001pt;text-align:justify;text-indent:0in&apos;&gt;The Notes carry an interest rate of 10% per annum, calculated on the basis of a 360-day year, based on the $1 million Notes Payable effective balance. Such interest is payable every three months in cash, or, at the holder&amp;#146;s option, in unrestricted shares of Common Stock, if a registration statement is then in effect for such shares of common stock.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:none&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none&apos;&gt;In connection with the Financing Transaction, the Company entered into a Registration Rights Agreement, dated October 17, 2016, with the Investors, pursuant to which the Company filed a registration statement related to the Financing Transaction with the Securities and Exchange Commission (&amp;#147;SEC&amp;#148;) covering the resale of (i) the shares of Common Stock that will be issued to the Investors upon conversion of the Notes, and (ii) the Warrant Shares that will be issued to the Investors upon exercise of the Warrants.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none&apos;&gt;The Notes are secured by the assets of the Company pursuant to a Security Agreement, dated October 17, 2016, between the Company and the &amp;#147;collateral agent&amp;#148; (as defined in the Notes) for the benefit of itself and each of the Investors.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:none&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none&apos;&gt;The Notes , prior to their amendment described below, provided that they were convertible into shares of Common Stock at a conversion price equal to the lesser of (i) the final unit price of the Company&amp;#146;s proposed public offering initially filed with the SEC on July 28, 2016, and (ii) 150% of the closing price of the Common Stock as reported by the OTC Markets Group, Inc. on the date of issuance of the Notes (subject to adjustment as provided therein). As such, the conversion price of the Notes was $4.13, which is the final unit price of the Company&amp;#146;s public offering.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:none&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none&apos;&gt;Each Warrant , prior to its amendment described below, had an exercise price equal to the lesser of (i) the final unit price of the Company&amp;#146;s proposed public offering initially filed with the SEC on February 17, 2017, and (ii) 150% of the closing price of the Common Stock as reported by the OTC Markets Group, Inc. on the date of issuance of the Warrants (subject to adjustment as provided therein), which Warrants may be exercised on a cashless basis as provided in the Warrants. As such, the exercise price of the Warrants was $4.13, which is the final unit price of the Company&amp;#146;s public offering.&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:none&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none&apos;&gt;On September 29, 2017, the Company entered into amendments (the &amp;#147;Amendments&amp;#148;) to the Notes and Warrants pursuant to which, among other things set forth in the Amendments, (1) the exercise price of the Warrants was reduced from $4.13 per share to $2.00 per share, and (2) the conversion price of the Notes was reduced from $4.13 per share to $2.00 per share. Under the Amendments, Sigma paid the Investors an aggregate amount equal to $500,000 (representing 50% of the outstanding principal balance of the Notes) plus all accrued interest on the Notes on October 2, 2017. In consideration of the foregoing, the Investors agreed to, among other things, extend the payment date of the remaining 50% of the outstanding principal balance of the Notes from October 17, 2017 to the earlier of May 18, 2018 or the closing of the Company&amp;#146;s next underwritten public offering of securities in which the Company raises gross proceeds of at least $3,000,000 (should the Company elect to commence and close such an offering of securities).&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-autospace:none&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none&apos;&gt;As of September 30, 2017, the Notes Payable balance is $994,909 which balance was reduced to $500,000 on October 2, 2017.&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
	<us-gaap:DebtInstrumentIssuanceDate1 contextRef='D170101_170930_DebtInstr-Note1'>2016-10-17</us-gaap:DebtInstrumentIssuanceDate1>
	<us-gaap:DebtInstrumentDescription contextRef='D170101_170930_DebtInstr-Note1'>Company entered into a Securities Purchase Agreement</us-gaap:DebtInstrumentDescription>
	<us-gaap:DebtInstrumentFaceAmount decimals='INF' contextRef='E17Q3_DebtInstr-Note1' unitRef='USD'>1000000</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage decimals='INF' contextRef='E17Q3_DebtInstr-Note1' unitRef='Pure'>0.1000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentDescription contextRef='D170101_170930_DebtInstr-Note2'>Company entered into a Registration Rights Agreement</us-gaap:DebtInstrumentDescription>
	<us-gaap:DebtInstrumentIssuanceDate1 contextRef='D170101_170930_DebtInstr-Note2'>2016-10-17</us-gaap:DebtInstrumentIssuanceDate1>
	<us-gaap:DebtInstrumentCollateral contextRef='D170101_170930_DebtInstr-Note2'>secured by the assets of the Company</us-gaap:DebtInstrumentCollateral>
	<us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature contextRef='D170101_170930_DebtInstr-Note2'>convertible into shares of Common Stock</us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature>
	<us-gaap:RevenueFromContractWithCustomerTextBlock contextRef='D170101_170930'>&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;NOTE 5 - Continuing Operations&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;margin-right:-2.7pt;text-autospace:none&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;margin-right:-2.7pt;text-align:justify;text-autospace:none&apos;&gt;The Company has sustained losses and has negative cash flows from operating activities since its inception. However, the Company has raised significant equity capital and is currently developing new product lines to increase future revenues. On February 21, 2017, the Company closed an underwritten public offering of equity securities resulting in net proceeds of approximately $5.25 million, after deducting underwriting discounts and commissions and other offering expenses payable by the Company. As such, the Company believes it has adequate working capital and cash to fund operations through 2017.&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
	<us-gaap:EarningsPerShareTextBlock contextRef='D170101_170930'>&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;NOTE 6 &amp;#150; Loss Per Share&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;The following data show the amounts used in computing loss per share and the weighted average number of shares of dilutive potential common stock for the periods ended September 30, 2017 and 2016:&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border:solid black 1.0pt;border-collapse:collapse;border:none&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;227&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot; style=&apos;width:169.9pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;9 Months Ending&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;9-30-17&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;9-30-16&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;top&quot; style=&apos;width:77.05pt;border:none;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;top&quot; style=&apos;width:77.05pt;border:none;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Loss from continuing&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;top&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;top&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Operations available to &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;top&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;top&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Common stockholders (numerator)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;border:none;border-bottom:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(3,049,616)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;border:none;border-bottom:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(1,931,833)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;border:none;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;border:none;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Weighted average number of &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;common shares Outstanding &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;used in loss per share during &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;the Period (denominator)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;border:none;border-bottom:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,330,565&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;border:none;border-bottom:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,121,821&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Dilutive loss per share was not presented as the Company had no common equivalent shares for all periods presented that would affect the computation of diluted loss per share or its effect is anti-dilutive.&lt;/p&gt;</us-gaap:EarningsPerShareTextBlock>
	<us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef='D170101_170930'>&lt;p style=&apos;margin:0in;margin-bottom:.0001pt&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;div align=&quot;center&quot;&gt; &lt;table border=&quot;0&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot; style=&apos;border:solid black 1.0pt;border-collapse:collapse;border:none&apos;&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;227&quot; colspan=&quot;3&quot; valign=&quot;bottom&quot; style=&apos;width:169.9pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;9 Months Ending&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;9-30-17&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;center&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:center&apos;&gt;9-30-16&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;top&quot; style=&apos;width:77.05pt;border:none;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;top&quot; style=&apos;width:77.05pt;border:none;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Loss from continuing&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;top&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;top&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Operations available to &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;top&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;top&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;top&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Common stockholders (numerator)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;border:none;border-bottom:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(3,049,616)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;$&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;border:none;border-bottom:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;(1,931,833)&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;border:none;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;border:none;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;Weighted average number of &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;common shares Outstanding &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;used in loss per share during &lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr align=&quot;left&quot;&gt; &lt;td width=&quot;213&quot; valign=&quot;top&quot; style=&apos;width:159.95pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;the Period (denominator)&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;border:none;border-bottom:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;4,330,565&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;21&quot; valign=&quot;bottom&quot; style=&apos;width:15.8pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;/td&gt; &lt;td width=&quot;103&quot; valign=&quot;bottom&quot; style=&apos;width:77.05pt;border:none;border-bottom:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt&apos;&gt; &lt;p align=&quot;right&quot; style=&apos;margin:0in;margin-bottom:.0001pt;text-align:right&apos;&gt;3,121,821&lt;/p&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest decimals='INF' contextRef='D170101_170930' unitRef='USD'>-3049616</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest decimals='INF' contextRef='D160101_160930' unitRef='USD'>-1931833</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted decimals='INF' contextRef='D170101_170930' unitRef='Shares'>4330565</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted decimals='INF' contextRef='D160101_160930' unitRef='Shares'>3121821</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
	<us-gaap:SubsequentEventsTextBlock contextRef='D170101_170930'>&lt;p style=&apos;margin:0in;margin-bottom:.0001pt;text-align:justify&apos;&gt;&lt;b&gt;NOTE 7&lt;/b&gt; &lt;b&gt;&amp;#150; Subsequent Events&lt;/b&gt;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;margin-bottom:0in;margin-bottom:.0001pt;text-indent:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;margin-bottom:0in;margin-bottom:.0001pt;text-align:justify;text-indent:0in&apos;&gt;On October 6, 2017, pursuant to an advisory agreement with the Underwriter, the Company issued to the Underwriter a total of 141,000 shares of the Company&amp;#146;s common stock in exchange for the surrender by the Underwriter of its Unit Purchase Option to acquire up to 70,500 Units.&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;margin-bottom:0in;margin-bottom:.0001pt;text-indent:0in&apos;&gt;&amp;nbsp;&lt;/p&gt; &lt;p style=&apos;margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;margin-bottom:0in;margin-bottom:.0001pt;text-align:justify;text-indent:0in&apos;&gt;On October 13, 2017, the Company granted two employees five-year options to purchase an aggregate of 20,000 shares of common stock, with each option having an exercise price of $1.92 per share, and vesting over the four-year period following the date of grant.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
	<us-gaap:SubsequentEventsDate contextRef='D170101_170930_SubsequentEventType-Event1'>2017-10-06</us-gaap:SubsequentEventsDate>
	<us-gaap:SubsequentEventDescription contextRef='D170101_170930_SubsequentEventType-Event1'>Company issued to the Underwriter a total of 141,000 shares of the Company&amp;#146;s common stock in exchange for the surrender by the Underwriter of its Unit Purchase Option</us-gaap:SubsequentEventDescription>
	<us-gaap:SubsequentEventsDate contextRef='D170101_170930_SubsequentEventType-Event2'>2017-10-13</us-gaap:SubsequentEventsDate>
	<us-gaap:SubsequentEventDescription contextRef='D170101_170930_SubsequentEventType-Event2'>Company granted two employees five-year options to purchase an aggregate of 20,000 shares of common stock</us-gaap:SubsequentEventDescription>
	<context id='D170101_170930'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-09-30</endDate>
		</period>
	</context>
	<context id='E17Q3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2017-09-30</instant>
		</period>
	</context>
	<context id='I170814'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2017-08-14</instant>
		</period>
	</context>
	<context id='E16'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2016-12-31</instant>
		</period>
	</context>
	<context id='Y17Q3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<startDate>2017-07-01</startDate>
			<endDate>2017-09-30</endDate>
		</period>
	</context>
	<context id='Y16Q3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<startDate>2016-07-01</startDate>
			<endDate>2016-09-30</endDate>
		</period>
	</context>
	<context id='D160101_160930'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<startDate>2016-01-01</startDate>
			<endDate>2016-09-30</endDate>
		</period>
	</context>
	<context id='E15'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2015-12-31</instant>
		</period>
	</context>
	<context id='E16Q3'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2016-09-30</instant>
		</period>
	</context>
	<context id='I160317'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2016-03-17</instant>
		</period>
	</context>
	<context id='I160428'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2016-04-28</instant>
		</period>
	</context>
	<context id='I170215'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2017-02-15</instant>
		</period>
	</context>
	<context id='D170101_170930_TimeReference-InJanuary2017'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
			<segment><xbrldi:explicitMember dimension='fil:TimeReferenceAxis'>fil:InJanuary2017Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-09-30</endDate>
		</period>
	</context>
	<context id='D170101_170930_TimeReference-InFebruary2017'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
			<segment><xbrldi:explicitMember dimension='fil:TimeReferenceAxis'>fil:InFebruary2017Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-09-30</endDate>
		</period>
	</context>
	<context id='I170808'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2017-08-08</instant>
		</period>
	</context>
	<context id='I170816'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
		</entity>
		<period>
			<instant>2017-08-16</instant>
		</period>
	</context>
	<context id='E17Q3_CounterpartyName-AguarPrecisionMachineLlc'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:CounterpartyNameAxis'>fil:AguarPrecisionMachineLlcMember</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-09-30</instant>
		</period>
	</context>
	<context id='D170101_170930_DebtInstr-Note1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:DebtInstrumentAxis'>fil:Note1Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-09-30</endDate>
		</period>
	</context>
	<context id='E17Q3_DebtInstr-Note1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:DebtInstrumentAxis'>fil:Note1Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<instant>2017-09-30</instant>
		</period>
	</context>
	<context id='D170101_170930_DebtInstr-Note2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:DebtInstrumentAxis'>fil:Note2Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-09-30</endDate>
		</period>
	</context>
	<context id='D170101_170930_SubsequentEventType-Event1'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:SubsequentEventTypeAxis'>fil:Event1Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-09-30</endDate>
		</period>
	</context>
	<context id='D170101_170930_SubsequentEventType-Event2'>
		<entity>
			<identifier scheme='http://www.sec.gov/CIK'>0000788611</identifier>
			<segment><xbrldi:explicitMember dimension='us-gaap:SubsequentEventTypeAxis'>fil:Event2Member</xbrldi:explicitMember></segment>
		</entity>
		<period>
			<startDate>2017-01-01</startDate>
			<endDate>2017-09-30</endDate>
		</period>
	</context>
	<unit id='Pure'>
		<measure>xbrli:pure</measure>
	</unit>
	<unit id='USD'>
		<measure>iso4217:USD</measure>
	</unit>
	<unit id='Shares'>
		<measure>xbrli:shares</measure>
	</unit>
	<unit id='UsdPerShare'>
		<divide>
			<unitNumerator>
				<measure>iso4217:USD</measure>
			</unitNumerator>
			<unitDenominator>
				<measure>xbrli:shares</measure>
			</unitDenominator>
		</divide>
	</unit>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>sglb-20170930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by edgar-services.com using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2017 [PPXK2X91H1YFVLAJKX0D]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://www.sigmalabs.com/20170930"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
	<link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis' xlink:label='us-gaap_SubsequentEventTypeAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SubsequentEventTypeAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Subsequent Event Type [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SubsequentEventTypeAxis' xlink:to='lab_us-gaap_SubsequentEventTypeAxis'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_Note2Member' xlink:label='fil_Note2Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note2Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 2</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note2Member' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Note 2, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note2Member' xlink:to='lab_fil_Note2Member'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementTable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statement</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementTable' xlink:to='lab_us-gaap_StatementTable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureTextBlock' xlink:label='us-gaap_DebtDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DebtDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>NOTE 4 - Notes Payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DebtDisclosureTextBlock' xlink:to='lab_us-gaap_DebtDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireFurnitureAndFixtures' xlink:label='us-gaap_PaymentsToAcquireFurnitureAndFixtures'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsToAcquireFurnitureAndFixtures' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Purchase of Furniture and Equipment</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsToAcquireFurnitureAndFixtures' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Purchase of Furniture and Equipment</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PaymentsToAcquireFurnitureAndFixtures' xlink:to='lab_us-gaap_PaymentsToAcquireFurnitureAndFixtures'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit' xlink:label='us-gaap_IncomeTaxExpenseBenefit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxExpenseBenefit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Provision for income Taxes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxExpenseBenefit' xlink:to='lab_us-gaap_IncomeTaxExpenseBenefit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrent' xlink:label='us-gaap_LiabilitiesNoncurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Long-Term Liability</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesNoncurrent' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total Long-Term Liability</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesNoncurrent' xlink:to='lab_us-gaap_LiabilitiesNoncurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAssetNoncurrent' xlink:label='us-gaap_BusinessCombinationContingentConsiderationAssetNoncurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_BusinessCombinationContingentConsiderationAssetNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investment in Joint Venture</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_BusinessCombinationContingentConsiderationAssetNoncurrent' xlink:to='lab_us-gaap_BusinessCombinationContingentConsiderationAssetNoncurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PropertyPlantAndEquipmentNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Property and Equipment, net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PropertyPlantAndEquipmentNet' xlink:to='lab_us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total current assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrent' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total current assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsCurrent' xlink:to='lab_us-gaap_AssetsCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus' xlink:label='dei_DocumentFiscalPeriodFocus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentFiscalPeriodFocus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Fiscal Period Focus</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentFiscalPeriodFocus' xlink:to='lab_dei_DocumentFiscalPeriodFocus'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_TextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_TextBlockAbstract' xlink:to='lab_us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain' xlink:label='us-gaap_DebtInstrumentNameDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DebtInstrumentNameDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt Instrument, Name</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DebtInstrumentNameDomain' xlink:to='lab_us-gaap_DebtInstrumentNameDomain'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis' xlink:label='us-gaap_DebtInstrumentAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DebtInstrumentAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt Instrument [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DebtInstrumentAxis' xlink:to='lab_us-gaap_DebtInstrumentAxis'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PolicyTextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Policies</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='lab_us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit' xlink:label='us-gaap_GrossProfit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GrossProfit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>GROSS PROFIT</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GrossProfit' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>GROSS PROFIT</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GrossProfit' xlink:to='lab_us-gaap_GrossProfit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract' xlink:label='us-gaap_AssetsAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>ASSETS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsAbstract' xlink:to='lab_us-gaap_AssetsAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityIncorporationStateCountryName' xlink:label='dei_EntityIncorporationStateCountryName'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityIncorporationStateCountryName' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Incorporation, State Country Name</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityIncorporationStateCountryName' xlink:to='lab_dei_EntityIncorporationStateCountryName'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityVoluntaryFilers' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Voluntary filer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityVoluntaryFilers' xlink:to='lab_dei_EntityVoluntaryFilers'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_AguarPrecisionMachineLlcMember' xlink:label='fil_AguarPrecisionMachineLlcMember'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_AguarPrecisionMachineLlcMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Jaguar Precision Machine, LLC</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_AguarPrecisionMachineLlcMember' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Jaguar Precision Machine, LLC, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_AguarPrecisionMachineLlcMember' xlink:to='lab_fil_AguarPrecisionMachineLlcMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInNotesPayableCurrent' xlink:label='us-gaap_IncreaseDecreaseInNotesPayableCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInNotesPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes Payable {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInNotesPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Notes Payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInNotesPayableCurrent' xlink:to='lab_us-gaap_IncreaseDecreaseInNotesPayableCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>LOSS BEFORE PROVISION FOR INCOME TAXES</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>LOSS BEFORE PROVISION FOR INCOME TAXES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:to='lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonoperatingIncomeExpense' xlink:label='us-gaap_NonoperatingIncomeExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NonoperatingIncomeExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Nonoperating Income (Expense)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NonoperatingIncomeExpense' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Nonoperating Income (Expense)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NonoperatingIncomeExpense' xlink:to='lab_us-gaap_NonoperatingIncomeExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNet' xlink:label='us-gaap_SalesRevenueNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SalesRevenueNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Revenues {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SalesRevenueNet' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Revenues</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SalesRevenueNet' xlink:to='lab_us-gaap_SalesRevenueNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesOutstanding' xlink:label='us-gaap_PreferredStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred Stock, Shares Outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockSharesOutstanding' xlink:to='lab_us-gaap_PreferredStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, Value, Issued</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockValue' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Common Stock, Value, Issued</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockValue' xlink:to='lab_us-gaap_CommonStockValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Liabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>TOTAL LIABILITIES</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Liabilities' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>TOTAL LIABILITIES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Liabilities' xlink:to='lab_us-gaap_Liabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsDate' xlink:label='us-gaap_SubsequentEventsDate'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SubsequentEventsDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Subsequent Event, Date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SubsequentEventsDate' xlink:to='lab_us-gaap_SubsequentEventsDate'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentCollateral' xlink:label='us-gaap_DebtInstrumentCollateral'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DebtInstrumentCollateral' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt Instrument, Collateral</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DebtInstrumentCollateral' xlink:to='lab_us-gaap_DebtInstrumentCollateral'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage' xlink:label='us-gaap_DebtInstrumentInterestRateStatedPercentage'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DebtInstrumentInterestRateStatedPercentage' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt Instrument, Interest Rate, Stated Percentage</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DebtInstrumentInterestRateStatedPercentage' xlink:to='lab_us-gaap_DebtInstrumentInterestRateStatedPercentage'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StatementLineItems' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Statement [Line Items]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StatementLineItems' xlink:to='lab_us-gaap_StatementLineItems'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_TimeReferenceDomain' xlink:label='fil_TimeReferenceDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TimeReferenceDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Time Reference</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TimeReferenceDomain' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Time Reference, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TimeReferenceDomain' xlink:to='lab_fil_TimeReferenceDomain'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesPaidNet' xlink:label='us-gaap_IncomeTaxesPaidNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncomeTaxesPaidNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Income Taxes Paid, Net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncomeTaxesPaidNet' xlink:to='lab_us-gaap_IncomeTaxesPaidNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>FINANCING ACTIVITIES</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets' xlink:label='us-gaap_PaymentsToAcquireIntangibleAssets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsToAcquireIntangibleAssets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Purchase of Intangible Assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsToAcquireIntangibleAssets' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Purchase of Intangible Assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PaymentsToAcquireIntangibleAssets' xlink:to='lab_us-gaap_PaymentsToAcquireIntangibleAssets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued Expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:to='lab_us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:label='us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Basic and diluted weighted-average common shares outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:to='lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:label='us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>LIABILITIES AND STOCKHOLDERS&apos; EQUITY</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CityAreaCode' xlink:label='dei_CityAreaCode'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_CityAreaCode' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>City Area Code</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_CityAreaCode' xlink:to='lab_dei_CityAreaCode'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventDescription' xlink:label='us-gaap_SubsequentEventDescription'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SubsequentEventDescription' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Subsequent Event, Description</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SubsequentEventDescription' xlink:to='lab_us-gaap_SubsequentEventDescription'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentDescription' xlink:label='us-gaap_DebtInstrumentDescription'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DebtInstrumentDescription' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt Instrument, Description</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DebtInstrumentDescription' xlink:to='lab_us-gaap_DebtInstrumentDescription'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProvisionForOtherLosses' xlink:label='us-gaap_ProvisionForOtherLosses'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProvisionForOtherLosses' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note Payable debt discount amortization</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProvisionForOtherLosses' xlink:to='lab_us-gaap_ProvisionForOtherLosses'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LaborAndRelatedExpense' xlink:label='us-gaap_LaborAndRelatedExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LaborAndRelatedExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Payroll Expense</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LaborAndRelatedExpense' xlink:to='lab_us-gaap_LaborAndRelatedExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RetainedEarningsAccumulatedDeficit' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accumulated deficit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RetainedEarningsAccumulatedDeficit' xlink:to='lab_us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract' xlink:label='us-gaap_StockholdersEquityAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Shareholders&apos; deficit:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='lab_us-gaap_StockholdersEquityAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LocalPhoneNumber' xlink:label='dei_LocalPhoneNumber'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_LocalPhoneNumber' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Local Phone Number</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_LocalPhoneNumber' xlink:to='lab_dei_LocalPhoneNumber'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityRegistrantName' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Registrant Name</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityRegistrantName' xlink:to='lab_dei_EntityRegistrantName'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain' xlink:label='us-gaap_RepurchaseAgreementCounterpartyNameDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RepurchaseAgreementCounterpartyNameDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Counterparty Name</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RepurchaseAgreementCounterpartyNameDomain' xlink:to='lab_us-gaap_RepurchaseAgreementCounterpartyNameDomain'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock' xlink:label='us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock' xlink:to='lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription' xlink:label='us-gaap_PriorPeriodReclassificationAdjustmentDescription'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Reclassification</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PriorPeriodReclassificationAdjustmentDescription' xlink:to='lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareTextBlock' xlink:label='us-gaap_EarningsPerShareTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerShareTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>NOTE 6 - Loss Per Share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerShareTextBlock' xlink:to='lab_us-gaap_EarningsPerShareTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FinancingReceivablesTextBlock' xlink:label='us-gaap_FinancingReceivablesTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_FinancingReceivablesTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>NOTE 3 - Note Receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_FinancingReceivablesTextBlock' xlink:to='lab_us-gaap_FinancingReceivablesTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net Cash Provided by (Used in) Investing Activities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net Cash Provided by (Used in) Investing Activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-gaap_ProfitLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProfitLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProfitLoss' xlink:to='lab_us-gaap_ProfitLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-gaap_NetIncomeLoss'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net Income (Loss)</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetIncomeLoss' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net Income (Loss)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetIncomeLoss' xlink:to='lab_us-gaap_NetIncomeLoss'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding' xlink:label='us-gaap_CommonStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, Shares, Outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockSharesOutstanding' xlink:to='lab_us-gaap_CommonStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash and cash equivalents</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/periodStartLabel' xml:lang='en-US'>Cash and Cash Equivalents, at Carrying Value, Beginning Balance</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:role='http://www.xbrl.org/2003/role/periodEndLabel' xml:lang='en-US'>Cash and Cash Equivalents, at Carrying Value, Ending Balance</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:to='lab_us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription' xlink:label='dei_AmendmentDescription'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_AmendmentDescription' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amendment Description</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_AmendmentDescription' xlink:to='lab_dei_AmendmentDescription'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_CurrentFiscalYearEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fiscal Year End</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_CurrentFiscalYearEndDate' xlink:to='lab_dei_CurrentFiscalYearEndDate'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_Event1Member' xlink:label='fil_Event1Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Event1Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Event 1</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Event1Member' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Event 1, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Event1Member' xlink:to='lab_fil_Event1Member'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityInformationDateToChangeFormerLegalOrRegisteredName' xlink:label='dei_EntityInformationDateToChangeFormerLegalOrRegisteredName'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityInformationDateToChangeFormerLegalOrRegisteredName' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Information, Date to Change Former Legal or Registered Name</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityInformationDateToChangeFormerLegalOrRegisteredName' xlink:to='lab_dei_EntityInformationDateToChangeFormerLegalOrRegisteredName'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries' xlink:label='us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loss on Investment in Joint Venture</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Loss on Investment in Joint Venture</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries' xlink:to='lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RecognitionOfDeferredRevenue' xlink:label='us-gaap_RecognitionOfDeferredRevenue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RecognitionOfDeferredRevenue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Revaluation of derivative liability and debt discount related to notes payable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RecognitionOfDeferredRevenue' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Revaluation of derivative liability and debt discount related to notes payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RecognitionOfDeferredRevenue' xlink:to='lab_us-gaap_RecognitionOfDeferredRevenue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingExpense' xlink:label='us-gaap_OtherNonoperatingExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherNonoperatingExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other Expense - Debt discount amortization</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherNonoperatingExpense' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Other Expense - Debt discount amortization</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherNonoperatingExpense' xlink:to='lab_us-gaap_OtherNonoperatingExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare' xlink:label='us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockParOrStatedValuePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred Stock, Par or Stated Value Per Share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockParOrStatedValuePerShare' xlink:to='lab_us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_NotesPayableDebtDiscount' xlink:label='fil_NotesPayableDebtDiscount'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotesPayableDebtDiscount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes Payable, Debt Discount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_NotesPayableDebtDiscount' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Notes Payable, Debt Discount, as of the indicated date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_NotesPayableDebtDiscount' xlink:to='lab_fil_NotesPayableDebtDiscount'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent' xlink:label='us-gaap_DerivativeLiabilitiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DerivativeLiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Derivative liability</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DerivativeLiabilitiesCurrent' xlink:to='lab_us-gaap_DerivativeLiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total current liabilities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total current liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesCurrent' xlink:to='lab_us-gaap_LiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccruedLiabilitiesCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accrued liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccruedLiabilitiesCurrent' xlink:to='lab_us-gaap_AccruedLiabilitiesCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsNoncurrent' xlink:label='us-gaap_AssetsNoncurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Other Assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsNoncurrent' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total Other Assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsNoncurrent' xlink:to='lab_us-gaap_AssetsNoncurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCurrentReportingStatus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current with reporting</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCurrentReportingStatus' xlink:to='lab_dei_EntityCurrentReportingStatus'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain' xlink:label='us-gaap_SubsequentEventTypeDomain'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SubsequentEventTypeDomain' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Subsequent Event Type</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SubsequentEventTypeDomain' xlink:to='lab_us-gaap_SubsequentEventTypeDomain'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember' xlink:label='us-gaap_MinimumMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_MinimumMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Minimum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_MinimumMember' xlink:to='lab_us-gaap_MinimumMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharePrice' xlink:label='us-gaap_SharePrice'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SharePrice' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share Price</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SharePrice' xlink:to='lab_us-gaap_SharePrice'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net Cash Provided by (Used in) Financing Activities</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net Cash Provided by (Used in) Financing Activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:to='lab_us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:label='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid Assets</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Prepaid Assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:to='lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized' xlink:label='us-gaap_PreferredStockSharesAuthorized'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockSharesAuthorized' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred Stock, Shares Authorized</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockSharesAuthorized' xlink:to='lab_us-gaap_PreferredStockSharesAuthorized'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue' xlink:label='us-gaap_PreferredStockValue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockValue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred Stock, Value, Issued</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockValue' xlink:to='lab_us-gaap_PreferredStockValue'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_InJanuary2017Member' xlink:label='fil_InJanuary2017Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InJanuary2017Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>In January, 2017</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InJanuary2017Member' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the In January, 2017, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InJanuary2017Member' xlink:to='lab_fil_InJanuary2017Member'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock' xlink:label='us-gaap_SignificantAccountingPoliciesTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SignificantAccountingPoliciesTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>NOTE 1 - Summary of Significant Accounting Policies</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SignificantAccountingPoliciesTextBlock' xlink:to='lab_us-gaap_SignificantAccountingPoliciesTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1' xlink:label='us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Writeoff of Debt Discount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1' xlink:to='lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities' xlink:label='us-gaap_ProceedsFromPaymentsForOtherFinancingActivities'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amendment to Warrant Agreements</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProceedsFromPaymentsForOtherFinancingActivities' xlink:to='lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock' xlink:label='us-gaap_ProceedsFromIssuanceOfCommonStock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProceedsFromIssuanceOfCommonStock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Proceeds from issuance of common stock and warrants</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProceedsFromIssuanceOfCommonStock' xlink:to='lab_us-gaap_ProceedsFromIssuanceOfCommonStock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherPaymentsToAcquireBusinesses' xlink:label='us-gaap_OtherPaymentsToAcquireBusinesses'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherPaymentsToAcquireBusinesses' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Investment in Joint Venture {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherPaymentsToAcquireBusinesses' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Investment in Joint Venture</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherPaymentsToAcquireBusinesses' xlink:to='lab_us-gaap_OtherPaymentsToAcquireBusinesses'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncome' xlink:label='us-gaap_OtherNonoperatingIncome'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherNonoperatingIncome' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other Income- State Incentives</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherNonoperatingIncome' xlink:to='lab_us-gaap_OtherNonoperatingIncome'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenue' xlink:label='us-gaap_CostOfRevenue'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CostOfRevenue' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>COST OF REVENUE</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CostOfRevenue' xlink:to='lab_us-gaap_CostOfRevenue'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityAddressCityOrTown' xlink:label='dei_EntityAddressCityOrTown'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityAddressCityOrTown' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Address, City or Town</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityAddressCityOrTown' xlink:to='lab_dei_EntityAddressCityOrTown'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature' xlink:label='us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt Instrument, Convertible, Terms of Conversion Feature</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature' xlink:to='lab_us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1' xlink:label='us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1' xlink:to='lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesIssued' xlink:label='us-gaap_SharesIssued'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SharesIssued' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Shares, Issued</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SharesIssued' xlink:to='lab_us-gaap_SharesIssued'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock' xlink:label='us-gaap_RevenueFromContractWithCustomerTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RevenueFromContractWithCustomerTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>NOTE 5 - Continuing Operations</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RevenueFromContractWithCustomerTextBlock' xlink:to='lab_us-gaap_RevenueFromContractWithCustomerTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:label='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Cash Flow, Noncash Investing and Financing Activities Disclosure</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:label='us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts Receivable</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Accounts Receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:to='lab_us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims' xlink:label='us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Compensation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims' xlink:to='lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized' xlink:label='us-gaap_CommonStockSharesAuthorized'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockSharesAuthorized' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, Shares Authorized</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockSharesAuthorized' xlink:to='lab_us-gaap_CommonStockSharesAuthorized'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnsecuredDebtCurrent' xlink:label='us-gaap_UnsecuredDebtCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_UnsecuredDebtCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes Payable, Current Portion</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_UnsecuredDebtCurrent' xlink:to='lab_us-gaap_UnsecuredDebtCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract' xlink:label='us-gaap_LiabilitiesCurrentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesCurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current liabilities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='lab_us-gaap_LiabilitiesCurrentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentPeriodEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Period End date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentPeriodEndDate' xlink:to='lab_dei_DocumentPeriodEndDate'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentType' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>SEC Form</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentType' xlink:to='lab_dei_DocumentType'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCentralIndexKey' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Registrant CIK</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCentralIndexKey' xlink:to='lab_dei_EntityCentralIndexKey'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFaceAmount' xlink:label='us-gaap_DebtInstrumentFaceAmount'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DebtInstrumentFaceAmount' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt Instrument, Face Amount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DebtInstrumentFaceAmount' xlink:to='lab_us-gaap_DebtInstrumentFaceAmount'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_InFebruary2017Member' xlink:label='fil_InFebruary2017Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_InFebruary2017Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>In February, 2017</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_InFebruary2017Member' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the In February, 2017, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_InFebruary2017Member' xlink:to='lab_fil_InFebruary2017Member'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_TableTextBlockSupplementAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Tables/Schedules</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='lab_us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UseOfEstimates' xlink:label='us-gaap_UseOfEstimates'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_UseOfEstimates' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounting Estimates</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_UseOfEstimates' xlink:to='lab_us-gaap_UseOfEstimates'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsTextBlock' xlink:label='us-gaap_SubsequentEventsTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SubsequentEventsTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>NOTE 7 - Subsequent Events</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SubsequentEventsTextBlock' xlink:to='lab_us-gaap_SubsequentEventsTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestPaid' xlink:label='us-gaap_InterestPaid'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InterestPaid' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest Paid</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InterestPaid' xlink:to='lab_us-gaap_InterestPaid'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect' xlink:label='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>NET CASH DECREASE FOR PERIOD</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>NET CASH DECREASE FOR PERIOD</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect' xlink:to='lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade' xlink:label='us-gaap_IncreaseDecreaseInAccountsPayableTrade'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts Payable {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Accounts Payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInAccountsPayableTrade' xlink:to='lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpensesAbstract' xlink:label='us-gaap_OperatingExpensesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingExpensesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>EXPENSES:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='lab_us-gaap_OperatingExpensesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract' xlink:label='us-gaap_LiabilitiesNoncurrentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesNoncurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Long-Term Liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesNoncurrentAbstract' xlink:to='lab_us-gaap_LiabilitiesNoncurrentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseOtherNoncurrent' xlink:label='us-gaap_PrepaidExpenseOtherNoncurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PrepaidExpenseOtherNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid Stock Compensation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PrepaidExpenseOtherNoncurrent' xlink:to='lab_us-gaap_PrepaidExpenseOtherNoncurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:label='us-gaap_IntangibleAssetsNetExcludingGoodwill'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Intangible Assets, net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:to='lab_us-gaap_IntangibleAssetsNetExcludingGoodwill'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityAddressStateOrProvince' xlink:label='dei_EntityAddressStateOrProvince'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityAddressStateOrProvince' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Address, State or Province</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityAddressStateOrProvince' xlink:to='lab_dei_EntityAddressStateOrProvince'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_AmendmentFlag' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amendment Flag</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_AmendmentFlag' xlink:to='lab_dei_AmendmentFlag'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember' xlink:label='us-gaap_RangeMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RangeMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Range</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RangeMember' xlink:to='lab_us-gaap_RangeMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityInformationFormerLegalOrRegisteredName' xlink:label='dei_EntityInformationFormerLegalOrRegisteredName'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityInformationFormerLegalOrRegisteredName' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Information, Former Legal or Registered Name</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityInformationFormerLegalOrRegisteredName' xlink:to='lab_dei_EntityInformationFormerLegalOrRegisteredName'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract' xlink:label='us-gaap_SupplementalCashFlowInformationAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_SupplementalCashFlowInformationAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Supplemental Cash Flow Information</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_SupplementalCashFlowInformationAbstract' xlink:to='lab_us-gaap_SupplementalCashFlowInformationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromCollectionOfLoansReceivable' xlink:label='us-gaap_ProceedsFromCollectionOfLoansReceivable'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProceedsFromCollectionOfLoansReceivable' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes Receivable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProceedsFromCollectionOfLoansReceivable' xlink:to='lab_us-gaap_ProceedsFromCollectionOfLoansReceivable'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories' xlink:label='us-gaap_IncreaseDecreaseInInventories'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInInventories' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Inventory {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInInventories' xlink:role='http://www.xbrl.org/2009/role/negatedLabel' xml:lang='en-US'>Inventory</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInInventories' xlink:to='lab_us-gaap_IncreaseDecreaseInInventories'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationAndAmortizationAbstract' xlink:label='us-gaap_DepreciationAndAmortizationAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DepreciationAndAmortizationAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Noncash Expenses:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DepreciationAndAmortizationAbstract' xlink:to='lab_us-gaap_DepreciationAndAmortizationAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation' xlink:label='us-gaap_ShareBasedCompensation'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensation' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock-Based Compensation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensation' xlink:to='lab_us-gaap_ShareBasedCompensation'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued' xlink:label='us-gaap_PreferredStockSharesIssued'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PreferredStockSharesIssued' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Preferred Stock, Shares Issued</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PreferredStockSharesIssued' xlink:to='lab_us-gaap_PreferredStockSharesIssued'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityFilerCategory' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Filer Category</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityFilerCategory' xlink:to='lab_dei_EntityFilerCategory'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BasisOfAccounting' xlink:label='us-gaap_BasisOfAccounting'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_BasisOfAccounting' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Basis of Presentation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_BasisOfAccounting' xlink:to='lab_us-gaap_BasisOfAccounting'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DisclosureTextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='lab_us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:label='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Change in assets and liabilities:</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation' xlink:label='us-gaap_Depreciation'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Depreciation' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Depreciation</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Depreciation' xlink:to='lab_us-gaap_Depreciation'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentIncomeInterest' xlink:label='us-gaap_InvestmentIncomeInterest'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InvestmentIncomeInterest' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interest Income</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InvestmentIncomeInterest' xlink:to='lab_us-gaap_InvestmentIncomeInterest'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpenses' xlink:label='us-gaap_OperatingExpenses'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingExpenses' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total Expenses</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OperatingExpenses' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total Expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OperatingExpenses' xlink:to='lab_us-gaap_OperatingExpenses'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued' xlink:label='us-gaap_CommonStockSharesIssued'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockSharesIssued' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, Shares, Issued</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockSharesIssued' xlink:to='lab_us-gaap_CommonStockSharesIssued'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent' xlink:label='us-gaap_AccountsPayableCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsPayableCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts payable</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccountsPayableCurrent' xlink:to='lab_us-gaap_AccountsPayableCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseCurrent' xlink:label='us-gaap_PrepaidExpenseCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_PrepaidExpenseCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Prepaid Expense, Current</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_PrepaidExpenseCurrent' xlink:to='lab_us-gaap_PrepaidExpenseCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract' xlink:label='us-gaap_AssetsCurrentAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AssetsCurrentAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current Assets</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='lab_us-gaap_AssetsCurrentAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityAddressPostalZipCode' xlink:label='dei_EntityAddressPostalZipCode'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityAddressPostalZipCode' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Address, Postal Zip Code</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityAddressPostalZipCode' xlink:to='lab_dei_EntityAddressPostalZipCode'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus' xlink:label='dei_DocumentFiscalYearFocus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentFiscalYearFocus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Document Fiscal Year Focus</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentFiscalYearFocus' xlink:to='lab_dei_DocumentFiscalYearFocus'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCommonStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Number of common stock shares outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCommonStockSharesOutstanding' xlink:to='lab_dei_EntityCommonStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_TimeReferenceAxis' xlink:label='fil_TimeReferenceAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_TimeReferenceAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Time Reference [Axis]</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_TimeReferenceAxis' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the description of Time Reference, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_TimeReferenceAxis' xlink:to='lab_fil_TimeReferenceAxis'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:label='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Recently Enacted Accounting Standards</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:to='lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NatureOfOperations' xlink:label='us-gaap_NatureOfOperations'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NatureOfOperations' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Nature of Business</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NatureOfOperations' xlink:to='lab_us-gaap_NatureOfOperations'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices' xlink:label='us-gaap_StockIssuedDuringPeriodValueIssuedForServices'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Issuance of Common Stock for services</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockIssuedDuringPeriodValueIssuedForServices' xlink:to='lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net Cash Provided by (Used in) Operating Activities {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Net Cash Provided by (Used in) Operating Activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_CostOfGoodsSoldDiscontinuedOperations' xlink:label='fil_CostOfGoodsSoldDiscontinuedOperations'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_CostOfGoodsSoldDiscontinuedOperations' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes Payable, Original Issue Discount</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_CostOfGoodsSoldDiscontinuedOperations' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the monetary amount of Notes Payable, Original Issue Discount, as of the indicated date.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_CostOfGoodsSoldDiscontinuedOperations' xlink:to='lab_fil_CostOfGoodsSoldDiscontinuedOperations'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityWellKnownSeasonedIssuer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Well-known Seasoned Issuer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityWellKnownSeasonedIssuer' xlink:to='lab_dei_EntityWellKnownSeasonedIssuer'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesAndLoansReceivableGrossNoncurrent' xlink:label='us-gaap_NotesAndLoansReceivableGrossNoncurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NotesAndLoansReceivableGrossNoncurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes, Loans and Financing Receivable, Gross, Noncurrent</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NotesAndLoansReceivableGrossNoncurrent' xlink:to='lab_us-gaap_NotesAndLoansReceivableGrossNoncurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum' xlink:to='lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock' xlink:label='us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Schedule of Earnings Per Share, Basic and Diluted</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock' xlink:to='lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:to='lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted' xlink:label='us-gaap_EarningsPerShareBasicAndDiluted'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerShareBasicAndDiluted' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Basic and diluted net loss per common share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerShareBasicAndDiluted' xlink:to='lab_us-gaap_EarningsPerShareBasicAndDiluted'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense' xlink:label='us-gaap_ResearchAndDevelopmentExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ResearchAndDevelopmentExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Research and Development</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ResearchAndDevelopmentExpense' xlink:to='lab_us-gaap_ResearchAndDevelopmentExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Assets' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>TOTAL ASSETS</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_Assets' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>TOTAL ASSETS</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_Assets' xlink:to='lab_us-gaap_Assets'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent' xlink:label='us-gaap_OtherAssetsCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherAssetsCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other Assets, Current</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherAssetsCurrent' xlink:to='lab_us-gaap_OtherAssetsCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent' xlink:label='us-gaap_AccountsReceivableNetCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AccountsReceivableNetCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Accounts Receivable, net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AccountsReceivableNetCurrent' xlink:to='lab_us-gaap_AccountsReceivableNetCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityAddressAddressLine1' xlink:label='dei_EntityAddressAddressLine1'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityAddressAddressLine1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Address, Address Line One</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityAddressAddressLine1' xlink:to='lab_dei_EntityAddressAddressLine1'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityTaxIdentificationNumber' xlink:label='dei_EntityTaxIdentificationNumber'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityTaxIdentificationNumber' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Tax Identification Number (TIN)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityTaxIdentificationNumber' xlink:to='lab_dei_EntityTaxIdentificationNumber'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentIssuanceDate1' xlink:label='us-gaap_DebtInstrumentIssuanceDate1'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_DebtInstrumentIssuanceDate1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Debt Instrument, Issuance Date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_DebtInstrumentIssuanceDate1' xlink:to='lab_us-gaap_DebtInstrumentIssuanceDate1'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_Note1Member' xlink:label='fil_Note1Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note1Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note 1</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Note1Member' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Note 1, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Note1Member' xlink:to='lab_fil_Note1Member'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember' xlink:label='us-gaap_MaximumMember'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_MaximumMember' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Maximum</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_MaximumMember' xlink:to='lab_us-gaap_MaximumMember'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock' xlink:label='us-gaap_EarningsPerSharePolicyTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_EarningsPerSharePolicyTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Loss Per Share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_EarningsPerSharePolicyTextBlock' xlink:to='lab_us-gaap_EarningsPerSharePolicyTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Net Cash Provided by (Used in) Investing Activities {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Net Cash Provided by (Used in) Investing Activities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax' xlink:label='us-gaap_GainLossOnDerivativeInstrumentsNetPretax'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other Income-Decrease in fair value of derivative liabilities</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GainLossOnDerivativeInstrumentsNetPretax' xlink:to='lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' xlink:label='us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total shareholders&apos; deficit</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total shareholders&apos; deficit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' xlink:to='lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital' xlink:label='us-gaap_AdditionalPaidInCapital'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdditionalPaidInCapital' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Additional paid-in capital</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdditionalPaidInCapital' xlink:to='lab_us-gaap_AdditionalPaidInCapital'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet' xlink:label='us-gaap_InventoryNet'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_InventoryNet' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Inventory</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_InventoryNet' xlink:to='lab_us-gaap_InventoryNet'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent' xlink:label='us-gaap_NotesAndLoansReceivableNetCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_NotesAndLoansReceivableNetCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Notes Receivable, net</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_NotesAndLoansReceivableNetCurrent' xlink:to='lab_us-gaap_NotesAndLoansReceivableNetCurrent'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol' xlink:label='dei_TradingSymbol'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_TradingSymbol' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Trading Symbol</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_TradingSymbol' xlink:to='lab_dei_TradingSymbol'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_Event2Member' xlink:label='fil_Event2Member'/>
		<link:label xlink:type='resource' xlink:label='lab_fil_Event2Member' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Event 2</link:label>
		<link:label xlink:type='resource' xlink:label='lab_fil_Event2Member' xlink:role='http://www.xbrl.org/2003/role/documentation' xml:lang='en-US'>Represents the Event 2, during the indicated time period.</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='fil_Event2Member' xlink:to='lab_fil_Event2Member'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CounterpartyNameAxis' xlink:label='us-gaap_CounterpartyNameAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CounterpartyNameAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Counterparty Name [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CounterpartyNameAxis' xlink:to='lab_us-gaap_CounterpartyNameAxis'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis' xlink:label='us-gaap_RangeAxis'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_RangeAxis' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Range [Axis]</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_RangeAxis' xlink:to='lab_us-gaap_RangeAxis'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther' xlink:label='us-gaap_StockIssuedDuringPeriodSharesOther'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockIssuedDuringPeriodSharesOther' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Stock Issued During Period, Shares, Other</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockIssuedDuringPeriodSharesOther' xlink:to='lab_us-gaap_StockIssuedDuringPeriodSharesOther'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:label='us-gaap_StockholdersEquityNoteDisclosureTextBlock'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>NOTE 2 - Stockholders&apos; Equity</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:to='lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProvisionForLoanAndLeaseLosses' xlink:label='us-gaap_ProvisionForLoanAndLeaseLosses'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_ProvisionForLoanAndLeaseLosses' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Note Payable original issue discount</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_ProvisionForLoanAndLeaseLosses' xlink:to='lab_us-gaap_ProvisionForLoanAndLeaseLosses'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentForAmortization' xlink:label='us-gaap_AdjustmentForAmortization'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_AdjustmentForAmortization' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amortization - Patents</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_AdjustmentForAmortization' xlink:to='lab_us-gaap_AdjustmentForAmortization'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract' xlink:label='us-gaap_OtherNonoperatingIncomeExpenseAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Other Nonoperating Income (Expense) {1}</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract' xlink:role='http://www.xbrl.org/2003/role/terseLabel' xml:lang='en-US'>Other Nonoperating Income (Expense)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_OtherNonoperatingIncomeExpenseAbstract' xlink:to='lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense' xlink:label='us-gaap_GeneralAndAdministrativeExpense'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_GeneralAndAdministrativeExpense' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>General and administrative expenses</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_GeneralAndAdministrativeExpense' xlink:to='lab_us-gaap_GeneralAndAdministrativeExpense'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare' xlink:label='us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_CommonStockParOrStatedValuePerShare' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Common Stock, Par or Stated Value Per Share</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_CommonStockParOrStatedValuePerShare' xlink:to='lab_us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Total liabilities and shareholders&apos; deficit</link:label>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_LiabilitiesAndStockholdersEquity' xlink:role='http://www.xbrl.org/2003/role/totalLabel' xml:lang='en-US'>Total liabilities and shareholders&apos; deficit</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_LiabilitiesAndStockholdersEquity' xlink:to='lab_us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityPublicFloat' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Public Float</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityPublicFloat' xlink:to='lab_dei_EntityPublicFloat'/>
	</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>sglb-20170930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by edgar-services.com using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2017 [PPXK2X91H1YFVLAJKX0D]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://www.sigmalabs.com/20170930"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DocumentDocumentAndEntityInformation">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityRegistrantName' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityCentralIndexKey' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_DocumentType' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_DocumentPeriodEndDate' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_CurrentFiscalYearEndDate' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol' xlink:label='dei_TradingSymbol'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_TradingSymbol' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityTaxIdentificationNumber' xlink:label='dei_EntityTaxIdentificationNumber'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityTaxIdentificationNumber' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityCommonStockSharesOutstanding' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityPublicFloat' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityFilerCategory' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityCurrentReportingStatus' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityVoluntaryFilers' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityWellKnownSeasonedIssuer' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentDescription' xlink:label='dei_AmendmentDescription'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_AmendmentDescription' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_AmendmentFlag' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus' xlink:label='dei_DocumentFiscalYearFocus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_DocumentFiscalYearFocus' use='optional' order='16.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus' xlink:label='dei_DocumentFiscalPeriodFocus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_DocumentFiscalPeriodFocus' use='optional' order='17.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityIncorporationStateCountryName' xlink:label='dei_EntityIncorporationStateCountryName'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityIncorporationStateCountryName' use='optional' order='18.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityAddressAddressLine1' xlink:label='dei_EntityAddressAddressLine1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityAddressAddressLine1' use='optional' order='19.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityAddressCityOrTown' xlink:label='dei_EntityAddressCityOrTown'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityAddressCityOrTown' use='optional' order='20.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityAddressStateOrProvince' xlink:label='dei_EntityAddressStateOrProvince'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityAddressStateOrProvince' use='optional' order='21.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityAddressPostalZipCode' xlink:label='dei_EntityAddressPostalZipCode'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityAddressPostalZipCode' use='optional' order='22.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CityAreaCode' xlink:label='dei_CityAreaCode'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_CityAreaCode' use='optional' order='23.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LocalPhoneNumber' xlink:label='dei_LocalPhoneNumber'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_LocalPhoneNumber' use='optional' order='24.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_CondensedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_CondensedBalanceSheetsUnaudited"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_CondensedBalanceSheetsUnaudited">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract' xlink:label='us-gaap_AssetsAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_AssetsAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract' xlink:label='us-gaap_AssetsCurrentAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsAbstract' xlink:to='us-gaap_AssetsCurrentAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_CashAndCashEquivalentsAtCarryingValue' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent' xlink:label='us-gaap_AccountsReceivableNetCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_AccountsReceivableNetCurrent' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent' xlink:label='us-gaap_NotesAndLoansReceivableNetCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_NotesAndLoansReceivableNetCurrent' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet' xlink:label='us-gaap_InventoryNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_InventoryNet' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseCurrent' xlink:label='us-gaap_PrepaidExpenseCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_PrepaidExpenseCurrent' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent' xlink:label='us-gaap_AssetsCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_AssetsCurrent' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent' xlink:label='us-gaap_OtherAssetsCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AssetsCurrentAbstract' xlink:to='us-gaap_OtherAssetsCurrent' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet' xlink:label='us-gaap_PropertyPlantAndEquipmentNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_PropertyPlantAndEquipmentNet' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill' xlink:label='us-gaap_IntangibleAssetsNetExcludingGoodwill'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_IntangibleAssetsNetExcludingGoodwill' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAssetNoncurrent' xlink:label='us-gaap_BusinessCombinationContingentConsiderationAssetNoncurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_BusinessCombinationContingentConsiderationAssetNoncurrent' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseOtherNoncurrent' xlink:label='us-gaap_PrepaidExpenseOtherNoncurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_PrepaidExpenseOtherNoncurrent' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsNoncurrent' xlink:label='us-gaap_AssetsNoncurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_AssetsNoncurrent' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets' xlink:label='us-gaap_Assets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_Assets' use='optional' order='7.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:label='us-gaap_LiabilitiesAndStockholdersEquityAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_LiabilitiesAndStockholdersEquityAbstract' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract' xlink:label='us-gaap_LiabilitiesCurrentAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_LiabilitiesCurrentAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent' xlink:label='us-gaap_AccountsPayableCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_AccountsPayableCurrent' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnsecuredDebtCurrent' xlink:label='us-gaap_UnsecuredDebtCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_UnsecuredDebtCurrent' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent' xlink:label='us-gaap_AccruedLiabilitiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_AccruedLiabilitiesCurrent' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent' xlink:label='us-gaap_LiabilitiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesCurrentAbstract' xlink:to='us-gaap_LiabilitiesCurrent' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract' xlink:label='us-gaap_LiabilitiesNoncurrentAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_LiabilitiesNoncurrentAbstract' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent' xlink:label='us-gaap_DerivativeLiabilitiesCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesNoncurrentAbstract' xlink:to='us-gaap_DerivativeLiabilitiesCurrent' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesNoncurrent' xlink:label='us-gaap_LiabilitiesNoncurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesNoncurrentAbstract' xlink:to='us-gaap_LiabilitiesNoncurrent' use='optional' order='2.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities' xlink:label='us-gaap_Liabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_Liabilities' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract' xlink:label='us-gaap_StockholdersEquityAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_StockholdersEquityAbstract' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue' xlink:label='us-gaap_PreferredStockValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_PreferredStockValue' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_CommonStockValue' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital' xlink:label='us-gaap_AdditionalPaidInCapital'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_AdditionalPaidInCapital' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit' xlink:label='us-gaap_RetainedEarningsAccumulatedDeficit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_RetainedEarningsAccumulatedDeficit' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' xlink:label='us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StockholdersEquityAbstract' xlink:to='us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity' xlink:label='us-gaap_LiabilitiesAndStockholdersEquity'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_LiabilitiesAndStockholdersEquityAbstract' xlink:to='us-gaap_LiabilitiesAndStockholdersEquity' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_CondensedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_CondensedBalanceSheetsUnauditedParenthetical"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_CondensedBalanceSheetsUnauditedParenthetical">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_CostOfGoodsSoldDiscontinuedOperations' xlink:label='fil_CostOfGoodsSoldDiscontinuedOperations'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_CostOfGoodsSoldDiscontinuedOperations' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_NotesPayableDebtDiscount' xlink:label='fil_NotesPayableDebtDiscount'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='fil_NotesPayableDebtDiscount' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare' xlink:label='us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_PreferredStockParOrStatedValuePerShare' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized' xlink:label='us-gaap_PreferredStockSharesAuthorized'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_PreferredStockSharesAuthorized' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued' xlink:label='us-gaap_PreferredStockSharesIssued'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_PreferredStockSharesIssued' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesOutstanding' xlink:label='us-gaap_PreferredStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_PreferredStockSharesOutstanding' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare' xlink:label='us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_CommonStockParOrStatedValuePerShare' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized' xlink:label='us-gaap_CommonStockSharesAuthorized'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_CommonStockSharesAuthorized' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued' xlink:label='us-gaap_CommonStockSharesIssued'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_CommonStockSharesIssued' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding' xlink:label='us-gaap_CommonStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_CommonStockSharesOutstanding' use='optional' order='10.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_CondensedStatementOfOperationsUnaudited" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_CondensedStatementOfOperationsUnaudited"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_CondensedStatementOfOperationsUnaudited">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNet' xlink:label='us-gaap_SalesRevenueNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_SalesRevenueNet' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenue' xlink:label='us-gaap_CostOfRevenue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_CostOfRevenue' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit' xlink:label='us-gaap_GrossProfit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_GrossProfit' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpensesAbstract' xlink:label='us-gaap_OperatingExpensesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_OperatingExpensesAbstract' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense' xlink:label='us-gaap_GeneralAndAdministrativeExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_GeneralAndAdministrativeExpense' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LaborAndRelatedExpense' xlink:label='us-gaap_LaborAndRelatedExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_LaborAndRelatedExpense' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation' xlink:label='us-gaap_ShareBasedCompensation'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_ShareBasedCompensation' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense' xlink:label='us-gaap_ResearchAndDevelopmentExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_ResearchAndDevelopmentExpense' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpenses' xlink:label='us-gaap_OperatingExpenses'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OperatingExpensesAbstract' xlink:to='us-gaap_OperatingExpenses' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract' xlink:label='us-gaap_OtherNonoperatingIncomeExpenseAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_OtherNonoperatingIncomeExpenseAbstract' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentIncomeInterest' xlink:label='us-gaap_InvestmentIncomeInterest'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherNonoperatingIncomeExpenseAbstract' xlink:to='us-gaap_InvestmentIncomeInterest' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncome' xlink:label='us-gaap_OtherNonoperatingIncome'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherNonoperatingIncomeExpenseAbstract' xlink:to='us-gaap_OtherNonoperatingIncome' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax' xlink:label='us-gaap_GainLossOnDerivativeInstrumentsNetPretax'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherNonoperatingIncomeExpenseAbstract' xlink:to='us-gaap_GainLossOnDerivativeInstrumentsNetPretax' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingExpense' xlink:label='us-gaap_OtherNonoperatingExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherNonoperatingIncomeExpenseAbstract' xlink:to='us-gaap_OtherNonoperatingExpense' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonoperatingIncomeExpense' xlink:label='us-gaap_NonoperatingIncomeExpense'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_OtherNonoperatingIncomeExpenseAbstract' xlink:to='us-gaap_NonoperatingIncomeExpense' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit' xlink:label='us-gaap_IncomeTaxExpenseBenefit'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_IncomeTaxExpenseBenefit' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss' xlink:label='us-gaap_NetIncomeLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_NetIncomeLoss' use='optional' order='8.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted' xlink:label='us-gaap_EarningsPerShareBasicAndDiluted'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_EarningsPerShareBasicAndDiluted' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:label='us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' use='optional' order='10.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_CondensedStatementsOfCashFlowsUnaudited" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_CondensedStatementsOfCashFlowsUnaudited"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_CondensedStatementsOfCashFlowsUnaudited">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss' xlink:label='us-gaap_ProfitLoss'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_ProfitLoss' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:label='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' use='optional' order='2.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationAndAmortizationAbstract' xlink:label='us-gaap_DepreciationAndAmortizationAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_DepreciationAndAmortizationAbstract' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentForAmortization' xlink:label='us-gaap_AdjustmentForAmortization'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_AdjustmentForAmortization' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation' xlink:label='us-gaap_Depreciation'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_Depreciation' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims' xlink:label='us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RecognitionOfDeferredRevenue' xlink:label='us-gaap_RecognitionOfDeferredRevenue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_RecognitionOfDeferredRevenue' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProvisionForLoanAndLeaseLosses' xlink:label='us-gaap_ProvisionForLoanAndLeaseLosses'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_ProvisionForLoanAndLeaseLosses' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProvisionForOtherLosses' xlink:label='us-gaap_ProvisionForOtherLosses'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_ProvisionForOtherLosses' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:label='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable' xlink:label='us-gaap_IncreaseDecreaseInAccountsReceivable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccountsReceivable' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories' xlink:label='us-gaap_IncreaseDecreaseInInventories'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInInventories' use='optional' order='2.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' xlink:label='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade' xlink:label='us-gaap_IncreaseDecreaseInAccountsPayableTrade'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccountsPayableTrade' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInNotesPayableCurrent' xlink:label='us-gaap_IncreaseDecreaseInNotesPayableCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInNotesPayableCurrent' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities' xlink:label='us-gaap_IncreaseDecreaseInAccruedLiabilities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_IncreaseDecreaseInOperatingCapitalAbstract' xlink:to='us-gaap_IncreaseDecreaseInAccruedLiabilities' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' xlink:label='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' use='optional' order='2.0' preferredLabel='http://www.xbrl.org/2003/role/terseLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireFurnitureAndFixtures' xlink:label='us-gaap_PaymentsToAcquireFurnitureAndFixtures'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='us-gaap_PaymentsToAcquireFurnitureAndFixtures' use='optional' order='1.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets' xlink:label='us-gaap_PaymentsToAcquireIntangibleAssets'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='us-gaap_PaymentsToAcquireIntangibleAssets' use='optional' order='2.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromCollectionOfLoansReceivable' xlink:label='us-gaap_ProceedsFromCollectionOfLoansReceivable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='us-gaap_ProceedsFromCollectionOfLoansReceivable' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherPaymentsToAcquireBusinesses' xlink:label='us-gaap_OtherPaymentsToAcquireBusinesses'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='us-gaap_OtherPaymentsToAcquireBusinesses' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries' xlink:label='us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInInvestingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInInvestingActivities' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock' xlink:label='us-gaap_ProceedsFromIssuanceOfCommonStock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-gaap_ProceedsFromIssuanceOfCommonStock' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities' xlink:label='us-gaap_ProceedsFromPaymentsForOtherFinancingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-gaap_ProceedsFromPaymentsForOtherFinancingActivities' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities' xlink:label='us-gaap_NetCashProvidedByUsedInFinancingActivities'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract' xlink:to='us-gaap_NetCashProvidedByUsedInFinancingActivities' use='optional' order='3.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect' xlink:label='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect' use='optional' order='4.0' preferredLabel='http://www.xbrl.org/2003/role/totalLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_CashAndCashEquivalentsAtCarryingValue' use='optional' order='5.0' preferredLabel='http://www.xbrl.org/2003/role/periodStartLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue' xlink:label='us-gaap_CashAndCashEquivalentsAtCarryingValue_1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_CashAndCashEquivalentsAtCarryingValue_1' use='optional' order='6.0' preferredLabel='http://www.xbrl.org/2003/role/periodEndLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract' xlink:label='us-gaap_SupplementalCashFlowInformationAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_SupplementalCashFlowInformationAbstract' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestPaid' xlink:label='us-gaap_InterestPaid'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_SupplementalCashFlowInformationAbstract' xlink:to='us-gaap_InterestPaid' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesPaidNet' xlink:label='us-gaap_IncomeTaxesPaidNet'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_SupplementalCashFlowInformationAbstract' xlink:to='us-gaap_IncomeTaxesPaidNet' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:label='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices' xlink:label='us-gaap_StockIssuedDuringPeriodValueIssuedForServices'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='us-gaap_StockIssuedDuringPeriodValueIssuedForServices' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1' xlink:label='us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract' xlink:to='us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1' use='optional' order='2.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE1SummaryOfSignificantAccountingPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock' xlink:label='us-gaap_SignificantAccountingPoliciesTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_SignificantAccountingPoliciesTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquity" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE2StockholdersEquity"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquity">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock' xlink:label='us-gaap_StockholdersEquityNoteDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_StockholdersEquityNoteDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE3NoteReceivable" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE3NoteReceivable"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE3NoteReceivable">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FinancingReceivablesTextBlock' xlink:label='us-gaap_FinancingReceivablesTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_FinancingReceivablesTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE4NotesPayable" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE4NotesPayable"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE4NotesPayable">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureTextBlock' xlink:label='us-gaap_DebtDisclosureTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_DebtDisclosureTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE5ContinuingOperations" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE5ContinuingOperations"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE5ContinuingOperations">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock' xlink:label='us-gaap_RevenueFromContractWithCustomerTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_RevenueFromContractWithCustomerTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShare" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE6LossPerShare"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShare">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareTextBlock' xlink:label='us-gaap_EarningsPerShareTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_EarningsPerShareTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE7SubsequentEvents" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE7SubsequentEvents"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE7SubsequentEvents">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureTextBlockAbstract' xlink:label='us-gaap_DisclosureTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsTextBlock' xlink:label='us-gaap_SubsequentEventsTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DisclosureTextBlockAbstract' xlink:to='us-gaap_SubsequentEventsTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessPolicies" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NatureOfOperations' xlink:label='us-gaap_NatureOfOperations'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_NatureOfOperations' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesBasisOfPresentationPolicies" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesBasisOfPresentationPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesBasisOfPresentationPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BasisOfAccounting' xlink:label='us-gaap_BasisOfAccounting'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_BasisOfAccounting' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesReclassificationPolicies" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesReclassificationPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesReclassificationPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription' xlink:label='us-gaap_PriorPeriodReclassificationAdjustmentDescription'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_PriorPeriodReclassificationAdjustmentDescription' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesLossPerSharePolicies" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesLossPerSharePolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesLossPerSharePolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock' xlink:label='us-gaap_EarningsPerSharePolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_EarningsPerSharePolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesRecentlyEnactedAccountingStandardsPolicies" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesRecentlyEnactedAccountingStandardsPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesRecentlyEnactedAccountingStandardsPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' xlink:label='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesAccountingEstimatesPolicies" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesAccountingEstimatesPolicies"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesAccountingEstimatesPolicies">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PolicyTextBlockAbstract' xlink:label='us-gaap_PolicyTextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UseOfEstimates' xlink:label='us-gaap_UseOfEstimates'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_PolicyTextBlockAbstract' xlink:to='us-gaap_UseOfEstimates' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesTables" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock' xlink:label='us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedTables" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedTables"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedTables">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TableTextBlockSupplementAbstract' xlink:label='us-gaap_TableTextBlockSupplementAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock' xlink:label='us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TableTextBlockSupplementAbstract' xlink:to='us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessDetails" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityInformationDateToChangeFormerLegalOrRegisteredName' xlink:label='dei_EntityInformationDateToChangeFormerLegalOrRegisteredName'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityInformationDateToChangeFormerLegalOrRegisteredName' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityInformationFormerLegalOrRegisteredName' xlink:label='dei_EntityInformationFormerLegalOrRegisteredName'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityInformationFormerLegalOrRegisteredName' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityIncorporationStateCountryName' xlink:label='dei_EntityIncorporationStateCountryName'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityIncorporationStateCountryName' use='optional' order='3.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityDetails" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE2StockholdersEquityDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_TimeReferenceAxis' xlink:label='fil_TimeReferenceAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='fil_TimeReferenceAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_TimeReferenceDomain' xlink:label='fil_TimeReferenceDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_TimeReferenceAxis' xlink:to='fil_TimeReferenceDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_InJanuary2017Member' xlink:label='fil_InJanuary2017Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_TimeReferenceAxis' xlink:to='fil_InJanuary2017Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_InFebruary2017Member' xlink:label='fil_InFebruary2017Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='fil_TimeReferenceAxis' xlink:to='fil_InFebruary2017Member' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding' xlink:label='us-gaap_CommonStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockSharesOutstanding' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued' xlink:label='us-gaap_CommonStockSharesIssued'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockSharesIssued' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized' xlink:label='us-gaap_CommonStockSharesAuthorized'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockSharesAuthorized' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare' xlink:label='us-gaap_CommonStockParOrStatedValuePerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockParOrStatedValuePerShare' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther' xlink:label='us-gaap_StockIssuedDuringPeriodSharesOther'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_StockIssuedDuringPeriodSharesOther' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesIssued' xlink:label='us-gaap_SharesIssued'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SharesIssued' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharePrice' xlink:label='us-gaap_SharePrice'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SharePrice' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue' xlink:label='us-gaap_CommonStockValue'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_CommonStockValue' use='optional' order='8.0' preferredLabel='http://www.xbrl.org/2009/role/negatedLabel'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized' xlink:label='us-gaap_PreferredStockSharesAuthorized'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockSharesAuthorized' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare' xlink:label='us-gaap_PreferredStockParOrStatedValuePerShare'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockParOrStatedValuePerShare' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued' xlink:label='us-gaap_PreferredStockSharesIssued'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockSharesIssued' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesOutstanding' xlink:label='us-gaap_PreferredStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_PreferredStockSharesOutstanding' use='optional' order='12.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis' xlink:label='us-gaap_RangeAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_RangeAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember' xlink:label='us-gaap_RangeMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RangeAxis' xlink:to='us-gaap_RangeMember' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember' xlink:label='us-gaap_MinimumMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RangeAxis' xlink:to='us-gaap_MinimumMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember' xlink:label='us-gaap_MaximumMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_RangeAxis' xlink:to='us-gaap_MaximumMember' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1' xlink:label='us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum' xlink:label='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum' use='optional' order='6.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE3NoteReceivableDetails" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE3NoteReceivableDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE3NoteReceivableDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CounterpartyNameAxis' xlink:label='us-gaap_CounterpartyNameAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_CounterpartyNameAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain' xlink:label='us-gaap_RepurchaseAgreementCounterpartyNameDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CounterpartyNameAxis' xlink:to='us-gaap_RepurchaseAgreementCounterpartyNameDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_AguarPrecisionMachineLlcMember' xlink:label='fil_AguarPrecisionMachineLlcMember'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_CounterpartyNameAxis' xlink:to='fil_AguarPrecisionMachineLlcMember' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesAndLoansReceivableGrossNoncurrent' xlink:label='us-gaap_NotesAndLoansReceivableGrossNoncurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_NotesAndLoansReceivableGrossNoncurrent' use='optional' order='1.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE4NotesPayableDetails" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE4NotesPayableDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE4NotesPayableDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis' xlink:label='us-gaap_DebtInstrumentAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_DebtInstrumentAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain' xlink:label='us-gaap_DebtInstrumentNameDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DebtInstrumentAxis' xlink:to='us-gaap_DebtInstrumentNameDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_Note1Member' xlink:label='fil_Note1Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DebtInstrumentAxis' xlink:to='fil_Note1Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_Note2Member' xlink:label='fil_Note2Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_DebtInstrumentAxis' xlink:to='fil_Note2Member' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentIssuanceDate1' xlink:label='us-gaap_DebtInstrumentIssuanceDate1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentIssuanceDate1' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentDescription' xlink:label='us-gaap_DebtInstrumentDescription'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentDescription' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFaceAmount' xlink:label='us-gaap_DebtInstrumentFaceAmount'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentFaceAmount' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage' xlink:label='us-gaap_DebtInstrumentInterestRateStatedPercentage'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentInterestRateStatedPercentage' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentCollateral' xlink:label='us-gaap_DebtInstrumentCollateral'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentCollateral' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature' xlink:label='us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature' use='optional' order='6.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' xlink:label='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' xlink:label='us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted' use='optional' order='2.0'/>
	</link:presentationLink>
	<link:roleRef roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE7SubsequentEventsDetails" xlink:type="simple" xlink:href="sglb-20170930.xsd#idr_DisclosureNOTE7SubsequentEventsDetails"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE7SubsequentEventsDetails">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable' xlink:label='us-gaap_StatementTable'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='us-gaap_StatementTable' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis' xlink:label='us-gaap_SubsequentEventTypeAxis'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_SubsequentEventTypeAxis' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain' xlink:label='us-gaap_SubsequentEventTypeDomain'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_SubsequentEventTypeAxis' xlink:to='us-gaap_SubsequentEventTypeDomain' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_Event1Member' xlink:label='fil_Event1Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_SubsequentEventTypeAxis' xlink:to='fil_Event1Member' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='sglb-20170930.xsd#fil_Event2Member' xlink:label='fil_Event2Member'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_SubsequentEventTypeAxis' xlink:to='fil_Event2Member' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems' xlink:label='us-gaap_StatementLineItems'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementTable' xlink:to='us-gaap_StatementLineItems' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsDate' xlink:label='us-gaap_SubsequentEventsDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SubsequentEventsDate' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventDescription' xlink:label='us-gaap_SubsequentEventDescription'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_StatementLineItems' xlink:to='us-gaap_SubsequentEventDescription' use='optional' order='2.0'/>
	</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>sglb-20170930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by edgar-services.com using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2017 [PPXK2X91H1YFVLAJKX0D]. www.edgarsuite.com -->
<schema xmlns:nonnum='http://www.xbrl.org/dtr/type/non-numeric' xmlns='http://www.w3.org/2001/XMLSchema' xmlns:us-gaap='http://fasb.org/us-gaap/2017-01-31' xmlns:fil='http://www.sigmalabs.com/20170930' xmlns:dei='http://xbrl.sec.gov/dei/2014-01-31' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:xbrldt='http://xbrl.org/2005/xbrldt' targetNamespace='http://www.sigmalabs.com/20170930' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:xbrli='http://www.xbrl.org/2003/instance' elementFormDefault='qualified' attributeFormDefault='unqualified'>
	<annotation>
		<appinfo>
			<link:linkbaseRef xlink:type="simple" xlink:href="sglb-20170930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="sglb-20170930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="sglb-20170930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="sglb-20170930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessPolicies" id="idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessPolicies">
				<link:definition>000130 - Disclosure - NOTE 1 - Summary of Significant Accounting Policies: Nature of Business (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE3NoteReceivable" id="idr_DisclosureNOTE3NoteReceivable">
				<link:definition>000080 - Disclosure - NOTE 3 - Note Receivable</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesRecentlyEnactedAccountingStandardsPolicies" id="idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesRecentlyEnactedAccountingStandardsPolicies">
				<link:definition>000170 - Disclosure - NOTE 1 - Summary of Significant Accounting Policies: Recently Enacted Accounting Standards (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityDetails" id="idr_DisclosureNOTE2StockholdersEquityDetails">
				<link:definition>000220 - Disclosure - NOTE 2 - Stockholders&apos; Equity (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE7SubsequentEvents" id="idr_DisclosureNOTE7SubsequentEvents">
				<link:definition>000120 - Disclosure - NOTE 7 - Subsequent Events</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesReclassificationPolicies" id="idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesReclassificationPolicies">
				<link:definition>000150 - Disclosure - NOTE 1 - Summary of Significant Accounting Policies: Reclassification (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_CondensedStatementOfOperationsUnaudited" id="idr_CondensedStatementOfOperationsUnaudited">
				<link:definition>000040 - Statement - Condensed Statement of Operations (Unaudited)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessDetails" id="idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessDetails">
				<link:definition>000210 - Disclosure - NOTE 1 - Summary of Significant Accounting Policies: Nature of Business (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquity" id="idr_DisclosureNOTE2StockholdersEquity">
				<link:definition>000070 - Disclosure - NOTE 2 - Stockholders&apos; Equity</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE4NotesPayableDetails" id="idr_DisclosureNOTE4NotesPayableDetails">
				<link:definition>000250 - Disclosure - NOTE 4 - Notes Payable (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE5ContinuingOperations" id="idr_DisclosureNOTE5ContinuingOperations">
				<link:definition>000100 - Disclosure - NOTE 5 - Continuing Operations</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesAccountingEstimatesPolicies" id="idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesAccountingEstimatesPolicies">
				<link:definition>000180 - Disclosure - NOTE 1 - Summary of Significant Accounting Policies: Accounting Estimates (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesBasisOfPresentationPolicies" id="idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesBasisOfPresentationPolicies">
				<link:definition>000140 - Disclosure - NOTE 1 - Summary of Significant Accounting Policies: Basis of Presentation (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesTables" id="idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesTables">
				<link:definition>000190 - Disclosure - NOTE 2 - Stockholders&apos; Equity: Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_CondensedBalanceSheetsUnaudited" id="idr_CondensedBalanceSheetsUnaudited">
				<link:definition>000020 - Statement - Condensed Balance Sheets (Unaudited)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE3NoteReceivableDetails" id="idr_DisclosureNOTE3NoteReceivableDetails">
				<link:definition>000240 - Disclosure - NOTE 3 - Note Receivable (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_CondensedBalanceSheetsUnauditedParenthetical" id="idr_CondensedBalanceSheetsUnauditedParenthetical">
				<link:definition>000030 - Statement - Condensed Balance Sheets (Unaudited) - Parenthetical</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DocumentDocumentAndEntityInformation" id="idr_DocumentDocumentAndEntityInformation">
				<link:definition>000010 - Document - Document and Entity Information</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE7SubsequentEventsDetails" id="idr_DisclosureNOTE7SubsequentEventsDetails">
				<link:definition>000270 - Disclosure - NOTE 7 - Subsequent Events (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_CondensedStatementsOfCashFlowsUnaudited" id="idr_CondensedStatementsOfCashFlowsUnaudited">
				<link:definition>000050 - Statement - Condensed Statements of Cash Flows (Unaudited)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails" id="idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails">
				<link:definition>000230 - Disclosure - NOTE 2 - Stockholders&apos; Equity: Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails" id="idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails">
				<link:definition>000260 - Disclosure - NOTE 6 - Loss Per Share: Schedule of Earnings Per Share, Basic and Diluted (Details)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShare" id="idr_DisclosureNOTE6LossPerShare">
				<link:definition>000110 - Disclosure - NOTE 6 - Loss Per Share</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPolicies" id="idr_DisclosureNOTE1SummaryOfSignificantAccountingPolicies">
				<link:definition>000060 - Disclosure - NOTE 1 - Summary of Significant Accounting Policies</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedTables" id="idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedTables">
				<link:definition>000200 - Disclosure - NOTE 6 - Loss Per Share: Schedule of Earnings Per Share, Basic and Diluted (Tables)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesLossPerSharePolicies" id="idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesLossPerSharePolicies">
				<link:definition>000160 - Disclosure - NOTE 1 - Summary of Significant Accounting Policies: Loss Per Share (Policies)</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
			<link:roleType roleURI="http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE4NotesPayable" id="idr_DisclosureNOTE4NotesPayable">
				<link:definition>000090 - Disclosure - NOTE 4 - Notes Payable</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
		</appinfo>
	</annotation>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import namespace='http://fasb.org/us-gaap/2017-01-31' schemaLocation='http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd' />
	<import namespace='http://xbrl.sec.gov/dei/2014-01-31' schemaLocation='http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd' />
	<element abstract='true' nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Event1Member' name='Event1Member' />
	<element abstract='true' nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Event2Member' name='Event2Member' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_NotesPayableDebtDiscount' name='NotesPayableDebtDiscount' />
	<element abstract='true' nillable='true' type='xbrli:stringItemType' substitutionGroup='xbrldt:dimensionItem' xbrli:periodType='duration' id='fil_TimeReferenceAxis' name='TimeReferenceAxis' />
	<element abstract='true' nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_TimeReferenceDomain' name='TimeReferenceDomain' />
	<element abstract='true' nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_InJanuary2017Member' name='InJanuary2017Member' />
	<element abstract='true' nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_InFebruary2017Member' name='InFebruary2017Member' />
	<element abstract='true' nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note1Member' name='Note1Member' />
	<element abstract='true' nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_Note2Member' name='Note2Member' />
	<element abstract='true' nillable='true' type='nonnum:domainItemType' substitutionGroup='xbrli:item' xbrli:periodType='duration' id='fil_AguarPrecisionMachineLlcMember' name='AguarPrecisionMachineLlcMember' />
	<element nillable='true' type='xbrli:monetaryItemType' substitutionGroup='xbrli:item' xbrli:periodType='instant' xbrli:balance='debit' id='fil_CostOfGoodsSoldDiscontinuedOperations' name='CostOfGoodsSoldDiscontinuedOperations' />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>f10q093017_10q1.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 f10q093017_10q1.jpg
M_]C_X2T817AI9@  34T *@    @ # $   ,    !!/L   $!  ,    !!G(
M  $"  ,    #    G@$&  ,    !  (   $2  ,    !  $   $5  ,    !
M  ,   $:  4    !    I $;  4    !    K $H  ,    !  (   $Q  (
M   F    M $R  (    4    VH=I  0    !    \    2@ "  (  @ %N-@
M   G$  6XV   "<0061O8F4@4&AO=&]S:&]P($5L96UE;G1S(#$R+C @5VEN
M9&]W<P R,#$V.C W.C(V(#$V.C V.C P      20   '    !# R,C&@ 0 #
M     0 !  "@ @ $     0   R2@ P $     0   FT         !@$#  ,
M   !  8   $:  4    !   !=@$;  4    !   !?@$H  ,    !  (   (!
M  0    !   !A@("  0    !   KB@        !(     0   $@    !_]C_
MX@Q824-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R4D="(%A96B 'S@ "
M  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@                  ]M8
M 0    #3+4A0("
M                 !%C<')T   !4    #-D97-C   !A    &QW='!T   !
M\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:   "+    !1B6%E:
M   "0    !1D;6YD   "5    '!D;61D   "Q    (AV=65D   #3    (9V
M:65W   #U    "1L=6UI   #^    !1M96%S   $#    "1T96-H   $,
M  QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $/   " QT97AT
M $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA<F0@0V]M<&%N>0
M9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$              !)S4D="
M($E%0S8Q.38V+3(N,0
M                        6%E:(        /-1  $    !%LQ865H@
M                 %A96B        !OH@  ./4   .06%E:(        &*9
M  "WA0  &-I865H@        )*    ^$  "VSV1E<V,         %DE%0R!H
M='1P.B\O=W=W+FEE8RYC:               %DE%0R!H='1P.B\O=W=W+FEE
M8RYC:
M      !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O
M;&]U<B!S<&%C92 M('-21T(              "Y)14,@-C$Y-C8M,BXQ($1E
M9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M        9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N
M(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R96YC92!6:65W:6YG
M($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M         '9I97<      !.D_@ 47RX $,\4  /MS  $$PL  UR>     5A9
M6B       $P)5@!0    5Q_G;65A<P         !
M     H\    "<VEG(     !#4E0@8W5R=@        0     !0 *  \ %  9
M !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@ ;0!R '< ? "! (8
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MU[_TW^!]1]/IJ->5]IS6O]-U,8[_ +,VT &X6>G8^QA:7L].OTZF[-WK^_\
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M6M8W:P!K1V'GJH9F%>F[W\OZK)$2O5A]FQ_]$S_-']RA?10VFQS:V AI((:
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M(^LN'GMLJRXZ?GXYVY.)>X-+3^_6Y^WU*_\ 7_1^IH?M'I__ '*I_P"W&?\
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M=O\ *_TBU^E_S.;_ %6_]2]9%--K<W(M>V*W >F?;K,;^/TC?H+7Z7_,YO\
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M5R\3'QK,2MUE-3W'?+G5L<3[[.7.;N5D,K/5&[0!Z=(, :?1])NV/YOV._\
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MHO%GJ[ZG,V^H+8>'S(J.-M]GYO\ A$:C*RJ3D']"\Y$3/JZ0TU_N'=])6/\
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M+?LOV;T-=GI?0Y]VWT_9]-%_7_\ @O\ I*"7S'S+,-DZ'D?T>S^H[\BA^O\
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M965N0FET8F]O;      +<')I;G1E<DYA;65415A4     0   #A"24T$.P
M   !L@   !     !       2<')I;G1/=71P=71/<'1I;VYS    $@    !#
M<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O
M;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;
M16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $       !2
M1T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B0&_@
M        0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M      !";&0@56YT1B-2;'0               !2<VQT56YT1B-0>&Q 8L
M          IV96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P
M  !09U!#     $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L
M=                %-C;"!5;G1&(U!R8T!9        .$))30/M       0
M )8    !  $ E@    $  3A"24T$)@      #@             _@   .$))
M300-       $    'CA"24T$&0      !    !XX0DE- _,       D
M      $ .$))32<0       *  $          CA"24T#]0      2  O9F8
M 0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M     0 U     0 M    !@       3A"24T#^       <   ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@     ____________________
M_________P/H   X0DE-! @      !     !   "0    D      .$))300>
M       $     #A"24T$&@     #40    8              FT   ,D
M#@!3 &D 9P!M &$ ( !& &D 9P!U '( 90 @ #$    !
M          $              R0   )M                      $
M                    $     $       !N=6QL     @    9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   )M     %)G:'1L;VYG   #)     9S
M;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2    !W-L:6-E
M241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0
M  Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0
M  I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !2
M8W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T
M;VUL;VYG   ";0    !29VAT;&]N9P   R0    #=7)L5$585     $
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M!!0       0    !.$))300,     "NF     0   *    !\   !X   Z(
M "N* !@  ?_8_^(,6$E#0U]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'
M0B!865H@!\X  @ )  8 ,0  86-S<$U31E0     245#('-21T(
M         /;6  $     TRU(4" @
M                               18W!R=    5     S9&5S8P   80
M  !L=W1P=    ?     48FMP=    @0    4<EA96@   A@    49UA96@
M BP    48EA96@   D     49&UN9    E0   !P9&UD9    L0   "(=G5E
M9    TP   "&=FEE=P   ]0    D;'5M:0   _@    4;65A<P  ! P    D
M=&5C:   !#     ,<E120P  !#P   @,9U120P  !#P   @,8E120P  !#P
M  @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D
M($-O;7!A;GD  &1E<V,         $G-21T(@245#-C$Y-C8M,BXQ
M       2<U)'0B!)14,V,3DV-BTR+C$
M                                     %A96B        #S40 !
M 1;,6%E:(                     !865H@        ;Z(  #CU   #D%A9
M6B        !BF0  MX4  !C:6%E:(        "2@   /A   ML]D97-C
M     !9)14,@:'1T<#HO+W=W=RYI96,N8V@              !9)14,@:'1T
M<#HO+W=W=RYI96,N8V@
M                    9&5S8P         N245#(#8Q.38V+3(N,2!$969A
M=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="               N245#(#8Q
M.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M                     &1E<V,         +%)E9F5R96YC92!6:65W:6YG
M($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$              "Q2969E<F5N
M8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M                      !V:65W       3I/X %%\N !#/%  #[<P !!,+
M  -<G@    %865H@      !,"58 4    %<?YVUE87,          0
M                  */     G-I9R      0U)4(&-U<G8        $
M  4 "@ / !0 &0 > ", *  M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T
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M5_KG^W?\!_R8_2G]NOY+_MS_;?___^T #$%D;V)E7T--  '_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1" !\ * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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M>I?\E4_&K_J2L!N/?H655N865EF\"#[&FR7 ^MZC[5O]2_Y)I^-7_4E9=/\
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ME6UK*['5#U+LDN)9&]_Z.YC6MW.]B<.:%55@?O 2_P"DM$1TD1Y:?M8C*^M
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MNQU9;4U^_87>I5L_G/8K>!U/)NR15;EX1;O+/1QRYSR\-L_1AUNSW^I0]_\
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M/B4+()./9/[COR)QR6*JM4$$ZDWI7^+L_P#_U>YZA_R9C_UJ?R+-ZC3Z[*J
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M]'L_J._(H?K_ /P7_24+?MGI/W^GL@[MLS'YVW=^<@!J-5'9_]DX0DE-!"$
M     'L    ! 0   !@ 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '
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M2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U31E0
M245#('-21T(                  /;6  $     TRU(4" @
M                                                   18W!R=
M 5     S9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4<EA9
M6@   A@    49UA96@   BP    48EA96@   D     49&UN9    E0   !P
M9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0   _@
M   4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U120P
M!#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@
M2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@245#
M-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M                                                         %A9
M6B        #S40 !     1;,6%E:(                     !865H@
M    ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(        "2@
M   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                        9&5S8P         N245#
M(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M           N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A
M8V4@+2!S4D="                             &1E<V,         +%)E
M9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y
M-C8M,BXQ                                  !V:65W       3I/X
M%%\N !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4    %<?YVUE
M87,          0                        */     G-I9R      0U)4
M(&-U<G8        $      4 "@ / !0 &0 > ", *  M #( -P [ $  10!*
M $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H GP"D *D K@"R +<
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MCPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W KS"PL+(@LY"U$+:0N
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MQ %S   ! P4! 0$             !P@) 0(#!08$"@L!  $$ P$! 0
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M#7>FNP         %&^NLZ+;#97&W-3R%[4 D8
M              %R[/SLG\6WYX?:/-Q.2    6NU.POJ%R>_<CQIZ-]P
M             *+YIR]#H(U<@  V+GS;"TZ69+6W1M:R+\NA\6&MNA?L79V
M         ,&DZ+6+CT1 '$5-)GM0"1X=\8&^=(Z>[_/-]&C3&/*Z(XQQ?EK9
MNMFU/-J9]6]BSW)G2])0    1**9LRD*YH[VS<?7&[5NSBUCM7&!4%RQ?;(S
M0NQFBVP  IC$AK$5^8SZ \Q$^^G%@R3=H(ZA1VHE?Q(ROU_HJ&2U_H<\%YM%
MP   *;9IKFQ/&3;%<XH9HNVQZ(7I/LCE*B*U-,@ &V+'_"AJ]EU,FDLBXH<\
MKKC154N$]";;QQ?MN=637%"5<BW2</7,RL721J?1=!9)QWA5C,N@XG6
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MZN3ZSOF-ZN0"U>+VMWUVW2.I/:\U7:;;LI]/TV^#J88SY^GCYJ_EP
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M2"?0SR:K+W"I=UFQZZ]DSOJ:FX         !@TG1:Q<>B( XBII,]J 2.Q5
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MO;MM<EBN=:8R            8-)T6L7'HB .(J:3/:@$C
M   KAK@7<0@^V_/,DC/ONOC:D2=FPJ6RNK-BEE58=3YXM21JF;+%M$2LZ&</
M(MLFG,5:MYHJ,??W8R        !<)5U0LVVP[;Y#:[54 "J:6-1!HTN8I98,
M29?8T);18G"3"3<?2MF/<,W:^5W+GAUK-Y JYDRPQ3OW\YSD<)6ZK@
M                     &#2=%K%QZ(@#B*FDSVH!(P
M+'>S5K7K9'_0,/D<BDO2SMQKYM/0-3?5#YDNO"DX@QE$#F\\:^@,^"SD="JR
M=$%!R5UP         !5,$<"V*N-*;;48[W/V.'+A@=\5K!=ZDHZ(J\ZI3&Q&
M-V%^LCCE0.<]VBCG@W;9..QPZN>?Z8Q(GX5U/9M_*-G35^9KO[/A=K/JW%-1
M!6F-P                       #!I.BUBX]$0!Q%329[4 D8
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M>9H&^P       %IFQ%4U:9'[?C.YS?.L[[.,N[TG=^NU5M-;(>5\V/M[S?\
M.SZ^HA:([V/IA\UWQ/%4\P[?C=/V.-Z;X,ZVIEB"EZFEV^MFF,>Z>O5TC'L2
M(?,IZ3J:+:R:V>S2D^^P'YS>NW?U=),CE>W7>]RD   !1/80WHH&X
M       8-)T6L7'HB .(J:3/:@$CIKFNNM M                "UP5RRHQ
M:7Z+XWJE^70RW%P         "KMHS2WJ\^?KV9245MO0-%N['<N[97N-T92_
M.]M?0;Y NMP_!F_Q[_2?R!%]==<_0#YOMOZI:%M-3N-W/6LJ          !8
M&G;)0JW;5GR/^I*8Y?5Y]@WS/]1RK>>[9RO6]K9T   !4+@-LFP
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MVJ9B<LJ,(;;\-O<*W<'?$Z2N<9KHX,;BF@XTQ:GI00\*LA]&G!N37
M             ,;1(>P:-BWMVGOH0\[VS]3/G*X%";]3T(+57UU^-T3[D;^1
MOU?4\1=I5!]M/B'U9*[6LA]CY]DUT                \N4$<>-_A;]T^8V
M2NXW]!7CCT>Z*NK '*1LJ !;OC+7<CG/IV4W:9    MW2^>ZW83RLT3&C<
M "[=98X'W)VJI[NBZVL7'HB .(J:3/:@$CM4S$[94812T^!:^8QETM]$%4Z4
M/YCI<53WD'RJ]'GV;OTKP3U[V.E;>U%-XD*2==+O>Q$WQRORY<LL
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MI+S;/?M'N/0TY?)]9;N.8FD?,EBE26%\YPYIYNFJIV*LO7R
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M]#UV\7'HB .(J:3/:@$CM4S$[9481.W8S1(O
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M5>-Z^BMH[Z*O G?BAT,]I_DN#+T@Q-5)5XV\(S[^YS-.W.I.Y&K0_OYYMV^
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M'8=HN@IVE<O(7EW_ %4_,UQ_IB"CANS691=%NSSN_P"0Y>C#N_MDWV=';)@
MJL"^+<ZU9O;TV^%TI'/\-_7[&_CQZKXF:=K<,N;Z&[?DNWWE#@\?P.7,OWZJ
MOF.Y+TW!0  QC1VX#JM8_9G"_GV]"U1#A.H=]3O@?V=Z-4L6K(K:33GTM+KU
M\VJ9@WE_&G(A_8NT+,ZP$^AH'ULDYK48AZ6XF.RA0I/"G/2#S[>KI77&*LY)
M.I4$GT/7;Q<>B( XBII,]J 2.U3,3ME1A&+;CC5YA1[OE^&*H@
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MWVG-):^H   ,6-DE[L9^"+W!YC4NG9I./\X_7\UO+ZGNU0@OM>)\1U]\:B
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MR.M:XR !C3VTG091U3V->1))BT^AWR.^GJ<^A[Y'^S/IOKFQ-HU+450
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M2U%4        P:3HM8N/1$ <14TF>U )':IF)VRHPC%MQQJ\PH]WR_#%40
M  6Q/TN.?S&2[B]N+Z0PY3./R&K6%V8E;BKSB'#4<:C-Q*U6D]>#5'.ZSF:&
M-K'*Z,2-E\ROL"OOI=\FWW]1M%6KZ-2["@    &$,06A:ELU&1\)O<KX-%7=
MV[57&B4)5AQZ9>K9XWF01_I6BF_2<:5QKRNK7(ZW7PZ<>O1C/T(4I:%V^P
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M+%)K 5Z"A'6REKC2S:S=W.^?>HW&[BNN,59R2=2H)/H>NWBX]$0!Q%329[4
MD=JF8G;*C",6W'&KS"CW?+\,51          %@W!N53*;!D    ,9HD445X6
M0[0-^A*Y:)9;>8VA[@^EZA+(D%A$DJS>Y4\7.=?$HVC\G4?QZL7#Q[NN#X?:
MRF:MSS(9C6MB#MKDG$B^2UD[PYR[I45Q%XFI)VGIM63B7^K+"[QFXR+:
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M/E;M[@       #&$>Q/\R12Q=&(9#:Q32)KA3*6+LPV,EGW9&7O'W#G2UN
M     7@T3BRITD<N1 M-&!O4I>EV].<_  'N;LY]7&0MW<V[.JU7VYSZAE-Z
MV0 !!$<MM)U-H'+TAO9=Q9@E8^P(_H;ZQG.N+Y)];)XV-GE=<8JSDDZE02?0
M]=O%QZ(@#B*FDSVH!([5,Q.V5&$;N.+M.DM4N[7C(NT             H%H
M            "F:A1/)G(       %=##HO%&AVY9'_'-4\:;:)QC(98^I'XQ
MVO8D:W9=$NF:I       6 T#AR]VT;M9O^[)@+=>7QL\IT4::9#)A*NR(Z5-
M3$TU*TE,Y]0RF];( !D-2QOI 3Z'@G32E9M\3NAHG$](2?S[P;LMN2+)UUQB
MK.23J5!)]#UV\7'HB .(J:3/:@$CM4S$[9480^WX\W=-#1Y:5R\
M  M !! YX             +PN#$         %,&FQEH!K+V(812X5C,-I-S6
M.$U?V(;[*E<J       5#=ZCD],M]43BSE,4E]ZG*46 VIG43$&8   &+7!6
M<CG/J&4WK9    LSK 3Z&@?3R?F(Y%[2:/!?5C^K:\&],JV$MJZXQ5G))U*@
MD^AZ[>+CT1 '$5-)GM0"1VJ9B=LJ,(_;T4ZZ/L;4LB+<V5R-=L;I:JK6A@2U
M,N#5 U6,H&-S.L1SQ9PK5GURCLTW-&0*        &VM<;XS;/OH
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MUPI;?,I5W(YW?%R^=NO!CJ(+U70B&D?8[.O??,?<4]/=>]EDJ4I^0CR.I3X
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M6E2+\>P>%4L9W/1\K]KO%P       +ME*:-8CN]V9;N%S+@
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MQT<>8<W0TGC5C/KU5>G7LJTC\%HO?-I:* 3&<^H93>MD    22M<HU<[U9X
M   R.&M$M\+'HZ?M-(N/1$ <14TF>U )':IF)VRHPG%CPQ8?/U4TTZ^1-6("
M<\_$FXF!A'.LZ2%C[/GVWHW2S-F^5F['B@ &/7&"0Z6MW.;ALL^SBFJ8&0(?
M.SU78MV_8I[.?9,J+;V9X^"*2_3>'_0EKKHXVN;L+5=LQC@U3S6]%.@]=>?L
M&RN?CXINGCUSD4S13- L QBNI59/)OO1%:P3NVT&N]RFU[Y2(N2=*7:/M+F_
M*\W%6N[*=$7%XNC7H&T&NO.@E>VKV@ -M^ECW#5ND:S9KS/6ZKNJ67)]6J,7
MS:6B@$QG/J&4WK9    J:UT3IC>BNX   !G-=\&#1O&L7'HB .(J:3/:@$CM
M4S$[9483.PH"W/RMZC9.G?;4&,U?S</R,PK\J8J.\?S)@              &
M0(?.QT7:*+==QF+G=&P                           %4E:JM(CI#V9;(
M]S+P   O%T:] V@UUYT$KVU>T !MMTD>Y2M4K5@CFJ^EXNBM\VEHH!,9SZAE
M-ZV0             #!I.BUBX]$0!Q%329[4 D=JF8G;*C":V'!M-YK["&)W
M?R".J*V1Y)OV;3%<#D^3?&@WYS=+%UJ(TU5[?ABZ03KBHE=A<5*.BUJLYHDN
MMT$>]_QEK#:]-K>LK#YV.B[11;KN+S7/,$+'Z:.3IHFW0;7N][=':_5ZY[#D
M;7.U6N65RO$NC?OC(AET];=2C!W5;440  -"FN0       *I*U5:1&23K2U1
M)AZW9;EG17H4;I7BZ->@;0:Z\Z"5[:O:  -^CCO(6VIZ]&&:NF]W3<H%;MC:
M2 3"<^H93>MD              P:3HM8N/1$ <14TF>U )':IF)VRHPFL^@B
MQT35]-,U40B!D_8P86F,XD;CF]8HIC9J*TR?M+E&%ZN](\9!"G;5$^Q;])D]
MS1^3:,36U-''U>1&IS^2Y>MNG(-Y*[FUY32Y!S#YV.B[11;L.%S^IM?@(1?C
MQG=XQV2N(3VN6'-]SGL.B/,=U'^UE<X:9;<=D(ALLQ[.F#3*+.PHQUK:OT>_
MYU[6118"\,0G03RA8&,*!<% J%P525JJTB+DO:=_6_J%*%)/Q'.L*429?-6S
M5Y>+HUZ!M!KKSH)7MJ]H !QM1!AE9H4=/J-D+U7&O=N\U5]R<^H93>MD
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MC)#U9<(ZWH:UPT,NZY2O%T:] V@UUYT$KVU>T  DGT'&8KI4]>VM Z2]V-T
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M!M!MKSH-_P!M7Y!>!MMTD>Y2OTC7B'LYSLTLJ\]JU%/0EY:*ON].?4,IO6R
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M$ <14TF>U )':IF)VRHPFT^A:PT34MN$Z;+@ 5Z_/C;^A"[Z>8Z2#5>4&M;
M:VQYC*^]ROH!IVQ;%74'MNU8XWD=!VL.FC/;CK9CTAYJ[O>=UO@!PIO*7S):
M6!D# H1L>I(O*C9=EQN3V'OQA$B>!$9$QJQ(9M(S*)5Z\ZM7"_S97G6,K$#E
M.Z6S$#8L/E7KJ;QQ1RN7S^/I!8@E>^PD_?QHN@KVF.<D'JSMN>:]!K]-0-6*
MB?<UV'ZG:'10%!%/6O35&Q^MJ>JQ\F$Q#.9FAHO/#53:2*J;7BZ->@;0T;SH
M&VH  EOTK/D=EYV>13\/W!W'1J^4GN^%D7OFTM% )C.?4,IO6R
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M+HUZ!M#1O.@;:@ &FO2\QJKE"U"G#&U^F<Q3HGL<16^;2T4 F,Y]0RF];(
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M3T;I'UQKN/&C#R]9:*BVH*Y[@]*U)5K/6X;QHE)_-3W'D8\I2,41  -\5W!
MH@53!P&2F^0 !7%6H* D44#;( %ZFZ.>A+>T2KDVP  *;]+%>0K=-5IA;-:N
MM*I/4:OZS-' IK.?4,IO6R              8-)T6L7'HB .(J:3/:@$CM4S
M$[9482NS88L=60+$HY&FX  S6]'8;6L>;7IY  HEFB!54JOBB6:(%52J^!VY
MPQ9U1[D   >;5Y7/OD+*]!>B6:(%52J^  *)9H@55*KXO?(X8VXQO.H(:@
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M,EL;DX7#@                                  "\-@8\AGS@
M                           !D;MUHA72FAKZ0UTR              8-
M)T6L7'HB .)J:1O:K^244S3.+30;Y
M     J%3%ID   "@7&*&0                           *J8L<YRM]ZZX
M              M4VT+QE%SZ*A?)Q7;6\%^
M                     !>&?./+C(
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M5%2%I-YV'97/"6!:L?C1DVF&K<,E1#YNY^;'U07GOY1?/FJ$@' J1R"9-80
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M:U]K7VM?:UN*'H4!"BI[GT ?5!>>_E%\^:I/8 0L$YG3!8$HW,%F.Q,%@/S
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MX*2H(@J=,!3%NU53<!&)',HBN\3$J39NBF5TK(W9;<')1]]6,@J&0K2*^9Y
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M]*R@)A#QZBYSJ)IH%, *8DD&8/1DHHQ6;A$BCIDB^HUA0$D3.F))$POHV19
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M%*&,W4LF_75OO@FXV3@,X8>CI>S6$>[9SEO'7">?]\/>VEY4IMT[E'BTW;<
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M7&TF#3MRPZ]HQ%TQ;"THMV1N\8/H]*Z\S&_^4,02G^5QB[T<VXJZ"(G$Z0H
M9TF2GDHW3(Z<G<"@DL0_R35$QRJJJKA)!(4P!)O,D\3CNRW=OH7E=\+;41?<
M9<%XW%&X_GXIL_7*#Q5,%%+7:,U69F+%JL"4:->&CZ%*."DT8U0?"1]%;1Q:
MO--E'D,9%2H+SW\HOGS5%[&.N]7\PR[DO>?-J[X @\72ITY>OB>%EZ%%ZG\I
M8N\#=8$JB+J<0SJUIZ,E8ZY+.C[C+>F,I"&62;/#+$2W*V_(W@"HIB995(A5
M"*%02J1?I)D<N!7.LJ*+BW5V["Y[[9-I)7D:E<C4KD:E<C4H8-39R-2N1J5
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M<_C*Y_&5S^,KG\97/XRN?QE<_C*Y_&4A/1QUI#9'(QK%TYC(G&UV2\)!XTO
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MF38V9]T1R@(Q>92"?!:A@5"G*(K FVW <NU69,2/&S*E[=EYAPZLJ>*9TX&
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MOB5N>I;%TJP3D+?E6(P<B:-7DKGN!TG;EO2,Z_M6UD61#HIID()@HPE$/G5
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MZ MZ<D$VL%-PDO:<>[*[4$NSTB&TV1XL'$:8_A5;&F .Q.00/0U'^H@;2-U
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M=.T$N82=>.D#4+UUL;R#Y)9K)3";I"1FBHH23T"F,X4<T([*'Z@E793E(ML
M%"& ')#'C4=E<-*CE.4"@804&/3"Y[%1E DHKV?4M.ZI!I(VS<#67:!]=/C
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MO:AC25PQ:ZDK,0CTCZ?BF5NXMCUB0).Q\VJ8I:,Z2$BQ1*(' 2HJD 44!.H
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MY@5=B9E!.)4P6@P*WE8L8A0BKQDI=J+5]#+LBD.!&12J(-STLW=MPMD[E>!
M$U0I),QS2!MB;Q!1):PI] JQQ*9+YL1V44-ZIDARHE*<E._V4Y9=%.!M:())
M*^SD=7LY'5[.1U>SD=7LY'5[.L KV?95<%L&5AL8/$E+<1+N$^6([*#ZZ=*E
M0(X7!:N <1X!J63.4&J1C4R1*F [M &P/24=E/%  JJVZ;CDJ\ED_")'*_EK
M7(=.(:]P7O/FGWE_XZ#[=!3[M%]5S>;/W?R4J)WMK&0)1UV/ O-1 XR'KNC[
MA6]?_FE/)VM[EMON^D#;HN4N+4NS B=M._"OHF0*^:?-[N\"B@) ]<@L%/O*
M3?N78OW5\N0^X,5?=1.S\O9MHZ@)@^< J'I4)OTR0VCN@7Y1AW2OUZ,??-5Z
M#L86RD*LU&-O#QK7N"]Y\T^\O_'0?;H*?=HOJN;S9^[^2EZDS;5F#*2<D-'S
MYDY6%EVIG"1G)YR+?OX=:W9W?4M6X4P+:]P&HEHSBJ$,V5C;=3(9%K11 **J
MF 2387Z!S'CGF.K@;/A!0!HJ@&'YDH[*DEP $5!44_\ +X!%I*HF&S;)**<4
M= Q$CSC8CNZ)AK:B*D@W2@6\B@XAV,XU?MBS+8RD@4?9W%7W43L_+"GPF @%
M.!Z.<$Z(8#@W;'6%!$4@,("'I$=E;-H/5 02<[RU&(=N=5 R*-URS=^TQ8Q4
MN:;42!JW:]P4=BH?76RME;*V5LK96S;6Z/H?>7_CH/MT%/NT7U7-YL_=_)7$
MX%AQ1X[%6+;MP?,AJZUVKAF*W#6CYQ@U(%P6^JMXZWUT5'\ D R,8Z%P=(P/
M>'L])3;H2L<)A2G7D([L^;;RD;N[#_,O7'AR.7 *TW+L/0-Q<-YY+AVC90;T
M4[D-TJ2"9RP:)[K=21UW$C=ARI1+%N2-A&D>)SR!OZ=Q5]U$[/RS#L!^O]:2
MF^I2B?$!!#;31+A_*V;:44!,'KD%@I=,3A-RP(-UW8.%L-VD,4H^* .&O<*'
MX:AWP$ TH!AYE7,JYE7,JYE24F4!([(H(#MI]Y?^.@^W04^[1?5<WFS]W\E(
MR0 LDZWVSV52#F+^DI%40<D,JH3= K<&":K:=MU$CF7@EJ5=M=JBRYZ+Q=OI
M, TZ*FN@K!<)2 G7D:]B+B8R:&X.X13?.(;/D@&VE#@F$PL#E/ZR BN0#(('
M<4R8F1)<: K05FB1F@ZC5EUE8Y<4V3-*/)%,&K9Y;<0X9W?-L#OKF:':(H/2
MD5B,5*E!OV#_ "1'90!M!\H""3C>6I,AVQBG ]-FQUA2:F3H"@ ?)"I)?=(5
MS]H#@@@*J16TO.(2KFU()Y<4\A.0=J133(<5+N&JQ. 8@J4^7V"F@_4$6[\M
M*'!$ <$-6^K6^K0**@+ RI@)M$K[R_\ '0?;H*?=HOJN;S9^[^CR:9U$CLG"
M!X:Z%62]NWDT>% R1RB/R0'93Y;85PMO"DCQ:1CAVMT.$ G,!97C*-HE2.8O
MN;V?7-[/KF]GUS>SZYO9]<WL^N;V?4A+PQFMAQR\<L ',M\G9MI10$P>N06"
M@2XU(,1&D$ 1'Y;Q?@$=.06IDB0QW[MNUJ[+K.@24:2;B0MNSK;CK/L.>LD\
M\6<QTX=VW>,7,N-H#3[OEBS0II,Y!2E8NR0*JUME,407 U#4=ZD^[?>7_CH/
MMT%/NT7U7-YL_=_1AI$40,^!DY1>0KIJHT6E&"UJ9#;M1:7K#O@;O&[F@( T
M8F[6P:=+ W(X7,L*4:Z>':1:Z-%(4H&* T0-VER)JEE[-:2PCC2)H<:Q0#\+
M8JCXRB247&<2:@Q=&"'PSB1.ECENQ5;M6[=$VP0V#6P:V#6P:V#12F&I(5 (
MU0<.%>7.*:LC)B4NRCFV!OT41-6P:V#6P: HC2JP(A,O@6)PP32=7-'L0G[M
M3=&:MGDLOCS&:K9GJLNBXK?BX@+ANNL!/Y9K=>FQS.RMS*B0%WW?*MC+H8]M
M_$%PL)O3YI@M[&F9L26;C6V% <(2%#4=ZD^[?>7_ (Z#[=!3[M%]5S>;/W?T
MEPV\25:+':_;+-0:2[UJ,?>[MJ9OD1Z--\H^$KXP,*'*\<Y#XF1=!E6-;U\7
MV%?%]A7Q?85\7V%?%]A7Q>8F <MLJCLF-'H+9?8(*.<M,A31RTQ$K+)S1<B^
M6&2*Q\OL>'\7V%?%]A7Q?85\7V%?%]A7Q?85\7V%?%]A3C++-6F>5&*1_BVQ
MH,NL2U\7V%#EUB8/BVRHN76):^+["OB^PKXOL*#,+$*<Y:9*TI?B$E4O>+HQ
M$%IJ17M^TW4@O:>-F:!BMR,VNK*V+DE8FS[0R1!)X;LR]2WGI^Q9-6Q)JLA0
M</N^:@JJ\GP0BVD?:[+-.F[.,DDWQZX8*!(T-1WJ3[M]Y?\ CH/MT%/NT7U7
M-YL_=_26ZB:8J*('I5NW6IQ$)J4Z@5B4G&K%%TQ*<G+6E!'M@KP*%#'MAKEK
M2N6M*Y:TKEK2N6M*)'LRT6,9F&W(UDW1>1K5Z_.Q9JII,6)314>S0;KM6#]R
MC").!7C&K<X1K79RUI7+6E<M:5RUI7+6E#&M1 L:S"@8, #P+&EVC4H)P@J%
MC[=.[4DK3+'N5(@HUR4:Y*-<E&@@5%*+;IPII:C]V,9C*<46B;':,R0EO-VJ
MA !-$Z#E0SB-CW8+Q$2H1Q$1[<C0P,J3<O'(O@$%7+B49.L.,,92SRVYC3]"
M*7^OA9TH*DNV7H:CO4GW;[R_\=!]N@I]VB^JYO-G[OZ:FB18?!HTO'(J%Y4C
M7*D:Y4C7*D:Y4C7*D:Y4C7*D:Y4C7*D:1C$*CHM$46T6EXQ*-1!T2-0XR$:C
MX..C$?&1T6B+F1C$.*$8@8G*D:Y4C7*D:Y4C7*D:Y4C7*D:Y4C7*D:M2*C?%
M-HFW."@TMYLHZ0@U1:1D 93E5N5RJW*Y5;E!&VX2O VW2\;$J%;,44J7!, C
M_47L>E=,5" U. BB<M/N]:.YINOIU1N(+/NG&=R&NZ^S6ZQOJ*<)/(RAJ.]2
M?=OO+_QT'VZ"GW:.J"03\0[<KKL729/#.Z\,[KPSNO#.Z\,[KPSNO#.Z\,[K
MPSNO#.Z\,[KPSNO#.Z\,[KPSNO#.Z\,[KPSNO#.Z\,[KPSNO#.Z\,[KPSNO#
M.Z\,[KPSNO#.Z\,[H$'Q:X4E0)2%<)]7"?5PGU<)]7"?5PGU<)]7"?5PGU"D
M_I,'A0CW*Y"(L7J;@6KU%8J#\%$7JY6S5%^@X8&<IKNF+Y<YFCY(G"?5PGU<
M)]7"?5PGU<)]7"?5PGU<)]5H,5W#I%%NFFNBV3,FDQ.H5HS$SXK>/ B;=1'A
MMJ500.'@TJ31*C1N.-)E6 8_U%['R5.R^[U!])LD<->T9EE\4WC>*#QT9055
MROCT-1WJ3[M]Y?\ CH/MT%/NTDF50[B,05!M&Q[0^Y!5N05;D%6Y!5N05;D%
M6Y!5N05;D%6Y!5N05;D%6Y!5N05;D%6Y!5N05;D%6Y!5N05;D%6Y!5N05;D%
M6Y!5N05;D%6Y!5N05;D%6Y!5N05;D%6Y!5N05;D%6Y!5N05;D%6Y!5N05 2"
MK<@J.RC'9>0,Z3C(MG6Y!4 0@%W(*C,HQS7(&=$C(QG6Y!5N05;D%6Y!5N05
M;D%6Y!5N05;D%0%CP]"L@WCRR]U@T-#7H=R_?@@]:JE(1G\D:C_47L?)/V7W
M?2$B]CV^,+.M2Y#XTMC#=AW'+D@XJ3;$518T-1WJ3[M]Y?\ CH/MT%/NTJJ9
M(33B"1E96/4)S"&I%U$KJ&>VT1)D,:]=IO8-5^1[%'54>,DW1W$0FY%_#[RC
MF(2)S"&HCV'/0/X83*.(I)0\M"$>*.H<C-PX@VSEM*0[EMS"&KF$-7,(:N80
MU<PAJYA#5S"&KF$-7,(:C24*6BOX8X'>1! YA$5S"(KF$17,(BN81%<PB*YA
M$5S"(KF$17,(BN81%<PB*YA$4,LR2KGE$E6J]>,B:%[$%#F,-2+YF>CS0)F&
M3:G+S"&KF$-7,(:N80U<PAJYA#5S"&KF$-7,(:D'L:8JIN$M<DY"1EQW1EO&
MMKSDSE6P9I.SLA1ETQ"J#AL9RX(U*2YF!U/:!E1KB8D!&XV2YR'!0L?ZB]CY
M)^R^[Y5JBNVQI?-J6C#8NU066WR+E>^H:]\C/8]%N:AJ.]2?=OO+_P =!]N@
MI]VII4Z2;IZMQE7JP)>.6J"@+QO>2::6(5 C+3ID.0DIIM<ZL?'IS#JW3)OT
MIDD)=$A$JJNHX"2+PYO'+4@]6$"/5N,^<*&B86TIZ];=B+)R1,LCXOS(,++-
M+GMZX_'+5XY:O'+5XY:O'+5XY:O'+5XY:O'+4J]6&D'B](.#J#Q2UQ2UQ2UQ
M2UQ2UQ2UQ2UQ2UQ2UQ2UQ2UQ2UQ2UQ2UQ2UX@"!XPFQX],!/'+5&/5A%T]7X
MZCU<$O'+5XY:O'+5XY:O'+5XY:O'+5XY:O'+4]EGJ!5"I>!RA/RC_4'F2U_$
MW9"OI5A*:<R.'%OS8I^-F.Y*?<<^(H5-\K#S#?N8_P!1>Q\D_9?=\1 ZZV+,
M175F6;@\8WG<,W,P[RVI$(ADR4H:CO4GW;[R_P#'0?;H*?=J52!1(QF[ARHL
MV.;8A6$+CGK1OB,#19F3)..H"XT<_6#DB&S);,A(VYI3PDQMK&E_ZCD,Q15Y
MYGS#!I-+Y"0C7">Q"D>"%$,W,NNHF5QH,:V6SM$N.H7#^GF]$;:8R^>"3+3)
MVQ"MB%;$*V(5L0K8A6Q"MB%;$*,BFH")T-]<"I(<8:XPUQAKC#7&&N,-<8:X
MPUQAKC#7&&N,-<8:XPUQAI10Y@VJT7ZZV(5'G03,Z,@"GBFZY=J-!P1K8A6Q
M"MB%;$*V(5L0K8A7":*4?C2#>\\27+*92R5B')=UW/;&EK(+=_C*PG=D0;@R
MKB2F.Y3;JN'3-5RZ?HJJ"Y9.B%<M#@="/]1>Q\D_9?=]OJ$-IQ&XXW#=D2EP
MXBTJZA(@(C&)8<$HFAJ.]2?=OO+_ ,=!]N@I]VI'RS;SO\96-<M.,0WA(9%T
M8Q<G;&IIX]R!C3+["Q8ZS,TX4G*Q=J.<9LUIKYYT\6;D!*:?Y"FH=PW=6Y25
M(]^7<*%FY'7LFWYO5?D"=<,];MT2$M=>1+ER5*?,ITCYAYY;Z&R.0ACIHJF*
MR23K@)TN@&[X8]*)B0/DD[V'\FDD15QX-(:40(D%%]<QW+]>09%DXN^749.V
MQ>:;E@BFT69D,"<?ZB]CY)^R^[Y1NFFIAQ>]YQU>MK9MN]GE64R5=C@R\N_/
M0U'>I/NWWE_XZ#[=!3[M2/EFWG?XRA3BEXPAG 2R?CUF#:)9J.'#,ACV[=CJ
MPY&5%*Z8:17:-1CT2,HO>/1%#%I%)7BOU' )/FB3\K1)BK4@I( R1(DF7Y:R
MW!!-0ZM,F#ARJL1\SF9)!\@7AOJX;ZN&^KAOJX;ZDV[LX((K.!*J!ES?LT4X
M&]!2[U<,:,7=K;10WJX8UPQKAC3DBI2HK*D%1T90.*XINH;:5VB8[POV7R4B
M"96(5*#4 .FKQ5*$YC>@OKE^YM9DI)W/E+;=N8[G<P$UDN]DU N%NHD1A'^H
MO8^2?LON^1=I,D=+"EN1%MXCO;&EH2V7;DL"Y781K"$1H:CO4GW;[R_\=!]N
M@I]VI'RS;SO\9Z4B[PJ*\&E9CP]>T05[1!7M$%>T05[1!7M&%(7&6G5QAN>T
M04XN0Y087&@(N91D_3^6D_:,1<W(T*%C1#3(%WET;V 9P[T@V0Y<_@YL*OP<
MV#7X.;!K\'-@U^#FP:S-A&V\30:%S%;NDY7Q+Y,>+16PE#@FI=)0I=U>D$U3
M#P1I=)0I=U>MU>MUQ0HKG#PKBDT54QI*D>_>>7^2V[V*[D_K])?7,=RF[E&S
MNW;ZR^0]K3N9\;O;B?+7&^4<2!C1_J+V/DG[+[OID[A.UL#J180SI1"[X3(S
M@R#AP I.J&H[U)]V^\O_ !T'VZ"GW:D?+-O.CYRDDQ5'PIZ(B9%.1:+!'VC;
MZ4JD*5J!%*1ML)DY7;0OPM:%%P:TX0M)VI!JT2WK?3,>TH)PBWMF"<JIVI;A
M%;L@(6 ;L4$@+Z4TC*B5@L8#QZR9?"*5*LBBC'0,.E%XG:P*]\R+IRLT.HH"
M(E<%/'RSR010D5UXY5)=(WVU:@V+9[:P6E O9*]FD5!KMP%N1JF5VB,<HH8D
M9]?+";HQ8&!9H*(,DTG9PCR[Q6"9% 9)A2+5 E>':[)8B::%)4CYB04119(7
M5$N'#59N\,H<$S .T*;=[%=R?U^DOKF.YC74E'ST@QUZL5M25^7S8EC-FKJ3
M6\:X=A'^HO8^2?LON^,L4(RSKKE[8I_J+R+=4.<7SYJ[.B*U#4=ZD^[?>7_C
MH/MT%/NU(^6;>='SE-C@01<?6NN'A)-?^DK!.8\$ +>PD]XT&K J_M9)B"<@
MNJOL:K+[QE5A6FGT@@TMTQC-'<I+A<U^+N%6"!"%AO2P*!CJK"D!G@''CA5P
MKG\$BLX]BL#'5/?AP*5E#,S2TO<F-6.0\^W=?V)X.78QL3<>$0,*_HU B8+/
MC9:;"Z\BF,<ZODVJZB+?QR] ^7KQR^[XY<*<.7"E,#KH*"]<#2[YP >-7H'[
MBO&K[%G"BQ*2I+S%\.HUM&0'P\,DVNB"BYF)>MI$BX$ *;=[%=R?U^DOKF.Y
M(B[6?W$M9N&([5/CB6MR2C>_8]Q'^HO8^2?LON^4[OY(U'>I/NWWE_XZ#[=!
M3[M2/EFWG0*)GA3 8_@E2E\.K1V:RJ$HFH,'8LW%P+$J\":WDWUKJ$6<0"TQ
MS2*\>I*P!Z1E(!,1?P8J*3=IE;L;@@F:HR=K+.KWF8F9;L5% 9^F*+MH5!D%
M$8QT57P"U/HPZK?FT:E!8,,W6R']@=E8DDV97D_NQIC'4QD3 RL=(V$WCX'!
M$$J52'VA6HAXV96@SG[,:*W=*QUSG(/B4&C8!0!HD->#3H&J J"T)16B(&.W
M1.!FJ6^LU3 O+P.)XL4P,P+O'BU%2KLE4*24+O"<$%<_2K,UHL8^XFQ4KD*V
MD,:NG+Z.(58JM-N]BNY/Z_2 @!YQ R2,8WNB!G)MGIZU#MM2F3+8FK6C>_8]
MQ'^HO8^2Y6*B1PV47.HU5 GA5J\*M7A5J\*M7A5J,V4"HY(U$*)2/O+_ ,=!
M]N@I]VI'RS;SJ?G$O,'[@H@ G5X8.1XM3*C1D1&6AJ\-%SY6]GM1H;,:J![#
MM:]AVM>P[6I")C[=)S:'H)%-4& .%EUFZ:3;TQ7=P_G))<Z2GCEJ5=+'(Y67
MX^"SOCY@@R)*,0E6$/.7_<B=WO5+F?%*A>[@;%;-FJ+'@M*U4.(MC8B<C;ZD
M5!!'+LVP<*D7I2E"0#:9Z0:*^W!\:78+[:(O"[1? )Y"0,4J,JN IR*AP%Z
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M$$R3D?&.4!W3I>8=D$S=G^^$>*ID6@W#)Z-U%(=.'.8"%(<J*!51+:0*DN!
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MYJJ6%8AKXL9UU!=?=V]+'%%F2&:];>993/F,^H5,W#@"VM>NL-31[/=1K5/
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M/5[X]R5>N&[PZ>O4VLG6 S(=4#B8E;X5OA6^%;X5OA0B82F Y1^OZ#<ONO\
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M7AFHO>Z6O\C:W>W+[K_Z1=.WYJJ/V>J'[^#WRI!4+"VQ P#TP&$6N.[):6W
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M=X]#IS!@"V,\ZVHB_KLTU8)DL:W9&06H2?N7,NH+35%9.L\<(X#QA;W3ZDK
M=9<O/$UF0&E_6U@33?9FI&P^FFK)O]'FN9";OE=N<J;_ *=1V"MF:\I&S9S1
MOJWS#99G^G#.F*7NM0@[5#"!0*L+@=8.N91)XHY(\4T+=+W.VL]WI2Z?6F_1
MY;6MX!+([PB&N3(MRV;CG..8\X8^R(RU :A,(93N'(-P8SUM(\-$P#O*:4?[
M$ 43&%%3<50,".=KL,5-%RJBFHJ8Y<06FY@K2(T6(*#59$%&:QCBP*( R6*=
M-LH111H4X+M#B#TOAFY7S1L<[Y(2"Y:B?Q+42^);C0.&5>*:B<731(K<Q'JP
MME HA#E4]*E7^>%1LG-N/5L6Y8Z<UVGB\V$4*J:ENSIF_P D@E$QSB;<3:IH
MDP@"X_\ 0B! ,LF0NU7>$EY?GD.?=K6,CIF=6Q/2_34QS!Z?=1]CZ@[?]!>]
MTM?Y&UN]N7W7_P!(NG;\U5'[/5#]_$/O'1 !1PUJ-T^7[F"ZSX@U^D2^"LRI
MJ>?8J6@,ZL;SPG 8TQIIIN"_-%=B855LG4+#:8X%8MO:0L[%:Y?TQ2]Q7YC?
M3_=-O6K 8%D(C2?:&G%W;5[.L./RZE8>_,.QK?ITVM*VEI.'#[UYJ13)P*R#
MI9DG61+KZ=&5YV1Q1AJ>L_+>?L(AF9)9PX67<E.J375JY<'=%(<S'IB=']SD
M\(2$80,88! -</GP$?#:\BD;9%U67/ V;K8U"9'MK53F36 V>2&L-J5(IR;>
M-I1_L03U^JKPN5&U[>?OG$F^$2@&)["/<TZD7<#Y9Z7*!AUQ+K'=[!K8-;!K
M8-;!H-H&2,05M)9#!@[Y+LX$2S[=WM!-=6BT"6UJ^TO7&>UL_J$*W4I;LZ9O
M\D@=JC>K"'_^A3_\E*]U>7YY#@(A<V,+1NJZ+^M&(R?9L1"L[=A_07O=+7^1
MM;O;E]U_](NG;\U5'[/5#]_$/O+1!_9G=*:C)E"B@<!$=AE</X@-<PI$(! .
M B&T" J!S[P@4% 'T&+M-)81PQ.78@F1 /0<#"! $! # :BD.H;6/J/-@K'R
MROC#='+IH%R].LV@-JW34Z.9%+6^GOR!DC@75=@V4U"XGF,46I?\1 63:5HD
M7P1<DSJN,17Q)=\*TKIBC@\B@ 9P;[+.5X)W)-"1RLI96/)"[%H-"(M]AS5@
MD"4DS7+XQO7C&]>+0&O%(T+UN44W0*'$_$ _9ULFW'HB !?V1+1QC:L;<\)*
M0C&>B91M:N5+*O2Z .7: F(YTEB/P)^090"!DF]65DVHU1<)M>M)"$0OFSWR
MD9=J*_':@)1!;LZ9O\D@=JC>K"'_ /H4_P#R4KW5Y?GD$#;FJG,]Y8PC<B9
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MZ_\ I%T[?FJH_9ZH?OXA]XZ(?[,?(,8"T ")3;2UOEK?+6^6M\M;Y:#]J@.
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MV*9Q'@*;BD:BJ;E+:DXMJ4>6LZ7B$%TS0B2QBPR0F-#-S"U051/0CLH3; U
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MZON08'&6OW"$TC.8J]!@,( 53:L"NWK8Z&&^7L.<118.BAJ?<97T_?\ 1?\
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MM/E?L[$W*"M H@8"N&IR"N@ %.F<'OW?T _<0OS TN<4RY[O$I4"HI%(/HV
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M^L"PY20S'C"WG=F8_P!06D#%EI3NH+25=##%6-,;&DTL=8[25W 'Y D*<\_
MLKP@]2FGR9T^9 TTZB<F:6,MZ)];.'-9>,R.2G/Q V@.WY(B 4HIN%S)>!+G
MN8HE3(4ASA;%LO+TD+6M*.M")RZ&W%O1-((:>]6&.LGY:PFWQ2?&N -)^ T=
M,N$M)>G2X<*S5@Z;[C:ZNLFZ<)W,.I\/6\#>8= ?[.PDS@?Y8G !R;>06G;2
M?$*8QP)1C 12SL?2M[N[8M2+MB.(02C\E0V[6<<D'LRU6;)&-:[R12F(!T^J
M?K&2RW,XUQO?.8+[QX; &@#3]UYM2&&<N])2& ZL(J( A>L?'J:Y.5L*Y7'U
MRN/KE<?7*X^N5Q]$BXW?TEM$8SJ-"3AJW+[K_P"D73M^:JC]GJA^_B'WCHA_
MLQ\ZHF58FQ4I2\0I^(L<OR?51TRK)Y7Q9:^9;,S]@:[, W;@S.^6].^2- G5
MGPMJNCR.D]I3E'Y)@VCEZ\AMBWB)?MJI*HEL['$W?2MI6?&VA%GV@;(L<YF+
M(Z3&6<>8<B":@=/Z@)ZA< *M1S]@4I/Q 8!I'/V E%4M06GU=#\0&!^#?&J/
M3S:5F] .&FBX93V@M\D:6,0B>4[M5NZYS'1*'!656L'"KR2".BVD<W   /DB
M.P)%XW;L9^Y7.2;H$2TDH1PGK_ZCL=%,F_@ 'I&Z"%,%6SICN_$]WZB?^BN3
MP#D7I7V!?=C7%"KF *O+\\E&/NG.X;I)E4WR^@O>Z6O\C:W>W+[K_P"D73M^
M:JC]GJA^_B'WCHA_LQ\_]7S 4H4%$<CXYLC)=KZC-'5^8'=-%N$KH\ZU.HO3
MJPTV]3[1[J6;I/6RR:;LBI2J@-<0HU(/4F+;(MV&NR[82R;EN(]G8#B8H44$
MFQ"[P&/M-1DE3%U+])[2/JIO-3_G_P!#@I:]^F7IQTZZHPZ!&A-RL/\ S_Z'
M0H_0!T-$)K,Z:&F[3UK40_Y_="20QG0*T),93'>-[.Q3:J>TH[X5OA6^%;X5
MOA1U"E#,E])6[!I-]RK3P[=ER%L_&MN6:FF!RT41"MZMZM\*WPK?"M\*57!.
MM3%[H2)"-D%%<QZEL)8"B=7?4ZR3G\JB*JH],/I9.TYWKEY[NK#V(L;P%Z:I
M[LUH/[7'3ET@IGCZ[2;Y6MY?GD7WQ;97N#-L4P1U/ZQ%,N8(SUE+(.6TU2J>
M@O>Z6O\ (VMWMR^Z_P#I%T[?FJH_9ZH?OXA]XZ(?[,?23 <Z;A'QC#4!T^+'
MOAYE'".4\-3)2)ND\/:XM7N!6^/^OQJ[M9*WO^BJ+%%/_HJQMLF_^@[$]QQ4
M+UX,#V\"'_1'C= H?]%&.!/_ .Q3CBO_ &*<<5_[%..*_P#8IQQ0_P#13C@:
M#_HIQP =03K+X_S!JN)_T2X]3+_[%&.-JG_15C@A=;/6:LO*NNG_ -B?'W'#
M_HHQN _^Q3CBO_8IQQ7_ +%..*_]BG'%?^Q3CBO_ &*<<5_[%..*#_HIQSMF
MNN7C6[+A@>OAA"VT0_Z*<>&,'_13CBO_ &*<<4?_ **\<$*7_HOQJ=7_ -BG
M'%?^Q3CBO_8IQQ7_ +%..*'_ **<;C3G_HFQXHG<W6QGY%_DOJ=ZM\CLY*?E
M;D>X.P3E#4=D/0MTD<6Z6G!E%#UUY,-Y7S';.D&R]=VE'*^N'2[J>LW3MTI-
M$^4,?942=BK'WF AKC4^H@-416R]=,=@/6)IU?N<J:B$4C)C1>]TM?Y&UN]N
M7W7_ -(NG;\U5'[/5#]_$/O'1#_9CZ6"BR82$<TEF.3>G]@K(;J\>F5E&)7N
M#2EJ*M99WCW(K5=>TKK;U[-W!7LW<%>S=P5[-W#7LW<->S=PU[-W#7LW<-!;
MEP!1K;N?=U*6U<C?,R]KW5L]G+@I6U;H7;9Z@KC99_7M6ZT#O(R1CFHVO=!"
M&B)<AN5R-<KD:Y7(URN1KE<C7*Y"N5R%<LD*&-D  S1V5L>(F$:NM_)6I:NF
M_(5UYFQ!X![7+WM<O>UR][0,'M-H:5=JP."<R7*I:/3]S[/&QKTZ,96VKI$@
M;=M/J'$ 3G W#,@+Q%-)1Z!M6.GRV-76FC3]U-<T=.C'0?\ 0KTP4"X:U0XB
MU>:BP.W*IG9?,C"U5FFMXI<2P>H^,E/07O=+7^1M;O;E]U_](NG;\U5'[/5#
M]_$/O'1#_9CZ:8#" !L BJY*654<%!LV*/#)7#)7#)7#)7#)7#)7#)7#)7#)
M2Z"*A.H:S8I:M!8L47O#3HZ#4R>N5NR+KI,T8\7K([R/3WM-!HI:9HJ+4KDL
M+7)86N2PM<EA:Y+"UR6%KDL+7)86B1D0A6N)C%$PTZAXA.0U71D872]T+8V,
M7Z:W+(D*Y;$URV)KEL37+8FBL&"8E7?  HE$5=X"Z9O\D@=KT[NU13[<AK:M
MXJ5V((-]<0<0 UZ)VNR:W#D[3Y'8OL):;<6+Z"][I:_R-K=[<ONO_I%T[?FJ
MH_9ZH?OXT(966T0N6J6%_'1M>/C:\?&UX^-KQ\;7CXVO'QM>/C:\?&UX^-KQ
M\;7CXVO'QM>/C:\?&T,A&A7,HRN91E<RC*YE&5S*,KF497,HRN91E<RC*YE&
M5S*,KF497,HRN91E<QC!H9&, .91E<RC*YE&5S*,KF497,HRN91E<RC*YE&5
MS*,KF493F5B46?4*?1B^KE62B3O/'1M+/H_P^NURR'75XV.*XZQKIHIT\K/=
M1Y+4\='5X^-KQ\;7CXVO'QM>/C:\?&UX^-KQ\;1W\;LUUO&1,+/!*>7U7_E:
MZ%)BEZ9@@;9\M7LZ9O\ )(':^2IW5Y?GD6(W,&H-0S EP9_##H12CAU%>@O>
MZ6O\C:W>W+[K_P"D73M^:JC]GJA^_BZ15E+FT=:3[MG_ ,#6C:OP-:-J_ UH
MVK\#6C:OP-:-J_ UHVK\#6C:OP-:-J_ UHVK\#6C:OP-:-J_ UHVK\#6C:C:
M'-&I"ET.:-#&NBQNDI8TIX7HV5X7HV5X7HV5X7HV5X7HV5X7HV5X7HV5X7HV
M5X7HV5X7HV5X7HV5X7HV5X7HV5X7HV4FGT<D!4_1V7#PO1LKPO1LKPO1LKPO
M1LKPO1LKPO1LKPO1LKPO1LKPO1LKPO1LH6O1L"IR9Z*EK,L'X/T]Z]-;*NA_
M1XN/X&M&U!HCT?M":T-+.F^U]8ZVBG1T8O5;TIZ9,?:$K5T0Z.75J!H:T;5^
M!K1M7X&M&U?@:T;5^!K1M7X&M&U?@:T;5^!K1M7X&M&U%T-:--L'H^THVM+*
M+/#DU8%5'2KT/,G$0Z>]OY)@)*ZT5RK!\I;LZ9O\D@=KY*O=7E^>1<A%$\T7
M7FRT(S,3_7/EW&UHP*%I6QZ"][I:_P C:W>W+[K_ .D73M^:JC]GJA^_C%B]
MDY0<=7?N?#V[:^'MW4&/+M&BXYNL2DQ_<XI_#VZQKX>W=7P]NZOA[=U?#V[J
M^'MW5\/;NKX>W=1L>7L='7W&9GSOJ5L[I!:-,?P_Z7FDZOTO-)U?I>Z3J_2]
MTG5^E[I.K]+W2=7Z7NDZOTO=)U?I>Z3J_2]TG5^E[I.K]+W2=7Z7FDZOTO-)
MU'Z7^DP@!TM]*(E_2XTGU^EQI/K]+C2?7Z7&D^OTN-)]?I<:3Z_2XTGU^EQI
M/K]+C2?7Z7&D^OTN-)]6_P!-;3%;,K'8LN2/C/AQ>%&QS=Y04QO=BB6MVR;G
MDNHZOC6[@'K-6)=<;TYK/QQ=Y;0^'EW!7P]NZOA[=U?#V[J^'MW5\/;NKX>W
M=7P]NZOA[=U?#V[J)CJ[3F625;.]:%[6K9FE#HUZM=/N)>G]?VKO">3$L;Y5
MLC*\?4:P6E7XXWDR)?#U]7P]?4GCB464E62L<ZTS?Y) [7R5>ZO+\\AQ( :C
M8'.%TR6:M&V5IO$FF;%5_8KL#T%[W2U_D;6[VY?=?_2+IV_-51^SU0_?RU2I
MGNM0B>SA%KA!4D]CH=C^.UU<C1]K:P^TTW%*LNBU9J.@!,H!X4H&(EM)PBUP
M@KA%H&[98'@G4Z[,M,VY;C63E8.#,\R-C",D4BD61X05P@KA!7""N$%<(*X0
M5P@KA!7"+0)[RFLC7#B/1;:<#J<ZN=T,_C[UD*^/O60KX^]9"OC[UD*^/O60
MKX^]9"OC[UD*^/O60KX^]9"OC[UD*^/O60KX^]9"OC[UD*^/O60H,^]8VI/+
MO6AGT=(FB#)V/\O+-VH+=;-$#]-:T4R&LKA%KA!7""N$%<(*X05P@KA!7""N
M$%-0*F[NHJQ[CZO^3[R@VO2!T_9HSQH8M#.F2E;JZ=YSJW55FF$MS'23*O\
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M_)(':^2KW5Y?GD.!#!KFFI.00R!CS$V"LCV9(2<K:/H+WNEK_(VMWMR^Z_\
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M4)JW@K>"MX*W@H#!6^%;P5OA0F"MX*W@K>"DAVK76']6?)LXBQ[F7**9N*%
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M+X?61<OA]9%R^'UD7+X?60RR$.%2U2%AD-OZR*;*^O2T\ZO %.$I0#;>>L)
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M(F9C9$IS)T%3H4D,*P6Z.:D S2F=Y$Y2V19%0\  @M%*0HS-C>'5L;E@A^2
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MLJEEJ2GF_6=99.X82B=HESH4\G)7U]4VDS*4"<K)IL7,SGI&C78JGREI-*4
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M;*RPV[T.#,5M+2VKX4C\(BS$E4-9+EZI,T<I 'XR3C("-!Y@M%Z#= QT[BG
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M@7#CL@#J' =D>_"IV*E8#($["1.T[ AYUQAQA"#*;R<&*V7-M((TSLLA0!L
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M!/2#LZTPRVDC$+[OQ)!V88;$S;R[<+J2W+KFPFZ^5OQ4^$Q5)2><4F0G*9O
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ML.A*0D(4G#A"B)R-DU1V+50Y[6)[-Y@PASJE/I2H#J>L/6IP2Q*Q23+%:+"
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MX^XUM\4;GYI@=^@0WXW&8^3Q0GQSQ]QWQ8W?SC V)0-J,J8HFL:ZIXH(DHV
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MLNSPQRD45C 4;3TB7!._?G%?3N]N.SR5+Q=64UK-F*<BN;M]HN%\[XI\P_\
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M2/$3T$&<CO4R4]IGP[C,R79$V"R?[LF903_S6](&7IO_ .UP,7:I\3$_3?\
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MEA*T)<";0J8E,6?!TB1VB(;#CC:N<>B2>(1@4DSBG5H*N*$;4.2U<L*!-O\
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MU>?'3.^KSXZ9WU>?$Z5P!1OF5\2X].CRG?/C+V<U3UB5N@)PE1D3.9YZCHN
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M4MXB%#C_ "512H4)&GYVU9+4.*%Y7UX)3,2Q3T2_UAU:HJS^3QPJ&0@VJ5*
MY@41M'S3"D8%2&P?-CT:MX^9'HU;Q\R/1JWCYD>C5O'S(]&K>/F0LAM5VH^;
M"II(EL'9V!#B')V#9XX;\;C,?)XH3XYX^X[XL;OYQAKOT0F%=^GW9)!B3R%D
M; '&8]$YO)Y8E2I6";YR'@,!0<&';,(#=>^P1>6EE$]@R-HC"G/\P!V7U2\,
M)6>V#J53G:^ZD2E<!,F<].+<CG=L7"?[0X9;F*W:F-<[)&D*LZ74N3M"G5K
M,K2D3F+=9-D8,8Q;:O.A1JEI*-$BKCXO<+%0@JF+) &W9GQ0E]MR3(-P)!TZ
MI"%T-.]@4T@%1<,@H&R29*5,ST$"R'FUTR5N*!MD);B@DJ&P1:+Q;"/:F\=,
MM1"%(FJ<A,@\U)! OF!BO3,!4NK+2TG9$AX8"U3()E9%B2-OW12D&<*J*D)4
MAP  )F2--LP!O$P<+9WA!*KH5*??NP\TA1"B--W'&0TR <;54UB)N.)02):[
M=8$*+K:D#V9I *PD#$E,C(DFR^ZW8A:JIY*C.S"4F5^M296&5FS#>:5E2A5&
M@@I2% J$IZ%*PZ=!$4V85#X5EJ,,TXP%R (5(%2DSD9BT6B\7Q2-9+4AJB1+
M$E:@DGFR,@A2DFW7 R;(E]5FY29K64)1,@2YS:BN^<[(3E3SL\]*E8W$E!04
MF6$8RL.&1G81(3LAU^OJVELJ-@"YF\WXB!=&2.TJ%+#KX$D!)(D"9JD;!JOM
MC*U2/.:'"E,%1(E(#W>&1G"5+$VA:>(;]LM4 ID! *U"1U1:#P<L)FA=^@#E
MA1%FH0M3B@01H)X_=!(TP3-.%)F;3MC1IT;1G*R;+6!15.\ :M-L=;UB,.J=
MN]!RYO+JMQY[FA26\2$G6LA4PFR^1A&;YM44RVEC$$(45."=LBE2 F8G*Q1$
MYVQ6U=<5I;J4%MH)ZL*QIM,PI:1*7Q23L14O4"5>S*498P[K/Q0L715OUX:;
M:ZL2*NL2%&=H25-@$ZQ.%LR,P93T:=,^**8&1 5Q0D%FV6I/)"UK8FE0D))2
M3NV"/LRO)3'V<^2GD@_U97DI@@4ZA+6E,>AX$\D%)8,U6"Q/)"EN-&7Y(3JG
ML0MUI) .N7%#?C<9CY/%"?'/'W'?%C=_.,-=^B$PKOT_A$X+XT\/+"&Z=PI*
M3,VJ'@)C[2KRE\D3JG2I)NF5&W=]TG8,6F&U4[A 6<)D3<)G0M/#"/:74%XI
MTE$^%1,.L.-@M $B[3,&1"%2,M(D=F'G:)E3E,39(*Q( !G.2!BVQSM849JA
MY-026A<>=*<SK$KM7NMN.L".8-.SLV0&U&Q.N+T\$(2E4U3-@ERW1,DRU=YB
ME2DF3BB. F,MJGUA*14,K),KD.8CJN )BBJJ3+C5$I$PVV'2+!(D &0O$R8_
MRI5?W4^;'^4ZK^Z_S8_RI5?W4^;'^5*K^ZGS8/\ ])U7]U_FQ_E.J_NO\V/\
MJ57]U/FQEKKF2.4RD/)(4XT&AIG:0)V:!;:-$XI&V%)(;0+I:AJ)U;$.,FX(
M!WS[HF+!IA)(M-^WO0080"JX]^F))MW??X(F53/X  )F;+-V4! &SWV;FU#H
M5>!9 90A19GJ7+P$145V:TP+Y;DW,)Z4[Y*0)F5U\I[1BKK*VN0AA*20%+ %
M^@* %VHQ1=D\H4XJGHJ@K5A*BDI5B1,X'7$D3$I%"02;[)139AV5R1UZJ*0>
M8R^LSP@W,H2;S=.&:/M7D%324RE$(4NGK&\9(D1]>2E1PW81,;QA->^RM*2)
MVI6-$]*$Z]<4JIVXN*$;4+"P+/?@SP\$$6<'+&C@@%  ).QW&MOBC<_-,#OT
M"&_&XS'R>*$^.>/N.^+&[^<8:[]$)A7?I_"'K$DC<XXL2=X1.D4 2;9SNW(]
M(WOKY8(J5)(T2*N/W4HL(G"R\)F7-EH.[Q0E1J%=0#<%+GIT8@(52MI>0^A(
M*BL) (NL(<43;K$'K4MJ)\0^$&&ZC(FF&ZH*.,F:04Z)!MH@JGI(G*R>B).L
MI=1K;"B!M@H2=T C9G9"TK0<0,I2,P1HEK@SIG3+4GWQ"D]0ZB7QDRWK>XA*
M% 2.GWIP&E'G:92XR(QG$0JP2EP\X1]5B V?>,%17,ZYF<248HW0>:VLDZ[4
MD6;^Q%'54CB4MH/."B1,6S "=O21"DTZ&:HE 3_6$J4$@7!.%Q-TND;962B9
MR;*9?H7?7PE)R?*9G_9.?\1 4O),K,]3+G_$0A?[ERJ1_P!B[_Q$69+E/ZIW
MU\!)R?*9S_U3OKX2IS)<J,]3+G'4"*=Q_+J-K J:2TAQ!F1+G3>,Q*X BW3!
MKJJHQH(MF3.=NBZ4B-,X74#HE &S,$GCU^ZP@VP%J4G"#I,,A4R9Z):M-H@E
M.*9VN6 2H@3N]^#@[^&%$J$=(1.8]P2-$2"@##M4_4,H0D<W$K"2;09 BV.H
MIZ9UU>MM.(<!A)ILO=98O*G4.H3+8(008#E?6T2JG4%I*MY38,+?S%M;5(@3
M2HA"0LC0DJ*4J,K9#1#F2=E:JH0Q.1YRA,6W=34R-HTICM+F6=,$9J*5M86\
MEL)*BX>BIQM:R9$SMCJ,_;H7:5-@F&E 3L$^LPBVP#>CLN6,GI11JJU813MM
MA8."W'*8 E=LQ3K8RQQ)*-#:!+F#4$Q3.E!2@N* F);,(VH6I"@"!RPXZA8*
M1LJG&9T5.%-NTK86HN32E0*BF29%1)F+B!9I@TP)Q@WVR\/% +JP=T\?<:V^
M*-S\TP._0(;\;C,?)XH3XYX^X[XL;OYQAKOT0F%=^G\:ZVF4H*589$BP;1$(
M:?J-]1XW8?-2\CHB4RB7"HP0DMF?Z/D,)/L[2A/XJ#_NC"@T'&S.?-7??9)3
M2A+: V+(2K+ZHX-(4DJ.WB2V-["-N/3IE^C7YD!:7QY"_,@SJR$["%CAP1(U
M!)&M+A_,CTXE^C7YD>F3Y#GF1Z9/D.>9'ID^0YYD>F3Y#GF0HBI ^0YYD6U0
M/R'/,BA#RP0XZ0))4G03;-LSLU2VH2[UZ2T;0"A9(G^5U=N\(:E4I(G=@<L^
M9Q0I1K!( V8'/,BE0I<UJ<('2U$_ZJ>C7RPASKPI)MM0LF[7U4-CV@81HP.>
M9Q1Z9/D.>9'ID^0YYD>F3Y#GF1Z9/D.>9'ID^0YYD>F3Y#GF1Z9/D.>9$R\-
MQ"Q_NS',7)>LA1&]U(\,#%F((!L ;6);R3/=@CVT2\1SS($ZH'Y#GF1Z9/D.
M>9'ITCY#GF1]I3Y#GF1]H2?D.>9'ID^0YYD>F3Y#GF1Z9/D.>9"Y5"0 /]6Y
MYD)Q/)O^(OC;A*<VJ>J:^!SDIF=(Y[-NNRW7"7:)"'=L(5]%H0TS398TVT#S
MU!M2>;+6!+?LAZLJ.T#0S1*9X _3 SD+,)6A>O3%3D%#B:H*,E:5CK4X\4TR
MQ)J7$JD #()3MZ(]IS!97)4S,J5.T_&.C;C-V,TK&Z4>S(D2MAO$<9LFMP3U
MRAOKL_86C$E7.?I3:GG#X>@@1DBZ#,V:AQ+Q)'6L+E),Y@)<LG=/3=#=)3X%
M$)E(=6?@RT/*\$4U.AL# X3=*\2UGP0C:AXHG8G1MP\T^1P:]F,W>IRD+>;"
M3+#<%$Z)'PPMS1/C,8)W#N-;?%&Y^:8'?H$-^-QF/D\4)\<\?<=\6-W\XPUW
MZ(3"N_3^-."H03,62 -N[&.G<"4:+2/! #500=/.7Q*$)]J<>4-@D^%P0XV]
MUR<*1:O !N3=,"52GRD>?!+-8R#^4M/$J/M]-Y8\Z.=74Q^6/.C[92^6GSHY
MM;3 ^./.C[?3>6/.C[?3>6/.C[?3>6/.C[?3>6/.C[?3>6/.BS,*;RQYT69A
M2_K!YT92MO,J,!#Q)^LMZ!%DC"&?;&,:4_'3*[QX4U[=3S3;TQP<Z"E%?3S\
M<>=%"\G,Z/"ETGTAGT2->SKA#0JV.L M)6G5HY\X4CVZGL_+'G1(5]-Y8\Z
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M 6U.'&E4[BF5LL4TXA%"]5)ZSJ7<:II)400FR:E2-MUPE*=HM?J*9M*4*2"
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M4BBU-JB;29> PA2UME6(G"=5DK].@@2,KB1.3Z@TCH3 )$@9IF;93%\@<1M
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M;;%'09HUEZ\SM4Y(-'$BZ8QS60%:5"6[&8AEBD_<B:9);0VE&,.3YZE)""V
M;)%/..F*ANE9*2%'0D:]0$$K6"G1:>Y1^/Q&&-KBA.W[@0O=A5HL.G=BTB1.
MN6W:1HX+XJBI22< N,],(\;EBF[]$;GYIA.W[IM6( ).F$M.H<*I:,/G""<9
M0/RBD?G1]J;\I/+'VIORD\L?:F_*3RQ]J;\I/+'VIORD\L-+ZW&)_!*2;O&@
MMTV(*E\*0T2T%48%*!(U0WXW&8^3Q0GQSQ]QWQ8W?SC"MH^"'ML^$P-L0UM0
MD;$./J3("9N%]LKQ(B=^Q#S#+TEIM-I$[]4X#S%2Y(:E.<4HSRGS3.&VVFZ9
M!3USJT@G'+FXU$3E?(70?_J++[?_ (@<L5SM'G>7..8+B\5:=A0(AUO+ZZFZ
MJ?P5U4M/Q70(#KM73J*[.E5F[;?$>F8WZK_B8],QOU7_ !,>F8WZK_B8J:;/
MLSI6664)4@J<>1,DD$#K'5@V:@##8/:/+Y2_[QL;<4",O[8Y4P$KFLN5:T B
M5@!3.=MX-D(IJ+M/1U *;13U+KGP?R5IX1%-F2T']X.+5C) M$IBVU1MUD^X
MK_T8\,.>-QF)MJ5@N3HDD$RL!D-9UDDF9),7JX>6':IH.%\#FX9S!W% [QAS
M,1V@HJ?.DI5AZY\MKLP@?#+FNXQ]]0[0=L<IJ:E[*7DLI35K<<"@XV00ES$1
M9<4S,]B%T=6TP&NL"3BZ)(L!YP!G( 'FRQ3$XRNO-%3K8IZLKF4!4Q:+.<@2
MTBT6:8[.9IE[-,W5T=.AHK"@,:$*6MM)0E2\/4A?5IDYT4IL!$9M35;Z7D/L
M);&)3B@,*@04S<.&P2)DK0,.D9CV&<R^G#[M275+5(XN;A"0DJ! 3B4H3Q\X
MDV0AOJV<76*,U 8C,"\ZIBR.@QO0PS35=,PPX& Z2HH!1C782+")_&LBFRY'
M:++Q0JZ7U_-M%L[0G?$4%%E^;-/Y>:9F09=6L ELS)"5A(&YMQ[54RZZ^V_A
MF>&%L/(FT+B" 9W7V@B6B5ANE,S7UHQ)4D),B 9"4I&T681H,QLVP.I01(VS
M4#X,/?JA+@"21KD=T3G(B\'0=8F(*7$SMF)$ [,S(S$KAH-HO(*E%0 ( D)R
MD)2%]H$A?.X$S,39!"2=)F;M8PB_8%^F%/)3S<<Y$DZ9R)Q G43IA"0>B9[X
MEKV/#K,3"CIOW1I/\AM%L*;69B8(V#=K-DKP):-4%U8!!421HM-HOGNWC;AU
M)Z1%X,MPVGBTC2)*43:2398--P%@&H13&P34?!##I&GB,5O[^S!##!I0E)4X
MVB9Q R'6+ )V!;*&Z\YXSUZ4*2#U]+T5$$SY^L66V3.LP^G+<Z9<<6G"0'F%
M$ 6BQ#HA]VG="IDW$'7J4J%8YX=%_<H_'XC#&UQ0G;]P(7!*)W\L$A)PSNMY
M8K0L$20->O9A'C<L4W?HC<_-,)V_=)4@VS[[H QG?.SLPE-,^L%)F9*4/ 3'
MVIWRG(^U.^4Y'VIWRG(^U.^4Y'VIWRG(6:E]:DD2$U*-NZ1"K3,[?+#N.??.
M&_&XS'R>*$^.>/N.^+&[^<8>P+2,*9VF7$8>2M0G,W;9A3F(23(PVRR9*%EL
MN(F&L1!&QM0Z GG>_#ZJ5U !%LRJZ9U0 ^4D[&(^$PI5'7U%.HB1+*U-D[!*
M2)B+.TN8_P!X=\Z#[!VFK.=8K'4OW:)85"V>NR"JNS:H6]KZU9X5$F'/;Z^I
M4S+FA*YD'9Q67:H^U5OE)Y(^U5OE)Y(^U5OE)Y(8>RK-:YE85SB'2@D2L',E
M.W79"6D]H<SQ :7UZO&A+:^UV>LNI)(+-4M$S^4<4R-J"<\S[,ZQ NZY\O;_
M %D]$=0A*12)Z,K%3TS^#O>XK_T?'#BYB4^,PIN1FG:E%W@ADU+ 733YPD"9
M?D@V3VX:_=^?5]+D%F)ME];2M,Y(2>KU7[L=I>R-;VZ[5HHZREZM"16I" LD
M%16%(=3ALLDA1UB,OJQVK[4!:2"[_6:&:K)G#_X9;-5O./#%1[3VI[9>T&>#
M#4Y9(&>F>63EM0X%]I^U2E&X^TY>9:O_ .6" JJ[4=J^JG\"IR^?SLLE +/:
M?M<&MFIRZ?!EDH4I/:OM9U>@>TY?_P#*X_S7VL_O67__ "N$=K.PW:3/EURL
M(7[344YDE!*AU?L]'3J"IFV:Y2U&'Z-OM+F(S0J5A4:AW" >C-045B0OD-J&
MZG.ZRLJJT,H1-Q8= *!*:2X2H;]V@1_55!+.HDCP60)2QZ8Z0X8,U61>8O,7
MF+;8N$*QIG9H BQ!WA!PDQ>85:;8QDB*-*+"%F<]J&0I)GL2U1EQHZQUHXS/
M"M29C#=S3;$CFU3/]*OSH5[/FSIQ"1QNND;DE1UM;4I7;\99^E.&T-I(6#;8
M.Y1^/Q&&-KBA.W[@0N' H=]L&0'?N14*LM2!9M[0A'C<L4W?HC<_-,)V_=<\
M1S4V[D%3)2";YSXHZ2/G<L=)'SN6.DCYW+'21\[ECI(^=RQ*IPE(NE/CBU'
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M&[VTZ8E__L'V+_\ /<L_XR*?#]__ &,D%?\ XYEFS_\ %P&__P#8+L:)C_\
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M[P/'=_IU13[0\'<?#I&!20.';%L%X8=R6J=TI[$[IZ8RU*)3#FQJ,=H?T?\
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M)&V1G,12HRW+WVG$KFHJ;"5J "NCA$U$$3$[)3)TQ1T?M+8K&VDI4"I(F0@
MR ,[P= VH:ILOR.M==0HE2D,J4F1U%()WQ!<>R6J2D:V71X4"*$55,XP Y>Z
MG #8;$DD3.Q%)4LN386RE*I3(&$63*0H"961;I B@9RW+GVU!V;BU-R2I)!$
ML2!-1*I801*W68R[LX\\E.:E,S-2<(+DUR)!)FF9!DDBRR<,99U1]I;.)2Y?
M5J"K@E5Y.L$1F&:,-R0V'$24 %8DG"2)!0E.ZV9&J&'W\JIGT.H!2'6D+PS
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M ,Q>]9"F\V[7',&P.:DU2W\)^-A6LA,Q9,7W1UHMMA"!H]PTXR3.=LIZM@B
MUUB@=M7K!#2V'U]*VU>K8<CJGWE$$:2KC<,..Z3[BC\?B,,;7%"=OW A>[#O
M?I/<=VH1XW+%-WZ(W/S3"=O\0,-^-QF/D\4)\<\?<=\6-W\XPI*;Y<4.I>;6
M22;ALG61!J"L)0JZ9D>_=CT[?E"/3M^4(].WY0BG4_6LH257J6D#A(BCSF@[
M39=3TZ<MIZ>514M-JQM(2E9DE2QAFGFG%.5Z1&79J_VYR!UAMS$4M5B%+E;H
M(2-.DQ79VCMCDHI74) !JT8Y@DVB4M.A1@J5VSR26-1^UIN/R8;7_P XY)(?
M_%HGX(HLKH^V63-U#2E$J75-X9*3*R4R3M@1C';OL[?_ -]'JX>9';KL[B4)
M"58.$X+!M"*O*JSMEDJWU@R**I!2)RO)PDW?%A[%VTR*143]L3I/BQ_G7(?[
MXCS89>5VSR,I"M%6B?@$5.94?;+)DTZZ-MD)75(!Q(E,G"%"5AE(DF=H$9?G
M%3G='64J66VL-*\VZX"VFTE)4@!)T<Z^\1VH<34(E6K64<X68G%+&/58;98K
M=^*<JJF3HL5J$>G;\H1Z=ORA'IV_*$4=0#C0VN9"+3*7?>8S)>:*4D5"9)E@
M$CC*N=C6F5FJ<4]4GM5E331?6Y)RI2DR62J71(F,5T]%YTYIV:<[7Y.:]]3A
M2H5;?5C&O$)DR5=?))W83_\ 6>1C"A(MJT7@;4?YUR'^^(\V*6J<[99(IM*Y
MD)JT$\( X88S&B[:9$AA(3,+JTA5@(N2E0TZX>4.W'9[G( ^V 7?(,974'MS
MV?#3*YJ_K0G+"18,,E';*9ZX;J:7M?DR&TL-HY]6V#-"9&4L0EJMGL"/\ZY#
M_?$>;#B!VSR,E0E95HX>;';&EJ.U^3J<S&A0RWAJFR$J2O$2N<B$RN*0HST0
M[3-=L<E4XA2EJ":E*IA0( Z,Q:09@:)7$QV?['T[Y<S*BK7WEJ2IM32DNID
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M#Q)OQ W;$I00JC7B\0\L?5TJA\E7$8^SJ\E7+'V=7DJY8^SJ\E7+"O;Z-Q2
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M8O3W_)B]/?\ )B]/?\F+T]_R8O3W_)B]/?\ )B]/?\F+T]_R8O3W_)B]/?\
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MWQ!W'6:JE<=6XDA&!*5%*KYS5/#M@$Z)2,99F&59(V.TN=K?0FJ=9"BTV@C
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M#UA.'38#9,Z3.W5!ROVV2%SYV.:Y*OMYH&J4E6&^$4.6U94D2*L3BU "2I=
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M%($ATA?H-FG7%9G&>4:5-E">KPH8"PL3Q%764[@ (-F$DSOL@ANG6&=6&E\
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MK(OLCJ'JII2YRYJGR.&4*<15,R GTWI\$XZGKTXI_&>EX86',PI D"8Q+?\
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ML<AA3N7T)"E"1ZQ"[MC"D<,?8F/(>Y(2,UR\EL&:>J;63/3/&DB4M4'JLNK
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M([15;M<VY1+:$DI4X5IDHDDB8 LLL-^B'5OA:I*N )-YUKNLA#+S%6DLI"Y
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MRB$KG;+3#B0#9O=P0C;'%$Y=\S!+:TB6LG:T".SK.5N/)5[6X'9%8Q)ZNP#
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M%DF],,MT?8KM BKZG11Y4#/"GXKV*.SW8/L[DM6Q^Y\\KZW_ ,69:0PD5$D
MHZIY4E66GJT"7PU71]U78+[J:2HI^VN59Y4/%[-T+1V;'6-%M)+E(^Z^$A0)
M7-M-F"1-HCLYFWWA?]+O9M_MO1+;<>SFE[.*5DM0T00A-%7U(ZYVK1-2GTJP
MA*5)DJ1C_J/IT,LY=^^,F2P&6 AA!E5*<P]7U[<QL27<+-,=AJ![)QU^6U2U
M-K;:;Q+5U0;DM1J72H "8"0D@[T=CLUS/L,S6]FJ1BF02:)]Y6%IHH^'6!FZ
M5Y V!':;,^SWW,4-!V\>ZQ1J*O*,L80%*7,%MUI]51BF5$F9,CKG&;]FOO8R
M3L[G.63<#32V6ZL(25R P5E2I">8 F24RLD+([!G*J/+*+LKE6:*J&6*5"6>
MJ4I"DJ4II%0EE (D 48"2)%4I13_ 'E&00E]M>/FCHJ</2Z]/QO];#_W?Y#E
M=%4U^9=I,U>!J6U.(9]I=+@<^KJ,3>*['U:IW35?'W1?<UV*H7&?O,I^TM=4
M)?SA"T]G4FI;YF-QA_VI*04JQR9N*)$VQV$S;M+_ -,G9S,NW^64]+5UN;4W
M9UQ[)'J=Q@AE-+7N-^T+J$K)+X=PMH2I)023*'^UN753.59A2,,M%FG534R)
MLI4V4]6E3B[YV%8-EH!LCLA]T=)1)RVBH\RJ:FJJ&T>SJJF:A  0ZZEU:7TA
M20L)<92D$XL2C&3-=DUA=1EBPXDI()Q8<!M9MGM8#LZ([+=GOO=[--OY>PL-
M5"S3M+J>I0C /9U5M6M./FV8TA,IR NCM'V.K/N[3EK?:%#F5MU+E!14^;T[
M3"@IM^G>5F$FL24CJW0VZD@G"VD&*/[O^P::W*/N^H4AU#KP72U52\XG ]UJ
MZ>H73/-D@+3)M*R25+)G*.WF0_>16N9CE>>4IHLN14K74):J&W0M:VTU50E"
M%*;3(J82XLBPH"8?K<WI>KHW*M[JII=39B)$L8P]&4L).]%XA 0;9F[:VX$D
MDS.SL[!A;N8,?5I2"F8TS_*1X(#+* $@:AQ 0\5"R49U^C:_/BI2WZ3JA+YV
M['W^4S"DG-%]FOJPGI\RLIYW<Z9*Q*4R9'=^\7LS3]ED9MG.8/E(;+'7NI"5
M%4VIS4@K "29$*22DR!!C[TJSM)V>9H6<QHW*5IH-)1,"H;>4<*BT)S3()YR
MB9DIE)4??9F]8LAERDPMA1&$NAQR>$$D3"1*PS$S9*V$>S>CZ]=T]D:-J'_C
M=5Q1F_Z5/T!".XE6*4S*%6W]^N#+3 !%T67?@!#1.YO&.T*<PIT.)0PR0%)2
MJ1),Y8DG5HC^%T_ZMKS(_A=/^K:\R/X73_JVO,C^%T_ZMKS(_A=/^K:\R%)5
ME=/^K:]7%0I&7,)DDF?5M:_$&Y&:-TJ &TN "4A9A$[!9?/W3AGHA]D'1+OM
MC,'Y7IXSL1U07\+7LG9A+DKP.X(1MCBCOUJ[AVHW.6$=SOU&._9A3!]&Z,*A
MK%^UOSAWLKV5IW$U#H(/5I6+5&?^A?2;Q\0QE]5GO:2MITU+T@!45#9-A5(A
MQ:;)'68HJE><.OO<T\YT+/1.R3PPXRZD]4EM)!MMWS+>[@A,;I^DJ%QWZX=\
M0=UW<\$521TBBS?A[KR")FZW2=<4KN;%2\N0J>%,B=(-BP4ZH0C*JC!0 ]%:
ME RVD<V&:1VJJ6LM('6):4$E=G.!!!2H3MYPV3#M)V)98I&"D872%-5 6>DK
M&PI !U$"=\XR[+LQ^^WM@UE]*X5H;ILXKTH)4,)2I"GRDHE<  =F*JM[053U
M>'Q)QRH5U[RA,FU3DYFWX1(O@-T[#C[Q>6K"^EM;2$J,P6@ DI7H.B5@A2&L
MQJ6*F9P]6X4) T73(W-R*5IRKJ7%)5-86H*2NRX@CG">@PDTK2:6GT^S@-*.
MW(2.NW3"D4[6&I YKA"0LG\I8$Y:I6S@H8"QFDK%\T"?C 8]<+JW5U(#;:2T
M$% '7?#+@,N:=!2<1-\(&8N4;;++BELN,%Y+Z"9B>-1(2K#I3*V=LH2Y1??3
MVQ9[,>Q,,%A.;UZ+6DR5)I-1U6$F6'6+P(S%VHKJ^L[4/NN++]6M#O345)FX
M07IB9G??9.'13O527E4K;8!*0@+2 %*$K0#KO(O$,NY2Y-XJFYUI,E"^S $D
MV_&T;,+4B@IO9W4)2XHH^M;E:I;!N2LGX2IV7QE]$_E66B@:5Z=+2A6(&'#B
M:<)4E+E@MD+S'LF7TE,SV,8HF RLI4C,%U(3A?\ :%)4IA3%@+6 !R<RN*-F
MG;<2W1?6TV()$JE0PN*7*8""+BWA</PC I<R53#*&T)+81UF,.2DLJ"U%$B+
MBD!1TPM06-^ R$J49ZIC3MPBJ>ZKJM5L^%$N& RPB2@!.P :=7O1SR);$)DV
MHJ598)QG2U).'JVQ].$OI6GJ@D3F;^E=HCM+6YXZI[LQ7T0IBRRJ:RA2E*<Q
MH=*6B H-+2 3B4@8I2$5KO8_M1F.590IY2D)I'UTRR%%1 =#*PE11,!,CLG0
M(2UVN[3U5>M+[I"W:AYY?5+42$$O*5.<D%:>C--E@$.?=GV<HW&>U+U?4NO/
MD(0PMEQ*0RC&V[UA*""5)+(2)S"E&ZGI,P=;75I4LJ(,TG$9B14,6N\15?7(
M#:FI"9T@$G8E*,X3UB/2IMG9T!N\$)!(LB:@3M0PAM*IA1MEL;<8B1+9OAQ)
M6E) O) WHD:AORD\L234($ORD\1,65+?E"/M#?E#EC[0WY0Y8YU4T-M0Y8^V
ML^4(;0FI;45&5B@=^V LK2;)R!F?!+AG"3A( .F&";I\$H[38#(!ACPJC"5&
M<-T&7)Q5"KIJPI %JBI1YJ0E(4HE1%B2!-4DE%(S15%35*>+80PA3BBH%2;
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MW*J>F#I-/4(IT=6A#S*$J4I2&TX0%+*,)*PJ:P,*1;&1YN^VI2Z'/JYH6)Q
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MZ5&4A>--H@22=V'7$HQ! F9 D^"'$MTSJ2F_$DC3*R4XK::E7U+E&CK%ETE
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M20(0E! (U]YC+V**E6ZXVXHJP)4J0*0!T02-V4%/[GJI_HG/-A*U9/4R4?\
M5.^9 (R>J_5.>9%4T[2*8*DR!=2X@$Z@2BTQ596^)U!2;4S*;5"5I /!"6%]
M,+4=BWN& %)\$86 E)3:9V> &)KF0#\'=VHJJ<K4E24)//D)VRLYQMUV1-()
M&Q;!2 9C\$9P0)PX-0X^X_9\&*PV2P.>"$STK5X8+I4G"!KMBGHRRZ7'%800
M!A&RHXK!9J,-/5J%OA<I!@!9M$[<11#7:%<_95SDBSK; #:F<K9V<Z'<["%H
MI43F% !=FH3(^=='M3+3H:Q$<X 3(OE)1'#'5!IR<]0E]*,]<^":?C$5WZ17
MTC&Z?#^ ,'#TH65$=\^X)@VQ,"%!)$QK_DB1E.!+W,X2I6DV2VH.$WP"NT*L
M$K=FVZ"^I:<(%T[8<:82L*8FI4Y"8-G-D3,SURLA7L0P8%6]9,"PD680N*.D
M('6I2,1%UU@!OLF9S T0=L^$PX-@=R\1>(O$7B+Q%XB_NKCOUP[X@[KNYX(?
M\7CASOUPW[H8)[D)Z\B4],N.$%MQ&(@3M1'31OIY89#2DE25&XC8U3X8.O\
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M25"X[]<.^(.Z[N>"'_%XX<[]<-_C2^L!,Q9*7'%B#O")*19M#D@]6$@[G$F
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M;WD*C[&]Y"H^QO>0J/L;WD*C[&]Y"H^QO>0J/L;WD*C[&]Y"HJNO96A*4#I
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M7;Y_ZRV^*=*",0IFIW?$@P\9:.,Q="K+A"=N&^_1"-L<4=^M7NN_48[]F*-
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M7M0-N*9\B;K:IH&LRNE>=R1C[RLB16*9RWM!EXI:Q864=0R'>M"\76MH:YP
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M'F^7.>T4U1U!:J%U*@0LU+U.MM:F[24EM27,1)*K3&9O=I*#J^U-8\ZI[V1
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M4>+#VV?"8?VN/W"MJ+XM3BF=O\X1Z#YO\Z/0?-_G1Z#YO\Z/0?-_G1Z#YO\
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M]\@G?X(HVZ5A27G%E)*0G"9 F\83"'G#-*M5^O3*#U<DJG>K5;/0;;N&)E:
M9&ZRZ>B0&Q9MR)O'6.IEL6RX(GB$Y]^B%=4ZFPZ;)C>A1*TF0F9'9 V-)AQ
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M_P!&B<L3J?AHLPZS"*W,'4T5,KX520R-]1EPPS7T.;T=4RM13]2ZEPB6DX;
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MU%6W,\N^$6WVG7%%45-)JT!(GEK[_%TQ8EUW-%8CU^O TPU<%1;C-QPJ"1V
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M\VS4S>2I6E=%OWA$%ZD;5W/9-FG09%!ORRY4QPUD/Q]#Q2%$WQT JW)5=O\
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M_P#V#@.7N#::ND\(+IVZM3+2H.JO;"%>T4PI#N':2"J*G_+RUL^U%_\ D#+
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M,4_6^*)\'^ZW1]S5P_6:=C^:O^FG'C!OQL[5?FP8_O5$7+2I#K\G2*H:*/\
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M0$:Y]WL'"3&'74CLJX;TAK-N,"M+H)N9+50\#;'5KYB+P4$3/CEAJI[2WS=
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M)&TCYT1:RR7+)%S-3#L7N"B^7Y.:HQ[\0+/X#8+\/!-NM13;5,B16Q76B\%
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M*#H.F9O1FY BH(.E=6:0+BMJJT^X;7J\9F92+FHL^)4Z'48;K8N#)CSXCSH
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M=>02CR+MC&0V];XC)BLNR*S<:\UB2RPX\.J#I5QS/F(.32XI%R]4]PO[M7?
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M''GE_P!4_P!+CSR_ZI_I<>>7_5/]+CSR_P"J?Z7'GE_U3_2X,FVW7E;'6H-
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M$7Y%[SP>+GQ_X?'^R^AHOU/ATLVE)L4)MI(\7FR#5P Y+"+'02=034UU**:
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MH0:?=%EXBX:6S1=)=B\ >057R!1>U>"W4TR]*6C6006O3HY\M&W7HB)Z)S&
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MCCV^C3=:E4 VJ<Z%KURESQ6)5V6GY,-&S52%"S<V5K4.*$RJ)L[M_1;?;BN
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M2;-";DOUUH:CX0"!I-55IX1-21%U#DF:<557# E7+-&B15'M[4)<T1?\F/\
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MH\>!%I+TF"VT1"RZXY(5Q#;0! 0-'35ML6>L_;J+S'UDR#A]/%(22P_SDT'
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M(@-HHBIDID"9(1(G#-<UQMU:>U]/BS=V]VMPV+%LA:JT3E)HA,-N/UBYJHT
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M-R<YX)?,=FD13)]4:YKDEQ514%"R7SR<14Z98EL4NU*<TR$&-$@@DMYBFM<
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M- MZW;=B.3'X%*H](A0Z-2HL0Y,UQ&685#I,)C0+7?. ;BEJ,D*ET?(9$-9
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ML?\ $O?6<\7/[(SJD_/[?WN_OL/ ;P,H8"**:DG,4G ^1II$ESTYE[P5Q7;
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MA"8F)$)"2*BHJ+Q1>&$)MM\A551%Y>CL7)>#B@2IY>6.(.!\4/;[S2I8X9_
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MU=,&V;6HM"@7.$:-$2L)3($1)]4888E261;JS\D#-8SDB.JM#FXBZ4+W$?\
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M(=BP8T6!!C.R9;\B3.,VVV6V6E5=**XN2(*+A;NVZZ->I_<?;]R,],I-ZVQ
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MJ+&HLZ5';8)3XN#FB*F>.N&F;/=+_49!VSZFYTJ$K/3GO?;UN[$;I7 Q#8]
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MP<=_5X-+%(TC1ES.6\X"#H15%,T=TJO%.]SQ=PSZ.-=@6ATR6E0H-/\ 1!Z
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M\V#'N"^)+XU<>+K]E!N)^8W=+$%&FC>-*@BHVWI4R_[/%,A0B%%7CY.% W@
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MICI0MWK)+;Z]:97;MJD&V6*([$E:H+SD9V7$N% 88D 9'(30#8/LJ(EJ<$D
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M<TI_IGHTCW%)4[,>+M"8:16JULQU!4FFRW^$>5.AL42HRV&5'6\ZY&9:5"$
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M)AEL@DDV;;9&;$<30!UKPS5,\N&>"9;5EQM]ID7>9SA)LR13F(PXR;9\MUU
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M*(?]H(FI<^ZJ8)6MPKX&&'! 2YJTP[S43)%7E5(TT:5+AGVY8_YAW]]]]?\
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MJ;&A\ML6727-=0:LT[>W#/ZJU\>F*_\ NR)\:6-M_87[]?G0V8POO ^EHO\
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@Z;&_[PG@?VQ_MCT.U?R>?;G]MO#D^%>!Z./-SX8__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6795594400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Aug. 14, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">SIGMA LABS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Registrant CIK</a></td>
<td class="text">0000788611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">SEC Form</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Period End date</a></td>
<td class="text">Sep. 30,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Fiscal Year End</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">sglb<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Tax Identification Number (TIN)</a></td>
<td class="text">271865814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Number of common stock shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,718,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Current with reporting</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Voluntary filer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryName', window );">Entity Incorporation, State Country Name</a></td>
<td class="text">Nevada<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3900 Paseo del Sol<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Santa Fe<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NM<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">87507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">438-2576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State or Country Name where an entity is incorporated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nineDigitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6795458496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,691,487<span></span>
</td>
<td class="nump">$ 398,391<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts Receivable, net</a></td>
<td class="nump">105,725<span></span>
</td>
<td class="nump">288,236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Notes Receivable, net</a></td>
<td class="nump">775,267<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">188,907<span></span>
</td>
<td class="nump">187,241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid Expense, Current</a></td>
<td class="nump">49,896<span></span>
</td>
<td class="nump">36,056<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,811,282<span></span>
</td>
<td class="nump">909,924<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and Equipment, net</a></td>
<td class="nump">446,449<span></span>
</td>
<td class="nump">564,933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, net</a></td>
<td class="nump">261,660<span></span>
</td>
<td class="nump">226,450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAssetNoncurrent', window );">Investment in Joint Venture</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseOtherNoncurrent', window );">Prepaid Stock Compensation</a></td>
<td class="nump">49,528<span></span>
</td>
<td class="nump">167,562<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total Other Assets</a></td>
<td class="nump">758,137<span></span>
</td>
<td class="nump">959,445<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">4,569,419<span></span>
</td>
<td class="nump">1,869,369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">114,747<span></span>
</td>
<td class="nump">112,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Notes Payable, Current Portion</a></td>
<td class="nump">994,909<span></span>
</td>
<td class="nump">561,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">219,570<span></span>
</td>
<td class="nump">125,116<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,329,226<span></span>
</td>
<td class="nump">799,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">93,206<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Long-Term Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">93,206<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">1,329,226<span></span>
</td>
<td class="nump">892,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, Value, Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued</a></td>
<td class="nump">4,578<span></span>
</td>
<td class="nump">3,135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">16,046,185<span></span>
</td>
<td class="nump">10,734,857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(12,810,570)<span></span>
</td>
<td class="num">(9,760,954)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders' deficit</a></td>
<td class="nump">3,240,193<span></span>
</td>
<td class="nump">977,038<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' deficit</a></td>
<td class="nump">$ 4,569,419<span></span>
</td>
<td class="nump">$ 1,869,369<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationAssetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized arising from contingent consideration in a business combination, expected to be realized beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6411-128476<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationAssetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13433-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13495-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An amount representing an agreement for an unconditional promise by the maker to pay the Company (holder) a definite sum of money within one year from the balance sheet date (or the normal operating cycle, whichever is longer), net of any write-downs taken for collection uncertainty on the part of the holder. Such amount may include accrued interest receivable in accordance with the terms of the debt. The debt also may contain provisions and related items including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among a myriad of other features and characteristics. This amount does not include amounts related to receivables held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=82891408&amp;loc=d3e4531-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6787-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseOtherNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseOtherNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4590271-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4568740-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6795717952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets (Unaudited) - Parenthetical - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_CostOfGoodsSoldDiscontinuedOperations', window );">Notes Payable, Original Issue Discount</a></td>
<td class="nump">$ 5,091<span></span>
</td>
<td class="nump">$ 69,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_NotesPayableDebtDiscount', window );">Notes Payable, Debt Discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 358,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">7,500,000<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">4,577,651<span></span>
</td>
<td class="nump">3,133,789<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">4,577,651<span></span>
</td>
<td class="nump">3,133,789<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_CostOfGoodsSoldDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Notes Payable, Original Issue Discount, as of the indicated date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_CostOfGoodsSoldDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_NotesPayableDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Notes Payable, Debt Discount, as of the indicated date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_NotesPayableDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fil_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6795802464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statement of Operations (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Revenues</a></td>
<td class="nump">$ 78,046<span></span>
</td>
<td class="nump">$ 189,952<span></span>
</td>
<td class="nump">$ 518,802<span></span>
</td>
<td class="nump">$ 642,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">COST OF REVENUE</a></td>
<td class="nump">81,214<span></span>
</td>
<td class="nump">69,259<span></span>
</td>
<td class="nump">267,160<span></span>
</td>
<td class="nump">207,744<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">GROSS PROFIT</a></td>
<td class="num">(3,168)<span></span>
</td>
<td class="nump">120,693<span></span>
</td>
<td class="nump">251,642<span></span>
</td>
<td class="nump">434,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>EXPENSES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">576,855<span></span>
</td>
<td class="nump">437,870<span></span>
</td>
<td class="nump">1,814,843<span></span>
</td>
<td class="nump">1,314,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Payroll Expense</a></td>
<td class="nump">295,890<span></span>
</td>
<td class="nump">259,010<span></span>
</td>
<td class="nump">973,172<span></span>
</td>
<td class="nump">727,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-Based Compensation</a></td>
<td class="nump">199,225<span></span>
</td>
<td class="nump">105,641<span></span>
</td>
<td class="nump">505,630<span></span>
</td>
<td class="nump">236,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and Development</a></td>
<td class="nump">57,947<span></span>
</td>
<td class="nump">37,526<span></span>
</td>
<td class="nump">225,562<span></span>
</td>
<td class="nump">88,504<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Expenses</a></td>
<td class="nump">1,129,917<span></span>
</td>
<td class="nump">840,047<span></span>
</td>
<td class="nump">3,519,207<span></span>
</td>
<td class="nump">2,366,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest Income</a></td>
<td class="nump">13,675<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">26,616<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncome', window );">Other Income- State Incentives</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">154,568<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Other Income-Decrease in fair value of derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">93,206<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Other Expense - Debt discount amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(56,441)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Nonoperating Income (Expense)</a></td>
<td class="nump">16,175<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">217,949<span></span>
</td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">LOSS BEFORE PROVISION FOR INCOME TAXES</a></td>
<td class="num">(1,116,910)<span></span>
</td>
<td class="num">(719,320)<span></span>
</td>
<td class="num">(3,049,616)<span></span>
</td>
<td class="num">(1,931,833)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income Taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (1,116,910)<span></span>
</td>
<td class="num">$ (719,320)<span></span>
</td>
<td class="num">$ (3,049,616)<span></span>
</td>
<td class="num">$ (1,931,833)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per common share</a></td>
<td class="num">$ (0.24)<span></span>
</td>
<td class="num">$ (0.23)<span></span>
</td>
<td class="num">$ (0.70)<span></span>
</td>
<td class="num">$ (0.62)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted-average common shares outstanding</a></td>
<td class="nump">4,574,460<span></span>
</td>
<td class="nump">3,129,675<span></span>
</td>
<td class="nump">4,330,565<span></span>
</td>
<td class="nump">3,121,821<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of expenditures for salaries, wages, profit sharing and incentive compensation, and other employee benefits, including equity-based compensation, and pension and other postretirement benefit expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6795751296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Net Cash Provided by (Used in) Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="num">$ (3,049,616)<span></span>
</td>
<td class="num">$ (1,931,833)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Noncash Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization - Patents</a></td>
<td class="nump">2,289<span></span>
</td>
<td class="nump">6,526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">134,865<span></span>
</td>
<td class="nump">131,879<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Stock Compensation</a></td>
<td class="nump">506,994<span></span>
</td>
<td class="nump">240,756<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecognitionOfDeferredRevenue', window );">Revaluation of derivative liability and debt discount related to notes payable</a></td>
<td class="num">(93,206)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForLoanAndLeaseLosses', window );">Note Payable original issue discount</a></td>
<td class="nump">74,794<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForOtherLosses', window );">Note Payable debt discount amortization</a></td>
<td class="nump">56,441<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts Receivable</a></td>
<td class="nump">182,511<span></span>
</td>
<td class="nump">160,623<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(1,666)<span></span>
</td>
<td class="num">(64,530)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid Assets</a></td>
<td class="num">(13,840)<span></span>
</td>
<td class="nump">4,590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Accounts Payable</a></td>
<td class="nump">2,572<span></span>
</td>
<td class="nump">104,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInNotesPayableCurrent', window );">Notes Payable</a></td>
<td class="nump">301,839<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued Expenses</a></td>
<td class="nump">94,454<span></span>
</td>
<td class="nump">24,799<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</a></td>
<td class="num">(1,801,569)<span></span>
</td>
<td class="num">(1,322,366)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Net Cash Provided by (Used in) Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireFurnitureAndFixtures', window );">Purchase of Furniture and Equipment</a></td>
<td class="num">(16,381)<span></span>
</td>
<td class="num">(26,907)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of Intangible Assets</a></td>
<td class="num">(37,498)<span></span>
</td>
<td class="num">(61,556)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfLoansReceivable', window );">Notes Receivable</a></td>
<td class="num">(775,267)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Investment in Joint Venture</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries', window );">Loss on Investment in Joint Venture</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Provided by (Used in) Investing Activities</a></td>
<td class="num">(829,146)<span></span>
</td>
<td class="num">(79,741)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock and warrants</a></td>
<td class="nump">5,225,650<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Amendment to Warrant Agreements</a></td>
<td class="num">(301,839)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Provided by (Used in) Financing Activities</a></td>
<td class="nump">4,923,811<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">NET CASH DECREASE FOR PERIOD</a></td>
<td class="nump">2,293,096<span></span>
</td>
<td class="num">(1,402,107)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents, at Carrying Value, Beginning Balance</a></td>
<td class="nump">398,391<span></span>
</td>
<td class="nump">1,539,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents, at Carrying Value, Ending Balance</a></td>
<td class="nump">2,691,487<span></span>
</td>
<td class="nump">137,702<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest Paid</a></td>
<td class="nump">50,418<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income Taxes Paid, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Cash Flow, Noncash Investing and Financing Activities Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of Common Stock for services</a></td>
<td class="nump">85,408<span></span>
</td>
<td class="nump">152,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1', window );">Writeoff of Debt Discount</a></td>
<td class="num">$ (301,839)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in current portion (due within one year or one business cycle) of obligations evidenced by formal promissory notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest. Includes, but is not limited to, payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPaymentsToAcquireBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPaymentsToAcquireBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of noncontrolling interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireFurnitureAndFixtures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireFurnitureAndFixtures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfLoansReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfLoansReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3095-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3098-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=84234705&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForLoanAndLeaseLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to estimated loss from loan and lease transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.11)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=SL6953423-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForLoanAndLeaseLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForOtherLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to other loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForOtherLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecognitionOfDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of previously reported deferred or unearned revenue that was recognized as revenue during the period. For cash flows, this element primarily pertains to amortization of deferred credits on long-term arrangements. As a noncash item, it is deducted from net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecognitionOfDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786794704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 1 - Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">NOTE 1 - Summary of Significant Accounting Policies</a></td>
<td class="text"><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>NOTE 1 &#150; Summary of Significant Accounting Policies</b></p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>Nature of Business &#150; </b>On September 13, 2010 Sigma Labs, Inc., formerly named Framewaves, Inc., a Nevada corporation, acquired 100% of the shares of B6 Sigma, Inc. by exchanging 6.67 shares of Framewaves, Inc. restricted common stock for each issued and outstanding share of B6 Sigma, Inc. The acquisition has been accounted for as a &#147;reverse merger&#148; and, accordingly, the operations of Framewaves, Inc. prior to the date of acquisition have been eliminated. Unless otherwise indicated or the context otherwise requires, the term &#147;B6 Sigma&#148; refers to B6 Sigma, Inc., a Delaware corporation, which, until the short-form merger referenced below, was our wholly-owned, operating company acquired in September 2010; the terms the &#147;Company,&#148; &#147;Sigma,&#148; &#147;we,&#148; &#147;us&#148; and &#147;our&#148; refer to Sigma Labs, Inc., together with B6 Sigma, Inc. Prior to December 29, 2015, we conducted substantially all of our operations through B6 Sigma. On December 29, 2015, we completed a short-form merger of B6 Sigma into Sigma. As a result, B6 Sigma became part of Sigma and no longer exists as a subsidiary.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none'>B6 Sigma, Inc., incorporated February 5, 2010, was founded by a group of scientists, engineers and businessmen to develop and commercialize novel and unique manufacturing and materials technologies. The Company believes that some of these technologies will fundamentally redefine conventional quality assurance and process control practices by embedding them into the manufacturing processes in real time, enabling process intervention and ultimately leading to closed loop process control. The Company anticipates that its core technologies will allow its clientele to combine advanced manufacturing quality assurance and process control protocols with novel materials to achieve breakthrough product potential in many industries including aerospace, defense, oil and gas, bio-medical, and power generation.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>Basis of Presentation</b> &#150; The accompanying financial statements have been prepared by the Company in accordance with Article 8 of U.S. Securities and Exchange Commission Regulation S-X. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2017 and 2016 and for the periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. The Company suggests these condensed financial statements be read in conjunction with the December 31, 2016 audited financial statements and notes thereto included in the Company&#146;s Form 10-K. The results of operations for the periods ended September 30, 2017 and 2016 are not necessarily indicative of the operating results for the full year.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>Reclassification</b> &#150; Certain amounts in prior-period financial statements have been reclassified for comparative purposes to conform to presentation in the current-period financial statements.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>Loss Per Share &#150; </b>The computation of loss per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, &#147;Earnings Per Share.&#148;</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>Recently Enacted Accounting Standards</b> &#150; The FASB established the Accounting Standards Codification (&#147;Codification&#148; or &#147;ASC&#148;) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States (&#147;GAAP&#148;). Rules and interpretive releases of the Securities and Exchange Commission (&#147;SEC&#148;) issued under authority of federal securities laws are also sources of GAAP for SEC registrants.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Recent Accounting Standards Updates (&#147;ASU&#148;) through ASU No. 2015-01 contain technical corrections to existing guidance or affects guidance to specialized industries or situations. The Company has evaluated recently issued technical pronouncements and has determined that these updates have no current applicability to the Company or their effect on the financial statements would not have been significant.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>Accounting Estimates</b> - The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowance for bad debts and inventory obsolescence.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6634144144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">NOTE 2 - Stockholders' Equity</a></td>
<td class="text"><p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>NOTE 2 &#150; Stockholders&#146; Equity</b></p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Common Stock</b></p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Effective March 17, 2016, our Amended and Restated Articles of Incorporation were amended pursuant to a Certificate of Change Pursuant to Nevada Revised Statutes 78.209 (the &#147;Certificate of Change&#148;) filed with the Nevada Secretary of State. The Certificate of Change provided for both a reverse stock split of the outstanding shares of our common stock on a 1-for-100 basis (the &#147;Reverse Stock Split&#148;), and a corresponding decrease in the number of shares of our common stock that we are authorized to issue (the &#147;Share Decrease&#148;).</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>As a result of the Reverse Stock Split, the number of issued and outstanding shares of our common stock on March 17, 2016 decreased from 622,969,835 pre-Reverse Stock Split shares to 6,229,710 post-Reverse Stock Split shares (after adjustment for any fractional shares). Pursuant to the Share Decrease, the number of authorized shares of our common stock decreased from 750,000,000 to 7,500,000 shares of common stock. All amounts shown for common stock included in these financial statements are presented post-Reverse Stock Split.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>On April 28, 2016, the Company&#146;s Amended and Restated Articles of Incorporation were amended to increase the number of authorized shares of the Company&#146;s common stock from 7,500,000 to 15,000,000 shares of common stock.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Effective February 15, 2017, our Amended and Restated Articles of Incorporation were amended pursuant to a Certificate of Change Pursuant to Nevada Revised Statutes 78.209 (the &#147;Certificate of Change&#148;) filed with the Nevada Secretary of State. The Certificate of Change provided for both a reverse stock split of the outstanding shares of our common stock on a 1-for-2 basis (the &#147;Reverse Stock Split&#148;), and a corresponding decrease in the number of shares of our common stock that we are authorized to issue (the &#147;Share Decrease&#148;).</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>As a result of the Reverse Stock Split, the number of issued and outstanding shares of our common stock on February 15, 2017 decreased from 6,307,577 pre-Reverse Stock Split shares to 3,153,801 post-Reverse Stock Split shares (after adjustment for any fractional shares). Pursuant to the Share Decrease, the number of authorized shares of our common stock decreased from 15,000,000 to 7,500,000 shares of common stock, $0.001 par value per share. As of March 31, 2017, the Company had 7,500,000 shares of authorized common stock, $0.001 par value per share.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>In January, 2017, the Company issued 20,000 shares of common stock to two directors in equal amounts of 10,000 shares each, valued at $1.72 per share, or $34,404.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>In February, 2017, the Company issued 5,232 shares of common stock to a director valued at $3.25 per share, or $17,004.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;margin-top:0in;margin-right:-2.7pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify;text-indent:0in'>On February 14, 2017, The&nbsp;NASDAQ&nbsp;Stock Market LLC informed the Company that it had approved the listing of the Company&#146;s common stock on The&nbsp;NASDAQ&nbsp;Capital Market, effective as of February 15, 2017. The Company&#146;s common stock ceased trading on the OTCQB on February 15, 2017, and on such date the common stock commenced trading on The NASDAQ&nbsp;Capital Market under the ticker symbol &#147;SGLB&#148;.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>On August 8, 2017, the Company issued 7,489 shares of common stock to a director valued at $2.27 per share, or $17,000.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>On August 16, 2017, the Company issued 8,213 shares of common stock to a director valued at $2.07 per share, or $17,000.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>As of September 30, 2017 and December 31, 2016, there were 4,577,651 and 3,133,789 shares of common stock issued and outstanding, respectively.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-indent:.5in;text-autospace:none'><b>Preferred Stock</b></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none'>The Company is authorized to issue 10,000,000 shares of preferred stock, $0.001 par value. No shares of preferred stock were issued and outstanding at September 30, 2017 and 2016.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-indent:.5in'><b>Stock Options</b></p> <p style='margin:0in;margin-bottom:.0001pt;text-indent:.5in'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>On September 28, 2017, the Company granted to an officer (i) a five-year stock option to purchase up to 2,500 shares of common stock, at an exercise price equal to $1.91 per share, which was the closing market price of our common stock on September 28, 2017 (i.e., the date of grant), which option vested and became exercisable in full on the date of grant, and (ii) a five-year stock option to purchase up to 47,500 shares of common stock, at an exercise price equal to $1.91 per share (the closing market price of our common stock on the date of grant), which option is subject to vesting.</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>The weighted average period over which total the compensation cost of the options of $90,723 ($11,937 in 2017) will be recognized is 4 years. The weighted average exercise price of all outstanding options as of September 30, 2017 is $3.58 and the weighted average fair value of the options on the grant dates was $2.88. The estimated fair value of the options was determined using the Black-Scholes pricing model using the following assumptions:</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" style='border:solid black 1.0pt;border-collapse:collapse;border:none'> <tr align="left"> <td width="136" valign="top" style='width:102.35pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Expected term:</p> </td> <td width="104" valign="top" style='width:77.65pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>5 years</p> </td> </tr> <tr align="left"> <td width="136" valign="top" style='width:102.35pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="104" valign="top" style='width:77.65pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="136" valign="top" style='width:102.35pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Volatility:</p> </td> <td width="104" valign="top" style='width:77.65pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>67.3 &#150; 155.62%</p> </td> </tr> <tr align="left"> <td width="136" valign="top" style='width:102.35pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="104" valign="top" style='width:77.65pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="136" valign="top" style='width:102.35pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Dividend yield:</p> </td> <td width="104" valign="top" style='width:77.65pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>0.00%</p> </td> </tr> <tr align="left"> <td width="136" valign="top" style='width:102.35pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="104" valign="top" style='width:77.65pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="136" valign="top" style='width:102.35pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Risk-free interest rate:</p> </td> <td width="104" valign="top" style='width:77.65pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>1.13 - 2.27%</p> </td> </tr> </table> </div> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b>Warrants</b></p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>As of September 30, 2017, the Company had outstanding warrants to purchase a total of 80,000 shares of common stock at an exercise price of $2.00 per share. Each warrant, prior to its amendment described below in Note 4, had an exercise price equal to $4.13. If not exercised, the warrants to purchase the 80,000 shares will expire on October 17, 2019. In addition, as of September 30, 2017, the Company had outstanding warrants to purchase a total of 1,621,500 shares of common stock at an exercise price of $4.00 per share. If not exercised, the warrants to purchase the 1,621,500 shares will expire on February 21, 2022. The 1,621,500 warrants trade on The NASDAQ&nbsp;Capital Market under the ticker symbol &#147;SGLBW&#148;.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <b>Unit Purchase Option</b></p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>On February 15, 2017, Sigma Labs, Inc. (the &#147;Company&#148;) entered into an underwriting agreement (the &#147;Underwriting Agreement&#148;) with Dawson James Securities, Inc., as underwriter (the &#147;Underwriter&#148;) in connection with a public offering (the &#147;Offering&#148;) of the Company&#146;s securities. &nbsp; Pursuant to the Underwriting Agreement, the Company has granted the Underwriter the right to purchase from the Company 70,500 Units at an exercise price equal to 125% of the public offering price of the Units in the Offering, or $5.1625 per Unit. The Unit Purchase Option has a term of five years and is not redeemable by us. A &#147;Unit&#148; is defined as of one share of the Company&#146;s common stock, par value $0.001 per share and one warrant to purchase one share of the Company&#146;s common stock, par value $0.001 per share, at an exercise price of $4.00 per share.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786808400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 3 - Note Receivable<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivablesTextBlock', window );">NOTE 3 - Note Receivable</a></td>
<td class="text"><p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>NOTE 3 &#150; Note Receivable</b></p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>On May 1, 2017, the Company completed funding a loan in the principal amount of $250,000 to Jaguar Precision Machine, LLC, a New Mexico limited liability company, pursuant to a Secured Convertible Promissory Note dated May 1, 2017 delivered by Jaguar to the Company. The loan bears interest at the rate of 7% per annum, is due and payable in full on May 1, 2018, is secured by certain assets of Jaguar, and is convertible at the Company&#146;s option into 10% of the outstanding shares of the common stock of Jaguar unless Jaguar exercises its right under specified circumstances to repay all principal and accrued interest on the loan. The purpose of the loan is to provide working capital to Jaguar to, among other things, stand up a metallurgical laboratory and become ASM9100 certified for contracts related to AM of high-precision aerospace and defense components, in furtherance of our strategic alliance. Sigma will receive from Jaguar priority for use of certain machines and services of Jaguar.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>On March 27, 2017, the Company completed funding a loan in the principal amount of $500,000 to Morf3D, Inc., an Illinois corporation, pursuant to a Secured Convertible Promissory Note dated March 27, 2017 delivered by Morf3D to the Company. The loan bears interest at the rate of 7% per annum, is due and payable in full on March 27, 2018, is secured by certain assets of Morf3D, and is convertible at the Company&#146;s option into 10% of the outstanding shares of the common stock of Morf3D unless Morf3D exercises its right under specified circumstances to repay all principal and accrued interest on the loan. The purpose of the loan is to provide working capital to Morf3D to, among other things, lease an EOS M 400 system for Morf3D for Morf3D to expand production for contracts related to AM of high-precision aerospace and defense components, in furtherance of our strategic alliance and in contemplation of a possible acquisition of or merger with Morf3D (although discussions regarding a possible acquisition of or merger with Morf3D are not currently ongoing).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financing receivables. Examples of financing receivables include, but are not limited to, loans, trade accounts receivables, notes receivable, credit cards, and receivables relating to a lessor's right(s) to payment(s) from a lease other than an operating lease that is recognized as assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -URI http://asc.fasb.org/topic&amp;trid=2196771<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6632720864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 4 - Notes Payable<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">NOTE 4 - Notes Payable</a></td>
<td class="text"><p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>NOTE 4</b> <b>&#150; Notes Payable</b></p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;margin-bottom:0in;margin-bottom:.0001pt;text-align:justify;text-indent:0in'>Effective October 17, 2016, the Company entered into a Securities Purchase Agreement with two accredited investors (the &#147;Investors&#148;) for the private placement by the Company of Secured Convertible Notes in the aggregate principal amount of $1,000,000 (the &#147;Notes&#148;) and warrants (the &#147;Warrants&#148;) to purchase up to 80,000 shares (the &#147;Warrant Shares&#148;) of the Company&#146;s common stock (&#147;Common Stock&#148;) (subject to adjustment in certain circumstances), for aggregate gross proceeds, before expenses, to the Company of $900,000 (the &#147;Financing Transaction&#148;). The Notes carry a one-time upfront interest charge of a total of $100,000, which is being expensed to interest expense monthly over the 1-year term of the Notes and correspondingly increases in the Notes Payable balance each period.</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;margin-bottom:0in;margin-bottom:.0001pt;text-indent:0in'>&nbsp;</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;margin-bottom:0in;margin-bottom:.0001pt;text-align:justify;text-indent:0in'>The Notes carry an interest rate of 10% per annum, calculated on the basis of a 360-day year, based on the $1 million Notes Payable effective balance. Such interest is payable every three months in cash, or, at the holder&#146;s option, in unrestricted shares of Common Stock, if a registration statement is then in effect for such shares of common stock.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none'>In connection with the Financing Transaction, the Company entered into a Registration Rights Agreement, dated October 17, 2016, with the Investors, pursuant to which the Company filed a registration statement related to the Financing Transaction with the Securities and Exchange Commission (&#147;SEC&#148;) covering the resale of (i) the shares of Common Stock that will be issued to the Investors upon conversion of the Notes, and (ii) the Warrant Shares that will be issued to the Investors upon exercise of the Warrants.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none'>The Notes are secured by the assets of the Company pursuant to a Security Agreement, dated October 17, 2016, between the Company and the &#147;collateral agent&#148; (as defined in the Notes) for the benefit of itself and each of the Investors.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none'>The Notes , prior to their amendment described below, provided that they were convertible into shares of Common Stock at a conversion price equal to the lesser of (i) the final unit price of the Company&#146;s proposed public offering initially filed with the SEC on July 28, 2016, and (ii) 150% of the closing price of the Common Stock as reported by the OTC Markets Group, Inc. on the date of issuance of the Notes (subject to adjustment as provided therein). As such, the conversion price of the Notes was $4.13, which is the final unit price of the Company&#146;s public offering.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none'>Each Warrant , prior to its amendment described below, had an exercise price equal to the lesser of (i) the final unit price of the Company&#146;s proposed public offering initially filed with the SEC on February 17, 2017, and (ii) 150% of the closing price of the Common Stock as reported by the OTC Markets Group, Inc. on the date of issuance of the Warrants (subject to adjustment as provided therein), which Warrants may be exercised on a cashless basis as provided in the Warrants. As such, the exercise price of the Warrants was $4.13, which is the final unit price of the Company&#146;s public offering.</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none'>On September 29, 2017, the Company entered into amendments (the &#147;Amendments&#148;) to the Notes and Warrants pursuant to which, among other things set forth in the Amendments, (1) the exercise price of the Warrants was reduced from $4.13 per share to $2.00 per share, and (2) the conversion price of the Notes was reduced from $4.13 per share to $2.00 per share. Under the Amendments, Sigma paid the Investors an aggregate amount equal to $500,000 (representing 50% of the outstanding principal balance of the Notes) plus all accrued interest on the Notes on October 2, 2017. In consideration of the foregoing, the Investors agreed to, among other things, extend the payment date of the remaining 50% of the outstanding principal balance of the Notes from October 17, 2017 to the earlier of May 18, 2018 or the closing of the Company&#146;s next underwritten public offering of securities in which the Company raises gross proceeds of at least $3,000,000 (should the Company elect to commence and close such an offering of securities).</p> <p style='margin:0in;margin-bottom:.0001pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none'>As of September 30, 2017, the Notes Payable balance is $994,909 which balance was reduced to $500,000 on October 2, 2017.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786849984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 5 - Continuing Operations<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">NOTE 5 - Continuing Operations</a></td>
<td class="text"><p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>NOTE 5 - Continuing Operations</b></p> <p style='margin:0in;margin-bottom:.0001pt;margin-right:-2.7pt;text-autospace:none'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;margin-right:-2.7pt;text-align:justify;text-autospace:none'>The Company has sustained losses and has negative cash flows from operating activities since its inception. However, the Company has raised significant equity capital and is currently developing new product lines to increase future revenues. On February 21, 2017, the Company closed an underwritten public offering of equity securities resulting in net proceeds of approximately $5.25 million, after deducting underwriting discounts and commissions and other offering expenses payable by the Company. As such, the Company believes it has adequate working capital and cash to fund operations through 2017.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786780752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 6 - Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NOTE 6 - Loss Per Share</a></td>
<td class="text"><p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>NOTE 6 &#150; Loss Per Share</b></p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>The following data show the amounts used in computing loss per share and the weighted average number of shares of dilutive potential common stock for the periods ended September 30, 2017 and 2016:</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" style='border:solid black 1.0pt;border-collapse:collapse;border:none'> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="227" colspan="3" valign="bottom" style='width:169.9pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>9 Months Ending</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>9-30-17</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>9-30-16</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="103" valign="top" style='width:77.05pt;border:none;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="103" valign="top" style='width:77.05pt;border:none;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Loss from continuing</p> </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="103" valign="top" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="103" valign="top" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Operations available to </p> </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="103" valign="top" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="103" valign="top" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Common stockholders (numerator)</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="103" valign="bottom" style='width:77.05pt;border:none;border-bottom:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(3,049,616)</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="103" valign="bottom" style='width:77.05pt;border:none;border-bottom:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(1,931,833)</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;border:none;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;border:none;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Weighted average number of </p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>common shares Outstanding </p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>used in loss per share during </p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>the Period (denominator)</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;border:none;border-bottom:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,330,565</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;border:none;border-bottom:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,121,821</p> </td> </tr> </table> </div> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Dilutive loss per share was not presented as the Company had no common equivalent shares for all periods presented that would affect the computation of diluted loss per share or its effect is anti-dilutive.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786772960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 7 - Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">NOTE 7 - Subsequent Events</a></td>
<td class="text"><p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>NOTE 7</b> <b>&#150; Subsequent Events</b></p> <p style='margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;margin-bottom:0in;margin-bottom:.0001pt;text-indent:0in'>&nbsp;</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;margin-bottom:0in;margin-bottom:.0001pt;text-align:justify;text-indent:0in'>On October 6, 2017, pursuant to an advisory agreement with the Underwriter, the Company issued to the Underwriter a total of 141,000 shares of the Company&#146;s common stock in exchange for the surrender by the Underwriter of its Unit Purchase Option to acquire up to 70,500 Units.</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;margin-bottom:0in;margin-bottom:.0001pt;text-indent:0in'>&nbsp;</p> <p style='margin-top:0in;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;margin-bottom:0in;margin-bottom:.0001pt;text-align:justify;text-indent:0in'>On October 13, 2017, the Company granted two employees five-year options to purchase an aggregate of 20,000 shares of common stock, with each option having an exercise price of $1.92 per share, and vesting over the four-year period following the date of grant.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786771376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 1 - Summary of Significant Accounting Policies: Nature of Business (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Business</a></td>
<td class="text"><p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>Nature of Business &#150; </b>On September 13, 2010 Sigma Labs, Inc., formerly named Framewaves, Inc., a Nevada corporation, acquired 100% of the shares of B6 Sigma, Inc. by exchanging 6.67 shares of Framewaves, Inc. restricted common stock for each issued and outstanding share of B6 Sigma, Inc. The acquisition has been accounted for as a &#147;reverse merger&#148; and, accordingly, the operations of Framewaves, Inc. prior to the date of acquisition have been eliminated. Unless otherwise indicated or the context otherwise requires, the term &#147;B6 Sigma&#148; refers to B6 Sigma, Inc., a Delaware corporation, which, until the short-form merger referenced below, was our wholly-owned, operating company acquired in September 2010; the terms the &#147;Company,&#148; &#147;Sigma,&#148; &#147;we,&#148; &#147;us&#148; and &#147;our&#148; refer to Sigma Labs, Inc., together with B6 Sigma, Inc. Prior to December 29, 2015, we conducted substantially all of our operations through B6 Sigma. On December 29, 2015, we completed a short-form merger of B6 Sigma into Sigma. As a result, B6 Sigma became part of Sigma and no longer exists as a subsidiary.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify;text-autospace:none'>B6 Sigma, Inc., incorporated February 5, 2010, was founded by a group of scientists, engineers and businessmen to develop and commercialize novel and unique manufacturing and materials technologies. The Company believes that some of these technologies will fundamentally redefine conventional quality assurance and process control practices by embedding them into the manufacturing processes in real time, enabling process intervention and ultimately leading to closed loop process control. The Company anticipates that its core technologies will allow its clientele to combine advanced manufacturing quality assurance and process control protocols with novel materials to achieve breakthrough product potential in many industries including aerospace, defense, oil and gas, bio-medical, and power generation.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786810000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 1 - Summary of Significant Accounting Policies: Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">Basis of Presentation</a></td>
<td class="text"><p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>Basis of Presentation</b> &#150; The accompanying financial statements have been prepared by the Company in accordance with Article 8 of U.S. Securities and Exchange Commission Regulation S-X. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows at September 30, 2017 and 2016 and for the periods then ended have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. The Company suggests these condensed financial statements be read in conjunction with the December 31, 2016 audited financial statements and notes thereto included in the Company&#146;s Form 10-K. The results of operations for the periods ended September 30, 2017 and 2016 are not necessarily indicative of the operating results for the full year.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6632964000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 1 - Summary of Significant Accounting Policies: Reclassification (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text"><p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>Reclassification</b> &#150; Certain amounts in prior-period financial statements have been reclassified for comparative purposes to conform to presentation in the current-period financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6785985024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 1 - Summary of Significant Accounting Policies: Loss Per Share (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss Per Share</a></td>
<td class="text"><p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>Loss Per Share &#150; </b>The computation of loss per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, &#147;Earnings Per Share.&#148;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6616351216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 1 - Summary of Significant Accounting Policies: Recently Enacted Accounting Standards (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Enacted Accounting Standards</a></td>
<td class="text"><p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>Recently Enacted Accounting Standards</b> &#150; The FASB established the Accounting Standards Codification (&#147;Codification&#148; or &#147;ASC&#148;) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States (&#147;GAAP&#148;). Rules and interpretive releases of the Securities and Exchange Commission (&#147;SEC&#148;) issued under authority of federal securities laws are also sources of GAAP for SEC registrants.</p> <p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Recent Accounting Standards Updates (&#147;ASU&#148;) through ASU No. 2015-01 contain technical corrections to existing guidance or affects guidance to specialized industries or situations. The Company has evaluated recently issued technical pronouncements and has determined that these updates have no current applicability to the Company or their effect on the financial statements would not have been significant.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6615588208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 1 - Summary of Significant Accounting Policies: Accounting Estimates (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyTextBlockAbstract', window );"><strong>Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Accounting Estimates</a></td>
<td class="text"><p style='margin:0in;margin-bottom:.0001pt;text-align:justify'><b>Accounting Estimates</b> - The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowance for bad debts and inventory obsolescence.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84177426&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6634867024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - Stockholders' Equity: Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques</a></td>
<td class="text"><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" style='border:solid black 1.0pt;border-collapse:collapse;border:none'> <tr align="left"> <td width="136" valign="top" style='width:102.35pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Expected term:</p> </td> <td width="104" valign="top" style='width:77.65pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>5 years</p> </td> </tr> <tr align="left"> <td width="136" valign="top" style='width:102.35pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="104" valign="top" style='width:77.65pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="136" valign="top" style='width:102.35pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Volatility:</p> </td> <td width="104" valign="top" style='width:77.65pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>67.3 &#150; 155.62%</p> </td> </tr> <tr align="left"> <td width="136" valign="top" style='width:102.35pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="104" valign="top" style='width:77.65pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="136" valign="top" style='width:102.35pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Dividend yield:</p> </td> <td width="104" valign="top" style='width:77.65pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>0.00%</p> </td> </tr> <tr align="left"> <td width="136" valign="top" style='width:102.35pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="104" valign="top" style='width:77.65pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="136" valign="top" style='width:102.35pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Risk-free interest rate:</p> </td> <td width="104" valign="top" style='width:77.65pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>1.13 - 2.27%</p> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the inputs and valuation techniques used to measure fair value, and a discussion of changes in valuation techniques and related inputs, if any, applied during the period to each separate class of assets, liabilities, and financial instruments classified in shareholders' equity that are measured on a recurring and/or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6629313072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 6 - Loss Per Share: Schedule of Earnings Per Share, Basic and Diluted (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TableTextBlockSupplementAbstract', window );"><strong>Tables/Schedules</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"><p style='margin:0in;margin-bottom:.0001pt'>&nbsp;</p> <div align="center"> <table border="0" cellspacing="0" cellpadding="0" style='border:solid black 1.0pt;border-collapse:collapse;border:none'> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="227" colspan="3" valign="bottom" style='width:169.9pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>9 Months Ending</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>9-30-17</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;border-top:solid windowtext 1.0pt;border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;padding:0in 5.4pt 0in 5.4pt'> <p align="center" style='margin:0in;margin-bottom:.0001pt;text-align:center'>9-30-16</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="103" valign="top" style='width:77.05pt;border:none;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="103" valign="top" style='width:77.05pt;border:none;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Loss from continuing</p> </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="103" valign="top" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="103" valign="top" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Operations available to </p> </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="103" valign="top" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="21" valign="top" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="103" valign="top" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Common stockholders (numerator)</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="103" valign="bottom" style='width:77.05pt;border:none;border-bottom:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(3,049,616)</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>$</p> </td> <td width="103" valign="bottom" style='width:77.05pt;border:none;border-bottom:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>(1,931,833)</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>&nbsp;</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;border:none;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;border:none;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>Weighted average number of </p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>common shares Outstanding </p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>used in loss per share during </p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> </tr> <tr align="left"> <td width="213" valign="top" style='width:159.95pt;padding:0in 5.4pt 0in 5.4pt'> <p style='margin:0in;margin-bottom:.0001pt;text-align:justify'>the Period (denominator)</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;border:none;border-bottom:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>4,330,565</p> </td> <td width="21" valign="bottom" style='width:15.8pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>&nbsp;</p> </td> <td width="103" valign="bottom" style='width:77.05pt;border:none;border-bottom:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt'> <p align="right" style='margin:0in;margin-bottom:.0001pt;text-align:right'>3,121,821</p> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TableTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TableTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6761736016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 1 - Summary of Significant Accounting Policies: Nature of Business (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationDateToChangeFormerLegalOrRegisteredName', window );">Entity Information, Date to Change Former Legal or Registered Name</a></td>
<td class="text">Sep. 13,  2010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">Framewaves, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryName', window );">Entity Incorporation, State Country Name</a></td>
<td class="text">Nevada<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State or Country Name where an entity is incorporated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationDateToChangeFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when Former Legal or Registered Name was changed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationDateToChangeFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6796138720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - Stockholders' Equity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Aug. 16, 2017</div></th>
<th class="th"><div>Aug. 08, 2017</div></th>
<th class="th"><div>Feb. 15, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Apr. 28, 2016</div></th>
<th class="th"><div>Mar. 17, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">4,577,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,153,801<span></span>
</td>
<td class="nump">3,133,789<span></span>
</td>
<td class="nump">3,133,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,229,710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">4,577,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,153,801<span></span>
</td>
<td class="nump">3,133,789<span></span>
</td>
<td class="nump">3,133,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,229,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,213<span></span>
</td>
<td class="nump">7,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.07<span></span>
</td>
<td class="nump">$ 2.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued</a></td>
<td class="num">$ (4,578)<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TimeReferenceAxis=fil_InJanuary2017Member', window );">In January, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Stock Issued During Period, Shares, Other</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fil_TimeReferenceAxis=fil_InFebruary2017Member', window );">In February, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Stock Issued During Period, Shares, Other</a></td>
<td class="nump">5,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TimeReferenceAxis=fil_InJanuary2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TimeReferenceAxis=fil_InJanuary2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fil_TimeReferenceAxis=fil_InFebruary2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fil_TimeReferenceAxis=fil_InFebruary2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6760492752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - Stockholders' Equity: Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</a></td>
<td class="nump">67.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</a></td>
<td class="nump">155.62%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</a></td>
<td class="nump">1.13%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</a></td>
<td class="nump">2.27%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786810000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 3 - Note Receivable (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CounterpartyNameAxis=fil_AguarPrecisionMachineLlcMember', window );">Jaguar Precision Machine, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableGrossNoncurrent', window );">Notes, Loans and Financing Receivable, Gross, Noncurrent</a></td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableGrossNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) more than one year from the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the debt. The debt also may contain provisions and related items including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among a myriad of other features and characteristics. This amount does not include amounts related to receivables held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableGrossNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CounterpartyNameAxis=fil_AguarPrecisionMachineLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CounterpartyNameAxis=fil_AguarPrecisionMachineLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6610025904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 4 - Notes Payable (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fil_Note1Member', window );">Note 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuanceDate1', window );">Debt Instrument, Issuance Date</a></td>
<td class="text">Oct. 17,  2016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt Instrument, Description</a></td>
<td class="text">Company entered into a Securities Purchase Agreement<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fil_Note2Member', window );">Note 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuanceDate1', window );">Debt Instrument, Issuance Date</a></td>
<td class="text">Oct. 17,  2016<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt Instrument, Description</a></td>
<td class="text">Company entered into a Registration Rights Agreement<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCollateral', window );">Debt Instrument, Collateral</a></td>
<td class="text">secured by the assets of the Company<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature', window );">Debt Instrument, Convertible, Terms of Conversion Feature</a></td>
<td class="text">convertible into shares of Common Stock<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discussion of whether the debt instrument is secured or unsecured, and, if secured, a description of the collateral and guarantees required or provided.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the conversion terms of a debt instrument which may include the conversion ratio (including all potential conversion ratios if contingently adjustable), type of debt or equity security into which the debt is convertible, the dollars of debt or the number of shares into which the instrument is convertible (or potentially convertible into), the conversion period, any contingencies associated with the conversion terms, and the existence and amount of a beneficial conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21521-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21506-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84159872&amp;loc=d3e21475-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIssuanceDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the debt instrument was issued, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIssuanceDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fil_Note1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fil_Note1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fil_Note2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fil_Note2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6635726784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 6 - Loss Per Share: Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">LOSS BEFORE PROVISION FOR INCOME TAXES</a></td>
<td class="num">$ (1,116,910)<span></span>
</td>
<td class="num">$ (719,320)<span></span>
</td>
<td class="num">$ (3,049,616)<span></span>
</td>
<td class="num">$ (1,931,833)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted-average common shares outstanding</a></td>
<td class="nump">4,574,460<span></span>
</td>
<td class="nump">3,129,675<span></span>
</td>
<td class="nump">4,330,565<span></span>
</td>
<td class="nump">3,121,821<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786089536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 7 - Subsequent Events (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2017</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=fil_Event1Member', window );">Event 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsDate', window );">Subsequent Event, Date</a></td>
<td class="text">Oct.  06,  2017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventDescription', window );">Subsequent Event, Description</a></td>
<td class="text">Company issued to the Underwriter a total of 141,000 shares of the Company&#146;s common stock in exchange for the surrender by the Underwriter of its Unit Purchase Option<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=fil_Event2Member', window );">Event 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsDate', window );">Subsequent Event, Date</a></td>
<td class="text">Oct. 13,  2017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventDescription', window );">Subsequent Event, Description</a></td>
<td class="text">Company granted two employees five-year options to purchase an aggregate of 20,000 shares of common stock<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the event occurred after the balance sheet date but before financial statements are issues or available to be issued, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=fil_Event1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=fil_Event1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=fil_Event2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=fil_Event2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>41
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M/_RNPBX8N[?_V/@B*#OX=1?R"U!+ P04    " "6A&Y+F5R<(Q &  "<)P
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MP9_--&:3X;"??Q!;OG'Q&U!+ P04    " "6A&Y+-94'\[0!  #2 P  &
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MOFSL?V6,!TQE<X4CU. 'FPT)E0_'&SS;<<Q&PYMN^D%L_L;Y!U!+ P04
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MT6.+2M4IT*XSFEBH<_J8'(YIP$? MPY&M[))Z.1LS%MP/E8YW86"0$+I@X+
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M_ >;# &5"\>]/YMAS ;#Z7;\063ZQOE?4$L#!!0    ( ):$;DOE9K0*M $
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M$FH7S$=OFW'-1L=A-[T@-C_CX@]02P,$%     @ EH1N2S-9+:FT 0  T@,
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MZVV3UBPY3O?3"R+S,R[_ E!+ P04    " "6A&Y+S8H;([(!  #2 P  &0
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MJ(S;'NQ>3>-A"HSLY\E'E_&;_P%02P,$%     @ EH1N2VO:MB^< 0  70,
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MX)#3*'IK R!E<8>G.>!=7QP%?8CF#FV73SP[P8[S96;+BVK^ 5!+ P04
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M$ST774OL%HHW?;<'PR\G_PM02P,$%     @ EH1N2W:X9"+H 0  0 4  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C<N>&ULC51M;YLP$/XKB!]0$Y,$%@%2
MTZK:I$V*.JW[[)#C1;4QLTWH_OW\0AE+G*E?L._\//?<G?%E(Q>OL@%0P1NC
MG<S#1JE^AY L&V!$WO$>.GU2<<&(TJ:HD>P%D),E,8IP%&T1(VT7%IGU'421
M\4'1MH.#".3 &!&_]T#YF(>K\-WQW-:-,@Y49#VIX3NH'_U!: O-44XM@TZV
MO L$5'EXO]KM4X.W@)<61KG8!Z:2(^>OQOARRL/() 042F4B$+V<X0$H-8%T
M&K^FF.$L:8C+_7OT)UN[KN5()#QP^K,]J28/TS X044&JI[Y^!FF>C9A,!7_
M%<Y -=QDHC5*3J7]!N4@%6=3%)T*(V]N;3N[CNXD3B::GX G IX)J=5!3LAF
M_D@4*3+!QT"XWO?$7/%JAW5O2N.TK;!G.GFIO><"XR1#9Q-HPNP=!B\PJQF!
M=/19 OLD]OB*COWTV)MA[#)T*7;_DU][^6O+7_]387I1H0_SR2^R\8ILK@/$
MT86(#W.CDJU79'O=B1N=3+S\Y .=\&#B&R*I5R3]0"=\F/A"!"W^8 :BMF]7
M!B4?.CLW%MYY/-QC^P+^PMUL^49$W78R.'*EWY']VRO.%>A4HCM]*XT>9[-!
MH5)FF^B]<(_:&8KWT[Q"\] L_@!02P,$%     @ EH1N2W=%U7!K'   <W(
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M?-'S*'G<4M017WJ'2 32+F9/\"9.',:[1G/ QHQ]X #GSK=(YN''J*!06GM
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MEBF"4,S!+"A8C2^Q,/ F6TM?_>4[L"0(IOKN)Z%7^_-_#P\&/[Q@27$M21O
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MP3[&@*NOXPFD/+X:*&  B*]Q+#(GRVZA2;"$X 4XI<HD@Y6"V;1CK.7,0 )
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MD7=R>.(=[QW CJF> PHS/Z!WZ(U&)][1< #J.,LW#=Z1<] 88(K^6>C8 ]D
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M7)/7ZJNB;%J+=%5S[CV@F'$QL:RL4BA,N^-C(S+P$ AL#UL>@61@3PE@K;R
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MTTR*_GS/L0-,=<(!+0F+\!5A=*ZHS<H(IVSMX- "B612(6TNEE$76*1\<.'
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M-]-G8Q^7QCRRWW6EW2Q;>[^9Y+DKUE!+]\UL0(=O5L;6TH>/]B%W&PNR=&L
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M5TU5G85MU_K2R/8I21QC_X#G] ]02P,$%     @ EH1N2^+-MX%< 0  9A$
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MZ=!O$3,<GP[A,/4GPMS\5ME_ U!+ P04    " "6A&Y+QSRIOW\!   Y$@
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M 5!+ 0(4 Q0    ( ):$;DL?(\\#P    !,"   +              "  0
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( ):$;DMF\PM@@@   +$    0
M          "  >D   !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ EH1N
M2T?HK*3N    *P(  !$              ( !F0$  &1O8U!R;W!S+V-O<F4N
M>&UL4$L! A0#%     @ EH1N2YE<G",0!@  G"<  !,              ( !
MM@(  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "6A&Y+AO[G./T"
M  " #   &               @ 'W"   >&PO=V]R:W-H965T<R]S:&5E=#$N
M>&UL4$L! A0#%     @ EH1N2R$>T%8"!   '!(  !@              ( !
M*@P  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( ):$;DM*
MNR:89P(  *4(   8              "  6(0  !X;"]W;W)K<VAE971S+W-H
M965T,RYX;6Q02P$"% ,4    " "6A&Y+:LV.WH0$  ##%   &
M    @ '_$@  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @
MEH1N2Y&]*N"F!   1Q8  !@              ( !N1<  'AL+W=O<FMS:&5E
M=',O<VAE970U+GAM;%!+ 0(4 Q0    ( ):$;DN'WK/3M $  -(#   8
M          "  94<  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4
M    " "6A&Y+WY\_MK,!  #2 P  &               @ %_'@  >&PO=V]R
M:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ EH1N2S65!_.T 0  T@,
M !@              ( !:"   'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+
M 0(4 Q0    ( ):$;DMY1C:CM $  -(#   8              "  5(B  !X
M;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " "6A&Y+FF4D!K,!
M  #2 P  &0              @ $\)   >&PO=V]R:W-H965T<R]S:&5E=#$P
M+GAM;%!+ 0(4 Q0    ( ):$;DN;(ZP9LP$  -(#   9              "
M 28F  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ EH1N
M2S"5/,JT 0  T@,  !D              ( !$"@  'AL+W=O<FMS:&5E=',O
M<VAE970Q,BYX;6Q02P$"% ,4    " "6A&Y+[3M99;0!  #2 P  &0
M        @ '[*0  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0
M   ( ):$;DN#0;":M $  -(#   9              "  >8K  !X;"]W;W)K
M<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ EH1N2PZ#LU>U 0  T@,
M !D              ( !T2T  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q0
M2P$"% ,4    " "6A&Y+-05LP;8!  #2 P  &0              @ &]+P
M>&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( ):$;DOE9K0*
MM $  -(#   9              "  :HQ  !X;"]W;W)K<VAE971S+W-H965T
M,3<N>&UL4$L! A0#%     @ EH1N2S-9+:FT 0  T@,  !D
M ( !E3,  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " "6
MA&Y+S8H;([(!  #2 P  &0              @ & -0  >&PO=V]R:W-H965T
M<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( ):$;DL7>.HPLP$  -(#   9
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M970R-"YX;6Q02P$"% ,4    " "6A&Y++-6@Q24"  #D!@  &0
M    @ 'Q0@  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    (
M ):$;DNM7Y2R10(  'X&   9              "  4U%  !X;"]W;W)K<VAE
M971S+W-H965T,C8N>&UL4$L! A0#%     @ EH1N2W:X9"+H 0  0 4  !D
M             ( !R4<  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"
M% ,4    " "6A&Y+=T75<&L<  !S<@  %               @ 'H20  >&PO
M<VAA<F5D4W1R:6YG<RYX;6Q02P$"% ,4    " "6A&Y+RS$P!6("  "!#
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:+GAM;%!+!08     )  D *X)   9;P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.8.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>22</ContextCount>
  <ElementCount>138</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>7</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000020 - Statement - Condensed Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_CondensedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>000030 - Statement - Condensed Balance Sheets (Unaudited) - Parenthetical</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_CondensedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Condensed Balance Sheets (Unaudited) - Parenthetical</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>000040 - Statement - Condensed Statement of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_CondensedStatementOfOperationsUnaudited</Role>
      <ShortName>Condensed Statement of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>000050 - Statement - Condensed Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_CondensedStatementsOfCashFlowsUnaudited</Role>
      <ShortName>Condensed Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>000060 - Disclosure - NOTE 1 - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>NOTE 1 - Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>000070 - Disclosure - NOTE 2 - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquity</Role>
      <ShortName>NOTE 2 - Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>000080 - Disclosure - NOTE 3 - Note Receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE3NoteReceivable</Role>
      <ShortName>NOTE 3 - Note Receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>000090 - Disclosure - NOTE 4 - Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE4NotesPayable</Role>
      <ShortName>NOTE 4 - Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>000100 - Disclosure - NOTE 5 - Continuing Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE5ContinuingOperations</Role>
      <ShortName>NOTE 5 - Continuing Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>000110 - Disclosure - NOTE 6 - Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShare</Role>
      <ShortName>NOTE 6 - Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>000120 - Disclosure - NOTE 7 - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE7SubsequentEvents</Role>
      <ShortName>NOTE 7 - Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>000130 - Disclosure - NOTE 1 - Summary of Significant Accounting Policies: Nature of Business (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessPolicies</Role>
      <ShortName>NOTE 1 - Summary of Significant Accounting Policies: Nature of Business (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>13</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>000140 - Disclosure - NOTE 1 - Summary of Significant Accounting Policies: Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesBasisOfPresentationPolicies</Role>
      <ShortName>NOTE 1 - Summary of Significant Accounting Policies: Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>14</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>000150 - Disclosure - NOTE 1 - Summary of Significant Accounting Policies: Reclassification (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesReclassificationPolicies</Role>
      <ShortName>NOTE 1 - Summary of Significant Accounting Policies: Reclassification (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>000160 - Disclosure - NOTE 1 - Summary of Significant Accounting Policies: Loss Per Share (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesLossPerSharePolicies</Role>
      <ShortName>NOTE 1 - Summary of Significant Accounting Policies: Loss Per Share (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>000170 - Disclosure - NOTE 1 - Summary of Significant Accounting Policies: Recently Enacted Accounting Standards (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesRecentlyEnactedAccountingStandardsPolicies</Role>
      <ShortName>NOTE 1 - Summary of Significant Accounting Policies: Recently Enacted Accounting Standards (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>000180 - Disclosure - NOTE 1 - Summary of Significant Accounting Policies: Accounting Estimates (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesAccountingEstimatesPolicies</Role>
      <ShortName>NOTE 1 - Summary of Significant Accounting Policies: Accounting Estimates (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>000190 - Disclosure - NOTE 2 - Stockholders' Equity: Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesTables</Role>
      <ShortName>NOTE 2 - Stockholders' Equity: Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>000200 - Disclosure - NOTE 6 - Loss Per Share: Schedule of Earnings Per Share, Basic and Diluted (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedTables</Role>
      <ShortName>NOTE 6 - Loss Per Share: Schedule of Earnings Per Share, Basic and Diluted (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>000210 - Disclosure - NOTE 1 - Summary of Significant Accounting Policies: Nature of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessDetails</Role>
      <ShortName>NOTE 1 - Summary of Significant Accounting Policies: Nature of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE1SummaryOfSignificantAccountingPoliciesNatureOfBusinessPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>000220 - Disclosure - NOTE 2 - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityDetails</Role>
      <ShortName>NOTE 2 - Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesTables</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>000230 - Disclosure - NOTE 2 - Stockholders' Equity: Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesDetails</Role>
      <ShortName>NOTE 2 - Stockholders' Equity: Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE2StockholdersEquityFairValueMeasurementsRecurringAndNonrecurringValuationTechniquesTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>000240 - Disclosure - NOTE 3 - Note Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE3NoteReceivableDetails</Role>
      <ShortName>NOTE 3 - Note Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE3NoteReceivable</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>000250 - Disclosure - NOTE 4 - Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE4NotesPayableDetails</Role>
      <ShortName>NOTE 4 - Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE4NotesPayable</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>000260 - Disclosure - NOTE 6 - Loss Per Share: Schedule of Earnings Per Share, Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedDetails</Role>
      <ShortName>NOTE 6 - Loss Per Share: Schedule of Earnings Per Share, Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE6LossPerShareScheduleOfEarningsPerShareBasicAndDilutedTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="sglb-20170930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>000270 - Disclosure - NOTE 7 - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE7SubsequentEventsDetails</Role>
      <ShortName>NOTE 7 - Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sigmalabs.com/20170930/role/idr_DisclosureNOTE7SubsequentEvents</ParentRole>
      <Position>27</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>sglb-20170930.xml</File>
    <File>sglb-20170930.xsd</File>
    <File>sglb-20170930_cal.xml</File>
    <File>sglb-20170930_def.xml</File>
    <File>sglb-20170930_lab.xml</File>
    <File>sglb-20170930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2017-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2014-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>47
<FILENAME>0001078782-17-001585-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001078782-17-001585-xbrl.zip
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M[<OQ-29/T!!)7GV;N=);$Q]S,,CH9"DY;_=M86SG1B&Y^?'O?\9^] YSS5C
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MHC<!5OCR_4%*9#(B+AX?_OK_ 5!+ P04    " "6A&Y+<Q27OND'   Z10
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M'1)MV]GWY'O]C_X?6]^__#]02P,$%     @ EH1N2_C.4C$C"@  N)   !4
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M0:BA;KU:'?3EH=AY*'0# E[@=G0FTKN0RZHC1,H$87#H5 +SSL4\ PSQ8'M
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M;?B $6&<:&(9Q!0VJ()*9RCZ@]&E[]SZ@9_Z-+EBJF[CF %> *+FME@(227
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MII,E&ORR6B*N;V>_2W8$FS&%,P>#+5O.%@^Y<T%R3M=13'>^9329/K%M.AL
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M9G Y/7)F*+595^E:YC3+A?ZXDIDUV::<Q4P(D8_<E^M]%# R ?A1]IOT52Z
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M4F&+\K5(C-:]OK4U=7BOV?;:\;W"/RI_YQR''C^C28M==R1FOE9O&QV0#X_
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M=KJ%?#T%_2Q!!7=Y!1:60*N%+>JIG_2&IKM+&SQLGS46.JK^%>.>UL %ZY)
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MU];7\OG1HO!^(0(667%MY4SLN1+GDO!AJ]CLPZN1WP&E@)/"L]L=I \H@&Q
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MMJ5OZ^D>-/^M$;D_:QAJ2GJ\F%&ZX.CEA5"-<DXYK;?YHD)":ZO=<YGC[F)
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M_$'\(XZ#^.7K_P=02P$"% ,4    " "6A&Y+HC5;1U0U   %TP$ $0
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64$L%!@     &  8 B@$  %R0      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
